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Abstract 
The bacterial cell wall surrounds the cytoplasmic membrane and protects the cell 
against osmolysis in addition to providing shape. The cell wall is comprised of 
peptidoglycan, repeating units of N-acetly glucosamine and N-acetyl muramic acid 
form glycan strands and are crosslinked by short peptides that contain both L- and      
D-amino acids. Owing to the unique nature of peptidoglycan, and its absence in 
eukaryotic organisms, the cell wall has become an important target for many 
antibiotics, including the β-lactams and glycopeptides. 
Newly synthesised peptidoglycan contains pentapeptides, which extend from the lactyl 
moiety of the MurNAc sugar. These chains consist of L-alanine-D-γ-
glutamate/glutamine-L-lysine/meso-diaminopimelic acid-D-alanine-D-alanine. The 
terminal D-alanine is often lost during cell wall maturation, either as a result of the 
crosslinking reaction, in which the penultimate D-alanine is attached to the side-chain 
of a neighbouring L-lysine or meso-diaminopimelic acid by an isopeptide bond, or as a 
consequence of the activities of DD-carboxypeptidases, and results in a tetrapeptide. 
The tetrapeptide can then be trimmed further to form a tripeptide by the action of            
LD-carboxypeptidases. Although many DD-carboxypeptidases have been well 
characterised, the majority of LD-carboxypeptidases that have been studied are active 
only against peptidoglycan fragments and so cannot be responsible for producing the 
tripeptides found in the cell wall. Of the LD-carboxypeptidases active against the 
mature cell wall, DacB (Streptococcus pneumoniae), Csd6 (Helicobacter pylori) and 
Pgp2 (Campylobacter jejuni), each has been shown to be essential in maintaining cell 
morphology. It should be noted, however, that neither Csd6 nor Pgp2 share any 
sequence similarity with DacB and belong to different peptidase families. 
This thesis concerns the structural and biochemical characterisation of DacB, herein 
renamed to LdcB (LD-carboxypeptidase B). The crystal structures of the apo form of 
LdcB from both S. pneumoniae and Bacillus subtilis were solved, revealing a single 
domain, globular protein with 2 sub-domains forming a V-shaped cleft in which the 
active site is located. LdcB binds one zinc ion per monomer, located at the bottom of 
the active site, and is a member of the LAS (lysostaphin, D-Ala-D-Ala peptidases, sonic 
hedgehog) family of metalloproteins. Additionally, the activity of LdcB as an LD-
carboxypeptidase was confirmed and the crystal structure of LdcB from S. pneumoniae 
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was solved in complex with a product mimic, M-Tri-Lys(D-Asn), revealing the molecular 
basis for peptidoglycan recognition in this family of enzymes. Finally, the affinity of 
LdcB for zinc and copper has been determined and it has been shown that catalysis is 
not inhibited by the substitution of zinc by copper or cobalt.  
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1.1 The bacterial cell envelope  
1.1.1 Overview 
Bacteria can be broadly separated into two groups based upon the configuration of 
their cellular envelope, the Gram-negatives and the Gram-positives. The cellular 
envelope of Gram-negative bacteria comprises a thin coat of peptidoglycan, one or 
two layers thick, sandwiched between two membranes, the inner phospholipid bilayer 
and the outer lipopolysaccharide (LPS) layer (Figure 1.1) (Koch, 2003). The outer 
membrane provides bacteria with resistance to toxic molecules, provides an anchor for 
extracellular proteins and is the reason that these organisms are classed as           
Gram-negative, as the outer membrane prevents crystal violet, the Gram stain, from 
binding to the bacterial cell wall.   
Gram-positive bacteria, on the other hand, lack an outer membrane and the 
protection against external stresses it provides (Koch, 2003). In compensation,     
Gram-positive bacteria have a peptidoglycan coat that is much thicker than that of the 
Gram-negatives (Figure 1.1) (Shockman and Barrett, 1983). This thick wall is 
sufficiently strong to withstand the turgor of the cell, which in Gram-positive 
organisms can be higher than 20 atmospheres (Mitchell and Moyle, 1957), and 
provides the bacteria with a scaffold onto which additional components may be built. 
These additional components include various proteins, a capsule/surface layer (S-layer) 
and anionic polymers, i.e. the wall teichoic acids (WTA) (Schäffer and Messner, 2005).  
 
 
Figure 1.1: Schematic representation of the Gram-negative (left) and Gram-positive (right) cell envelopes. 
Lipopolysaccharides, membrane associated proteins and anionic polymers are not included in the respective cell 
envelops for clarity. 
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1.1.2 The cell envelope as a drug target 
The cell envelopes of Gram-positive and Gram-negative bacteria protect from stresses 
that would otherwise cause lysis, such as osmotic shock. As such the disruption of the 
cell envelope has been seen as an ideal method of dealing with bacterial infection, 
initially by nature and later by man. For example, the first antibiotic used, penicillin, 
was discovered by Fleming in 1929 as the product of the fungus Penicillium 
chrysogenum (previously Penicillium notatum) (Fleming, 1929). Penicillin was shown, 
though the use of 14C-labelling, to function by preventing the peptide crosslinking of 
peptidoglycan that is an essential facet of the architecture of the cell wall            
(Yocum et al., 1980). Since the time of Fleming, penicillin has been adapted artificially 
to increase its effectiveness; ampicillin, for example, is a derivative that contains an 
amino group, aiding its penetration of the outer membrane of Gram-negative bacteria. 
In addition, a number of other drugs with varying modes of action, from the 
glycopeptides that also target the peptide crosslinks of peptidoglycan, to cationic 
peptides, such as polymyxin B, that target and disrupt the outer membrane of        
Gram-negative bacteria, have been introduced as potent antibiotics                
(Ainsworth et al., 1947; Hirsch et al., 1960; Nagarajan, 1991). Despite this, the overuse 
of antibiotics in general, and those that target the bacterial cell wall in particular, has 
resulted in the emergence of antibiotic resistant strains that either possess enzymes 
that are capable of degrading antibiotics (i.e. β-lactamases), or proteins/components 
that have a much lower affinity for the commonly used antibiotics (i.e. vancomycin-
resistance strains) (Arthur et al., 1996; Paterson and Bonomo, 2005). Furthermore, in 
the same time period, there has been a decline in the number of new antibiotics 
reaching the market for several reasons, ranging from inadequate screening 
techniques (Boucher et al., 2009) to a cynical preference within the pharmaceutical 
industry to concentrate on other aspects of human health (e.g. expensive cancer 
treatments, life-long remedies for, for instance, impotence) rather than the rather 
short-term treatments that often have a low profit margin, such as those required to 
treat bacterial infection (Hadley, 2004). However, it is clear that the development of 
new antibiotics is crucial, something that has recently been recognised by not only the 
UK research councils, which have pledged to form a “war council” to address the issue, 
and the Chief Medical Officer of the UK, Professor Dame Sally Davies, but by the British 
public, who have voted for antibiotic resistance to be topic of the Longitudinal prize, 
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which offers a £10 million reward to whomever can provide a solution to antibiotic 
resistance. The cell wall remains an attractive target for drug discovery because it 
avoids the need for any drug to enter and remain in the bacterial cell, and thus if the 
cell wall is to be targeted, a detailed understanding of its synthesis and maturation is 
required. 
1.2 Gram-positive cell wall structure 
1.2.1 Peptidoglycan 
Peptidoglycan is often termed the primary cell wall polymer, and it is found in the cell 
walls of both Gram-positive and Gram-negative bacteria. The three main roles of 
peptidoglycan are (i) to act as a physical barrier to withstand the turgor of the cell, (ii) 
to form a molecular mesh to control import and export and (iii) to produce a scaffold 
to which other components can be attached (Schneewind and Missiakas, 2012). 
Additional components are required for the assembly of a fully-functional cell wall, for 
instance the outer membrane of Gram-negative bacteria and the anionic polymers of 
Gram-positive bacteria (Koch, 2003; Shockman & Barrett, 1983).  
The composition of peptidoglycan in Gram-positive bacteria is quite well characterised; 
Salton and Pavlik (1960) used lysozyme treatment followed by acid hydrolysis and 
paper chromatography to confirm the presence of N-acetylglucosamine (GlcNAc) and 
N-acetylmuramic acid (MurNAc) in a range of Gram-positive organisms (Salton and 
Pavlik, 1960). Repeating units of GlcNAc-MurNAc, which are linked by β1-4 glycosidic 
bonds, have been shown by atomic force microscopy to form “cables” that run parallel 
to the cytoplasmic membrane, forming helices around the short axis of the cell 
(Hayhurst et al., 2008). The digestion of the cell walls of many bacteria by lysozyme, 
which cleaves the β1-4 glycosidic bonds in the glycan chains, followed by HPLC 
separation of the products and mass spectrometry has shown that the glycan chains 
are crosslinked through short stem peptides present on MurNAc to form a net-like 
structure (Atrih et al., 1999). In most Gram-positive bacteria, the peptide stem consists 
of L-Ala-D-γ-Glu/Gln-L-Lys-D-Ala-D-Ala (Figure 1.2), with the notable exception of the 
Bacilli, in which the L-Lysine at position three is replaced by meso-diaminopimelic acid 
(meso-DAP), which is often amidated (Figure 1.2, overleaf) (Vollmer et al., 2008a). 
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Figure 1.2: Chemical schematic of the cell wall stem pentapeptide. The lysine containing stem pentapeptide can be 
seen in the top panel, whilst an amidated, meso-DAP containing stem pentapeptide is observed in the lower panel. 
This figure was produced using ChemBioDraw v14.0.0.117 (PerkinElmer).  
 
In general, crosslinks between peptide stems are formed between the carboxyl group 
of the residue at position 4 on one strand and the ε-amino group on the side-chain of 
the amino acid at position three on a neighbouring chain, i.e. D-Alanine is linked to      
L-Lysine (or meso-DAP) in what is referred to as a 3-4 crosslink, though 3-3 and 2-4 
crosslinks are also known to occur in some bacteria (Figure 1.3, overleaf) (Mainardi et 
al., 2005; Vollmer et al., 2008a). Furthermore, various modifications can take place 
once peptidoglycan has been synthesised; the enzymes MurT and GatD have been 
shown, though the HPLC analysis of cell wall material in ΔmurT and ΔgatD strains, to 
catalyse the conversion of D-γ-glutamic acid to D-γ-glutamine in the stem peptide              
(Figueiredo et al., 2012), the importance of the which is underlined by the observation 
that genetically modified Staphylococcus aureus strains that are unable to amidate the 
peptide stem show decreased growth and increased susceptibility to both β-lactams 
and to lysozyme, a major component of the innate immune response (Figueiredo et al., 
2012). 
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Figure 1.3: Schematic representation of the crosslinks found within the bacterial cell wall. The left-most panel (A) 
shows the canonical 3-4 crosslink between L-Lys/meso-DAP and D-Ala. The centre panel (B) shows a 3-3 crosslink 
between D-Ala and a neighbouring D-Ala in two stem tripeptides. The right-most panel (C) shows a 2-4 crosslink 
between D-γ-Glu/Gln and D-Ala. 
 
1.2.2 Teichoic acids 
In addition to peptidoglycan, wall teichoic acids (WTA) comprise roughly 50% of the 
dry weight of the cell wall of Gram-positive bacteria (Neuhaus and Baddiley, 2003). 
One proposed function of WTA is to control cation homeostasis, helping to provide a 
pool of divalent cations for extracellular enzymes and controlling the porosity of the 
cell wall. Sedimentation studies have demonstrated that, under low ionic strength 
conditions, WTA adopts a rigid, rod-shaped form, resulting in charge-charge repulsion 
and increasing the porosity of the wall (Doyle et al., 1974; Neuhaus and Baddiley, 
2003). WTA is required for proper biofilm formation in Staphylococcus aureus; with 
bacteria that are unable to synthesise a component of the WTA, the D-alanyl esters, 
are unable to adhere to artificial surfaces such as glass or plastic, likely as a result of an 
increase in surface net-negative charge (Gross et al., 2001).  Furthermore, WTA is 
suggested to play a pivotal role in cell growth and division, with Bacillus subtilis cells 
losing their characteristic rod-shape when the enzymes responsible for the final 
attachment of WTA are depleted (Kawai et al., 2011), indicating that WTA is involved in 
the regulation of cell elongation in rod-shaped bacteria. 
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The chemical composition of WTA is known to vary from species to species, with two 
main WTA types having been identified from early paper chromatography studies in 
the staphylococci alone; WTA that contains poly-glycerol-phosphate and WTA that 
contains poly-ribitol-phosphate (Armstrong et al., 1959b). The structure of WTA was 
elucidated by Armstrong et al., (1959a), whereby the authors treated purified WTA 
with a variety of chemical compounds that were predicted to variably affect the 
components of WTA depending on where they were located on the polymer. For 
example, it was shown that periodate oxidation of WTA from B. subtilis, followed by 
sodium borohydride and acid hydrolysis, resulted in the formation of glycerol, not 
ethylene glycol as was predicted if glucose was present and attached to the ribitol 
moiety (Armstrong et al., 1959a). NMR studies have subsequently been used to 
confirm the structures of WTA predicted by the earlier chemical studies, with the 
chemical schematics of both poly-glycerol-phosphate and poly-ribitol-phosphates WTA 
shown in Figure 1.4. It has been demonstrated that WTA is attached to the 
peptidoglycan frame-work through a phosphodiester bond between the C6 hydroxyl of 
the MurNAc and the anomeric phosphate of the WTA linker unit (Poxton et al., 1978), 
with the family of enzymes responsible for catalysing this reaction having been 
identified by Kawai et al. (2011). 
 
 
Figure 1.4: The chemical structures of B. subtilis and S. aureus wall teichoic acid. Both types of WTA contain 
identical GlcNAc-ManNAc (N-acetyl mannosamine) linker units and have two glycerol phosphate moieties 
proceeding either a poly-glycerol of poly-ribitol tail. R represents sites of modification, such as the site of D-alanyl 
esterification. This figure was produced using ChemBioDraw v14.0.0.117 (PerkinElmer)  
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1.3 Peptidoglycan synthesis 
The biosynthesis of peptidoglycan begins in the cytoplasm of the cell with the 
synthesis of the soluble precursors UDP-GlcNAc and UDP-MurNAc-pentapeptide.       
UDP-GlcNAc is converted from glucosamine-6-phosphate in a two-step process 
catalysed by GlmM and GlmU in Mycobacterium tuberculosis, or by homologues in 
other bacteria (Mengin-Lecreulx and van Heijenoort, 1993; Jolly et al., 1999). Enzymes 
of the Mur family then catalyse the sequential steps required for the conversion of 
UDP-GlcNAc into UDP-MurNAc-pentapeptide. MurA, first identified by Strominger 
(1958) and biochemically characterised by Gunetileke and Anwar (1968), has been 
shown to catalyse the first reaction, transfering enolpyruvate from 
phosphoenolpyruvate (PEP) to UDP-GlcNAc to form UDP-GlcNAc-enolpyruvate. The 
next step involves the reduction of UDP-GlcNAc-enolpyruvate to UDP-MurNAc in a 
NADPH and FADH2 dependent manner by MurB, as shown by Benson et al. (1993) 
through the use of labelled 4R-[2H]NADPH in NMR experiments. Biochemical assays 
following the production of radiolabelled UDP-MurNAc-L-[14C]Ala by recombinant 
MurC have confirmed that it catalyses the first step of the stem pentapeptide 
production through the addition of L-alanine to UDP-MurNAc (Liger et al., 1995). 
Similar biochemical assays, also using radiolabelled substrates have shown that MurD, 
E and F function to sequentially add the remaining amino acids to the stem 
pentapeptide, with MurF adding the final D-Ala-D-Ala residues as a dipeptide (Ito and 
Strominger, 1973; Duncan et al., 1990; Pratviel-Sosa et al., 1991). 
The second stage of peptidoglycan synthesis takes place anchored to the cytoplasmic 
face of the plasma membrane; MraY has been shown to be capable of linking   
MurNAc-pentapeptide to undecaprenyl pyrophosphate (also known as bactoprenol), 
through the use of radiolabelled UDP-MurNAc-[14C]pentapeptide, to form 
undecaprenyl pyrophosphate-MurNAc-pentapeptide, or lipid I (Umbreit and 
Strominger, 1972). Analysis of the accumulation of the UDP-GlcNAc and              
undecaprenyl-pyrophosphate-MurNAc-pentapeptide peptidoglycan precursors in 
ΔmurG strains of E. coli suggested that MurG catalyses the transfer of GlcNAc onto 
lipid I to form Lipid II, which was confirmed in the same study through the use of in 
vitro transferase assays (Mengin-Lecreulx et al., 1991). The newly synthesised lipid II is 
then transferred out of the cell for incorporation into the cell wall, with the flippases 
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FtsW, MurJ, RodA and SpoVE capable of facilitating the movement of lipid II (Real et 
al., 2008; Mohammadi et al., 2011; Sieger et al., 2013). Interestingly, MurJ inactive E. 
coli mutants have recently been found to not accumulate the products of lipid II 
hydrolysis when exposed to ColM, a colicin that degrades lipid II (Sham et al., 2014), 
suggesting that MurJ acts as the primary lipid II flippase. This contradicts previous in 
vitro results implicating FtsW in this role, with the work by Sham et al., (2014) showing 
that the inactivation of FtsW does not perturb lipid II export, bringing into question the 
role of FtsW in lipid II export. The intraceullar synthesis and export of peptidoglycan is 
summarised in Figure 1.5. 
 
 
Figure 1.5: Schematic representation of peptidoglycan biosynthesis. The cytoplasmic steps of peptidoglycan 
synthesis are shown up to export of the Lipid II precursor by FtsW/RodA/SpoVE.  
 
1.4 Peptdoglycan incorporation 
Once on the outside of the cellular membrane, the newly synthesised muropeptide 
must be incorporated into the existing cell wall mass in a two-step process, 
glycosyltransfer (GT) followed by transpeptidation (TP). These reactions are mediated 
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primarily by a group of enzymes known as the high molecular weight (HMW) penicillin 
binding proteins (PBPs), which can be split into two groups based upon their activity. 
Class A PBPs possess a GTase domain in addition to their TPase domain, whilst class B 
PBPs possess only TPase activity, although they do possess an additional domain 
known as the ‘pedestal’ (Figure 1.6). It is thought that the pedestal domain positions 
the TPase domain away from the membrane and near to the peptidoglycan, although 
an allosteric site, 60 Å from the active site, has been located on the pedestal domain of 
PBP2A of S. aureus which causes a conformational change and opens the active site of 
the enzyme when muramic acid or peptidoglycan is bound, suggesting a possible 
regulatory role for the pedestal domain (Sauvage et al., 2008; Otero et al., 2013). In 
addition, non-PBP monofunctional glycosyltransferases (MGTs) are known to exist that 
can perform the glycosyltransferase reaction independently of the PBPs (Di Berardino 
et al., 1996; Spratt et al., 1996).  
 
 
Figure 1.6: The crystal structures of a class A PBP (top) vs. a class B PBP (bottom). The different domains of the 
PBPs are indicated; both classes possess a TPase domain. Class A PBPs also possess a GTase domain, whilst class B 
PBPs contain a ‘pedestal’ domain. The class A PBP is represented by PBP1b from E. coli (PDBid: 3VMA) (Sung et al., 
2009) whilst the class B PBP is PBP3, also from E. coli (PDBid: 4BJP) (Sauvage et al., 2014). The PBPs are shown as a 
cartoon ribbon with a transparent surface. The core RMSD between the TPase domains of the class A and class B 
PBPs is ~1.6 Å. 
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1.4.1 Glycosyltransfer 
The GT reaction inserts the new chain into the wall through the formation of a β1-4 
glycosidic bond between the C1 of a MurNAc sugar in the growing peptidoglycan chain 
and the 4-OH of a GlcNAc sugar in lipid II (Figure 1.7) (for a review on the structural 
details behind the GTase step see Lovering et al. (2008)). The reaction detaches the 
undecaprenyl pyrophosphate lipid from the MurNAc of the growing peptidoglycan 
chain, with the liberated undecaprenyl pyrophosphate being converted to 
undecaprenyl phosphate by UppP before being flipped back across the cytoplasmic 
membrane, by an as-of-yet unknown process, which may be catalysed by a protein or 
be facilitated by the lipid-nature of undecaprenyl phosphate, for use in further rounds 
of peptidoglycan, WTA or other cell envelope component biosynthesis                         
(Tatar et al., 2007). 
 
 
Figure 1.7: Schematic representation of peptidoglycan incorporation. Once on the external leaflet of the 
cytoplasmic membrane, the PBP enzymes perform the GTase reaction to link the new peptidoglycan monomer with 
the existing chain. This detaches the undecaprenyl pyrophosphate from the previously added monomer, allowing it 
to be recycled for further round of synthesis. The PBPs then link adjacent glycan strands together via the TPase 
reaction, here shown to form a 3-4 crosslink, linking a donor pentapeptide (which becomes a tetrapeptide as a 
consequence of the reaction) to an accepting tetrapeptide.  
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1.4.2 Transpeptidation 
Once peptidoglycan is incorporated into sugar backbone of the cell wall by the GT 
reaction, crosslinks are formed between stem peptides of adjacent cell wall 
muropeptides (Sauvage et al., 2008). In general, the TP reaction links the 4th amino 
acid of one peptide stem, known as the donor strand, to that of the 3rd amino acid of 
an adjacent peptide stem, or acceptor strand, to form a 3-4 crosslink                             
(Vollmer et al., 2008a). The mechanism of the transpeptidation reaction was initially 
investigated using class C PBPs, which hydrolyse the terminal D-alanine from the stem 
pentapeptide rather than transferring the acyl group of the reaction intermediate to 
an amino group (Rasmussen and Strominger, 1978). Penicillin was found to inhibit a    
B. subtilis carboxypeptidase by irreversibly binding to a serine residue present in the 
active site (Georgopapadakou et al., 1977), suggesting a role for this residue in 
catalysis. The role of the active site serine was substantiated by further studies utilising 
a radiolabelled depsipeptide substrate mimic, which permitted the identification of an 
acyl-enzyme intermediate (Rasmussen and Strominger, 1978). Subsequent 
crystallographic studies have confirmed the presence of acyl-enzyme complexes 
formed between PBPs and β-lactams (non-exhaustive list of PDBids: 3UPO, 3OCL, 
3OCN, 3UPN, 3ZG8). Taken together, these experiments allowed for the following 
reaction mechanism of transpeptidation to be proposed: (i) the peptidoglycan stem 
pentapeptide (Ala-D-γ-Glu/Gln-Lys/meso-DAP-D-Ala-D-Ala) is bound by the PBP; (ii) the 
active site serine of the PBP attacks the carbonyl carbon of the penultimate D-Ala 
residue, forming an acyl-enzyme intermediate and releasing the terminal D-Ala; (iii) 
the carboxyl carbon of the acyl-intermediate is then linked to the lysyl Nζ of the 
adjacent peptide stem to form an isopeptide bond (Scheffers and Pinho, 2005; Sauvage 
et al., 2008) (Figure 1.8, overleaf). In some species of bacteria, a poly-amino acid 
bridge, usually consisting of glycine, alanine, serine and/or aspartate/asparagine, is 
used to connect spatially distant peptide stems and allow for a highly crosslinked cell 
wall (Veiga et al., 2006; Vollmer et al., 2008a). When a poly-amino acid bridge is 
present, the 3rd step of the TP reaction links the carboxyl carbon of the D-Ala of the 
donor strand to the amino group of the last amino acid of the bridge, with the 1st 
amino acid of the bridge forming an isopeptide bond with the Nζ of the acceptor strand 
(Schneider et al., 2004; Vollmer et al., 2008a) (Figure 1.8, overleaf). The hydrolysis of 
the terminal D-Ala residue of the pentapeptide provides the energy required to form 
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the isopeptide bond, and hence shorter stem peptides, resulting from the action of 
DD-carboxypeptidases, are unable to act as donor strands for 3-4 crosslink formation 
(Scheffers and Pinho, 2005). The cleavage of the pentapeptide can therefore be used 
to regulate the amount of crosslinking present within the cell wall.  
Not all peptidoglycan that is incorporated into the cell wall becomes crosslinked. 
Depending on the method used, HPLC or size exclusion, separation of cell wall material 
of stationary-phase B. subtilis digested with cellosyl, a lysozyme that cleaves the sugar 
backbone of peptidoglycan whilst leaving crosslinks intact, revealed that between 30% 
and 40% of stem peptides are crosslinked (Atrih et al., 1999). The authors commented 
that the value obtained from HPLC analysis (33%) is likely the more accurate of the two 
due to difficulties in quantifying muropeptides separated by size exclusion. A similar 
study of S. pneumoniae, again using HPLC to separate digested cell wall components, 
suggested that 40% of stem peptides participate in crosslinking (Garcia-Bustos et al., 
1987). Both these values contrast drastically with the amount of crosslinking found in 
S. aureus, with various studies using HPLC to separate digested cell wall material 
suggesting that between 70-90% of stem peptides are crosslinked (Snowden and 
Perkins, 1990). The high percentage of crosslinked stem peptides found in S. aureus is 
suggested to result from a lack of carboxypeptidase activity in this organism, with the 
terminal D-Ala-D-Ala moiety being retained on all non-crosslinked stem peptides, 
allowing them to act as donor strands (Scheffers and Pinho, 2005). In B. subtilis,            
S. pneumoniae and other species, stem peptides that are not crosslinked during 
incorporation into the cell wall often have the terminal D-alanine residues removed by 
the action of DD- and LD-carboxypeptidases, with the major crosslinked species found 
in digested and HPLC separated B. subtilis 168 cell wall being tetrapeptide-tripeptide 
(Scheffers and Pinho, 2005; Vollmer et al., 2008b; Hoyland et al., 2014).  
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Figure 1.8: Chemical schematic of the cell wall crosslinks. (A) A direct 3-4 crosslink between a stem tripeptide and a 
stem tetrapeptide, both containing lysine. (B) A crosslink mediated by a peptide crossbridge consisting of D-alanine. 
This figure was produced using ChemBioDraw v14.0.0.117 (PerkinElmer). 
 
1.5 Localisation of the HMW PBPs 
1.5.1 Localisation patterns 
One function of the bacterial cell wall is to provide shape to the cell. Several cell 
morphologies have been documented, and it has been noted that some bacteria are 
pleomorphic and are able to alter their size and shape in response to environmental 
conditions. For example, Lactococcus lactis has been shown to differentiate into two 
populations when in a clinical biofilm, with cells at the base of the biofilm retaining the 
archetypical ovoid shape whilst those at the surface of the biofilm become rod-like, 
presumably to better exploit the different conditions of the biofilm (Perez-Nunez et al., 
2011). Additionally, filamentation in some bacterial species, such as E. coli, is thought 
to allow for better adhesion to a surface, as the surface area contact is increased 
dramatically (Jens et al., 2013). Thus, under normal circumstances, the cell wall is vital 
in providing a competitive advantage and ensuring the survival of the bacterial cell. As 
such, the synthesis of the cell wall must be linked to the bacterial cell cycle; the cell 
cannot grow without new peptidoglycan being synthesised, and new cell wall must be 
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deposited as cells divide to ensure a continuous cell wall surrounds both daughter 
cells. Consequently, it would be expected that the PBPs that incorporate new cell wall 
material would tend to localise to areas of growth and/or division (Scheffers and 
Pinho, 2005).  
In many rod-shaped bacteria, such as E. coli and B. subtilis, cells grow by the addition 
of peptidoglycan on the lateral axis, with division occurring at the mid-point of the cell 
(Figure 1.9, overleaf) (Scheffers and Pinho, 2005). PBPs would therefore be expected 
to localise to both sites to facilitate the incorporation of new peptidoglycan. This is 
indeed the case; functional GFP-fusions of the HMW PBPs not involved in sporulation 
in B. subtilis revealed distinct localisation patterns during vegetative growth (Scheffers 
et al., 2004). PBP1, PBP2c, PBP4 and PBP2b were found to localise to the septum, 
whilst PBP2a, PbpH, PBP3 and YrrR were found to localise either evenly along the 
membrane or as foci at the periphery of the cell (Scheffers et al., 2004). Interestingly, a 
fluorescence signal corresponding to GFP-labelled PBP1 was also observed along the 
cylinder of the cell, suggesting a dual role for this PBP (Scheffers et al., 2004). Indeed, 
PBP1 has since been shown to shuttle between the cylinder of the cell and the division 
site and is believed to be involved in the synthesis of peptidoglycan at both sites 
(Claessen et al., 2008). In E. coli, it has been shown that the deletion of PBP2 results in 
the appearance of spherical cells, linking the function of PBP2 to elongation. By 
contrast, mutation of PBP3 inhibited successful division at certain temperatures and 
produced filaments,  indicating that PBP3 is required for cell division (Spratt, 1975). 
PBP3 was later shown to localise specifically to the septum (Mercer and Weiss, 2002), 
further supporting its classification as a cell division PBP. Interestingly, in addition to 
localising in spot-like patterns along the entire bacterial cell, GFP-PBP2 was also found 
to localise to the septum, suggesting a possible bifunctional elongation and division 
role for this PBP (Den Blaauwen et al., 2003). Inhibiting PBP2 has been shown to 
eventually disrupt division (Vinella et al., 1993) because of the swelling of the cell, 
increasing its diameter and preventing the formation of the Z-ring, the multiprotein 
division complex that is required for division, rather than as a direct result of the 
absence of PBP2 from the septum (Vinella et al., 1993).  
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Figure 1.9: Schematic representation of the growth and division methods employed by rod-shape, spherical cocci 
and ovococci cells. In rod-shaped cells, elongation and division, although linked, occur independently. Spherical 
cocci grow through division only, with daughter cells ‘inflating’ after division into spheres. Ovococci experience a 
form of elongation known as peripheral growth, whereby they elongate during cell division, before the septum has 
fully closed. The septum is indicated by a red oval, with dotted arrows showing the movement of the cell wall.   
 
Unlike rod-shaped bacteria, spherical cocci such as Staphylococcus aureus only 
incorporate peptidoglycan at the division septum (Figure 1.9) (Scheffers and Pinho, 
2005). PBPs of Staphylococcus aureus would therefore be expected to localise only to 
the division septum, with the majority of the cell wall consisting of inert peptidoglycan 
from previous cell divisions. Indeed, PBP2, the only PBP of S. aureus that possesses 
both GT and TP activities (Scheffers and Pinho, 2005), has been shown, through the 
use of an N-terminally GFP tagged fusion integrated into the chromosome at the native 
PBP2 locus, to localise to the septum throughout division, being found along the entire 
septal disk following the closure of the septum (Pinho and Errington, 2005).  
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In addition to labelling the PBPs with fluorescent reporters (i.e. GFP), sites of 
peptidoglycan incorporation can be elucidated by labelling the nascent peptidoglycan 
with fluorescent molecules that interact with the D-Ala-D-Ala moiety of stem 
pentapeptides, such as fluorescently-labelled vancomycin, as the terminal D-Ala is lost 
from mature cell wall material as a result of the transpeptidation reaction or through 
the action of carboxypeptidases (Vollmer et al., 2008a; Vollmer et al., 2008b). 
Unfortunately, the lack of carboxypeptidase activity in the cell wall of S. aureus results 
in the D-Ala-D-Ala moiety remaining intact in old cell wall material, causing fluorescent 
vancomycin to stain uniformly (Lunde et al., 2010). Despite this, Lunde et al., (2010) 
labelled the site of nascent peptidoglycan incorporation in S. aureus by using 
telavancin, a fluorescent vancomycin derivative that binds preferentially to the             
D-Ala-D-Ala moiety of the lipid II precursor before it undergoes incorporation into the 
wall. Telavancin was found to stain exclusively at the septum, indicating that lipid II, 
and therefore peptidoglycan, incorporation occurs only at this site in S. aureus (Lunde 
et al., 2010).  
Besides spherical cocci, ovoid cocci (ovococci) are also found in Nature, as exemplified 
by Streptococcus pneumoniae. Whereas spherical cocci synthesise peptidoglycan only 
at the division septum, ovococci undergo a form of elongation known as peripheral 
growth (Figure 1.9, previous page) (Higgins and Shockman, 1970; Beilharz et al., 2012). 
These two distinct peptidoglycan insertion events are probably responsible for the 
characteristic ovoid shape from which the ovococci draw their name (Beilharz et al., 
2012). This form of growth was first confirmed by Higgins and Shockman (1970) in 
Streptococcus faecalis, although previous immunofluorescence work by Cole and Hahn 
(1962) had eluded to it. Higgins and Shockman (1970) fixed a mid-exponential culture 
of S. faecalis and examined the cells by electron microscopy following staining with 
uranyl acetate and lead citrate. They simulated a time-lapse sequence and determined 
that cell division was initiated by the formation of the septum at the equatorial ring, 
with septal cell wall synthesis occurring at the same time. However, Higgins and 
Shockman (1970) noted that the closure of the septum was halted prematurely and 
peptidoglycan was inserted at the periphery of the septum, elongating the new 
hemispheres of the soon-to-be daughter cells. Once elongation had produced new 
hemispheres of equal size to the old hemispheres, septal cell wall synthesis appeared 
to be resumed and division proceeded to completion (Higgins and Shockman, 1970; 
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Beilharz et al., 2012). As with rod-shaped bacteria, the presence of two distinct 
peptidoglycan incorporation events suggest that PBPs of S. pneumoniae localise as two 
groups; one localises to the septum and forms the septal cell wall, and another 
localises peripherally to the septum and synthesises the new hemispheres. 
Immunofluorescence studies using antibodies raised against the extracellular domains 
of the 5 HMW PBPs found in S. pneumoniae (PBP2x, PBP1a, PBP1b, PBP2a and PBP2b) 
revealed three distinct patterns of localisations at two sites (Morlot et al., 2003). 
PBP2x and PBP1a were found to localise at the septum whilst PBP2a and PBP2b 
localised to the peripheral zone of growth. PBP1b was found at both sites, although 
never at the two simultaneously (Morlot et al., 2003). Thus, in S. pneumoniae, two 
PBPs are utilised for elongation and two for division, with PBP1b capable of 
participating in either elongation or division.  
It is interesting to note that bacteria often also change shape during stationary growth, 
becoming smaller and rounder, likely resulting from a change in peptidoglycan 
metabolism (Nystrom, 2004). Recent studies have shown that this appears to directly 
relate to the amount of D-amino acids produced by the bacteria, with the deletion of 
bsrV, the gene encoding a non-specific racemase capable of catalysing the conversion 
of a range of L-amino acids into their D-isomers (Espaillat et al., 2014), causing a 
doubling in thickness of the cell wall (Lam et al., 2009). The D-amino acids, notably         
D-Met, D-Leu, D-Val, D-Ile, D-Phe and D-Tyr, have been shown by HPLC analysis of 
digested cell wall material to be incorporated into the cell wall and appear to provide 
stationary phase bacteria with resistance against osmolysis, suggesting that their 
incorporation increases the strength of the bacterial cell wall (Lam et al., 2009).  
In addition to being incorporated into the cell wall, the production of D-amino acids 
and their release into the environment appears to be utilised as a form of 
communication in some species; the addition of D-alanine to media containing Bacillus 
spores prevents their germination. This activity of D-alanine is in direct conflict with 
the addition of L-alanine, which stimulates germination (Cava et al., 2011). It is thought 
that, whilst the presence of L-alanine in growth media suggests an abundance of 
nutrients and thus is supportive of germination, the presence of D-alanine suggests 
conditions that have caused the lysis and breakdown of the bacterial cell, releasing D-
alanine from the cell wall (Cava et al., 2011). Furthermore, D-amino acids have been 
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shown to be capable of causing the breakup of B. subtilis biofilms, causing the 
detachment of amyloid fibers that hold the biofilm together (Kolodkin-Gal et al., 2010). 
Presumably the D-amino acids are again acting as messengers, indicating to the 
bacterial population that cell lysis is occurring and the environment is no longer able to 
support the biofilm.  
1.5.2 Determinants of localisation 
Historically, the HMW PBPs were thought to localise through protein-protein 
interactions, either with other PBPs or with cytoskeletal proteins that function to 
coordinate the cell cycle (Scheffers and Pinho, 2005). For example, PBP3 of E. coli, a 
monofunctional TPase, has been shown to localise to the septum during division 
through interactions with FtsW, a lipid II flippase, since PBP3 does not localise in FtsW-
depleted cells (Mercer and Weiss, 2002). Di Lallo et al., (2003) used a modified form of 
the bacterial two-hybrid screen, adapted to prevent non-specific hydrophobic 
interactions between membrane proteins, to demonstrate that FtsW interacted 
directly with PBP3 (Di Lallo et al., 2003), whilst Pastoret et al., (2004) and Derouaux et 
al., (2008) determined that the interaction occurred via the periplasmic loop located 
between transmembrane helices 9 and 10 (loop 9/10) on FtsW and the first 41 amino 
acids of PBP3 (Pastoret et al., 2004; Derouaux et al., 2008). In addition, monoclonal 
antibodies raised against the C-terminus of E. coli PBP1B have shown that the enzyme 
localises to the septum during cell division, with its localisation dependent on the 
presence of PBP3 (Bertsche et al., 2006). Bacterial two-hybrid studies have suggested a 
direct interaction between PBP1b and FtsW (Fraipont et al., 2011), however, PBP1b 
was not detected in the FtsW-PBP3 complex following a co-immunoprecipitation 
assay, although stable FtsW-PBP3 complexes were detected (Fraipont et al., 2011). 
While it is possible that the interaction between FtsW and PBP1b is transient or weak, 
it must also be considered that the interaction observed in the bacterial two-hybrid 
assay is due to the FtsW-PBP3 and PBP3-PBP1b interactions bringing PBP1b and FtsW 
into close enough proximity to allow the reporter, the two domains of Bordetella 
pertussis adenylate cyclase (Karimova et al., 1998), to interact and activate 
transcription of β-galactosidase.  
Despite the clear interactions between PBP3 and FtsW, PBP3 does not localise to the 
division septum when the cell is exposed to furazlocillin, a specific β-lactam inhibitor of 
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PBP3 that blocks transpeptidation and prevents it from interacting with peptidoglycan 
stem peptides, suggesting that PBP3’s ability to bind substrate is more important than 
its interaction with FtsW in determining correct localisation (Wang et al., 1998). 
Further evidence of substrate-dependent localisation of the PBPs can be found in a 
range of bacteria. In B. subtilis, functional GFP-fusions of PBP2a and PbpH, class B PBPs 
required for cell elongation (Wei et al., 2003), have recently been shown to be 
sequestered into patches along the lateral membrane when cells are exposed to nicin, 
a lantibiotic that sequesters lipid II away from its physiological location through 
interactions with the pyrophosphate moiety, indicating that the availability of nascent 
peptidoglycan determines their localisation (Lages et al., 2013).  
Substrate recognition has also been shown to affect HMW PBP localisation in                      
S. aureus; here, the β-lactam antibiotic oxacillin caused the delocalisation of PBP2 from 
the division septum, but did not affect other Z-ring proteins or lipid II localisation 
(Pinho and Errington, 2005). However, oxacillin-exposed PBP2 did localise to the 
septum in the presence of PBP2A, a β-lactam resistant PBP, suggesting a combination 
of protein-protein interactions and substrate recognition localise PBP2 in S. aureus 
(Pinho and Errington, 2005).  
1.6 Transpeptidation substrate availability is controlled by carboxypeptidases 
Carboxypeptidases are hydrolytic enzymes that cleave the C-terminal residue from 
peptides. In the context of the cell wall, this involves the cleavage of the stem peptide 
that is found on the MurNAc moiety (Vollmer et al., 2008b). The carboxypeptidases of 
the cell wall are a very diverse group of enzymes that contains members capable of 
cleaving progressively along the stem peptide; DD-carboxypeptidases cleave the 
terminal D-Ala from the stem pentapeptide, LD-carboxypeptidases remove the        
now-terminal D-Ala from the tetrapeptide and DL-carboxypeptidases and                    
LD-carboxypeptidases subsequently catalyse the formation of the dipeptide and 
monopeptide respectively (Vollmer et al., 2008b) (Figure 1.10). The final enzymes, 
which cleave the L-alanine from the MurNAc sugar, are known as muramidases rather 
than carboxypeptidases (Vollmer et al., 2008b) and will not be considered further.  
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Figure 1.10: Schematic showing the cleavage points of various cell wall carboxypeptidases. CPase = 
carboxypeptidase; DD = between two D-amino acids, LD = between the C-terminus of an L-amino acid, and the N-
terminus of a D-amino acid; DL =  between the C-terminus of a D-amino acid, and the N-terminus of an L-amino 
acid. 
 
The ability of carboxypeptidases to remove the terminal D-Ala-D-Ala moiety from 
peptidoglycan allows them to control substrate availability for transpeptidation, 
implicating them in controlling the localisation of the HMW PBPs and thus the 
morphology of the bacterial cell. Direct evidence of DD-carboxypeptidases controlling 
the availability of the transpeptidation substrate can be found in DacA, a low 
molecular weight (LMW) PBP from S. pneumoniae (Figure 1.11). 
 
 
Figure 1.11: The crystal structure of a DacA (PBP3) from S. pneumoniae, a class C PBP. DacA contains a DD-
carboxypeptidase (DD-CPase) domain, with a second domain similar to the pedestal domain of class B PBPs, likely 
positioning the PBP to be within close proximity of its substrate (Morlot et al., 2005). DacA is shown as an orange 
cartoon ribbon with transparent surface. 
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In wild-type cells, immunofluorescence studies demonstrated that DacA was found to 
localise over the entire surface of S. pneumoniae, with the exception of the equatorial 
division site (Morlot et al., 2004). Conversely, immunofluorescence was used to show 
that the HMW PBPs, PBP2x and PBP1a localised only to the Z-ring, the multicomponent 
division complex at the site of division, consistent with their role as division PBPs 
(Morlot et al., 2003). In agreement with the observed localisation patterns of DacA, 
PBP2x and PBP1a, staining of S. pneumoniae with fluorescent vancomycin 
demonstrated that the stem pentapeptide was located primarily at the division site 
(Morlot et al., 2004). Upon loss of DacA activity, the ordered localisation of PBP2x and 
PBP1a to the Z-ring was abolished, whilst other proteins that form the Z-ring were 
unaffected (Morlot et al., 2004). Severe morphological defects were also observed, 
with cells undergoing asymmetric division and becoming smaller and more spherical 
(Figure 1.12) (Schuster et al., 1990; Morlot et al., 2004; Barendt et al., 2011). Barendt 
et al., (2011) were unable to repeat the localisation pattern observed for DacA by 
Morlot et al., (2004), however, Barendt et al., (2011) used FLAG-tagged DacA in their 
immunofluorescence studies, rather than raising antibodies against DacA as did Morlot 
et al., (2004), raising the possibility of aberrant localisation of the FLAG-tagged protein 
or non-specific binding of the anti-FLAG antibody. Whilst these possibilities remain, the 
clear differences between the localisations observed by Morlot et al., (2004) and 
Barendt et al., (2011) will have to be reconciled if we are to fully understand the role of 
DacA in cell morphogenesis. 
 
 
Figure 1.12: Electron microscopy showing the morphologies of wild-type S. pneumoniae (A) and a ΔdacA strain 
(B), taken from Schuster et al., (1990). ΔdacA S. pneumoniae divide asymmetrically and produce mis-shapen, 
rounder cells of varying sizes. Arrows indicate division septa.  
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Several carboxypeptidases have been shown to be essential for maintaining cell 
morphology in the helical bacteria Helicobacter pylori and Campylobacter jejuni. 
Although HMW PBPs have been identified in both species, LMW PBPs that provide 
carboxypeptidase functionalities are surprisingly absent, and have been replaced by 
non-PBP carboxypeptidases. The first carboxypeptidase discovered to affect the 
morphology of H. pylori was Csd3/HdpA, which possesses both DD-carboxypeptidase 
and DD-endopeptidase activities and is a zinc metallopeptidase (Bonis et al., 2010). 
The physiological role of HdpA was elucidated by deletion studies, which 
demonstrated that ΔhdpA strains of H. pylori formed shorter, wider cells than the    
wild-type, with a proportion of the population forming a branched phenotype            
(Figure 1.13) (Bonis et al., 2010). When hdpA was placed under the control of an 
inducible promoter and overexpressed, HdpA resulted in cells becoming spherical, but 
were still able to divide as normal (Bonis et al., 2010). Peptidoglycan analysis of cells 
overexpressing HdpA revealed a decrease in the peptidoglycan pentapeptide content 
of the cell wall, confirmed by fluorescent vancomycin labelling of the pentapeptide in 
growing cells (Bonis et al., 2010).  
 
 
Figure 1.13: Scanning electron microscopy pictures of N6 H. pylori (A) and ΔhdpA N6 H. pylori (B), taken from 
Bonis et al., (2010). The HdpA mutant shows a branched phenotype. 
 
Pgp2 (C. jejuni) and Csd6 (H. pylori) also contribute to cell shape maintenance; deletion 
of either caused helical-to-rod transitions (Sycuro et al., 2013; Frirdich et al., 2014). 
Sequence similarities suggested that these enzymes may be LD-transpeptidases, but 
Sycuro et al., (2013) noted that Costa et al. (1999) failed to identify LD-crosslinks in the 
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peptidoglycan of H. pylori and suggested that Csd6 is, instead, an LD-carboxypeptidase 
(Sycuro et al., 2013). The function of Csd6 was confirmed when the protein was 
purified from heterologous overexpression in E. coli and incubated with the 
peptidoglycan of a Δcsd1csd6 mutant of H. pylori. It was discovered that Csd6 was able 
to completely hydrolyse the uncrosslinked tetrapeptides present in the peptidoglycan, 
but was unable to cleave the terminal D-alanine from crosslinked stem tetrapeptides 
(Sycuro et al., 2013). Unlike the loss of the pentapeptide through DD-carboxypeptidase 
activity, which prevents crosslink formation as only the pentapeptide can act as a 
donor in the transpeptidation reaction, it was not immediately apparent why the loss 
of the tetrapeptide would so drastically affect the morphology of the cell as both the 
stem tetrapeptide and the tripeptide could still act as acceptors for the TP reaction. 
Thus a decrease in the amount of either the tetrapeptide or tripeptide content of the 
cell, together with an increase in the amount of the other should not affect the cell in 
any meaningful way (Sycuro et al., 2013). A similar study of Pgp2 revealed the same 
results (Frirdich et al., 2014), allowing both proteins to be classified as                             
LD-carboxypeptidases. 
 1.7 Other carboxypeptidase functions 
In addition to controlling the availability of the D-Ala-D-Ala moiety, and thereby 
controlling the localisation of the HMW PBPs, carboxypeptidases perform a number of 
other functions within the bacterial cell, being required for the recycling of 
peptidoglycan, for instance, and in the resistance against antibacterial agents. 
1.7.1 Peptidoglycan recycling 
Although peptidoglycan is often considered a static structure, the cell wall is constantly 
being degraded and re-synthesised, with a turnover rate of around 50% per generation 
in many species (Reith and Mayer, 2011). Radiolabelled meso-DAP has been used to 
demonstrate that only 6-8% of the cell wall material of E. coli is lost to the 
environment, despite the turnover of half the cell wall per generation (Goodell and 
Schwarz, 1985). The much greater mass of peptidoglycan in the cell wall of             
Gram-positive bacteria in comparison to Gram-negatives implies that is the former 
group must recycle the soluble products of peptidoglycan degradation or else face a 
significant loss of resource. Recently, a number of the genes required for recycling in   
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E. coli have been identified in Gram-positive organisms, however, several key enzymes 
required for turnover in E. coli have not been found in Gram-positives, including 
AmpG, required for the uptake of anhydromuropeptides (Reith and Mayer, 2011). 
Whilst it is not clear whether cell wall recycling systems or the chemical compositions 
of mature cell walls is the root of the genetic differences between the two bacterial 
classes, fractionation of the cell wall of B. subtilis by HPLC has revealed that 
anhydroMurNAc only makes up 0.4% of all muropeptides in this species and thus are 
likely not targeted for recycling, possibly explaining the absence of AmpG (Atrih et al., 
1999; Reith and Mayer, 2011).   
For peptidoglycan recycling to occur, the mature cell wall must first be degraded. This 
occurs by the action of a number of enzymes, including endopeptidases that cleave the 
peptide crosslinks and lytic transglycosylases that hydrolyse the β1-4 links of the glycan 
strands (Reith and Mayer, 2011; Lee et al., 2013). The predominant form of 
muropeptide found in the cell wall of E. coli following digestion with a muramidase 
from Chalaropsis sp. and separation via HPLC was determined to be                      
GlcNAc-MurNAc-tetrapeptide or crosslinked tetrapeptide-tetrapeptide (Glauner et al., 
1988). Once inside the cytoplasm, the GlcNAc-MurNAc-tetrapeptide is degraded 
further by the actions of amidases to produce GlcNAc, MurNAc and the tetrapeptide 
(Jacobs et al., 1995; Votsch and Templin, 2000; Reith and Mayer, 2011). The 
importance of hydrolysing the tetrapeptide to produce the tripeptide in the next step 
of the pathway has been highlighted by work by Templin et al. (1999). Deletion studies 
of LdcA, an LD-carboxypeptidase and member of the S66, clan SS family of 
carboxypeptidases (Templin et al., 1999; Korza and Bochtler, 2005; Das et al., 2013), 
resulted in cells that lysed soon after entering the stationary phase. Digestion of the 
sacculi of these cells by a muramidase and analysis by HPLC revealed that the cells lost 
the majority of their stem pentapeptides and 3-4 crosslinks, dramatically reducing the 
amount of crosslinks present within the cell (Templin et al., 1999). This reduction of 
crosslinking was suggested by Templin et al., (1999) to be due to the inability of the 
cell to add a single D-alanine to the tetrapeptide to produce the pentapeptide, which is 
required to act as a donor in the formation of crosslinks. Although LdcA is found in       
B. subtilis and other Gram-positives (Reith and Mayer, 2011), its importance has yet to 
be demonstrated, as the majority of muropeptides found in the cell wall of B. subtilis 
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were determined by HPLC to be tripeptides (Atrih et al., 1999), and thus can be 
recycled and used directly in peptidoglycan biosynthesis.  
Of all the LD-carboxypeptidases studied to-date, LdcA is perhaps the best 
characterised. LdcA has been shown to be specific for the meso-DAP-D-Ala                  
(or L-Lys-D-Ala) peptide bond, but only in soluble peptidoglycan fragments; the 
enzyme was apparently inactive against mature peptidoglycan (Templin et al., 1999; 
Baum et al., 2005), consistent with its role in peptidoglycan recycling and localisation 
to the cytoplasm. Owing to the lysis of ΔldcA cells upon entering the stationary phase 
(Templin et al., 1999), LdcA has been considered a potential antibiotic target, with 
several inhibitors having been identified, including the β-lactam antibiotics, but only at 
high concentrations (Baum et al., 2005). Presumably, LdcA is inhibited only by high 
concentrations of β-lactams because it has evolved to recognise the meso-DAP/L-Lys-
D-Ala moiety of the stem peptide, rather than the D-Ala-D-Ala moiety that β-lactams 
mimic. With this in mind, Baum et al., (2005) were successful in developing a potent 
inhibitor of LdcA, DTZ, that mimics meso-DAP/L-Lys-D-Ala (Figure 1.14).  
 
 
Figure 1.14: Chemical structures of D-Ala-D-Ala (top left) and Lys-D-Ala (top right) and their non-hydrolysable 
mimics (bottom left and right). Penicillin mimics D-Ala-D-Ala but is non-hydrolysable, irreversibly binding to the 
TPase domain of PBPs. DTZ, described by Baum et al., (2005), mimics Lys-D-Ala and inhibits LdcA. The R group on 
penicillin represents a variable group. This figure was produced using ChemBioDraw v14.0.0.117 (PerkinElmer).    
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The crystal structures of LdcA from both Pseudomonas aeruginosa (PaLdcA)           
(PDBid: 1ZL0, 1ZRS, 2AUM and 2AUN) (Korza and Bochtler, 2005) and 
Novosphingobium aromaticivorans (NaLdcA) (PDBid: 3G23) (Das et al., 2013) have 
been solved; the proteins superpose with a core RMSD of 2.0 Å over 242 Cαs. LdcA is a 
globular protein comprising two domains (Figure 1.15, overleaf). The N-terminal sheet 
domain comprises a 5-stranded parallel β-sheet, with three α-helices connecting the 
strands. The C-terminal domain contains a 7-stranded β-barrel, that is composed of a                 
3-stranded parallel β-sheet and a four-stranded antiparallel β-sheet (Korza and 
Bochtler, 2005). The active site of LdcA contains a catalytic triad, consisting of Ser104, 
His261 and Glu191 in NaLdcA (Ser115, His285 and Glu217 in PaLdcA), and is located 
between the two domains. The location of the active site is similar to the nucleophilic 
elbow of αβ-hydrolases, in which the active site serine is located in a sharp turn 
between a β-strand and an α-helix (Korza and Bochtler, 2005). Though a structure of 
LdcA with bound substrate is not available, docking experiments performed by Das et 
al., (2013) on NaLdcA have implicated several residues in substrate recognition and 
binding. Of the residues identified, Tyr78, Asp105, Asn167, and Glu195 of NaLdcB are 
highly conserved amongst LdcA orthologues, but their essentiality was not assessed 
through biochemical methods (Das et al., 2013).   
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Figure 1.15: (A) The structures of NaLdcA and PaLdcA superposed; (B) Surface representation of NaLdcA with 
catalytically important residues shown. (A) The two LdcA structures superpose well, with both N- and C- terminal 
domains present in both structures, although there are some differences in the N-terminal domains. PaLdcA is 
shown as a red cartoon ribbon, NaLdcA is shown as a blue cartoon ribbon. The transparent surface is that of 
NaLdcA. (B) The catalytic triad (H261, S104, E191) is located between the N- and C- terminal domains and is shown 
in stick representation with bold annotation. Residues identified by Das et al., (2013) as important for ligand binding 
are also shown as sticks but with non-bold annotation. Residue numbering corresponds to NaLdcB. The surface of 
NaLdcA is shown in translucent white.  
 
1.7.2 Antibiotic resistance 
Whilst the terminal D-Ala-D-Ala moiety of the stem pentapeptide is essential for the 
formation of the 3-4 peptidoglycan crosslink, which links independent glycan strands 
together into the peptidoglycan mesh, it is a figurative chink in the armour of the cell 
wall. Not only do molecules that target D-alanine effectively inhibit the formation of 
crosslinks and thus kill bacteria, they only affect bacterial cells as D-alanine is not 
utilised by eukaryotes. A class of antibiotics, the glycopeptides, function in this manner 
and are exemplified by vancomycin (Yim et al., 2014) (Figure 1.16). 
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Figure 1.16: Schematic showing the mode of action of vancomycin. Top panel: vancomycin is absent so the PBP is 
able to bind both the donor and acceptor stem peptides and perform the transpeptidation reaction, forming a 
crosslink. Bottom panel: vancomycin binds to the terminal D-Ala-D-Ala of the stem pentapeptide, preventing PBPs 
from binding and inhibiting crosslink formation. 
 
Unfortunately, many bacteria have evolved resistance to vancomycin. Many 
vancomycin-resistant species have replaced the terminal D-Ala-D-Ala residues of the 
stem pentapeptide with D-Ala-D-Lac or D-Ala-D-Ser, towards which vancomycin has 
little or no affinity (Popieniek and Pratt, 1987; Bugg et al., 1991), but which are still 
recognised as donor stems by the PBPs for use in TP reactions (Arthur et al., 1996). It 
should be noted, however, that PBP5, required for β-lactam resistance in              
Enterococcus faecium D366, appears to be unable to recognise D-Lac terminating 
pentapeptides as vancomycin and β-lactams, when used together, are able to lyse this 
strain (al-Obeid et al., 1992). 
In addition to replacing the terminal D-Ala-D-Ala of the stem pentapeptide with an 
amino acid to which vancomycin cannot bind, vancomycin resistant cells also produce 
a DD-carboxypeptidase, VanY, that cleaves the terminal D-alanine from stem 
30 
 
pentapeptides. VanY thus reduces the amount of D-Ala-D-Ala present on the cell 
surface to provide resistance to vancomycin (Wright et al., 1992). Like other 
vancomycin resistance genes (vanR, vanS, vanA, vanH and vanX) vanY is found on the 
vancomycin resistance plasmid pIP816 (Wright et al., 1992) and encodes a ~35 kDa 
protein (Wright et al., 1992) with hydrolytic activity only. VanY does not catalyse the 
transpeptidation reaction (Wright et al., 1992), is not sensitive to β-lactam antibiotics 
and does not display any β-lactamase activity, suggesting that its resistance to 
inhibition by β-lactams does not stem from the hydrolysis of the antibiotic (Wright et 
al., 1992).  
Recently, an enzyme that combines the functions of VanY and VanX, a further protein 
involved in vancomycin resistance that functions as a D-Ala-D-Ala dipeptidase, has 
been identified. Known as VanXYc, it is found in organisms that replace the terminal         
D-Ala-D-Ala of the dipeptide with D-Ala-D-Ser (Reynolds et al., 1999) and is active 
against both the pentapeptide terminating in D-Ala-D-Ala and the D-Ala-D-Ala 
dipeptide, but not against stem peptides ending in D-Ala-D-Ser, nor the D-Ala-D-Ser 
dipeptide (Podmore and Reynolds, 2002). A second enzyme, VanXYg, was identified 
based upon sequence similarities to VanXYc (McKessar et al., 2000), although the 
activity of VanXYc against DD-pentapeptides has yet to be demonstrated. The crystal 
structures of both VanXYg and VanXYc have been solved recently by Meziane-Cherif et 
al., (2014) and provide molecular insights into VanY-like enzymes. 
Both VanXYc and VanXYg are zinc metallopeptidases, confirming previous 
classifications by the MEROPS database as clan MD, family M15 members (Rawlings et 
al., 2012). This family contains many enzymes involved in a range of metabolic 
processes, including other bacterial cell wall modifying enzymes, and has often been 
referred to as the LAS family, because the family includes lysostaphin, a canonical        
D-Ala-D-Ala dipeptidase and the N-terminal peptidase domain of sonic hedgehog 
(Bochtler et al., 2004). Members of the LAS family are characterised by the presence of 
a core antiparallel β-sheet formed from at least four β-strands (Bochtler et al., 2004); 
this core is found in both VanXY enzymes, although two extra β-strands are present, 
which is not unusual within the family (Bochtler et al., 2004; Meziane-Cherif et al., 
2014). Several α-helices (α1-7) are positioned around the β-sheet and produce a 
globular, V-shaped domain at the bottom of which is a zinc binding site (Figure 1.17).  
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Figure 1.17: The superposed crystal structures of VanXYg and VanXYc. Both structures are shown as cartoon 
ribbons, with VanXYc shown in grey and VanXYg shown in yellow. The active site of VanXYc is shown, with the 
catalytic zinc ion shown as a grey sphere, coordinating residues as grey sticks and solvent molecules as red spheres. 
The active site of VanXYg is identical, with the exception that one the zinc-bound water molecules is replaced by a 
phosphate. The active site of VanXYg is not shown for clarity. The flexible lid region of both proteins is highlighted. 
 
The zinc is coordinated by two histidines (His95 and His156 in VanXYc; His107 and 
His167 in VanXYg) and an aspartate (Asp102 in VanXYc and Asp114 in VanXYg), 
conforming to the zinc-binding consensus sequence found in LAS family members        
(His-X3/6-Asp-Xnot conserved-His) (Bochtler et al., 2004), with two solvent molecules        
(two waters in VanXYc and a water and a phosphate in VanXYg) acting to complete a 
trigonal bipyramidal coordination sphere (Figure 1.17, previous page). The active site 
of both enzymes is blocked by a flexible loop region (amino acids 105-121 in VanXYc; 
117-132 in VanXYg) that the authors predict changes its conformation to permit the 
pentapeptide substrate to be accommodated (Meziane-Cherif et al., 2014). In addition 
to the apo-enzyme, the structures of both VanXY enzymes were solved in complex 
with a phosphinate transition state mimic of D-Ala-D-Ala, and VanXYc was solved with 
one of its substrates, D-Ala-D-Ala, bound (Figure 1.18) (Meziane-Cherif et al., 2014).  
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Figure 1.18: The active site of VanXYc with a phosphinate mimic of D-Ala-D-Ala bound (A) and D-Ala-D-Ala bound 
(B). Both molecules interact with VanXYc in similar ways, with almost identical hydrogen bonds formed. Whilst D-
Ala-D-Ala interacts with a copper ion through the carbonyl oxygen of the N-terminal D-alanine whilst the 
phosphinate mimic interacts through two oxygens, mimicking a tetrahedral transition state. Amino acids are shown 
as sticks with grey carbons, the zinc as a grey sphere, the copper as an orange sphere and the bound ligands in ball-
and-stick representation. D-Ala-D-Ala is shown with green carbons and the phosphinate mimic with pink carbons.   
 
The positions of the D-Ala-D-Ala substrate and the phosphinate mimic were identical 
and allowed Meziane-Cherif et al., (2014) to identify important interactions, with a 
range of nearby residues contributing hydrogen bonds (Figure 1.18). The C-terminal   
D-Ala of the dipeptide, and its equivalent in the phosphinate analogue, was found to 
form hydrogen bonds with Gln67, Ala88 and Arg62 (Gln79, Ala100 and Arg74 in 
VanXYg); amino acids that excluded substrate residues larger than alanine due to steric 
clashes. The N-terminal D-Ala of the D-Ala-D-Ala dipeptide was observed to coordinate 
the metal ion via its carbonyl oxygen, polarising the bond and placing the peptide bond 
in an ideal position to be hydrolysed by a nucleophilic water activated by the nearby 
Glu153 (Glu164 in VanXYg). The phosphinate mimic coordinated to the zinc ion with 
two oxygens and so likely mimicked a tetrahedral reaction intermediate (Meziane-
Cherif et al., 2014). Interestingly, Trp155 (Tr166 in VanXYg) appeared to aid in 
coordinating the dipeptide, but in doing so blocked the active site from the external 
solvent. Whilst this is the ideal environment for the hydrolysis of a dipeptide, this 
orientation of Trp155 would exclude the pentapeptide substrate of VanXYc and so 
presumably moves to accommodate the larger ligand, although evidence for this has 
yet to be observed.  
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1.8 LdcB/DacB 
An LD-carboxypeptidase, LdcB (previously DacB) was first identified in L. lactis (Courtin 
et al., 2006). The separation of digested cell wall material from an ldcB-null mutant by 
reverse-phase HPLC and subsequent analysis by MALDI-TOF mass spectrometry 
revealed an increase in the amount of tetrapeptide stem peptides found within the cell 
wall compared to the wild-type, suggesting that ldcB functioned as an LD-
carboxypeptidase (Courtin et al., 2006). An increase in the tetrapeptide content of cell 
walls from ldcB deficient strains has also been observed more recently in B. subtilis and 
S. pneumoniae (Barendt et al., 2011; Abdullah et al., 2014; Hoyland et al., 2014). The 
ΔldcB mutants of L. lactis did not suffer from growth defects under laboratory 
conditions, however cell morphology was not assessed (Courtin et al., 2006). As with  
L. lactis, growth defects were not observed in B. subtilis ΔldcB strains under laboratory 
conditions; by contrast, ldcB null mutants of S. pneumoniae exhibit severe division 
asymmetry, producing small, round cells or long, thick cells as a result of random 
septum localisation (Figure 1.19, overleaf) (Barendt et al., 2011).   
 
 
Figure 1.19: Phase-contrast and fluorescent vancomycin images of wild-type and ΔldcB encapsulated (IU1690) 
and unencapsulated (IU1945) S. pneumoniae, taken from Barendt et al., (2011). In both strains, the deletion of 
ldcB results in the appearance of small, round cells or long, thick cells (indicated by arrows in the upper panels) and 
a result of the formation of multiple division septa (indicated by arrows in the lower panels). 
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Barendt et al., (2011) have suggested that LdcB acts on stem tetrapeptides to localise 
PBPs to the division septa, in a manner similar to other carboxypeptidases              
(Section 1.5). This suggestion is consistent with the appearance of multiple division 
septa in ldcB-null mutants (Figure 1.19), but is inconsistent with the localisation of 
LdcB in patches all over the surface of S. pneumoniae (Figure 1.20, overleaf). This 
inconsistency can perhaps be reconciled as LdcB requires DacA to function (Barendt et 
al., 2011); although LdcB is present at the septum, it would not act on uncrosslinked 
stem pentapeptides without DacA, which is absent from the division site, having 
processed stem pentapeptides (Morlot et al., 2004). Alternatively, the presence of 
LdcB foci at the division septum in a small population of cells (Figure 1.20, overleaf) 
may be due to presence of a 3x FLAG epitope tag, which allows the visualisation of 
LdcB but possibly influences its localisation. It is unclear if LdcB activity influences the 
localisation of the PBPs, as no localisation studies have been performed in ΔldcB cells. 
Alternatively, LdcB activity could influence the localisation of other cell division 
proteins that localise through their interactions with peptidoglycan, such as StkP, 
which is thought to link cell division and peripheral cell growth (Beilharz et al., 2012).     
 
 
Figure 1.20: The localisation patter of 3xFLAG tagged LdcB, taken from Barendt et al., (2011). Cells are 
unencapsulated S. pneumoniae growing in the exponential phase. A polycolonial anti-flag antibody was used to 
visualise LdcB-3xFLAG (B2), DAPI was used to stain nucleoids (B3) and phase-contrast microscopy used to obtain an 
outline of the cell (B1). A false-colour image (B4) was produced, with DAPI coloured red and LdcB-3xFLAG coloured 
green. Arrows indicate the presence of LdcB-3xFLAG at the septum in some cells.  
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Finally, despite several published studies on LdcB, its LD-carboxypeptidase activity has 
not been demonstrated directly, though the presence of increased amounts of 
tetrapeptide in ΔldcB strains implies this activity. Sequence similarities with VanY and 
the VanXY enzymes suggest that LdcB adopts a similar, zinc metallopeptidase fold 
(Barendt et al., 2011), but neither the structure of LdcB, nor of the VanXY enzymes, 
were known at the outset of this study. 
1.9 Aims of this study 
In order to confirm the classification of LdcB as an LD-carboxypeptidase, and to 
elucidate its structure, LdcB from both B. subtilis (BsLdcB) and S. pneumoniae (SpLdcB) 
were studied. This thesis details the overexpression of SpLdcB and BsLdcB in a 
heterologous host (E. coli) and their subsequent purification to homogeneity. To 
determine the substrate specificity of LdcB, the activity of purified proteins was 
assessed against a range of synthetic substrates (Section 4.3). To analyse the              
LD-carboxypeptidase designation of LdcB, purified proteins were provided to 
collaborators in the Centre for Bacterial Cell Biology, Newcastle University, for the 
enzymatic activity to be tested against peptidoglycan isolated from ΔldcB strains of     
S. pneumoniae and B. subtilis (Section 4.3). To assess whether LdcB is a zinc-dependent 
metalloprotease, the activity of SpLdcB was assessed in the presence of EDTA, zinc, 
copper and cobalt (Section 5.5). Finally, to determine the structural basis of the 
biochemical properties of the enzyme, as summarised above, crystal structures of LdcB 
with and without substrate or product mimics were sought with an overall goal of 
understanding the reaction mechanism used by these enzymes (Sections 3.4, 4.2 & 
5.4). 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Chapter 2: 
Materials and methods   
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The following Chapter describes the materials and methods used in the 
overexpression, purification and biochemical characterisation of target proteins. It also 
describes the techniques used to crystallise and solve the structure of these proteins. 
2.1 Molecular biology 
2.1.1 Chemical suppliers 
All chemicals, unless otherwise stated, were purchased from Sigma Aldrich (Poole) or 
Fisher Scientific (Loughborough). Molecular biology reagents and kits were purchased 
from Thermo Scientific (Reading) or Qiagen (Manchester). 
2.1.2 General buffers and solutions 
HEPES based buffers were made from HEPES free acid powder and adjusted to the 
correct pH at room temperature by the addition of sodium hydroxide. Tris-based 
buffers were made from Tris base powder and adjusted to the desired pH at room 
temperature with hydrochloric acid. The components of standard protein and DNA 
electrophoresis reagents and buffers are detailed in Appendix 1. 
2.1.3 Growth media 
All standard bacterial cultures were grown in Luria Bertani broth (LB; defined in 
Appendix 1) either in liquid form or on solid LB agar plates, which contained 1.5 % 
(w/v) agar prior to autoclaving. For proteins that were selenomethionine-labelled for 
structure determination, the corresponding methionine-auxotrophic strains of 
Escherichia coli were grown in a defined growth medium that is defined in Appendix 1. 
When required, kanamycin (50 μg/ml) or ampicillin (100 μg/ml) was added to growth 
media to select for plasmid transformants. 
2.1.4 Strains and plasmids 
A list of all bacterial strains used in this study, along with their genotypes, can be found 
in Table 2.1. A list of expression vectors used in this study can be found in Table 2.2. 
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Table 2.1: List of E. coli strains used in this study. 
Strain Description Genotype 
DH5α Host strain, used for high efficiency 
cloning (Hanahan, 1983). 
F- endA1 hsdR17 (rk-mk+) 
supE44 thi-1recA1 gyrA (Nalr) 
relA1Δ(lacZYAargF)U169(Φ80
lacZΔM15) 
B834 (DE3) Parent strain of BL21, methionine 
auxotroph. Used for protein 
overexpression and labelling with           
Se-Met (Wood, 1966).  
E. coli B dcm ompT hsdS(rB-
mB-) gal ,met, λDE3 phage 
 
Table 2.2: Plasmids and constructs used in this study 
Plasmid Description Antibiotic 
selection  
Source 
pET28a  A high copy number plasmid with T7 
promoter. A multiple cloning site 
exists with optional N- or C-terminal 
6His•Tag. The N-terminal tag 
contains a thrombin cleavage site for 
tag removal following 
overexpression. 
Kanamycin.  Dr. R. 
Cleverley1 
pET28a-SpLdcB Bacterial expression vector pET28a 
with N-terminal His•Tag and 
thrombin cleavage site fused to 
SpLdcB. 
Kanamycin Dr. R. 
Cleverley1 
pET28a-BsLdcB Bacterial expression vector pET28a 
with N-terminal His•Tag and 
thrombin cleavage site fused to 
BsLdcB. 
Kanamycin Dr. R. 
Cleverley1 
p15TV-LIC-
BaLdcB 
Bacterial expression vector p15TV-
LIC with N-terminal His•Tag and TEV 
cleavage site fused to BaLdcB. 
Ampicillin Dr. D. 
Meziane-
Cherif2 
pET28a-SpLdcB-
E204A 
pET28a-SpLdcB with glutamate 204 
alanine mutation. 
Kanamycin This study 
pET28a-SpLdcB-
E204H 
pET28a-SpLdcB with glutamate 204 
histidine mutation. 
Kanamycin This study 
pET28a-SpLdcB-
R120A 
pET28a-SpLdcB with arginine 120 
alanine mutation. 
Kanamycin This study 
1Newcastle Structural Biology Laboratory, Institute for Cell and Molecular Bioscience, Newcastle University, 
Newcastle upon Tyne, England 
2Departement de Biologie Structurale et Chimie, Institut Pasteur, Unite de Bioinformatique Structurale, Paris, 
France 
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2.1.5 Preparation of competent cells 
A single colony was selected from an LB agar plate and used to inoculate 100 ml LB. 
The culture was incubated at 37 °C with shaking at 200 rpm until an optical density at 
600 nm (OD600) was reached of 0.3 - 0.6. The culture was transferred to ice and left to 
cool for 30 minutes, prior to centrifuging at 4000 x g for 5 minutes at 4 °C. The pellet 
was resuspended in 25 ml ice-cold, sterile 0.1 M MgCl2 and incubated on ice for 30 
minutes. The culture was then centrifuged at 4000 x g for 5 minutes at 4 °C and 
resuspended in 25 ml ice-cold, sterile 0.1 M CaCl2. Following incubation on ice for 30 
minutes, the culture was again centrifuged at 4000 x g for 5 minutes at 4 °C and 
resuspended in ice-cold, sterile 0.1 M CaCl2, 15 % (v/v) glycerol. 50 μl aliquots were 
taken and flash-frozen in liquid nitrogen. Competent cells were stored at -80 °C until 
required. One aliquot of each competent cell preparation was transformed with 
pET28a plasmid to assess transformation efficiency. 
2.1.6 Transformation of competent cells 
An aliquot of competent cells (50 μl) was defrosted on ice and 2 μl of plasmid (or 5 μl 
of mutagenesis reaction) was added. Cells were incubated with the vector for 30 
minutes before heat-shocking at 42 °C for 45 seconds. Following 2 minutes of 
incubation on ice, 300 μl of LB media was added and the cells were allowed to recover 
for 1 hour at 37 °C before plating onto LB agar containing the appropriate antibiotic. A 
control transformation was performed in parallel, without the addition of plasmid, to 
ensure the cells did not contain any inherent antibiotic resistance. LB agar plates were 
incubated at 37 °C overnight. 
2.1.7 QuikChange mutagenesis of SpLdcB 
A full list of primers used in this study can be found in Appendix 3; pET28a-SpLdcB was 
used as the template in the production of all mutants. The mutagenic primers were 
phosphorylated at their 5’ termini before deployment in the QuikChange reaction to 
promote the ligation and circularisation of the reaction products. The primer 
phosphorylation reactions contained 0.5 pmol/μl forward and reverse primer,               
1 x T4 PNK reaction buffer, 1 mM ATP and 0.06 U/μl T4 polynucleotide kinase 
(Fermentas) in a final reaction volume of 20 μl. The reactions were incubated at 37 °C 
for 30 minutes and the T4 PNK inactivated by incubation at 70 °C for 5 minutes. The 
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phosphorylated primers were then used in QuikChange reactions, which contained          
1 x Pfu polymerase reaction buffer, 50 ng dsDNA template, 5 μl of the phosphorylated 
primer mixture, 0.2 mM dNTPs and 2.5 U of Pfu polymerase (Promega). Table 2.3 lists 
the QuikChange conditions used. 
Table 2.3: Quickchange reaction conditions 
Segment Cycles 
 
Temperature Time 
1 1 95°C 30 seconds 
 
2 12–18 95°C 30 seconds 
 
55°C 1 minute 
 
68°C 12 minutes 
 
2.1.8 Visualisation of mutagenic products by agarose gel electrophoresis 
QuikChange reaction products were visualised by separation on 1 % (w/v) agarose gels 
stained with ethidium bromide (0.2 μg/ml) and 1 μl of 1 kb ladder (Fermentas) was 
used to estimate the sizes of the QuikChange products. All samples were mixed with 6x 
loading dye prior to loading into the gel. The gel was run at 150 V for 40 minutes 
before visualisation of the DNA on a UV transilluminator. Figure 2.1 shows a 
representative agarose gel. 
 
 
Figure 2.1: Representative mutagenesis agarose gel. DNA corresponding to a linearised pET28a-SpLdcBE204A can 
be seen in the E204A lane. The absence of DNA in the –ve control indicates successful digestion of the template 
plasmid by Dpn1.  
41 
 
2.1.9 Purification of plasmids from small-scale cultures 
The products of successful QuikChange reactions were transformed into chemically 
competent DH5α E. coli cells and single colonies were used to inoculate 10 ml LB 
containing the appropriate antibiotic. Cultures were allowed to grow overnight at          
37 °C, with shaking at 200 rpm, prior to centrifugation at 3000 x g for 5 minutes at 4 °C. 
The plasmid was extracted from these pellets using GeneJET plasmid miniprep kit 
(Thermo Scientific) as per the manufacturer’s instructions. Briefly, the pellet was 
resuspended in 250 μl resuspension buffer and 250 μl lysis buffer was added to lyse 
the cells. Following a 5 minute incubation in the lysis buffer, 350 μl neutralisation 
solution was added to precipitate proteins and genomic DNA and the precipitant 
removed by centrifugation. The supernatant was added to a silica spin-column and 
centrifuged. The column was washed twice with 350 μl ethanol wash buffer before 
elution of the bound plasmid with the addition of 50 μl elution buffer                           
(10 mM Tris-HCl pH 8.0, 1 mM EDTA).  
2.1.10 DNA sequencing 
All plasmids used in this study were sequenced by GATC biotech (Konstanz, Germany), 
using universal T7 primers (T7-minus1 and pET-RP) to obtain a forward and reverse 
read. BLAST (Altschul et al., 1990) was used to compare the sequences of the cloned 
genes with those found in the KEGG database (Kanehisa et al., 2004) or on the     
Bacillius subtilis specific database, Subtiwiki (Mäder et al., 2012). 
2.1.11 Analysis of proteins by SDS-PAGE electrophoresis 
15% polyacrylamide gels were constructed using a Mini-PROTEAN® Tetra Cell (Biorad). 
The components of the stacking and resolving gels are listed in Appendix 1. The 
protein concentration of each sample to be electrophoresed was measured and           
5-10 μg of protein, and 10 μl of prestained protein marker (Fermentas), was mixed 
with 6x SDS loading dye and heated to 95 °C for 2 minutes before loading. Gels were 
ran at 200 V for 45 minutes or until sufficient resolution had been achieved, as judged 
by the prestained marker. Gels were stained using Coomassie blue for 1 h before 
destaining overnight in destain solution.  
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2.2 Protein overexpression and purification 
2.2.1 Large-scale overexpression and purification of target proteins (native and        
Se-Met substituted) 
Recombinant Bacillus subtilis LdcB (BsLdcB; residues 61-273), S. pneumoniae LdcB 
(SpLdcB; residues 56-238) and Bacillus anthracis LdcB (BaLdcB; residues 55-243), were 
all overexpressed in the methionine auxotrophic B834 (DE3) strain of E. coli.  
Overnight starter cultures were used to inoculate 1 l of LB containing the appropriate 
antibiotic. Cells were grown in LB media at 37 °C to an OD600 of 0.4 and induced by the 
addition of IPTG to a final concentration of 1 mM. The culture was left to continue 
growing for 16 h at 18 °C for native proteins, or in minimal medium supplemented with 
selenomethionine for selenomethionine-labelled protein. Cells were harvested by 
centrifugation at 3000 x g for 25 minutes at 4 °C.  
2.2.2 Purification of target proteins by metal affinity chromatography (Ni+-NTA) 
The cell pellet was resuspended in 40 ml buffer A (50 mM HEPES.NaOH, pH 8.0,            
300 mM NaCl, 20 mM imidazole) per litre of culture and lysed on ice for 3 min with a 
Sonopuls HD2070 (Bandelin) sonicator at 90% power, 80% cycle. The cell lysate was 
clarified at 33000 x g for 20 min and the supernatant loaded, using an AKTA prime (GE 
Healthcare), onto a 5 ml Ni+-NTA column (GE Healthcare) pre-equilibrated with buffer 
A. The column was washed with buffer A until the chromatogram returned to baseline 
before tightly-bound proteins were eluted with buffer B (50 mM HEPES/NaOH, pH 8.0, 
300 mM NaCl, 500 mM imidazole) and the fractions containing the target protein were 
pooled. A typical chromatogram obtained from Ni+-NTA purification is shown in          
Figure 2.2 (overleaf). 
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Figure 2.2: Representative chromatogram of SpLdcB elution from a Ni-NTA column. 
 
2.2.3 Removal of hexahistidine tag by thrombin/TEV cleavage 
Prior to size exclusion chromatography, the N-terminal hexahistidine tag was removed 
from SpLdcB and BsLdcB samples by digestion with thrombin (Sigma-Aldrich). A ratio of 
1 unit of enzyme per mg of LdcB was added and the mixture incubated for 16 h at 
20°C. Removal of the hexahistidine tag of BaLdcB was accomplished by incubating 
BaLdcB with a ratio of 1 μg TEV protease (provided by Dr. Vincent Rao, Newcastle 
University, UK) per 10 μg of BaLdcB at 4 °C for 16 h. 
2.2.4 Purification of proteins by size exclusion chromatography (Superdex 75) 
Each pooled protein was concentrated by ultrafiltration (Amicon Ultra-15 10K, 
Millipore) to a volume of 1 ml before loading, using an AKTApurifier (GE Healthcare), 
onto a Superdex S75 HiLoad 16/60 (GE Healthcare) gel filtration column                     
pre-equilibrated in buffer C (10 mM HEPES/NaOH, pH 8.0, 100 mM NaCl). A typical size 
exclusion chromatogram can be observed in Figure 2.3 (overleaf). The final purity of all 
protein preparations was judged by SDS-PAGE to be >98 % (Figure 2.4, overleaf). 
44 
 
 
Figure 2.3: Representative chromatogram of SpLdcB elution from a Superdex S75 HiLoad 16/60 size exclusion 
column. The peak corresponding to SpLdcB is indicated by a black arrow. 
  
 
Figure 2.4: Representative purification gel. Overexpression of SpLdcB can be observed in the induced fraction (+ 
IPTG) but not in the uninduced (-IPTG). Furthermore the protein can be observed to be purified to homogeneity by 
Ni2+-NTA purification. The shift in size observed from size exclusion is consistent with the loss of the N-terminal 
hexahistidine tag. 
 
2.2.5 Extraction of native metals by dialysis against EDTA and subsequent buffer 
exchange 
To remove any natively bound metal ions or those acquired during Ni+-NTA 
purification, LdcB proteins were dialysed against 50 mM EDTA in buffer C for 16 h at 
4°C. Following dialysis, protein was concentrated to 250 μl and EDTA removed by 
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buffer exchange on a Superdex S75 HiLoad 10/40 (GE Healthcare) gel filtration column 
pre-equilibrated in buffer C. The removal of natively bound metals was confirmed by 
inductively coupled plasma mass spectrometry (ICP-MS). 
2.3 Biophysical characterisation of purified proteins 
2.3.1 Determination of protein concentration 
Protein concentration was routinely determined by use of the Bradford assay, in which 
15 μl of protein sample was mixed with 200 μl of Bradford reagent and made up to         
1 ml with milliQ water. Absorbance readings were taken at 595 nm and protein 
concentration determined by comparison to a standard curve prepared from known 
concentrations of bovine serum albumin (BSA) (Figure 2.5). If the absorbance reading 
fell outside the values in the standard curve, the protein sample was diluted before the 
assay was performed. 
 
 
Figure 2.5: BSA concentration standard curve. The curve was produced by adding 15 μl of BSA at known 
concentrations to 200 μl Bradford reagent in a final volume of 1 ml. 3 repeats were performed at each data-point. 
 
The Bradford assay is reliant on the biophysical properties of Coomassie Brilliant Blue 
G-250. Under acidic conditions the dye primarily absorbs light at λmax 470 nm and 
appears red in colour (Compton and Jones, 1985). Upon interaction with the basic and 
aromatic residues found within the protein sample, a spectral shift occurs and the dye 
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absorbs light at λmax 610 nm and the dye appears blue. The greatest difference 
between the two absorbance maxima is at 595 nm, and therefore readings at this 
wavelength allow the most accurate quantification of the red:blue ratio (Compton and 
Jones, 1985). As the ratio of red:blue dye is due to the interaction of the dye with the 
amino acids present in the protein sample, the absorbance change upon protein 
binding is specific to that protein. To ensure the standard curve derived from BSA was 
appropriate to calculate the concentrations of BsLdcB and SpLdcB, the Beer-Lambert 
law was used to determine the concentrations of initial purifications. The                      
Beer-Lambert law: 
𝐴 = 𝜀𝑐𝑙 
states that protein concentration (c) can be calculated if the extinction coefficient (ε), 
absorbance at 280 nm (A) and path length (l) are known. The extinction coefficient        
(M-1cm-1) was determined through the use of the ProtParam webserver: 
http://web.expasy.org/protparam/ (Wilkins et al., 1999). Readings obtained through 
the Bradford assay were found to closely match those obtained using absorbance at 
280 nm. 
2.3.2 Circular dichroism 
Plane polarised light is made up of two components, left handed (rotating               
counter-clockwise) and right handed (rotating clockwise) (Kelly et al., 2005). Under 
normal circumstances, both components have equal magnitude and sum to give 
radiation in one plane. However, should a material, such as a chiral chromophore, 
absorb more of one hand than the other, the sum of the remaining radiation becomes 
elliptical in nature (Kelly et al., 2005).  
The two chromophores usually found within proteins that can be exploited to obtain 
structural data are peptide bonds and aromatic side chains. Peptide bonds absorb 
below 240 nm (far UV) and so scans of between 180 – 250 nm give a general estimate 
of protein secondary structure. Aromatic side chains, absorbing between 260 and          
320 nm (near UV), allow for the monitoring of protein tertiary structure, such as 
conformational changes induced by ligand binding (Kelly et al., 2005). 
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Prior to obtaining CD spectra, the target protein was dialysed into 10 mM sodium 
phosphate buffer (pH 7.5), concentrated to ~0.1 mg/ml and placed in a 1 mm 
pathlength cuvette. Prior to collecting data, the CD spectropolarimeter was blanked 
against buffer. Scans were recorded from 180 – 250 nm on a JASCO J810 
spectropolarimeter in 0.5 nm steps, with 10 repeats performed for all readings. All 
data were processed in CDSSTR software to also account for differences in protein 
concentration and plotted using Microsoft Excel. 
2.4 Metal analysis of LdcB enzymes 
2.4.1 Inductively coupled plasma mass spectrometry (ICP-MS)  
Inductively coupled plasma mass spectrometry is a technique that can be used to 
identify and quantify the concentrations of metals and other elements typically found 
in biological samples, with a lower detection limit in the nM range (Ammann, 2007). 
Samples are dissolved in nitric acid prior to analysis to ensure the solubility of all metal 
ions. Following sample ionisation, magnetic fields are used to direct ions with specific 
mass/charge ratios to the detector, where the number of ions colliding with the 
detector is counted. ICP-MS can either be used to identify unknown metal cofactors 
found in protein samples or, if the metal is known, quantify the elemental 
concentrations (Ammann, 2007). Quantification is performed by comparing the 
number of ions colliding with the detector to a standard curve of the ion at known 
concentrations (Ammann, 2007). 
All samples analysed by ICP-MS were diluted 10-fold in 2.5% (v/v) Suprapure HNO3 
(Merck) containing 20 ppb Ag+ and Pt+ ions prior to analysis (ICP-MS; Thermo Electron 
Corp., X-Series). 67Zn, 66Zn, 65Cu, 63Cu and 59Co, ions were measured 100 times using the 
peak-jump method (30 ms dwell time, 5 channels, 0.02 AMU separation per isotope) 
and compared to matrix-matched elemental standards (VWR). Analyte counts were 
converted from ppb to μM and compared to the protein concentration, which was 
determined by the Bradford method. 
2.4.2 Calculating binding affinities for d-block metals and BsLdcB 
A common technique used to determine metal affinities is to compete the 
metalloprotein of interest against a metal chelator of known affinity for the metal ion. 
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The use of chelators that undergo a spectroscopic change upon the binding of a metal 
ion, such as 4-(2-pyridylazo)resorcinol (PAR), allows the competition assay to be 
monitored in an optical light spectrophotometer (Jefferson et al., 1990). 
PAR (200 µM) was incubated with ZnCl2 (45 µM), CuCl2 (25 µM) or CoCl2 (10 µM) for   
30 minutes to ensure the formation of 2:1 PAR:metal complexes. Increasing 
concentrations of BsLdcB (0 – 120 µM) were added to the PAR:metal complexes and 
the mixtures incubated at room temperature for 10 minutes to reach equilibrium. The 
absorbance of the mixture was monitored at 500 nm (Zn2+) or 514 nm (Cu2+ and Co2+) 
to allow for the calculation of the PAR-metal complex concentration using previously 
established extinction coefficients (McCall and Fierke, 2000).  The concentration of the 
PAR-metal complex was plotted against the concentration of added protein and the 
following equation, adapted from (Badarau and Dennison, 2011), used to determine 
the affinity of SpLdcB for PAR: 
 
𝐾𝑑 =
[𝐵𝑠LdcB][PAR2M
2+]
βPAR[𝐵𝑠LdcB ∙ M
2+][PAR]2
 
  
in which previously published formation constants (βPAR) of PAR with zinc                      
(1.26 x 1017 M-2 (Zhou et al., 1999)) or copper (3.2 x 1017 M-2 (Turski et al., 2012)) were 
used. M2+ represents the metal ion; Zn2+, Co2+ or Cu2+. 
2.5 Biochemical characterisation of LdcB proteins 
Unless otherwise stated, the biochemical characterisation of SpLdcB used protein 
samples that had been pre-incubated with 4 molar equivalents of ZnCl2. 
2.5.1 Carboxypeptidase activity 
2.5.1.1 Thin-layer chromatography (TLC) 
End-point and timecourse TLC assays were performed to analyse the carboxypeptidase 
activity of LdcB. To assess the metal-dependent carboxypeptidase activity of LdcB, the 
tetrapeptide Ala-D-Gln-L-Lys-D-Ala (Tetra-D; Activotec) or Ala-D-Gln-L-Lys-L-Ala          
(Tetra-L; Activotec) at 20 mM were incubated with 700 μM of SpLdcB for 2 h at 37 °C in 
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a buffer of 10 mM HEPES/NaOH, pH 8.0, 100 mM NaCl in a total reaction volume of      
10 μl. A control sample of SpLdcB was incubated with 50 mM EDTA before reacting 
with the tetrapeptide. Control reactions also utilised lysozyme in place of SpLdcB to 
ensure the degradation of the tetrapeptide was specific to SpLdcB (data not shown). 
The reaction mixtures were spotted onto silica gel TLC aluminium foils (Sigma) and 
placed in a glass TLC tank containing the TLC running buffer of butan-1-ol, acetic acid, 
water in a 3:1:1 ratio, and the lid greased to seal the tank. The TLC foils were left for  
40 minutes to achieve optimal species separation before staining with 0.1 % (w/v) 
ninhydrin solution in ethanol (Sigma). The TLC plates were dried and warmed with a 
domestic hairdryer to allow visualisation of the samples. To test SpLdcB, BsLdcB and 
BaLdcB (plasmid provided by Dr Djalal Meziane-Cherif, Institut Pasteur, France) 
dipeptidase and pentapeptidase activities, the above reaction conditions were used 
but with D-Ala-D-Ala dipeptide (Sigma) or Ala-D-γ-Gln-L-Lys-D-Ala-D-Ala (Sigma) 
substituting for the tetrapeptide. The SpLdcB-E204A, SpLdcB-E204H and SpLdcB-R120A 
(each at 700 μM) were tested for activity against the Tetra-D substrate (20 mM) only, 
as described above.  
Time-course analysis of SpLdcB followed a similar methodology as end-point TLC, with 
the following modifications. For SpLdcB-E204H and its comparison to both wild-type 
SpLdcB and SpLdcB-E204A, 20 mM tetrapeptide was incubated with 50 μM protein in a 
total reaction volume of 30 μl at 4 °C. Samples of the reactions (2 μl) were taken every 
15 minutes and the reaction stopped with the addition of ethanol to a final 
concentration of 50%. Following the spotting of the reaction mixtures onto silica gel 
TLC aluminium foils (Sigma), the running and staining of the TLC plates was performed 
as above. The activities of SpLdcB:copper and SpLdcB:cobalt were assessed and 
compared to apo SpLdcB (SpLdcB:zinc) by time-course, as described above.   
2.5.1.2 Quantitative release of D-alanine  
Purified SpLdcB, BsLdcB and BaLdcB, loaded with a molar equivalent of zinc, were 
flash-frozen in liquid nitrogen and provided to collaborators in the Institut Pasteur 
(Paris, France) for kinetic analysis. Carboxypeptidase activity was measured by Dr. 
Djalal Meziane-Cherif using the amino-acid oxidase-lactate dehydrogenase coupled 
assay (Badet et al., 1984; Araoz et al., 2000). Upon the release of D-alanine by LdcB, 
the amino acid is oxidised by D-amino acid oxidase (DAO) in an FAD-dependent 
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manner, producing pyruvate and releasing hydrogen peroxide. Pyruvate is then 
reduced by lactate dehydrogenase (LDH) in a NADH dependent manner, with the 
conversion of NADH to NAD+ followed at 340 nm to monitor the reaction (Figure 2.6). 
Catalase converts the hydrogen peroxide side-product into oxygen and water, 
permitting the cycling of FAD, a cofactor of DAO.  
The reaction was performed in 0.1 ml containing 50 mM HEPES, pH 7.5, 0.2 mM NADH, 
0.01 μg of lactate dehydrogenase (LDH), 0.03 μg of D-amino acid oxidase (containing 1 
molar equivalent of FAD) (DAO), 100 units of catalase at 37°C, 15 μg of enzyme and 
various concentrations of L-Ala-D-iso-Gln-L-Lys-D-Ala (0 to 3 mM). The raw data 
provided by Djalal Meziane-Cherif was fitted using the Michaelis-Menten equation in 
sigmaplot v11.0 (Systat Software Inc.). 
 
 
Figure 2.6: Reaction scheme for the conversion of D-alanine into lactate. (1) D-Alanine, liberated from the cell wall 
tetrapeptide by the activity of LdcB, is converted to pyruvate by D-amino acid oxidase, in an FAD dependent 
manner.   (2) Pyruvate is reduced by lactate dehydrogenase to produce lactate. This reaction is NADPH dependent, 
with the conversion of NADPH > NAD+ allowing the reaction to be monitored at 340 nm.   
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2.5.2 Identification of natively bound ligands 
The 2Fobs-Fcalc electron density map of the solved SpLdcB structure indicated a small 
ligand was bound to the active site. Whilst the crystallisation condition did contain a 
mixture of amino acids, including the enzymatic product D-alanine, the density found 
in the active site appeared too large to be explained adequately by a single amino acid. 
To determine the identity of this unknown ligand, possibly a dipeptide that co-purified 
with SpLdcB from E. coli, two approaches were adopted. The first strategy compared 
the molecular masses of native vs denatured SpLdcB, as determined by electrospray 
mass spectrometry, whilst the second approach linked                                                          
1-fluoro-2-4-dinitrophenyl-5-L-alanine amide (FDAA or Marfey’s reagent) to the 
unknown ligand to allow for its purification by reverse-phase HPLC and identification 
by comparison of elution volumes with control FDAA-amino acid derivatives. 
2.5.2.1 Electrospray mass spectrometry  
Purified SpLdcB was dialysed into 10 mM ammonium acetate buffer pH 8. Dialysis was 
performed for 24 hours, with buffer exchange occurring after 4 and 8 hours, to ensure 
trace ions would not interfere with the mass spectroscopy. Protein was then 
concentrated to 10 mg/ml (Amicon Ultra-15 10K, Millipore) and submitted for analysis 
by Dr Ault at the Mass Spectrometry facility, Astbury Centre for Structural Molecular 
Biology at the University of Leeds, United Kingdom. 
2.5.2.2 Marfey’s reagent and reverse-phase HPLC 
FDAA can react with either L- or D- amino acids to produce diastereomers            
(Figure 2.7, overleaf). Diastereomers containing L-amino acids form stronger 
intramolecular bonds than those containing D-amino acids (B'Hymer et al., 2003) and 
so experience a reduction in their polarity. This difference in polarity leads to               
D-derivatives having longer retention times on a reverse-phase HPLC column than their 
L-counterparts, and so HPLC can be used to purify a range of FDAA-amino acids from 
one another and from their own isomers (Bhushan and Brückner, 2004). 
Purified SpLdcB (80 mg/ml) was denatured by heating and the insoluble material 
removed by centrifugal filtration (Amicon Ultra-15 10K, Millipore). The flow-through, 
theoretically containing the small molecules that were found in the active site of 
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SpLdcB prior to the heat-step, was then used as the substrate in a Marfey’s reaction. 
An aliquot (200 ul) of flow-through was transferred to an opaque glass reaction vial to 
which 150 μl FDAA (50 mM final concentration) was added. The reaction was 
maintained at an alkaline pH by the addition of sodium bicarbonate (125 mM final 
concentration) and allowed to proceed for 1 hour at 37 °C with shaking. The reaction 
was stopped by the addition of HCl (50 mM final concentration) and the samples 
desiccated by freeze-drying for 48 hours. The samples were dissolved in 120 μl 50 % 
(v/v) DMSO (dimethyl disulphate) prior to loading onto a C18 reverse-phase HPLC 
column pre-equilibrated with 20 mM ammonium acetate, pH 4. The samples were 
loaded onto a 1260 Infinity Quaternary LC System HPLC and FDAA-derivatised amino 
acids eluted by a gradient of acetonitrile (0-50%). Retention times were compared with 
those produced by control reactions containing D- or L-alanine. 
 
 
Figure 2.7: Marfey’s reagent derivatisation of L and D alanine. The L-alanine diasteromer forms stronger 
intramolecular contacts than the D-disteromer. Hydrogen bonds are shown as a dashed line. Figure adapted from 
B’Hymer et al., (2003). 
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2.6 Crystallisation of target proteins 
2.6.1 Crystallisation trials 
Both BsLdcB and Se-Met substituted SpLdcB were concentrated to 15 mg/ml by 
ultrafiltration (Amicon Ultra-15 10K, Millipore) and four molar equivalents of zinc 
chloride were added. Crystallisation conditions at 20 °C for both proteins were 
obtained by sparse-matrix screening using the commercial screens PACT, JCSG+ and 
Morpheus (Molecular Dimensions) in 96-well MRC crystallisation plates (Molecular 
Dimensions). A Mosquito (TTP Labtech) was used for all initial screens, setting up two 
sitting drops (100 nl + 100 nl and 200 nl + 100 nl of protein and crystallisation 
condition, respectively) per condition. The best SpLdcB crystals were obtained after       
48 hours from Morpheus screen condition H8, containing a 0.1 M mixture of amino 
acids (glycine, L-glutamate, and racemates of alanine, serine and lysine), 0.1 M buffer 
system 2, pH 7.5 and 37.5 % MPD/PEG1000/PEG3350. By contrast, a single hit was 
achieved for BsLdcB, with several plates growing from a single nucleation point in       
0.1 M phosphate/citrate buffer, pH 4.2, 40 % PEG 300 over a period of ~2 months. 
Crystals of native SpLdcB with bound MurNAc-L-Ala-D-iso-Gln-L-Lys-(D-Asn) (Invivogen) 
were obtained as above, with the additional step of incubating the protein with the 
ligand at 2 mM final concentration for 30 min at room temperature prior to 
crystallisation screening. Crystallisation of metal-substituted SpLdcB occurred as 
above, with Cu2+ or Co2+ being added once zinc was removed. Successful crystallisation 
solutions were optimised manually in hanging drops in 24-well Linbro plates 
(Molecular Dimensions). 
2.6.2 In-house screening of crystals for diffraction 
Crystals were harvested in a suitably sized cryoloops (Hampton) and cryo-protected in 
paratone-N oil before being flash cooled in liquid nitrogen (-173 °C). Crystals were 
mounted on a copper anode Rigaku MSC microfocus generator and data collected at a 
1.54 Å on a Raxis IV++ image plate detector. Two images per crystal were collected, at 
relative phi angles of 0 ° and 90 °, to allow for indexing in MOSFLM (Leslie, 2006). 
Crystals were ranked based upon the diffraction pattern and resolution, with the best 
being collected at the Diamond Light Source (DLS) synchrotron.    
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2.6.3 Data collection 
2.6.3.1 Data collection for molecular replacement 
Diffraction data for BsLdcB were collected at DLS on beamline IO2 on 28/9/12 at a 
wavelength of 0.97 Å. 
Diffraction data of native SpLdcB with bound MurNAc-L-Ala-D-iso-Gln-L-Lys-(D-Asn) 
were collected at DLS on beamline IO2 on 11/03/13 at a wavelength of 0.92 Å. 
2.6.3.2 SAD data collection 
Data collection for Se-Met substituted SpLdcB took place on 28/9/12 on beamline IO2 
at DLS. A fluorescence scan was performed to determine the optimal wavelength for 
SAD data collection. Data were collected at a wavelength of 0.98 Å, sufficiently close to 
the selenomethionine K atomic absorption edge to permit phasing by the single 
wavelength anomalous dispersion method. 
2.6.3.3 Data collection for anomalous difference maps 
Data collection for SpLdcB with bound Co2+ occurred on 10/2/13 on beamline IO4 at 
DLS. Data were collected at 1.605 Å, above the K edge of Co2+ but below that of Cu2+ 
and Zn2+, and at 1.631 Å, below the K edge of all three metals. The presence of 
anomalous signal in the dataset above the K edge of Co2+ and its absence in the dataset 
collected below the edge allowed for the calculation of anomalous difference maps. 
Data collection for SpLdcB with bound Cu2+ occurred on 10/2/13 on beamline IO2 at 
DLS Data were collected at 1.494 Å, above the K edge of Cu2+ and Co2+ but below that 
of Zn2+, and at 1.631 Å, below the K edge of all three metals. The presence of 
anomalous signal in the dataset above the K edge of Cu2+ and its absence in the dataset 
collected below the edge allowed for the calculation of anomalous difference maps. 
2.6.4 Data processing 
XDS (Kabsch, 2010) was used to index and scale all SpLdcB and BsLdcB diffraction data. 
During the indexing step, the reflections present on the images are identified and 
assigned a Miller index (hkl). In addition, the crystal geometry is determined to allow 
for the integration of the reflections. The data is then scaled to average all symmetry 
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equivalent reflections (i.e. Friedel pairs h,k,l and –h,-k,-l) and sum partially recorded 
reflections into one, normalised set of structure factors, Ihkl. 
During scaling, the quality of data is assessed and an R-, or reliability, factor is 
produced. This value, known as Rmerge if data are being merged between datasets, or 
Rsym if a single crystal is used, is the extent at which the observed intensities of each 
unique reflection deviates from the one another. Rsym can be calculated using the 
following formula: 
 
𝑅𝑠𝑦𝑚 =
𝛴ℎ𝑘𝑙𝛴𝑗|𝐼ℎ𝑘𝑙,𝑗  − (𝐼ℎ𝑘𝑙)|
𝛴ℎ𝑘𝑙𝛴𝑗𝐼ℎ𝑘𝑙 ,𝑗
 
 
where Ihkl,j is the intensity of a reflection, j, and (Ihkl) is the mean intensity for all 
reflections within the averaged unique reflection. A small Rsym indicates only small 
differences between equivalent reflections. Unfortunately, whilst large multiplicity 
within a dataset should increase the quality of the data, as the accuracy to which 
intensities are can be averaged is improving, the Rsym value often increases. For 
datasets with large multiplicities, it is recommended that Rp.i.m be reported in place of 
Rsym (Weiss, 2001), as this accounts for the large multiplicity of the dataset by the 
addition of an (1/N-1) term to the Rsym equation: 
 
𝑅𝑝.𝑖.𝑚 =
𝛴ℎ𝑘𝑙
√1
𝑁 − 1 𝛴𝑗=1
𝑛 |𝐼ℎ𝑘𝑙,𝑗 − (𝐼ℎ𝑘𝑙)|
𝛴ℎ𝑘𝑙𝛴𝑗𝐼ℎ𝑘𝑙 ,𝑗
 
 
The (N/N-1) term ensures that the Rp.i.m value decreases with increased multiplicity 
and so reflects the increasingly accurate averaged intensity of the unique reflection. 
An additional metric of data quality is the I/σI value, which is the ratio between the 
averaged intensity and the standard deviation of the averaged intensity of all unique 
reflections. Higher I/σI values are therefore indicative of a carefully collected dataset. 
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2.6.5 Determination of an initial model by molecular replacement 
To calculate an electron density map from data collected by X-ray crystallography we 
require not only the intensities of each recorded reflection, but also the phase of the 
photons that contribute to the reflection. Whilst the intensities are collected, the 
phases are lost during data collection (Grunbaum, 1975).   
Molecular replacement uses the phases calculated from a similar structure to estimate 
those for the unknown structure and then refines the estimated phases until they 
approximate the true phases (Scapin, 2013). Although the structure of the molecule 
for which the phases are required is unknown, sequence identity can be used to 
suggest proteins that may be similar, with proteins sharing sequence identities of 
~30% usually adequate to use for molecular replacement.  
Before the phases of the unknown structure can be estimated, the known structure 
must be orientated and positioned correctly in the asymmetric unit. Two methods are 
generally used for this, Patterson-based (e.g. MolRep) and likelihood-based (e.g. 
PHASER).  
Patterson-based molecular replacement calculates Patterson maps for both structures. 
These maps contain peaks that represent the vectors between atoms, which can be 
either intermolecular or intramolecular (Turkenburg and Dodson, 1996). 
Intramolecular vectors are dependent only on the orientation of the molecule, not on 
its position and so similar intramolecular vectors can be observed between two 
structures if they are orientated in the same manner. Once the two molecules are 
correctly orientated, the intermolecular vectors, which account for both orientation 
and position, can be used to position the molecules (Turkenburg and Dodson, 1996). 
Likelihood-based molecular replacement tests the orientation and position of the 
model for consistency with the data, with the ideal solution being the model that best 
fits the observed data (McCoy et al., 2007). Like the Patterson-based method, the 
rotation and translations functions are calculated independently.  
PHASER (McCoy et al., 2007) was used to solve the structures of BsLdcB, SpLdcB with 
bound ligand, SpLdcB-Co2+ and SpLdcB-Cu2+ and is a part of the CCP4 suite 
(Collaborative Computational Project, 1994). Potential solutions were monitored by 
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observing the ‘contrast’ score in MolRep or ‘LLG’ score in PHASER before one round of 
rigid body refinement in Refmac5 (Murshudov et al., 1997) and manual inspection in 
COOT (Emsley and Cowtan, 2004). Table 2.4 contains a list of structures solved by 
molecular replacement, in addition to the models used to solve them. 
 
Table 2.4: A list of all structures solved by molecular replacement, the models used and their sequence similarity 
Structure Model  Sequence identity (%) 
BsLdcB SpLdcB – this study 30 
SpLdcB with bound ligand  SpLdcB – this study 100 
SpLdcB-Co2+ SpLdcB – this study 100 
SpLdcB-Cu2+ SpLdcB – this study 100 
 
2.6.6 Heavy atom substructure solution (SAD) 
The intensity of scattering produced by an atom during data collection is known as the 
atomic form factor (ƒ0(θ)) (Dauter et al., 2002). However, when a heavy atom is 
introduced as a scatterer, the atomic form factor must be modified to account for an 
additional signal produced by these atoms at specific wavelengths; at these 
wavelengths, the incident X-ray beam provides enough energy for an electron of a low 
energy shell to move to a higher energy shell and in doing so, emit an anomalous signal 
(Dodson, 2003). The full structure form equation is therefore: 
 
                                                    ƒ(θ, λ) = ƒ0(θ) + ƒ’(λ) + iƒ’’(λ)            
                                                                  
where ƒ’(λ) + iƒ’’(λ) represent the anomalous scattering of these heavy atoms at 
particular wavelengths. In most proteins, there are no anomalous scatters, and so the 
contributions of ƒ’’ and ƒ’ are zero. In this case, Friedel’s Law holds true and symmetry 
related reflections will possess identical intensities but have opposite, but 
complementary, phases (h,k,l = -h, -k, -l). When an anomalous scatterer is present, the 
contributions of iƒ’’ to the atomic form factor cause a breakdown in Friedel’s Law 
resulting in symmetry related reflections having different intensities and non-
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complementary phases. The differences in the atomic form factors can be used to 
determine the phases (Dauter et al., 2002; Dodson, 2003). 
The use of a single wavelength anomalous dispersion results in two possible phases, of 
which only one is correct. This ambiguity is usually solved by examining the electron-
density map that is produced for interpretable features such as alpha-helices (Dauter 
et al., 2002). 
The structure of SpLdcB was solved using SHELX (Sheldrick, 2008) as implemented in 
the HKL2MAP interface (Pape and Schneider, 2004), not only to locate the selenium 
heavy atom substructure, but also to determine the correct anomalous hand and to 
apply solvent flattening. An initial model was built by PHENIX.AUTOSOLVE (Adams et 
al., 2011), which successfully positioned 180 out of 185 amino acids.  
2.6.7 Calculation of anomalous difference maps 
In addition to allowing phasing, anomalous signals can be used to calculate an 
anomalous difference map, confirming the presence, or absence, of a heavy-atom 
scatterer. Phases were obtained by molecular replacement, using SpLdcB as a search 
model, and combined with anomalous data using CAD, of the CCP4 software suite 
(Collaborative Computational Project, 1994). FFT (Ten Eyck, 1985; Read and 
Schierbeek, 1988) was then used to calculate the anomalous difference map. 
2.6.8 Model building and refinement 
All electron density maps were improved by manual building cycles in COOT (Emsley 
and Cowtan, 2004), interspaced with restrained refinement either Refmac5 
(Murshudov et al., 1997) or PHENIX.REFINE (Afonine et al., 2012). The reliability of the 
model was assessed by comparing the measured amplitudes with those calculated 
from the model, producing an R-factor: 
 
𝛴ℎ||𝐹𝑜𝑏𝑠| − |𝐹𝑐𝑎𝑙𝑐||
𝛴ℎ|𝐹𝑜𝑏𝑠|
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where h is the sum of all reflections, Fobs are the observed amplitudes and Fcalc are 
the calculated amplitudes. As the measured amplitudes were used as data during 
model building, bias could be introduced that artificially lowered the R-factor. This bias 
can be avoided by calculating an R-factor, termed the Rfree, from a subset of reflections 
(usually 5%) that were not used in refinement. Once convergence was reached, water 
molecules and other ligands or small molecules were added. 
2.6.9 Model validation  
Models were validated through the use of COOT (Emsley and Cowtan, 2004), 
MOLPROBITY (Chen et al., 2010) and RAMPAGE (Lovell et al., 2003) to check geometry 
and Ramachandran outliers in addition to clashes. 
 
  
 
 
 
 
 
 
 
Chapter 3: 
Structural characterisation of LdcB from                    
S. pneumoniae and B. subtilis   
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3.1 Introduction 
In most species the terminal D-alanine of the pentapeptide stem is hydrolysed by DD-
carboxypeptidases from the class C penicillin binding protein (PBP) family (Lovering et 
al., 2012). LD-carboxypeptidases subsequently hydrolyse the L-Lys[A2pm]―D-Ala bond 
to release the tripeptide. Though tripeptides are found in many bacteria, very few of the 
corresponding LD-carboxypeptidases have been identified. This Chapter concerns one 
such LD-carboxypeptidase, called LdcB, the genetic disruption of which causes severe 
morphological defects (Barendt et al., 2011). Mutant strains develop into small, 
spherical cells or elongate into long, thick cells, as a result of division asymmetry 
produced by random septum localisation (Barendt et al., 2011). The morphological 
defects observed upon deletion of ldcB suggest that it could be of interest as an 
antibiotic target, with the design of these antibiotics aided by a crystal structure of LdcB. 
In this chapter we describe the crystallisation and structure determination of LdcB from 
S. pneumoniae and B. subtilis (Sections 3.2 and 3.3), and compare the structures with 
each other and other, related enzymes (Section 3.4). 
3.2 Crystallisation trials 
3.2.1 Crystallisation trials of native SpLdcB and BsLdcB 
Native SpLdcB and BsLdcB were purified as described previously (Section 2.2). Both 
proteins were found to be >95 % pure, as determined by SDS-PAGE (Section 2.2) 
following a 3-step purification process. The proteins were each concentrated to 15 
mg/ml for crystallisation trials, which were conducted in 96-well sitting-drop vapour 
diffusion trays utilising a Mosquito (TTP labtech) crystallisation robot and a range of 
commercially-available screens (Molecular Dimensions). Crystals grew in a number of 
conditions over a period of 7 days for both SpLdcB and BsLdcB. Rod-like SpLdcB crystals 
were observed to grow from JSCG+ (Newman et al., 2005) solution F8 (2.1 M malic acid) 
(Figure 3.1) whilst BsLdcB grew from PACT premier (Newman et al., 2005) solution E9 
(0.2 M potassium sodium tartrate 20% PEG 3350) in clumps of needles originating from 
a single nucleation point (Figure 3.1, overleaf).  
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Figure 3.1: Initial crystal forms of SpLdcB (A) and BsLdcB (B). 
 
Despite repeated attempts at optimising these crystallisation conditions, BsLdcB crystals 
failed to diffract and the best SpLdcB crystals diffracted to a maximum resolution of 3.6 
Å on the microfocus beamline I24 at the Diamond Light Source. Additionally, the lack of 
a suitable molecular replacement model in the PDB at the time of data collection 
prevented us from using these data for structure solution. The data collection statistics 
can be found in Table 3.1. 
 
Table 3.1: Summary of X-ray data collection statistics for initial SpLdcB crystals. 
aRmerge = hi|Ii(h) - I(h)/hiIi(h), where Ii(h) and I(h) are the ith and mean measurement of the intensity of 
reflection h. 
 
3.3 Crystallisation of Se-Met substituted SpLdcB and the addition of zinc 
3.3.1 Incorporation of selenomethionine 
The lack of a suitable molecular replacement model required to solve the structure of 
SpLdcB meant that an alternative phasing method was required. The substitution of 
 SpLdcB 
Data collection  
Space Group P21 21 2 
Unit cell dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
33.8, 78.3, 149.9 
90.00, 90.00, 90.00 
Wavelength (Å) 1.28 
Resolution (Å) 78.3-3.60 
(3.94-3.60)* 
Multiplicity 12.4 (12.1) 
Rmergea 0.194 (0.842) 
I/σI 11.7 (2.3) 
Completeness (%) 96.8 (85.4) 
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methionine by selenomethionine is a common method of introducing heavy atoms into 
protein crystals, from which single anomalous dispersion (SAD) data can be collected 
and used to solve the phase problem (Doublie, 1997). E. coli B834 cells containing 
pET28a-SpLdcB were grown in Se-Met media (Appendix 1) and the overexpression 
induced by the addition of 1 mM IPTG. A control culture was grown alongside, to which 
selenomethionine was not added. The control culture ceased growth after 
approximately 30 minutes, whilst the culture with selenomethionine continued 
growing, indicating selenomethionine incorporation was successful. Se-Met labelled 
SpLdcB was purified as previously described (Section 2.2) and used in crystallisation 
trials against commercially available crystallisation conditions (Molecular Dimensions) 
in 96-well sitting-drop vapour diffusion trays. Unfortunately, these crystals were of 
similar morphology to those produced by native SpLdcB and diffracted poorly in-house. 
3.2.2 Addition of zinc and effect on crystallisation of LdcB  
SpLdcB shares sequence identities of 38%, 36% and 30% to the known zinc metallo-
proteins VanY, VanXYg and VanXYc (Binda et al., 2012), indicating that LdcB is a metallo-
enzyme; unfortunately, although the structures of VanXYg and VanXYc have 
subsequently been solved, they were not available to use as molecular replacement 
models during structure solution. Moreover, the amino acids that co-ordinate the zinc 
ion in the structures of VanX (H116, D123, H184) (PBDid: 1R44), VanXYg (H107, D114, 
H167) (PBDid: 4f78) and VanXYc (H95, D102, H156) (PBDid: 4MUT) are all conserved in 
LdcB. Consequently, the metal content of the Se-Met labelled SpLdcB was assessed by 
inductively coupled plasma mass spectrometry (ICP-MS) (Thermo X-series). Following 
purification, SpLdcB was diluted to 5 mg/ml in 2.5 % (v/v) Suprapure HNO3 to denature 
the protein and ensure the solubility of the liberated metal ions. The sample was then 
ionised and a quadrupole magnet used to direct ions of specific mass/charge ratios 
towards a detector where the number of collisions were recorded. A standard curve of 
known metal concentrations was used to convert the number of ‘hits’ to μM 
concentrations for comparison with protein concentration. SpLdcB purifies with roughly 
50% zinc occupancy in addition some nickel, presumable as a consequence of Ni+-NTA 
purification (Figure 3.2, overleaf). The addition of excess zinc, followed by desalting of 
the proteins (HiTrap Desalting, 5 ml [GE Healthcare]) allowed the full occupancy of the 
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protein with zinc at an almost 1:1 stoichiometry, with the large excess of free zinc 
indicating a single, fully occupied binding site (Figure 3.3).  
 
 
Figure 3.2: Metal content analysis of purified SpLdcB. The concentration of zinc and nickel of SpLdcB after purification 
by Ni-NTA and size exclusion chromatography was assessed by ICP-MS. Protein concentrations were determined by 
the Bradford method. All readings were taken in triplicate and standard deviation shown as error bars.   
 
 
Figure 3.3: Metal content analysis of SpLdcB following zinc addition. The concentration of zinc and nickel of SpLdcB 
after the addition of zinc to purified protein, followed by separation on a HiTrap Desalting, 5 ml column was assessed 
by ICP-MS. Protein concentrations were determined by the Bradford method.   All readings were taken in triplicate 
and standard deviation shown as error bars. 
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The presence of a ligand or a cofactor can often stabilise proteins, and stable proteins 
are more likely to form crystals. Thus, a 4:1 excess of zinc chloride was added to SpLdcB 
prior to screening for crystallisation. Crystallisation experiments were conducted as 
described above (Section 3.2.1). The addition of zinc chloride had a marked affect on 
the crystals of SpLdcB, producing 3D crystals in the Morpheus (Gorrec, 2009) H8 
condition (0.1 M mixture of amino acids, 0.1 M buffer system 2, 37.5% 
MPD/PEG1000/PEG3350) within 48 hours of the experiment. The crystals of BsLdcB 
were not improved by the addition of excess zinc. 
The zinc-loaded, Se-Met labelled crystals were optimised in 24 well hanging-drop vapour 
diffusion trays as described previously (Section 2.6) using solutions obtained from 
Molecular Dimensions. The unique combinations of precipitants, buffer systems and 
additives found in the Morpheus screen make optimisation a non-trivial endeavour. The 
buffer system 2 (0.1 M sodium HEPES, MOPS (acid) pH 7.5) concentration was kept 
constant at 0.1 M, while the concentration of amino acids (L-Na-Glu, Ala (racemic), Gly, 
Lys (racemic), Ser (racemic)) and precipitants (MPD/PEG1000/PEG3350) were varied 
from 0 to 0.2 M in 0.05 M increments and from 15% to 52.5% in 7.5% increments, 
respectively. The crystals used for data collection grew from the original crystallisation 
condition (0.1 M mixture of amino acids, 0.1 M buffer system 2, 37.5% 
MPD/PEG1000/PEG3350) at 21°C with a protein:mother-liquor ratio of 2:1. The final 
dimensions of the optimised crystals were ~ 0.1 x 0.1 x 0.15 mm3 (Figure 3.4). 
 
 
Figure 3.4: Improved crystal form of SpLdcB. The 3D-crystal form was obtained upon the addition of excess zinc prior 
to crystallisation. 
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Several Se-Met SpLdcB crystals were harvested and cryo-protected in paratone-N oil 
before flash-cooling in liquid nitrogen. Diffraction was assessed in-house, with two 
images being taken at relative phi angles 90° apart. Crystals were ranked based upon 
spot sharpness, mosaicity and strength of diffraction. The best crystals were taken to 
Diamond Light Source for data collection on beamline IO2. Fluorescence scans were 
performed on the SpLdcB crystals to confirm the incorporation of selenomethionine 
(Figure 3.5). The scans also identified the appropriate wavelength at which the single 
anomalous dispersion (SAD) data for selenium should be collected.  
 
 
Figure 3.5: Metal content analysis (MCA) fluorescence scan of SpLdcB crystals. MCA scan assessing the incorporation 
of selenium into the crystals. The peak (red line) corresponds to the K-edge excitation wavelength of selenium. The 
blue line (f’) corresponds to the real component of anomalous scattering around the K-edge of selenium, while the 
green line (f’’) corresponds to the imaginary component. The light blue vertical line indicates the position of the peak 
(maximum of f’’), whilst the purple vertical line indicated the position of the inflection (minimum of f’). 
 
A dataset with a high multiplicity is desirable for solving a structure by SAD, as sampling 
every reflection multiple times increases the accuracy and precision at which small 
anomalous differences can be measured (Weiss, 2001). A total of 7200 images were 
collected with 0.1° oscillations and 0.1 s exposure per image at a wavelength of 0.979 Å, 
the wavelength at which the fluorescence scan (Figure 3.5) indicated would produce the 
greatest amount of anomalous scatter from the selenium heavy atom substructure. An 
example of the diffraction obtained is shown in Figure 3.6. 
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Figure 3.6: An example diffraction pattern produced by Se-Met labelled SpLdcB crystals. The crystal diffracted to 
1.8 Å. The spots are difficult to define with the human eye due to the resolution of the Pilatus detector and the use 
of fine slicing in data collection. 
 
3.3.3 Data processing and structure solution of Se-Met substituted SpLdcB  
Diffraction data were integrated with XDS (Kabsch, 2010) and reduced with SCALA 
(Evans, 2005). The crystals were assigned to the spacegroup I222 with unit cell 
dimensions of a = 48.8, b = 60.4, c = 138.2 Å, based upon the systematic absence of 
reflections where h+k+l=2n+1 and scaling statistics. Data collection statistics are 
summarised in Table 3.2. The calculated Matthews’ coefficient (Matthews, 1968) of      
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2.4 (A3/Da), suggested that one protein molecule was present within the asymmetric 
unit with a solvent content of 49.0 %. 
 
 
aRmerge = hi|Ii(h) - I(h)/hiIi(h), where Ii(h) and I(h) are the ith and mean measurement of the intensity of 
reflection h. 
 
The structure of SpLdcB was solved  by SAD using the Se-Met dataset in SHELX (Sheldrick, 
2007) as implemented in the HKL2MAP interface (Pape and Schneider, 2004). Analysis 
of the data using the SHELXC module of SHELX indicated that the anomalous signal 
extended to approximately 1.9 Å (d’’/sig > 0.80) (Figure 3.7).  
 
 
Figure 3.7: The output of SHELXC. The anomalous signal extended to around 1.9 Å.  
 
 SpLdcB 
PDBid 4OX5 
Data collection  
Space Group I222 
Unit cell dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
48.8, 60.4, 138.2 
90, 90, 90 
Wavelength (Å) 0.98 
Resolution (Å) 20.0-1.80 
(1.84-1.80)* 
Multiplicity 
Anomalous multiplicity 
24.3 (14.2) 
12.5 (6.9) 
Rmergea 0.077 (0.108) 
I/σI 34.4 (2.4) 
Completeness (%) 
Anomalous completeness 
98.6 (86.9) 
98.2 (83.9 
Table 3.2: Summary of X-ray data collection statistics for SpLdcB. 
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A total of six potential selenium sites were identified by SHELXD, with two that had an 
occupancy of greater than 0.5 (Figure 3.8). A total of three methionines are present 
within SpLdcB, suggesting one molecule was present within the asymmetric unit, 
consistent Matthews’ coefficient calculations (Matthews, 1968). Inspection of the 
electron density maps produced by SHELXE, displayed in COOT (Emsley et al., 2010), in 
addition to the ‘contrast vs cycle’ output of SHELXE, indicated that the original hand of 
the heavy atom substructure was correct (Figure 3.9).  
 
 
Figure 3.8: The output of SHELXD. The rapid drop-off in site occupancy following the identification of two Se peaks 
suggested that two selenium atoms were found within the asymmetric unit, corresponding to one protein monomer.  
 
 
Figure 3.9: The output of SHELXE. Following density modification by SHELXE produces a strong contrast between 
the solvent and non-solvent areas on the map in the correct hand. 
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Following identification of the correct hand, initial model building was performed by 
PHENIX.AUTOSOLVE (Adams et al., 2011), which successfully positioned 180 out of 185 
amino acids. The placement of the remaining amino acids, in addition to the zinc ion and 
solvent atoms, was performed in COOT and the fit of the model to the experimental 
electron density improved through cycles of manual (re)building in COOT interspaced by 
restrained refinement in PHENIX.REFINE (Afonine et al., 2012) until convergence. Final 
refinement statistics can be found in Table 3.3.  
 
* Highest resolution shell shown in parentheses. 
aRwork/Rfree = |Fpobs – Fpcalc|/Fpobs, where Fpobs and Fpcalc are the observed and calculated structure factor amplitudes, 
respectively. 
 
The final model of SpLdcB consisted of residues 56 - 237, with only residues 135, 136 
and 238 of the clone missing in the model, due to disorder. The electron density maps 
were of sufficient quality to also permit the building of residues -4 to -1 (GSHM), present 
from the pET28a vector. A Ramachandran plot, on which main chain phi angles are 
plotted against main chain psi angles, revealed the presence of 0 Ramachandran 
outliers; 96.7 % lie within the favoured regions, with 3.3 % found in allowed regions 
(Figure 3.10, overleaf).  
 SpLdcB 
PDBid 4OX5 
Resolution (Å) 20.0-1.80 
No. Reflections 25656 (1157) 
Rwork/Rfreea 0.191/0.253 
No. atoms 
Protein 
# proteins/AU 
  Ion/Ligand 
Water 
 
1476 
1 
3/22 
197 
B factors (Å2) 
Protein 
Ion/Ligand 
Water 
 
41.8 
36.9/50.7 
48.2 
R.m.s deviations 
  Bond lengths (Å) 
Bond angles (°) 
- 
0.018 
1.96 
Ramachandran  
   favoured (%) 
   allowed   (%) 
 
96.7 
100 
Table 3.3: Summary of X-ray data refinement statistics for SpLdcB. 
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Figure 3.10: Ramachandran plot of the Se-Met SpLdcB structure. Black shapes represent residues in favoured 
regions, orange shapes represent those residues in allowed regions. This plot was generated using the RAMPAGE 
webserver (Lovell et al., 2003) (http://mordred.bioc.cam.ac.uk/~rapper/rampage.php) 
 
3.3.4 Data processing and molecular replacement of BsLdcB 
All attempts at improving the quality of BsLdcB crystals failed, with the protein 
consistently crystallising as clusters of needles unsuitable for diffraction studies. 
However, inspection of the BsLdcB crystallisation screens, containing a 4:1 molar excess 
of zinc, after a period of 6 months revealed the presence of a cluster of plates originating 
from a single nucleation point (Figure 3.11) in the JSCG+ screen condition C6 (0.1 M 
phosphate/citrate buffer, pH 4.2 and 40% PEG 300). The cluster was harvested in 
paratone-N oil as described in Section 3.2.2. 
A native dataset of BsLdcB was collected successfully at Diamond Light Source on 
beamline IO2. A total of 900 images were collected with 0.1° oscillations and 0.1 s 
exposure per image (Figure 3.12, overleaf). Multiple diffraction patterns were found to 
be present in BsLdcB diffraction data (Figure 3.12). The dominant lattice was successfully 
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isolated from the diffraction pattern and data were integrated with XDS (Kabsch, 2010) 
and reduced with SCALA (Evans, 2005). The crystals were assigned to the spacegroup 
P212121 with unit cell dimensions of a = 42.7, b = 53.7, c = 102.4 Å, based upon the 
systematic absence of reflections where h+k+l=2n-1 and statistics following scaling. Data 
collection statistics are summarised in Table 3.4. 
 
 
                                                              Figure 3.11: BsLdcB plate-like crystals. 
 
 
Figure 3.12: An example diffraction pattern produced by BsLdcB. The crystal diffracted to 1.7 Å. Multiple lattices are 
present in the pattern, with spots belonging to the prominent lattice shown as red crosses. Predicted spots are shown 
as yellow crosses. Prediction and spot-finding was performed by Mosflm (Leslie, 2006), through the graphical 
interface iMosflm (Battye et al., 2011). 
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Table 3.4: Summary of X-ray data collection statistics for BsLdcB. 
aRmerge = hi|Ii(h) - I(h)/hiIi(h), where Ii(h) and I(h) are the ith and mean measurement of the intensity of 
reflection h. 
 
Matthews’ coefficient calculations predicted that 1 molecule of BsLdcB was present per 
asymmetric unit, with a solvent content of 47.1%. The structure of SpLdcB was used as 
a molecular replacement model to solve the structure of BsLdcB in PHASER (McCoy et 
al., 2007), with 1 molecule found per asymmetric unit.  
The correctly-positioned protein model was subjected to one round of rigid body 
refinement in Refmac5 (Winn et al., 2011) before cycles of manual building in COOT and 
restrained refinement in PHENIX.REFINE (Afonine et al., 2012). The final model of BsLdcB 
consisted of all cloned residues (61 – 273) in addition to a methionine (-1) present from 
the pET28a vector. A Ramachandran plot reveals the presence of 0 Ramachandran 
outliers; 98.1 % lie within the favoured regions, with 1.9 % found in allowed regions 
(Figure 3.13). Final refinement statistics can be found in Table 3.5. 
 
 
 
 
 
 
 
 
 
 BsLdcB 
PDBid 4OX3 
Data collection  
Space Group P212121 
Unit cell dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
42.7, 53.7, 102.4 
90, 90, 90 
Wavelength (Å) 0.97 
Resolution (Å) 47.6-1.70 
(1.73-1.70)* 
Multiplicity 3.2 (1.7) 
Rmergea 0.072 (0.235) 
I/σI 11.9 (2.4) 
Completeness (%) 95.7 (89.3) 
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Table 3.5: Summary of X-ray data  refinement statistics for BsLdcB. 
* Highest resolution shell shown in parentheses. 
aRwork/Rfree = |Fpobs – Fpcalc|/Fpobs, where Fpobs and Fpcalc are the observed and calculated structure factor amplitudes, 
respectively. 
 
 
Figure 3.13: Ramachandran plot of the BsLdcB structure. Black shapes represent residues in favoured regions, orange 
shapes represent those residues in allowed regions. This plot was generated using the RAMPAGE webserver (Lovell 
et al., 2003) (http://mordred.bioc.cam.ac.uk/~rapper/rampage.php) 
 BsLdcB 
PDBid 4OX3 
Resolution (Å) 47.6-2.0 
No. Reflections 35526 (1057) 
Rwork/Rfreea 0.176/0.247 
No. atoms 
Protein 
# proteins/AU 
  Ion/Ligand 
Water 
 
1753 
1 
1/5 
230 
B factors (Å2) 
Protein 
Ion/Ligand 
Water 
 
16.0 
10.7/23.8 
31.6 
R.m.s deviations 
  Bond lengths (Å) 
Bond angles (°) 
 
0.015 
1.76 
Ramachandran  
   favoured (%) 
   allowed   (%) 
 
98.1 
100 
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3.4 The structure of LdcB  
3.4.1 The structures of SpLdcB and BsLdcB  
The LdcB enzymes share a very similar overall fold with a core RMSD of 1.8 Å over 154 
Cα atoms; both enzymes are single domain proteins comprising two sub-domains 
separated by a V-shaped cleft (Figure 3.14 A+B). The first subdomain comprises a    four-
stranded, anti-parallel β-sheet (β3-6) that opposes the cleft, and the outside face of the 
β-sheet is flanked by three α-helices (α1, α4, α6). The second subdomain comprises an 
N-terminal, two-stranded, anti-parallel β-sheet (β1-2), somewhat discrete from the four 
helical bundle (α2, α3, α5, α7) that makes up the rest of the subdomain. Neither 
subdomain is formed by a contiguous, linear part of the primary sequence; the two 
subdomains are connected by six loops (β3-α1, β4-α2, α3-β5, β5-α5, α5-β6, α6-α7).  
 
 
Figure 3.14: Structure of LdcB. Cartoon representation of SpLdcB (A) and BsLdcB (B); α-helices (red) and β-strands 
(yellow) are numbered. The loops between secondary structure elements are coloured white. The bound zinc ion is 
shown as a grey sphere. Unless otherwise stated, this, and all subsequent figures, were produced with PyMOL 
(Schrodinger, 2010) 
 
The cleft between subdomains is 15-18 Å wide at the top, 15 Å deep and narrows down 
to the base where a Zn2+ ion is located, which is coordinated in a tetrahedral manner by 
three amino acids (Figure 3.15, overleaf). In SpLdcB, the liganding residues are His153, 
Asp160 and His207 (Figure 3.15, overleaf); the equivalent residues in BsLdcB are His185, 
Asp192 and His244 (Figure 3.15, overleaf). These zinc-ligands are universally conserved 
in LdcB sequences (Figures 3.16 and 3.17 overleaf), consistent with an important 
functional role in these enzymes. The zinc-ligands are themselves hydrogen bonded by 
a set of conserved amino acids. In SpLdcB (corresponding BsLdcB residues are labelled 
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in parentheses) Gly118 (Gly150) interacts with His153 (His185) while Glu152 (Glu184) 
hydrogen bonds with His207 (His244), providing structural rigidity to the active site 
(Figure 3.15). In addition to these Zn2+ binding amino acids, the active site contains 
Glu204 (Glu241) which might be capable of acting as an acid/base during catalysis, and 
Arg120 (Arg152), which, with its proximity to the zinc, could stabilise a negatively-
charged intermediate reaction state (Figure 3.15). These active site residues are strictly 
conserved in various LdcB and VanY family enzymes (Figure 3.17), with the exception of 
Gly118 equivalents, which are found to be replaced by threonine in two sequences. This 
mutation is not surprising as it is the carbonyl oxygen of the glycine that hydrogen bonds 
to the histidine, and thus the hydrogen bonding network is conserved despite this 
substitution. Possible catalytic mechanisms involving these residues are suggested and 
expanded upon in Section 4.5. 
 
 
Figure 3.15: Structure of the LdcB active site. Stick representations of SpLdcB (A) and BsLdcB (B) active 
sites. A zinc ion is coordinated by two invariant histidines and a well-conserved aspartate. The two 
histidines are hydrogen bonded to either a glutamate or glycine, providing rigidity to the active site. 
Carbons are shown in white and the bound zinc ion is shown as a grey sphere. 
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Figure 3.16: Conservation of zinc-coordinating residues. Weblogo (Crooks et al., 2004) motif showing the 
conservation of the zinc-coordinating residues (indicated by an asterisk) in LdcB sequences from a range of organisms  
(S. pneumoniae, S. pseudopneumoniae, S. mitis, S. infantis, S. oralis, G. sanguinis, L. fusiformis, G. adiacens, G. elegans, 
Fermicutes bacterium M10-2, K. huakuii, B. subtilis, B. anthracis, L. lactis,  C. difficile, S. aureus and L. monocytogenes). 
Amino acids are labelled based upon the sequence of SpLdcB. Polar amino acids (G,S,T,Y,C,Q,N) are shown in green, 
basic residues (K,R,H) in blue, acidic residues (D,E) in red and hydrophobic (A,V,L,I,P,W,F,M) amino acids are black. 
Sequences were aligned in MUSCLE (Edgar, 2004). 
 
 
 
Figure 3.17: Sequence alignment of a range of LdcB sequences with VanY, VanXYg and VanXYc. Sequence 
conservation is show as a rainbow (cyan>red), with red indicating highest conservation. All metal binding residues are 
shown in black boxes, their hydrogen bonding partners are shown in grey boxes with grey underline and residues 
hypothesised to be involved in catalysis are shown in blue boxes. Residues are numbered in reference to the SpLdcB 
sequence. Spp = S. pseudopneumoniae, Sm = S. mitis, Si = S. infantis, So = S. oralis, Gs = G. sanguinis, Lf = L. fusiformis,                         
Ga = G. adiacens, Ge = G. elegans, Fb = Fermicute bacterium M10-2, Kh = K. huakuii, Ll = L. lactis, Cd = C. difficile,            
Sa = S. aureus and Lm = L. monocytogenes). 
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3.4.2 Identification of native-bound ligands 
The active site of SpLdcB contains unattributed residual electron density that occupies 
the position of the fourth ligand in the tetrahedral coordination sphere of the zinc 
(Figure 3.18). To use the nomenclature common to proteases, the unattributed electron 
density extends as far as the S1’ subsite, the location ordinarily occupied by the scissile 
amino acid. The ligand is stabilised in this position by van der Waals’ contacts between 
the alanyl methyl group and the phenolic side chains of Tyr191 and Tyr201, and by 
hydrogen bonds to the side chains of Glu204 and the main chain amide nitrogen of 
Ala146 (Figure 3.18). Despite the high resolution of the SpLdcB diffraction data, it was 
not possible to determine the identity of the ligand from the shape of the electron 
density alone, which is of the approximate size expected of a dipeptide. Although the 
crystallisation condition did contain a number of amino acids, it did not contain any 
dipeptides nor any other molecules of the mass to account for the electron density, 
therefore the ligand is likely to have co-purified with the enzyme from E. coli during its 
overexpression.  
 
 
 
 
 
 
Figure 3.18: Unknown density in the LdcB active site. Electron density corresponding to an unknown ligand 
(green mesh) was observed in the active site of SpLdcB. Y191 and Y201 appear to stabilise the ligand, and E204 
and A146 are within hydrogen bonding distance. SpLdcB is shown in stick representation with white carbons, 
the bound zinc ion is shown as a grey sphere. Electron density maps are 2Fo-Fc and are contoured to 3.0 σ. 
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Two complementary methods were employed in an attempt to identify the ligand. First, 
purified SpLdcB was submitted for native and denatured mass spectrometry. By 
comparing the apparent mass of the native protein, which includes the masses of any 
bound ligands, with that of the denatured protein, the mass of any bound ligands could 
be deduced by simple subtraction. Databases such as the NIST chemical database 
(http://webbook.nist.gov) were queried with the mass differences obtained in a search 
for likely chemical identities. 
SpLdcB was dialysed into 10 mM ammonium acetate buffer pH 8 prior to being 
concentrated to 10 mg/ml and submitted to for native and denatured electrospray mass 
spectrometry at the Mass Spectrometry facility, Astbury Centre for Structural Molecular 
Biology at the University of Leeds, UK, by Dr James Ault. SpLdcB was analysed on a 
Platform II mass spectrometer (Waters). The denatured protein sample produced a mass 
of 21170.5 Da (Figure 3.19, overleaf), consistent with that of SpLdcB (21170.2 Da, 
calculated by the ProtParam webserver (Gasteiger et al., 2005)). The native protein 
produced a spectrum with a large peak at 21236.3 Da, corresponding to SpLdcB with 
bound zinc ion of 65.9 Da (21236.3 - 21170.2 = 66.1 Da). Additional peaks with masses 
of 21245.4 and 21335.1 Da in the native SpLdcB spectrum could correspond to 
molecules that fulfil unmodelled electron density.  
The unknown ligand is observed to coordinate to SpLdcB via the active site zinc            
(Figure 3.18) and thus the mass of SpLdcB:zinc (21236.3 Da) was subtracted from the 
remaining mass peaks (21245.4 and 21335.1 Da) to determine the mass of the ligand. 
This resulted in two mass differences; 9 Da, far too small to account for the observed 
density, and 99 Da. 99 Da does not correspond to any dipeptides (mass ranges of                
115 Da [Gly-Gly] – 373 Da [Trp-Trp]), or to any amino acids. A search of NIST with a mass 
difference of 99 Da produces a list of 195 candidates, with masses that range from 98.9 
– 99.16 Da. However, none of the proposed chemicals provide sufficient explanation for 
the observed electron density. Expanding the search further, to include molecules with 
masses ranging from 98 – 101 Da, produces a list of over 400 candidates and it quickly 
becomes unfeasible to interrogate the list effectively. 
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Figure 3.19: Electrospray mass spectra of SpLdcB native (top) and denatured (bottom). The differences seen between the mass of the denatured and native SpLdcB do not 
correspond to an amino acid or dipeptide. Electrospray mass spectroscopy was performed by Dr James Ault, Leeds University. 
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The second method employed to identify the unknown ligand assumed that the ligand 
was an amino acid or dipeptide. This assumption is not unwarranted as the reaction 
products of LdcB are an amino acid and a tripeptide; and a dipeptide could easily bind 
to an active site designed to accommodate tetrapeptides. The ligand, once theoretically 
extracted from SpLdcB by thermal denaturation and centrifugal filtration, was 
chemically linked to FDAA (1-fluoro-2-4-dinitrophenyl-5-L-alanine amide)                           
(Section 2.5.2.2). The resultant diastereomer was then loaded onto a C-18 reverse phase 
HPLC column and eluted by an acetronitrile gradient. Two peaks, in addition to two, 
large, free FDAA peaks, were observed. The retention time of the two peaks was 
compared to that of control FDAA-linked amino acids and dipeptides, with one peak 
matching that of FDAA-L-alanine and the other FDAA-D-alanine (Figure 3.20). 
 
 
Figure 3.20: Reverse-phase HPLC chromatograms for FDAA-linked L-alanine (A), D-alanine (B) and unknown ligand 
(C) and FDAA by itself (D). All significant peaks in panel C correspond to peaks in the other three panels; either FDAA-
linked L-alanine (1st peak), FDAA-linked D-alanine (2nd peak) or unlinked FDAA (peaks 3 and 4).  
82 
 
Although alanine cannot adequately explain the entirety of the electron density 
observed at the S1 and S1’ subsites, both stereoisomers fit well into the portion of the 
electron density at S1’, where the terminal D-alanine of the cell wall tetrapeptide would 
be located during catalysis (Figure 3.21), prior to and following refinement. Ultimately, 
the D-isomer of alanine was modelled as it is the enzymatic product of these enzymes. 
Unfortunately, the residual electron density coordinating directly to the zinc ion (purple) 
could not be modelled satisfactorily with any ligand arising from the enzymatic activity, 
the crystallisation milieu or purification media, and consequently the remaining electron 
density has been left unmodelled (Figure 3.21). 
 
 
Figure 3.21: D- and L-Alanine fitting into the unknown SpLdcB density.  Both D- and L- alanine fit equally well in the 
unknown density (green mesh). The identity of the second electron density mesh (purple) could not be determined 
and has been left unmodelled. SpLdcB is shown in stick representation with white carbons, the bound zinc ion is 
shown as a grey sphere. Electron density maps are 2Fo-Fc and are contoured to 3.0 σ. 
 
As mentioned previously, the shape of the electron density (both green and purple 
meshes) appears to be of a dipeptide. In addition, the proximity of the amino group of 
the D-alanine, within 1.55 Å of the unmodelled density, indicates that the D-Alanine may 
be covalently linked to another molecule (amino acid or otherwise). In addition, the size 
of the unmodelled electron density is similar to that of the density that corresponds to 
the D-alanine, albeit a different shape, suggesting that the unidentified molecule is likely 
around 90-110 Da in mass.    
Residual electron density was also identified in the active site of BsLdcB, in the vicinity 
of the catalytic zinc ion. This density was fulfilled by a phosphate anion, a component of 
the crystallisation condition, which refined satisfactorily (Figure 3.22).  
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Figure 3.22: Density of a phosphate ion in the BsLdcB active site. Density that corresponds to a phosphate ion was 
found in the active site of BsLdcB (blue mesh). Additional density was located within 4 Å of the first phosphate (green 
mesh), with electrostatic repulsion making it unlikely that the unknown density corresponded to a second phosphate. 
BsLdcB is shown in stick representation with white carbons, the bound zinc ion is shown as a grey sphere and the 
phosphate ion in ball-and-stick representation. Electron density maps are 2Fo-Fc and are contoured to 3.0 σ 
 
There is a further unmodelled electron density feature, this time in the S1’ subsite, the 
approximate size and shape of a phosphate anion. However, the proximity of this second 
density feature, 4 Å from the first, makes it unlikely that both are phosphate anions. 
Whilst it is possible that the presence of the nearby Arg152 could stabilise the 
electrostatic repulsion that would be experienced by two phosphates, we have chosen 
to leave the second electron density region unmodelled in the final structure. 
3.4.3 Comparing the LdcB structures 
During the course of this project, LdcB from Bacillus anthracis (BaLdcB) was crystallised 
and its structure solved by the Center for Structural Genomics of Infectious Disease 
(CSGID) (Hoyland et al., 2014). Like SpLdcB and BsLdcB, BaLdcB is comprised of a single 
domain, with two sub-domains separated by a V-shaped cleft, though the second           
sub-domain is less well-structured than in BsLdcB and SpLdcB and as a consequence the 
β1- β2 sheet is not formed (Figure 3.23).  
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Figure 3.23: Comparing the three LdcB structures. (A-C) Cartoon representations of SpLdcB (A), BsLdcB (B), and 
BaLdcB (C); α-helices (red) and β-strands (yellow) are numbered. The loops between secondary structure elements 
are coloured silver. The bound zinc ion is shown as a grey sphere. 
(D-F) The active sites of SpLdcB (D), BsLdcB (E), and BaLdcB (F). A zinc ion is coordinated in a tetrahedral manner in 
the structures by two invariant histidines and a well-conserved aspartate. The residual difference density (2Fo-Fc) 
features are shown contoured at a level of 3 σ and hydrogen bonds are drawn as dashed black lines. 
 
SpLdcB, BsLdcB and BaLdcB share pairwise sequence identities of ~30%, and they 
superimpose on ~155 common Cα atoms with an RMSD of 1.5 Å - 1.8 Å. The major 
differences between the LdcB structures are limited to the rather flexible and 
unconstrained N- and C-termini and the occasional longer loop in one structure in 
comparison to the others, due to sequence insertions. The protein atoms of the active 
sites of all three LdcB enzymes are, to all extents and purposes, indistinguishable            
(Figure 3.23, D-F). A further BaLdcB structure has been solved that contains no bound 
zinc ion, but there are negligible differences between it and its counterpart with zinc 
bound (Hoyland et al., 2014). The LdcB enzymes therefore do not appear to require zinc 
to correctly fold, though the presence of the metal ion is required for catalysis (Section 
4.3) (Hoyland et al., 2014). 
Interestingly, the structure of SpLdcB helps to explain the effect zinc has upon 
crystallisation of these enzymes. When zinc binding of LdcB was assessed in solution, 
the excess zinc was removed by size exclusion. By contrast, SpLdcB was crystallised with 
a 4:1 excess of zinc and so each molecule of SpLdcB binds one zinc in the active site and 
shares two further zinc ions with neighbouring LdcB proteins in the crystal lattice         
(Figure 3.24, overleaf). The two surface zinc-binding sites differ in that the first site 
(pink:green contact in Figure 3.23) is comprised of 3 amino acid ligands; His-2 and Glu56 
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from the pink monomer and His79 from the green molecule, and a water is present as 
the final ligand. The second site, between the green and blue molecules (Figure 3.24, 
overleaf), is comprised of His181 and Asp184 from the green monomer, a serendipitous 
tris ligand from the crystallisation milieu and His115 from the blue molecule. In a further 
act of serendipity, histidine -2 is from the pET28a vector used for overexpression; not 
only does the crystal contact involving His-2 improve the quality of the crystals, it 
stabilises the tag and allows the selenomethionine at position -1 to contribute to the 
anomalous signal, accounting for the 3rd site with 50% occupancy identified by SHELXD 
during the selenium heavy atom substructure search (Figure 3.8). Corroborating this, 
the B-factor of Mse-1 is almost double that of the other Se-Met residues of SpLdcB (Mse-
1 = 59.0 Å2, Mse105 = 24.2 Å2, Mse202 = 33.9 Å2). 
The intermolecular zinc binding sites, although not possessing any physiological 
relevance, are analogous to common zinc binding sites. The site between the pink and 
green monomers is comprised of a two histidines and a glutamate in the same 
arrangement as the metal binding site found in the canonical carboxypeptidase,  
pancreatic carboxypeptidase A (Christianson and Lipscomb, 1989), whilst the site 
situated between the green and blue monomers is identical to the catalytic zinc site of 
LdcB, being comprised of two histidines and an aspartate. A tris molecule completes the 
tetrahedral geometry of the green:blue metal binding site. The BsLdcB protein binds 
only 1 zinc ion per monomer, in the active site, and so the addition of excess zinc failed 
to promote crystal contacts and enhance crystallisation. 
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Figure 3.24: Zinc forms crystal contacts between SpLdcB monomers. Three neighbouring SpLdcB monomers are 
shown in cartoon ribbon representation. The zinc ions bound by these proteins are shown as grey spheres, with the 
liganding residues shown as sticks. The tris molecule is shown in stick representation with orange carbons. 
 
3.4.4 Comparison of SpLdcB and BsLdcB with LAS (lysostaphin, D-Ala-D-Ala 
metallopeptidases, sonic hedgehog) family proteins  
Using SpLdcB as a search model in DALI (Holm and Rosenström, 2010), over 50 similar 
structures were identified in the PDB (Table 3.6), including the structure of VanXYc, a 
dipeptidase/DD-carboxypeptidase; VanXYg, a second dipeptidase/DD-
carboxypeptidase; an endolysin from the Listeria bacteriophage A500; VanX, a                 
DD-dipeptidase and the N-terminal domain of sonic hedgehog, a protease involved in 
embryogenesis. Equivalent results were obtained using BsLdcB or BaLdcB as queries in 
DALI. The matched structures are all members of the wider LAS (lysostaphin, D-Ala-D-
Ala metallopeptidases, sonic hedgehog, (Bochtler et al., 2004)), family of proteases 
which, although share very little sequence identity, possess markedly similar active sites 
and core fold (Figure 3.25).  
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Table 3.6: Table summary of a section of DALI results. The structure of SpLdcB was used as a search model. 
PDBid Name Z-score % identity Reference 
4MUT VanXYc 18.6 32 Meziane-Cherif et 
al., 2014 
4F78 VanXYg 17.0 37 Meziane-Cherif et 
al., 2014 
2VO9 An endolysin from the Listeria 
bacteriophage A500 
9.5 19 Korndörfer et al., 
2008 
1R44 VanX 6.6 20 Bussiere et al., 
1998 
2WG4 N-terminal sonic hedgehog 5.3 19 Bishop et al., 2009 
1LBU D-Ala-D-Ala carboxypeptidase from 
Streptomyces albus 
4.4 19 Not published 
 
 
 
Figure 3.25: A comparison of the active sites of LdcB and other LAS family members. Both SpLdcB and BsLdcB share 
an active site closely superimposable on those of other LAS family enzymes. The zinc is co-ordinated by a H-X(3-6)-D-
X(not conserved)-H motif. A glutamate that plays an important role in catalysis is also shown; note that in D-Ala-D-Ala 
carboxypeptidase from Streptomyces albus, the equivalent amino acid is histidine, the first amino acid in the H-X-H 
motif common to many LAS carboxypeptidases. The structures shown, distinguished by the colouring of carbon 
atoms, are SpLdcB (white), BsLdcB (green), BaLdcB (orange), Enterococcus faecalis D,D-dipeptidase/D,D-
carboxypeptidase VanXYG (yellow; PDBid: 4F78), Enterococcus faecium aminodipeptidase VanX (blue; PDBid: 1R44) 
and S. albus D-Ala-D-Ala carboxypeptidase (pink; PDBid: 1LBU). 
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Although the overall folds of the various LAS super-family proteins differ, every member 
contains a core β-sheet comprised of a minimum of 4 antiparallel β-strands, which acts 
as a scaffold for the placement of residues used to bind a catalytic zinc ion (Bochtler et 
al., 2004). These Zn2+ ligands are invariably found to be His-Asp-His and can be identified 
by a H-X(3/6)-D-X(not conserved)-H consensus sequence. The first histidine of the zinc 
binding motif consistently extends from a loop that connects strands 1 and 2 of the β-
sheet (β3 and β4 in SpLdcB and BsLdcB, β1 and β2 of BaLdcB) and coordinates the Zn2+ 
ion through the N(ε) of its imidazole ring (Bochtler et al., 2004). The orientation of the 
histidine positions the N(δ) of the imidazole ring within hydrogen bonding distance of a 
main-chain carbonyl oxygen atom (Gly118 in SpLdcB) and its protonated state allows it 
to act as the hydrogen bond donor. The second residue of the triad, aspartic acid, 
extends from the second strand of the β-sheet and is either 3 or, in the case of SpLdcB 
and the Van-family enzymes, 6 amino acids downstream of the first histidine (Bochtler 
et al., 2004). Finally, the third histidine is found at various distances downstream of the 
first two amino acids, but invariably extends from the 4th strand of the β-sheet (Bochtler 
et al., 2004), which is β6 in SpLdcB and BsLdcB, β4 in BaLdcB. Like the first histidine, both 
nitrogens of the imidazole ring are used to lock the residue in the correct orientation, 
though the roles of the N(ε) and N(δ) are reversed; the N(δ) is used to coordinate the 
Zn2+ ion, resulting in a protonated N(ε) that then acts as hydrogen bond donor to a 
glutamate residue (Glu152 in SpLdcB, Glu184 in BsLdcB). 
In addition to the three protein ligands, the zinc ion is invariably coordinated by a fourth 
ligand, which tends to be either a water that is likely to act as the nucleophile in the 
reaction, or a solute from the crystallisation milieu. In the structure of the LAS family 
LytM proenzyme, an inhibitory loop folds into the active site and results in the fourth 
coordination ligand being an asparagine from the inhibitory loop (Bussiere et al., 1998; 
Bochtler et al., 2004; Odintsov et al., 2004). A phosphate anion from the crystallisation 
media occupies the fourth ligand site in coordinating the Zn2+ in BsLdcB, whilst an 
unknown ligand plays this role in SpLdcB (Section 3.4.2). 
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3.4.5 Comparing SpLdcB and BsLdcB with vancomycin resistance enzymes  
The LAS family can be divided into two sub-groups based upon a second conserved 
motif; those that contain a H-x-H motif, in which the first histidine has been shown to 
be the catalytic histidine, and those that contain the motif E-x-x-H (Bochtler et al., 2004). 
All three LdcB enzymes possess the E-x-x-H sequence and are therefore placed within 
the second group, alongside some vancomycin resistance enzymes including the                  
D-Ala-D-Ala dipeptidase VanX, the DD-carboxypeptidase VanY and the two bi-functional 
enzymes VanXYg and VanXYc, which possess both dipeptidase and carboxypeptidase 
activites (Meziane-Cherif et al., 2014). Sequence alignments of SpLdcB with VanX, VanY, 
VanXYg and VanXYc using BLAST (Altschul et al., 1990) reveal sequence identities of 
between 22 – 38 % , with SpLdcB sharing highest homology with VanXYg (36%, 79% 
coverage, E-value 1x10-21), followed by VanXYc (30%, 74% coverage, E-value 1x10-21) and 
VanY (38%, 47% coverage, E-value 2x10-19). This is not unexpected as all three of these 
enzymes target very similar substrates, the stem peptides of peptidoglycan. VanX is the 
least similar, with a sequence identity of only 22%, with 18% coverage (E-value 1.6). 
Again, this was expected, as VanX is a dipeptidase that cleaves D-Ala-D-Ala dipeptides, 
rather than a carboxypeptidase. 
Superposing the three LdcB homologues with VanXYc and VanXYg in COOT (Emsley et 
al., 2010) reveals core RMSDs of between 1.5 – 2.0 Å over 146 – 167 aligned Cα atoms 
(Table 3.6), with all active site residues aligning almost perfectly. Indeed, LdcB enzymes 
feature a serine (SpLdcB, Ser117; BsLdcB, Ser149; BaLdcB, Ser124) and glutamine 
(SpLdcB, Gln125; BsLdcB, Gln157; BaLdcB, Gln132) pair that interact with an arginine 
(SpLdcB, Arg120; BsLdcB, Arg152; BaLdcB, Arg127) present at the base of the active site 
to stabilise its conformation, a feature previously thought to be unique to the VanXY 
enzymes (Figure 3.26)(Meziane-Cherif et al., 2014). It is clear that LdcB enzymes have a 
much more solvent-accessible active site than the VanXY enzymes, a direct consequence 
of the absence from LdcB of the β4-α5/bi-substrate selectivity loop (Meziane-Cherif et 
al., 2014). Presumably the β4-α5/bi-substrate selectivity loop is required by the VanXY 
enzymes to cap the active site during the hydrolysis of dipeptide substrates, with the 
loop adopting a more open confirmation to allow the enzymes to be active against 
pentapeptide substrates (Meziane-Cherif et al., 2014).  
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Figure 3.26: A comparison of the active sites of SpLdcB and VanXYg. The active sites of LdcB and VanXY proteins are 
almost identical. Both proteins are shown in stick representation, with the carbons of SpLdcB shown in white, VanXYg 
is shown in yellow. Both confirmations of S71 of VanXYg are shown. The zinc is shown as a grey sphere and hydrogen 
bonds are shown as black dotted lines.  
 
Aside from the bi-substrate selectivity loop, the other notable difference between 
VanXYg and LdcB enzymes is the presence of a second domain formed from residues 1–
32 and 186–250 in VanXYg (Figure 3.27). This domain is of unknown function, and is not 
present in the structure or coding sequence for the other VanXY enzyme, VanXYc. 
Sequence homology suggests that this second domain may be present in VanY, where it 
has been hypothesized to be involved in membrane association (Meziane-Cherif et al., 
2014). Alternatively, this domain may function in a similar manner to the ‘pedestal’ 
domain of the class B PBPs such as PBP2b, which is hypothesised to project the catalytic 
domain of the protein away from the membrane to position it next to its substrate in 
the cell wall (Macheboeuf et al., 2006), though it should be noted that this second 
domain shares no sequence homology with the ‘pedestal’ of PBP2b. In either scenario, 
the function of this domain is clearly lost in VanXYg. 
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Figure 3.27: SpLdcB superposed onto VanXYg. SpLdcB is shown as a white cartoon ribbon, VanXYg as a yellow cartoon 
ribbon. An extra domain can be observed, formed of two antiparallel β-sheets, in VanXYg. 
 
The LdcB enzymes superpose less well with VanX (Table 3.7). The active site of VanX is 
much smaller and more constricted than that of SpLdcB, BsLdcB or BaLdcB, with the 
differences in active site shape likely arising from differing substrate specificities; a 
larger active site is required by LdcB enzymes to accommodate a ligand that is ~4 times 
the size as the D-Ala-D-Ala substrate of VanX. 
 
 SpLdcB BsLdcB BaLdcB* 
VanXYg RMSD: 1.6 Å 
# Cα aligned: 146  
RMSD: 2.0 Å 
# Cα aligned: 167  
RMSD: 1.5 Å 
# Cα aligned: 154-156  
VanXYc* RMSD: 1.6 Å 
# Cα aligned: 146-148  
RMSD: 1.9 Å 
# Cα aligned: 164-166  
RMSD: 1.5 Å 
# Cα aligned: 153-155  
VanX* RMSD: 2.3 Å 
# Cα aligned: 97-100  
RMSD: 1.9 Å 
# Cα aligned: 112-116  
RMSD: 1.9 Å 
# Cα aligned: 110-119  
    
 
 
Table 3.7: RMSD scores of the three LdcB enzymes (top) with VanXYg, VanXYc and VanX (side). 
* Multiple monomers are present within the asymmetric unit, RMSD values given are an average of the 
superimposition of all monomers and the number of aligned Cα atoms is given as a range.  
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3.4.6 Comparing LdcB enzymes to other LD-carboxypeptidases 
While the LdcB enzymes are the first of the LD-carboxypeptidases of the LAS family to 
be identified, several bacterial LD-carboxypeptidases have been characterised 
previously. These include LdcA (LD-carboxypeptidase A) from a range of organisms, 
including E. coli (Templin et al., 1999), Novosphingobium aromaticivorans (Das et al., 
2013) and Pseudomonas aeruginosa (Korza and Bochtler, 2005), and the recently 
discovered Csd6 and Pgp2 enzymes, two homologous LD-carboxypeptidases which aid 
to maintain the helical shape of H. pylori (Sycuro et al., 2013) and C. jejuni (Frirdich et 
al., 2014).  
LdcA was first isolated from the cytoplasm of E. coli and is essential in maintaining cell 
viability during stationary phase growth (Templin et al., 1999). It has been shown to 
cleave D-alanine from soluble tetrapeptides that are not incorporated into 
peptidoglycan (Templin et al., 1999). This is in contrast to LdcB, which is found on the 
exterior of the cell and cleaves tetrapeptides found within peptidoglycan. A protein 
BLAST (Altschul et al., 1990) comparison of the three LdcB homologues with various LdcA 
enzymes gives an average sequence identity of 67%, but with a coverage of only 3% (E-
value 0.17). Unsurprisingly, given the lack of sequence homology, there is little structural 
conservation between these proteins. Comparing SpLdcB with either of the two LdcA 
structures present in the PDB (P. aeruginosa LdcA PDBid: 1ZRS or Novosphingobium 
aromaticivorans LdcA PDBid: 3G23), reveals that these enzymes adopt distinct folds, 
with core RMSDs of 3.8 Å over 56 aligned Cα atoms and 5.0 Å over only 65 Cαs obtained, 
respectively (Figure 3.28). LdcA utilises a Ser-His-Glu catalytic triad during catalysis and 
is therefore not a metalloprotease (Korza and Bochtler, 2005). Whilst it is clear that LdcA 
and LdcB share similar activities, they accomplish these functions by different 
mechanisms and are unrelated in structure and sequence. 
 
93 
 
 
 
 
Equally, LdcB shares no sequence similarity with either Csd6 or Pgp2. Csd6 and Pgp2 
both belong to an LD-transpeptidase family that utilises a conserved Cys/His motif for 
catalysis (Biarrotte-Sorin et al., 2006), and are therefore also distinct from the 
metalloprotease LdcB. Interestingly, Csd6 has been shown to only hydrolyse D-Ala from 
monomeric stem peptides whereas LdcB is active against both monomeric and cross-
linked (tetra-tetra) stem peptides (Sycuro et al., 2013; Hoyland et al., 2014), but the 
absence of any structure or sequence similarity between these enzymes precludes 
useful comparison. 
3.5 Summary  
This chapter describes the crystallisation and structure determination of proteins 
encoded by the ldcB gene in S. pneumoniae and B. subtilis. The crystal structures allowed 
key features of these enzymes to be identified and comparisons made to related 
enzymes. 
Initial crystallisation trials of SpLdcB produced rod-shaped crystals that diffracted to 3.6 
Å. These crystals were not suitable for high resolution structural analysis. The addition 
of excess zinc following purification was shown to greatly enhance the quality of crystals 
produced. 
Diffraction data were collected from the improved zinc-bound Set-Met substituted 
SpLdcB crystals and the structure solved by Se-Met SAD. In addition, BsLdcB was 
crystallised and native diffraction data were collected. The BsLdcB structure was solved 
by molecular replacement with that of SpLdcB as the search model. 
Figure 3.28: The structure of SpLdcB (A) compared to LdcA from P. aeruginosa (B) and N. aromaticivorans 
(C). All three proteins are shown as cartoon ribbons. The structure of SpLdcB shares no common structural 
motifs with either of the LdcA enzymes.   
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The structure of LdcB reveals a single-domain protein comprised of two-subdomains 
separated by a V-shaped cleft, at the bottom of which is a Zn2+, coordinated by two 
histidines and an aspartate that extend from a four-stranded, antiparallel β-sheet, a 
characteristic feature of LAS family of peptidases (Bochtler et al., 2004). In addition, the 
presence of an E-x-x-H motif, in place of H-x-H, places LdcB enzymes in a subset of LAS 
enzymes alongside VanX, VanY, VanXYg and VanXYc. The similarities in structure of LdcB 
with VanY, VanXYg and VanXYc, in addition to their cleaving of substrates that differ in 
length by only one amino acid, suggests that these enzymes bind and catalyse the 
hydrolysis of their substrates in similar manners. Understanding the structure and 
function of LdcB would therefore provide key insights into not only                                                    
LD-carboxypeptidases, but potentially vancomycin resistance also, a subject of great 
interest in this era of increasing antibiotic resistance.  
The results presented herein provide the first structures of zinc-utilising                                          
LD-carboxypeptidases. Residues important in the binding of peptidoglycan stem-
peptides are highlighted through the appearance of conserved residues in VanXYg and 
VanXYc, though questions on how these enzymes differentiate between pentapeptide 
and tetrapeptide substrates remain to be answered.      
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Chapter 4: 
The structure of SpLdcB complexed with          
MurNAc-Ala-D-γ-Gln-Lys(D-Asn) & the biochemical 
characterisation of LdcB enzymes   
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4.1 Introduction 
LdcB has been implicated previously in cleaving D-alanine from cell wall tetrapeptides; 
the cell walls of ldcB null mutants in S. pneumoniae, L. lactis and B. subtilis showed an 
increase in the amounts of tetrapeptides accompanied by a decrease in tripeptide 
content (Courtin et al., 2006; Barendt et al., 2011; Hoyland et al., 2014). However, no 
direct observation of the catalytic activity of LdcB has been reported. The crystal 
structures of SpLdcB and BsLdcB that were described in Chapter 3 and by Hoyland et 
al., (2014), and that of BaLdcB, which was solved by the CSGID and that was also 
reported by Hoyland et al (2014), require complementing with an LdcB structure in 
complex with a peptidoglycan fragment in order to understand substrate specificity 
and the catalytic mechanism employed at a molecular level by this enzyme family. 
Such knowledge is also likely to provide key insights on molecular recognition and 
catalysis in the wider LAS family of peptidases. In this chapter the crystal structure of 
LdcB with a bound product mimic is described (Section 4.2), the catalytic properties of 
LdcB are investigated (Sections 4.3 & 4.4), and an enzymatic mechanism for LdcB is 
proposed (Section 4.5).  
4.2 Co-crystallisation 
4.2.1 Selection of ligands for co-crystallisation studies 
Although the crystal structures of SpLdcB and BsLdcB revealed key structural features 
of the enzymes, the enzymes in complex with a ligand would allow detailed analysis of 
the residues that line the active site and allow a determination of how the enzyme 
differentiates between L and D peptides. Since wildtype LdcB would be catalytically 
active against cell wall tetrapeptides, their use in co-crystallisation experiments was 
precluded. A further problem is the general unavailability of many of the precursors 
required for cell wall synthesis on a scale that supports structural studies. In instances 
where the target ligand is unavailable, is unstable or is degraded by the enzyme, a 
common method employed to trap enzyme:substrate complexes is with                         
non-hydrolysable substrate or product analogues (Oswald et al., 2008). For example, 
AMP-PNP or ADP have been substituted successfully for ATP in co-crystallisation 
studies on kinases (Ivey et al., 2004; Simanshu et al., 2005). In this instance, four 
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peptidoglycan mimics were found to be commercially available from InvivoGen;              
M-Tri-Lys, M-Tri-Lys(D-Asn), MDP and Tri-DAP (Table 4.1). 
 
Table 4.1: The chemical structures of commercially available cell wall fragments. All fragments were purchased 
from InvivoGen (http://www.invivogen.com) 
Name Mr  Structure 
 
M-Tri-
Lys(D-Asn) 
 
 
734.75 
 
 
 
M-Tri-Lys 
 
 
620.65 
 
 
 
MDP 
 
 
492.5 
 
 
 
Tri-DAP 
 
 
390.39 
 
 
4.2.2 Crystallisation trials of SpLdcB with a range of products and substrates  
To discover the molecular basis of substrate specificity in LdcB enzymes, the crystal 
structure of SpLdcB in complex with a range of commercially-available ligands was 
sought (Table 4.1). Native SpLdcB was purified and concentrated to 15 mg/ml and a 
4:1 molar excess of zinc was added (Section 2.2). The target ligand was added to a final 
concentration of 2 mM from concentrated stocks to avoid excessive dilution of the 
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protein. Crystallisation trials were conducted in 96-well sitting-drop vapour diffusion 
trays, utilising a Mosquito (TTP labtech) crystallisation robot and a range of 
commercially available screens (Molecular Dimensions, Qiagen, Hampton Research), 
with crystals growing over a period of 2 – 7 days. The crystallisation conditions were 
not optimised due to the limited availability of the ligands. Crystals were obtained for 
each of the four ligands under the different conditions, but with some overlap; all 
screens produced crystals from PACT C8, whereas only MDP produced crystals in 
Structure G8 (for a full list of conditions, see Appendix 4). Crystals (Figure 4.1) were 
harvested directly from the 96-well screen plates, cryo-protected in paratone-N oil and 
flash cooled in liquid nitrogen. Due to the proximity of a synchrotron trip, crystals were 
not tested in-house prior to diffraction data collection at the Diamond Light Source on 
beamline IO2; each dataset was collected at 0.92 Å with 0.1° oscillations and 0.1 s 
exposures per image. The total number of images collected was based upon the 
predicted space group of each individual crystal to ensure that complete data sets 
were collected. 
 
 
Figure 4.1: Crystals of SpLdcB co-crystallised with (A) Tri-DAP; (B) M-Tri-Lys(D-Asn); (C) M-Tri-Lys 
 
Each diffraction dataset was integrated with XDS (Kabsch, 2010) and reduced with 
SCALA (Evans, 2005). Diffraction data collection statistics for each crystal grown in the 
presence of a unique ligand are summarised in Table 4.2. Interestingly, it was noted 
that dataset 3 shares an almost identical unit cell with native SpLdcB, despite 
belonging to different space groups; native SpLdcB was found to be I222, whereas 
datasets 3 is P21212. Comparing the packing of the molecules in the unit cell showed 
that both cells were equivalent, suggesting that the difference in space group was due 
to the presence of two molecules in the asymmetric unit dataset 3 (P21212) and one 
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molecule in the native SpLdcB dataset (I222); non-crystallographic symmetry operators 
are present in dataset 3, whereas the native SpLdcB unit cell is constructed from 
crystallographic symmetry operators. An example of an identical situation has 
previously been highlighted on the ccp4 bulletin board (personal communication), 
using cellobiohydrolase I from Trichoderma reesei (Stahlberg et al., 1996) as a case 
study.  
The structure of SpLdcB was used as the molecular replacement model in PHASER 
(McCoy et al., 2007) to solve the structures of all four datasets. Following one round of 
rigid body refinement in REFMAC5 (Winn et al., 2011), difference electron density 
maps were inspected to determine the presence, or absence, of ligand in the vicinity of 
the active site zinc ion. Only in dataset (1), in which PHASER had positioned 5 chains in 
the asymmetric unit, was positive electron density found that corresponded to M-Tri-
Lys(D-Asn) in just one of the protein chains.  
 
Table 4.2: Summary of representative X-ray data collection statistics for SpLdcB with ligands.  
* Highest resolution shell shown in parentheses. 
aRmerge = hi|Ii(h) - I(h)/hiIi(h), where Ii(h) and I(h) are the ith and mean measurement of the intensity of reflection h. 
 
The model was refined in COOT through stages of manual (re)building interspaced with 
restrained refinement in PHENIX.REFINE (Afonine et al., 2012) with automatically 
generated NCS restraints, until convergence. TLS groups were identified through the 
use of the TLS server (Painter and Merritt, 2006) and 4 TLS groups were used to refine 
chains C and D, 2 groups were used for chains B and E, and 5 groups were used for 
Dataset 1 2 3 4 
Co-crystallised ligand M-Tri-Lys(D-Asn) M-Tri-Lys MDP Tri-DAP 
Condition PACT C8 Morpheus D8 Morpheus E8 PACT C8 
Space Group C2 P21212 P21212 P212121 
Unit cell dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
346.0, 42.5, 79.3 
90, 93.1, 90 
 
57.9, 139.1, 45.2 
90, 90, 90 
 
48.2, 58.4, 137.1 
90, 90, 90 
 
48.5, 59.2, 138.1 
90, 90, 90 
Wavelength (Å) 0.92 0.92 0.92 0.92 
Resolution (Å) 47.8 - 2.80 
(2.95 - 2.80)* 
53.43 – 2.30  
(2.42 – 2.30) 
45.71 – 2.15 
(2.22 - 2.15) 
46.05 – 1.90 
(1.94 – 1.90) 
Multiplicity 
 
3.4 (3.4) 
 
3.2 (3.1) 
 
3.2 (3.4) 
 
7.0 (5.3) 
Rmergea 0.134 (0.635) 0.047 (0.325) 0.031 (0.356) 0.144 (0.319) 
I/σI 7.8 (1.9) 13.7 (3.4) 16.7 (2.2) 8.9 (3.3) 
Completeness (%) 98.3 (98.3) 98.1 (97.7) 98.6 (97.5) 100 (100) 
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chain A. The MurNAc-L-Ala-D-γ-Gln-L-Lys-(D-Asn) ligand was built using JLigand 
(Lebedev et al., 2012) to output structure (.pdb) and restraint (.cif) files, and the ligand 
was subsequently positioned manually in the electron density in COOT. Restrained 
refinement in PHENIX.REFINE (Afonine et al., 2012) was used to optimise the position 
of the ligand. 
The final model of ligand-bound SpLdcB consisted of 5 protein chains, in which all 
cloned residues (56 - 237) except the terminal residue, D238, were present. In 
addition, histidine (-2) and methionine (-1) - contributed by the introduction of an             
N-terminal His-tag in pET28a - could be built in chains A, B, D and E. Density for chains 
A and B also permitted the building of serine (-3). The Ramachandran plot of the final 
structure revealed that 96.5 % of residues lay within the favoured regions, with 2.9 % 
found in allowed regions and just 5 Ramachandran outliers (Figure 4.2).  
 
 
Figure 4.2: Ramachandran plot of the SpLdcB-ligand structure. Black shapes represent residues in favoured 
regions, orange shapes represent those residues in allowed regions. This plot was generated using the RAMPAGE 
webserver (Lovell et al., 2003) (http://mordred.bioc.cam.ac.uk/~rapper/rampage.php) 
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The electron density of each Ramachandran outlier was inspected, with each amino 
acid fitting well into the observed density. With the exception of chain D, Met-1, which 
is at the N-terminus of the chain, the outliers were all internal residues that neither 
contributed to crystal contacts nor formed part of the active site. A summary of the 
final refinement statistics can be found in Table 4.3. 
 
Table 4.3: Summary of X-ray data refinement statistics for SpLdcB + M-Tri-Lys(D-Asn). 
* Highest resolution shell shown in parentheses. 
aRwork/Rfree = |Fpobs – Fpcalc|/ Fpobs, where Fpobs and Fpcalc are the observed and calculated structure factor 
amplitudes, respectively. 
 
4.2.3 The structure of SpLdcB with M-Tri-Lys(D-Asn) bound to the active site 
The structure of SpLdcB complexed with MurNAc-L-Ala-D-γ-Gln-L-Lys-(D-Asn) was 
solved. This ligand is a close relative of the true reaction product (Figure 4.3, overleaf) 
and differs in two ways. First, the ligand lacks GlcNAc, the second sugar of the 
disaccharide that is the glycan repeating unit in PG. Second, the terminal D-Asn group 
is covalently attached by a isopeptide bond between the main chain carbonyl of the 
terminal D-Asn and the side chain N of the penultimate lysine. In cross-links between 
peptide stems of S. pneumoniae, the side chain N of the penultimate lysine is linked 
by a peptide bond to the main chain carbonyl of a D-Ala. Hence the L-Lys―(D-Asn) 
linkage is a faithful mimic of the natural L-Lys―(D-Ala), albeit the chemistry of the side 
chains of the terminal D-amino acids clearly differ.  
 SpLdcB-ligand 
PDBid 4OXD 
Refinement  
Resolution (Å) 47.8-2.80 
No. Reflections 47327 (1979) 
Rwork/Rfreea 0.273/0.335 
No. atoms 
Protein 
# proteins/AU 
  Ion/Ligand 
Water 
 
7014 
5 
21/51 
111 
B factors (Å2) 
Protein 
Ion/Ligand 
Water 
 
44.3 
38.7/69.7 
28.7 
R.m.s deviations 
  Bond lengths (Å) 
Bond angles (°) 
 
0.005 
0.84 
Ramachandran  
   favoured (%) 
   allowed   (%) 
 
95.8 
99.6 
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Figure 4.3: Schematic representations of the chemical structures of the true LdcB reaction product (A) and the 
product mimic (B).  The product mimic lacks the repeating GlcNAc-MurNAc sugars of the true substrate. 
Additionally, the D-alanine that is covalently attached to the Nζ of the lysine residue has been replaced by D- 
asparagine. Both crosslink types are found in many bacterial species, and thus the Lys-(D-Asn) linkage is faithful to 
the crosslinks found in nature. 
 
Analysis of the interfaces between the 5 protein chains in PISA (Krissinel and Henrick, 
2007) indicated that none of them represents stable multimeric forms (all buried 
surface areas < 5% total protein surface). The five molecules are highly superimposable 
(Table 4.4, overleaf), but some key differences in the active sites remain. For instance, 
in each chain B, C and E, the zinc is co-ordinated by a likely nucleophilic water to form 
tetrahedral co-ordination geometry. In chain D, the fourth zinc ligand is not evident, 
perhaps due to local disorder in the active site or the limiting resolution of the 
diffraction data. In the remaining molecule, chain A, residual electron density was 
retained throughout refinement into which MurNAc―L-Ala―D-γ-Gln―L-Lys―(D-Asn) 
could be built and refined unambiguously (Figure 4.4, overleaf).  
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Table 4.4:  RMSD values between Ligand-bound SpLdcB chains (4OXD) 
 4OXD Chain A 4OXD Chain B 4OXD Chain C 4OXD Chain D 4OXD Chain 
E 
4OXD Chain A - 0.63 0.64 0.76 1.03 
4OXD Chain B 0.63 - 0.55 0.65 0.86 
4OXD Chain C 0.64 0.55 - 0.56 0.64 
4OXD Chain D 0.76 0.65 0.56 - 0.61 
4OXD Chain E 1.03 0.86 0.64 0.61 - 
 
 
 
Figure 4.4: Cartoon representation of ligand-bound SpLdcB. The MurNAc―Ala―D-γ-Gln―L-Lys―(D-Asn) is drawn 
as a ball-and-stick model with Refmac-weighted 2Fobs-Fcalc electron density displayed at a contour level of 1 σ in 
black. α-helices are show in red, β-strands in yellow and loops in white. The zinc ion is shown as a grey sphere.  
 
The structure of the ligand-bound form of SpLdcB is entirely consistent with its            
LD-carboxypeptidase function. First, the MurNAc moiety, which is not involved in 
catalysis, is situated at the very top of the inter-subdomain cavity and makes little 
104 
 
contact to the protein. This part of the ligand has the highest B-factors (mean of 93 Å3, 
vs a mean for the intact ligand of 83 Å3), and thus the weakest electron density. The 
MurNAc O1 and O4 atoms, which define the location of the flanking, β1-4-linked 
GlcNAc sugars in PG, project away from the protein surface so that the glycan chain 
would be accommodated by the protein without steric clashes. The oxygen of the               
N-acetyl group is stabilised against the side chain of Met202 by van der Waals’ forces 
(Figure 4.5), however this residue, and therefore interaction, is not conserved across 
LdcB homologues. 
 
 
Figure 4.5: Interactions between the M-Tri-Lys(D-Asn) substrate and SpLdcB at subsite S3. The MurNAc sugar of 
the M-Tri-Lys(D-Asn) ligand form Van der Waals contacts with M202 (silver line), whilst the L-stereoisomer of 
alanine is selected for by Tyr144. The M-Tri-Lys(D-Asn) ligand is shown as ball and stick representation.   
 
The Cα and Cβ atoms of L-alanine at position 1 of the peptide pack against the face of 
Tyr144 to discriminate against the D-stereoisomer in this subsite, S3. L-alanine is 
favoured by contacts to Tyr144 and Met202, which discriminate against all L-amino 
acids bulkier than alanine (Figure 4.5). The NH2 group of the D-γ-Gln of position 2 is 
located in subsite S2, within hydrogen bonding distance of Glu204 (Figure 4.6, 
overleaf), an invariant amino acid in LdcB sequences, and stereoselectivity at this 
position is maintained because L-γ-glutamine would clash with Tyr144. 
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Figure 4.6: Interactions between the M-Tri-Lys(D-Asn) substrate and SpLdcB at subsite S2. E204 and A203 
coordinate the D-γ-Gln. These contacts would not occur with commonly occurring amino acids, providing selectivity 
for D-γ-Gln. Hydrogen bonds are shown as black, dashed lines. The M-Tri-Lys(D-Asn) ligand is shown as ball and stick 
representation. 
 
The γ-glutamine is selected for by specific interactions with the main chain carbonyl of 
Ala203 and the side chain of Glu204, whilst ensuring the scissile peptide bond is in the 
catalytic position. These key aspects of molecular recognition could not occur with 
commonly occurring amino acids. It is possible that canonical glutamine could be 
accommodated at this position, due to the absence of contacts to one face of the 
peptide, providing scope for the conformational changes needed to accommodate 
glutamine. The substitution of glutamine for γ-glutamine at this site would, however, 
only be possible in the absence of the glycan strands of the natural substrate, due to a 
‘shortening’ of the chain (Figure 4.7, overleaf). 
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Figure 4.7: The structure of MurNAc-tetrapeptide (A) compared to a mimic in which D-γ-Gln is substituted by       
D-Gln (B). The substitution results in a shortening of the chain by ~3 Å. 
 
Position 3 of the peptide is occupied by L-lysine. D-lysine could not be accommodated 
at this position because of the presence nearby of Glu107. As expected of a reaction 
product complex, the lysine carboxylate is located adjacent to the active site zinc in 
subsite S1 (Figure 4.8, overleaf). One of the carboxylic oxygens completes the zinc 
tetrahedral geometry with His153/Asp160/His207 and the second oxygen forms a salt 
bridge with Arg120, which is either arginine or lysine in LdcB orthologues. The L-lysine 
carboxylate thus represents a post-hydrolysis state, placed appropriately for the 
peptide bond of the substrate to be hydrolysed by the water molecule that fulfils the 
fourth zinc ligand in the absence of substrate. 
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Figure 4.8: Interactions between the M-Tri-Lys(D-Asn) substrate and SpLdcB at subsite S1. The ligand displaces the 
solvent molecule from the zinc coordination sphere and becomes the 4th ligand. The second oxygen of the lysine 
carboxyl group interacts with Arg120 and Asp160. Hydrogen bonds are shown as black, dashed lines. The                  
M-Tri-Lys(D-Asn) ligand is shown as ball and stick representation. 
 
The sidechain of the L-lysine twists back against the rest of the peptide and projects 
into the protein core to place the terminal D-Asn in subsite S1’ against the main chain 
atoms of Ala146 and the side chains of Tyr191, Tyr201, (Figure 4.9) The interactions 
between the protein and the ligand are summarised schematically in Figure 4.10 
(overleaf).  
 
 
Figure 4.9: Interactions between the M-Tri-Lys(D-Asn) substrate and SpLdcB at subsite S1’. The D-Asn, linked to the 
L-Lys at position 3 by an iso-peptide bond, interacts with Ala146, Tyr201 and Tyr191. Hydrogen bonds are shown as 
black, dashed lines. The M-Tri-Lys(D-Asn) ligand is shown as ball and stick representation. 
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Figure 4.10: Schematic summary of the interactions made between SpLdcB and the product mimic,                       
M-Tri-Lys(D-Asn). Hydrogen bonds are shown with dotted black lines, hydrophobic interactions shown by solid 
green lines and Van der Waals forces by a purple dotted line. The figure was made with Poseview (Stierand et al., 
2006; Stierand and Rarey, 2010) (http://poseview.zbh.uni-hamburg.de/) 
 
Excluding metal binding residues and the catalytic arginine and glutamate, all the 
residues that contact the tetrapeptide ligand are strictly conserved, with the exception 
of M202, which only interacts with the MurNAc sugar by van der Waal’s interactions; 
Ala203, which interacts via a carbonyl oxygen and thus can be substituted by all amino 
acids; Y144, which is functionally conserved as either a tyrosine or phenylalanine; 
Ala146, which is highly conserved and again, interacts via a mainchain atom; Y191, 
which is functionally conserved as either a tyrosine or phenylalanine; and Y201, which 
is functionally conserved as either a tyrosine or isoleucine. In addition, there are 
several stretches of amino acids that are either strictly or highly conserved that are not 
found near the active site (Figure 4.11). One stretch of conserved residues (151-160 in 
SpLdcB) are found to line the lower part of the active site and may prevent LdcB from 
binding larger ligands. However, their conservation in the VanY family enzymes, which 
bind pentapeptides, suggest that these ligands would have to be larger than a 
pentapeptide to be excluded from the active site. 
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Figure 4.11: Sequence alignment showing residue conservation in a range of LdcB and VanY-like enzymes. 
Conserved amino acids involved in ligand binding are shown in black boxes with black underline. A blue box and 
blue underline indicates conserved amino acids located at the bottom of the active site. Purple boxes with purple 
underline indicate conserved amino acids located at other sites on the protein. Residues are numbered in reference 
to the SpLdcB sequence. Spp = S. pseudopneumoniae, Sm = S. mitis, Si = S. infantis, So = S. oralis, Gs = G. sanguinis,  
Lf = L. fusiformis, Ga = G. adiacens, Ge = G. elegans, Fb = Fermicute bacterium M10-2, Kh = K. huakuii, Ll = L. lactis, 
Cd = C. difficile, Sa = S. aureus and Lm = L. monocytogenes). 
 
In the true enzyme-substrate complex, subsite S1’ would be occupied by the scissile             
D-alanine; the structure of VanXYg solved in complex with a phosphinate transition 
state mimic (PDBid: 4muq, (Meziane-Cherif et al., 2014) supports this hypothesis. The 
phosphinate moiety is a transition state mimic of peptide bond hydrolysis because the 
reaction proceeds via an unstable oxyanion tetrahedral intermediate that the 
chemically-inert phosphinate mimics. VanXYg superimposes on SpLdcB with an RMSD 
of 1.6 Å on 144 matched Cαs, and the alanyl carboxylate moiety of the phosphinate is 
situated in an analogous position to that of the L-Lys―(D-Asn) peptide linkage 
observed in SpLdcB (Figure 4.12, overleaf). The phosphate atoms of the phosphinate 
transition state mimic superimpose almost identically with the phosphate anion found 
adjacent to the zinc ion in the structure of BsLdcB (Figure 3.22, Section 3.4). In 
addition to Tyr191 and Tyr201, which interact with D-Asn, Ser151 and Gln125 (strictly 
conserved in LdcB sequences) aid to determine specificity for the terminal D-alanine by 
hydrogen bonding with the carboxylic oxygens of D-Ala (Figure 4.12, overleaf); the 
carboxylic oxygens of L-Ala would be orientated in a position too distant for hydrogen 
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bonding to these amino acids. Tyr201 discriminates against any amino acid bulkier 
than alanine at the S1’ subsite, though the D-Asn of the product mimic is permitted 
because it is linked to L-lysine by an isopeptide bond rather than by a canonical 
peptide bond. The amide nitrogen of Ala146 also participates in stereoselectivity, but 
as this is a main chain atom it is perhaps no surprise that sequence conservation is not 
maintained at this position.  
 
 
Figure 4.12: A comparison of the ligand-bound active sites carboxypeptidases. (A) The active site of SpLdcB (white) 
with bound MurNAc―L-Ala-D-γ-Gln―L-Lys―(D-Asn) (turquoise carbons) is compared to that of the active site of 
VanXYg (blue) containing a phosphinate transition state analog (pink carbons) of D-Ala―D-Ala (PDBid: 4MUQ). The 
phosphinate in VanXYg coordinates the active site zinc in a similar manner to that of the lysyl carboxylate in the 
MurNAc―L-Ala-D-γ-Gln―L-Lys―(D-Asn) bound to SpLdcB. The D-alanyl moiety of the phosphinate ligand in 
VanXYg, which occupies subsite S1’, is matched by the D-alanine (green carbons) in Apo SpLdcB (Section 3.4.2) 
(white) and the D-Asn of the MurNAc―L-Ala-D-γ-Gln―L-Lys―(D-Asn) ligand. The zinc ions are shown as grey 
spheres. 
 
Although the structure of SpLdcB in complex with M-Tri-Lys(D-Asn) revealed important 
aspects of ligand binding, peptidoglycan cross-links between peptide stems could not 
be accommodated in the observed conformation of the ligand. Rotation of the 
sidechain torsion angles of the L-lysine into an extended, thermodynamically-favoured 
conformation results in the side chain passing beyond Arg120, Leu128 and Tyr132 to 
project beyond the surface of the protein (Figure 4.13, overleaf).  
111 
 
 
Figure 4.13: Proposed path of cross-linked cell wall peptides. 
(A) The terminal D-Asn of the ligand when bound to SpLdcB occupies the S1’ subsite rather than projecting to the 
surface of the protein. Rotation of the lysyl’s torsion angles presents the terminal D-asparagine to the surface, 
which has been modelled here as D-Ala to illustrate the structure of the L-Lys-D-Ala cross-link observed between 
stem peptides. The path of the lysine is flanked by two highly conserved amino acids in LdcB sequences, Arg120 and 
Ser117, in addition to the functionally conserved Leu128. Tyr132 also flanks the lysine, but this amino acid is not 
conserved between sequences.  
(B) The proposed positions of the two, post-hydrolysis ligands (orange carbons) in the active site of SpLdcB (white). 
The D-alanine from the SpLdcB structure occupies the S1’ site of the protein, whilst the lysine side chain has been 
rotated and modelled in an extended conformation. The altered conformation of the lysine presents the Nζ to the 
surface of the protein, in an ideal position to accommodate peptide cross-links. The zinc ions are shown as grey 
spheres. 
 
In this conformation, cross-linked peptide stems attached to the terminal Nζ would not 
be occluded by the body of the protein, consistent with the reported ability of LdcB to 
cleave cross-linked peptides (Hoyland et al., 2014). In some bacteria, the lysine is 
replaced with meso-diaminopimelic acid, a carboxy derivative of lysine that is 
amidated in bacilli (Figure 4.14, overleaf). Whilst the aminocarboxy derivative could be 
stabilised in the observed conformation by a similar set of specific interactions, it 
would also occlude cross-linked peptide stems. Diaminopimelic acid is thus likely to 
follow the same path predicted for lysine, by forming a simple, extended conformation 
to project into solvent. 
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Figure 4.14: L-Lysine (A) vs. meso- diaminopimelic acid (B) containing stem peptides. Meso-DAP is an epsilon-
carboxy derivative of lysine, and thus the two stem peptides are of the same length. The site of amidation in the 
meso-DAP peptide is shown by an asterisk.  
 
Comparing the topology of the ligand bound to SpLdcB to that of cell wall fragments 
bound to other cell wall binding proteins (i.e.  PDBid 2WWD, 2APH, 2CB3) reveals that 
the ligand is flexible enough to follow multiple paths through the various active sites of 
the many peptidoglycan binding proteins (cell wall synthases, hydrolases, 
immunorecognition proteins etc). Despite this flexibility, however, geometric 
validation in COOT (Emsley et al., 2010) indicated that all torsion angles remain within 
acceptable parameters and it is therefore unlikely that LdcB exploits ligand distortion 
to aid in catalysis. One notable exception was identified in the PDB file of a 
peptidoglycan recognition protein (2CB3), which contained a ligand that was 
constructed as a single, unique molecule that required a custom restraint file, rather 
than being constructed of defined sugars and amino acids (MurNAc, L-Ala, D- γ-Gln, L-
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Lys [or meso-DAP], D-Ala). Manual inspection of the torsion angles between each 
amino acid in COOT revealed that it, like the other ligands, has been constructed with 
the correct geometries.  
The major difference between many of the peptidoglycan ligands found in the 
literature and the M-tri-Lys(D-Asn) ligand that co-crystallised with SpLdcB is in the 
conformation of the lysine component, as mentioned previously, which is found 
wrapped around the active site rather than in the more common extended 
conformation. It is, however, unlikely that that this conformation is true to the 
biological role of the enzyme, as expanded upon above. Interestingly, many of the 
ligands were observed to superpose onto one another identically at the MurNAc sugar 
and N-terminal L-alanine residues, with flexibility being imparted by the relatively long 
D-γ-glutamine residue, and in part by the lysine or meso-DAP sidechain. 
Several key structural changes occur upon ligand binding in SpLdcB (Figure 4.15, 
overleaf). First and foremost, substrates are occluded in the empty form of the enzyme 
by a loop between residues Gly163 and Glu171, which blocks access to the active site. 
Most of these residues (Asp167 to Glu171) move by 10-15 Å in the presence of ligand 
to open up the cleft by re-folding into an additional turn at the N-terminus of α-helix 4. 
The re-arrangement of these residues is accompanied by further conformational 
changes in Trp206, the indole ring of which moves by up to 9 Å, which not only aids to 
open up the active site of the enzyme, but also allows the side chain of Glu204 to       
re-arrange to take up a position capable of interacting with the substrate. It is 
unknown if this movement occurs prior to or post-catalysis. The importance of Glu204 
and the zinc ion for catalysis is highlighted by the observation that tetra-D is a much 
poorer substrate for the E204A variant of SpLdcB, and the absence of activity in the 
presence of EDTA (Section 4.3). The conformational changes seen on ligand binding to 
SpLdcB contrasts with the absence of significant conformational changes described for 
VanXYg in complex with phosphinate (PDBid: 4muq (Meziane-Cherif et al., 2014). 
However, it should be noted that the ‘closed’ confirmation of SpLdcB also has a small 
molecule bound in the active site, and VanXYg may undergo conformational changes 
when interacting with a larger, pentapeptide substrate. 
 
114 
 
 
 Figure 4.15: Conformational changes in SpLdcB on ligand binding. (A, B) Cartoon representations of apo SpLdcB 
(A) and SpLdcB with bound MurNAc-Ala-D-γ-Gln-Lys-(D-Asn) (B); α-helices (red) and β-strands (yellow) are 
numbered. The loops between secondary structure elements are coloured silver. The bound zinc ion is shown as a 
grey sphere. Key residues that move upon ligand binding are shown in stick representation. 
 
B-factor analysis of SpLdcB in both the opened and closed conformations reveals that 
the mobile, substrate binding loop has the highest thermal motion in the open 
conformation (Figure 4.16), perhaps indicating why many of the LdcB stuctures solved 
are in the closed conformation. It should be noted that the portion of the binding loop 
that folds into the N-terminus of α-helix 4 is more stable in the open conformation, as 
would be expected due to hydrogen bonds formed with the remainder of the helix. In 
addition, a portion of the C-terminus of α-helix 2 could not be built in the open 
conformation of LdcB, suggesting disorder which is confirmed by B-factor analysis. The 
entire α-helix was modelled in the closed conformation of SpLdcB, suggesting greater 
order. It is unclear as to whether the increased stability of α-helix 2 is due to ligand 
binding or is the result of a change in crystal contacts between native and liganded 
SpLdcB. 
4.2.4 Modelling of the tetrapeptide susbtrate 
Using the structure of SpLdcB with M-Tri-Lys(D-Asn) bound, together with the 
structure of SpLdcB that was solved with D-Ala bound in the active site and the 
structures of VanXYc and VanXYg with D-Ala bound, a model of SpLdcB with the entire 
tetrapeptide ligand bound can be proposed (Figure 4.17, overleaf). In this model, the 
contacts made by the MurNAc sugar, L-Ala, D-γ-Gln and L-Lys are maintained, with the 
side-chain of L-Lys occupying the path proposed in Section 4.2.3. The D-alanine has 
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been modelled in at the S1’ subsite, replacing the D-Asn of the M-Tri-Lys(D-Asn) 
product mimic and superposing well onto the D-alanine residue found to co-purify 
with SpLdcB.  
 
 
Figure 4.16: B-factor analysis of SpLdcB in the closed (A) and open (B) conformations. B-factor values are shown 
both by thickness of the tube, with thickers sections having higher B-factors, and by the colour of the tube; areas of 
high B-factors are shown in red, with lowest B-factors shown in blue. α-helix 2 and 4 are highlighted, as it the mobile 
loop that changes conformation between forms, as these areas show the greatest change in B-factor values 
between the two conformations.  
 
 
Figure 4.17: The modelled path of the tetrapeptide substrate of SpLdcB. Met202 interacts with the MurNAc sugar 
N-acetyl group via Van der Waals forces whilst Tyr144 stacks against the ligand Ala to sterically occlude D-Ala at this 
point. Ala203 and Glu204 interact with D-γ-Gln. The Lys residue of the ligand coordinates to the zinc ion, completing 
the zinc’s tetrahedral coordination sphere, with the side-chain of the Lys projecting out of the active site. Tyr201 
and Tyr191 stack against the terminal D-Ala, which is in turn hydrogen bonded to Ala146, Gln125, Ser151 and 
Arg120. The tetrapeptide ligand (MurNAc-Ala-D-γ-Gln-Lys-D-Ala) is shown as ball-and-stick representation, the key 
interacting residues from SpLdcB as sticks with white carbons and the surface of SpLdcB is shown in transparent 
white. The zinc ion is shown as a grey sphere. Hydrogen bonds made by the tetrapeptide ligand with SpLdcB are 
shown as black dashed lines, whilst van der Waals forces are shown as a solid silver line. 
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4.3 Biochemical and biophysical assays on the native enzyme 
4.3.1 Thin-layer chromatography (TLC) of SpLdcB reaction products  
To confirm that LdcB enzymes are LD-carboxypeptidases, the enzymes were tested for 
activity against the synthetic tetrapeptides tetra-D (L-Ala―D-Gln―L-Lys―D-Ala) and 
tetra-L (L-Ala―D-Gln―L-Lys―L-Ala). The two peptides differ from the natural cell wall 
tetrapeptide in two ways; first, they lack the N-terminal MurNAc sugar moiety and 
second, D-γ-Gln is replaced by D-Gln (Figure 4.18).  
 
 
 
Figure 4.18: Chemical structures of substrates used in this study. Tetrapeptide substrates used for catalytic studies 
(Tetra-D, Tetra-L), compared to the true substrate (cell wall tetrapeptide). 
 
Whilst the changes from the natural substrates most likely results in lower binding 
affinities for the enzyme, the two peptides do allow for discrimination between            
LD- and LL-carboxypeptidase activities. Following a 2 hour incubation of the protein 
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with the peptides, in the presence of either zinc or EDTA, the reactions were spotted 
onto a silica TLC plate to allow the products to be resolved. After optimum separation 
had been achieved, the TLC was stained with ninhydrin, which reacts with terminal 
amines and lysine sidechains to stain the products. The TLCs revealed that SpLdcB was 
active against only the tetra-D ligand, and that this activity was dependent on the 
presence of zinc; activity was abrogated in the presence of EDTA (Figure 4.19, 
overleaf). 
 
 
Figure 4.19: Activity of SpLdcB against peptidoglycan tetrapeptides. Thin layer chromatography (TLC) of SpLdcB 
incubated with various substrates. D-alanine is less polar than the tetrapeptide and migrates faster in TLC. SpLdcB is 
able to hydrolyse only the Tetra-D substrate, and only in the presence of zinc. 
 
These results agreed with those obtained by Dr Christine Aldridge, Newcastle 
University (Hoyland et al., 2014), in which SpLdcB was incubated against cell wall 
material isolated from an ldcB deficient strain of S. penumoniae (S. pneumoniae 
R6ΔldcB). The ldcB mutant exhibited an increased amount of tetrapeptides present 
within the cell wall, together with a co-committal decrease in tripeptide content; 
incubation with SpLdcB reversed this affect, but not in the presence of EDTA                 
(Figure 4.20, overleaf) (Hoyland et al., 2014). 
In addition to cell wall tetrapeptides, LdcB enzymes were tested for activity against       
D-ala-D-ala dipeptide and cell wall pentapeptide (Ala-D-γ-Gln-Lys-D-Ala-D-Ala). SpLdcB, 
BsLdcB and BaLdcB (plasmid provided by Dr. Djalal Meziane-Cherif, Institut Pasteur, 
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France) were incubated against the three substrates in the presence of zinc and the 
reaction products separated by TLC. All three enzymes showed activity against the       
D-Ala-D-Ala dipeptide and the tetrapeptide, while only SpLdcB showed weak activity 
against the pentapeptide (Figure 4.21, overleaf). 
 
 
Figure 4.20: HPLC chromatograms of muropeptides from S. pneumoniae strains, obtained after incubating PG 
with or without SpLdcB in the presence of Zn2+ or EDTA, followed by digestion with cellosyl and reduction with 
sodium borohydride. Figure taken from Hoyland et al., (2014), performed by Dr Christine Aldridge, Newcastle 
University. The muropeptides are: Tri, GlcNAc―MurNAc(r)―L-Ala―D-γ-Gln―L-Lys; Tetra, GlcNAc―MurNAc(r)―L-
Ala―D-γ-Gln―L-Lys-D-Ala; TetraTri, GlcNAc―MurNAc―L-Ala―D-γ-Gln―L-Lys―D-Ala―L-Lys―D-γ-Gln―L-
Ala―MurNAc(r)―GlcNAc; TetraTetra, GlcNAc―MurNAc―L-Ala―D-γ-Gln―L-Lys―(D-Ala)―D-Ala―L-Lys―D-γ-
Gln―L-Ala―MurNAc(r)―GlcNAc; deAc, deacetylation at GlcNAc; SA, L-Ser―L-Ala branch (at L-Lys). GlcNAc, N-
acetylglusosamine; MurNAc(r), N-acetylmuramic acid.  
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Figure 4.21: Activity of LdcB homologues against peptidoglycan pentapeptide and D-Ala-D-Ala dipeptide. Thin 
layer chromatography (TLC) of SpLdcB, BsLdcB and BaLdcB incubated with various substrates. D-alanine is less polar 
than the tetrapeptide and migrates faster in TLC. All three homologues are able to hydrolyse the tetrapeptide and 
D-Ala-D-Ala dipeptide substrates, but only SpLdcB is active against the pentapeptide. 
 
Although the ability of LdcB to hydrolyse the D-Ala-D-Ala dipeptide was unexpected, it 
is not surprising that the small substrate could enter an active site designed to 
accommodate tetrapeptides. It is likely that the long incubation time of the reaction, in 
addition to the high substrate concentration used, resulted in the hydrolysis of the 
dipeptide. Likewise, it is likely that the hydrolysis of the pentapeptide by SpLdcB is a 
reaction artefact; it has been shown that deletion of the DD-pentapeptidase dacA, 
responsible for hydrolysing cell wall pentapeptides to tetrapeptides in S. pneumoniae, 
causes the accumulation of pentapeptides (Barendt et al., 2011) that would not occur 
if LdcB was highly active against this substrate.  
Modelling the pentapeptide substrate in the active site of SpLdcB revealed potential 
interactions that might be necessary for catalysis. In the model, many of the observed 
interactions between the ligand and the protein were lost, possibly explaining the 
much weaker activity. Several observed contacts were maintained or new ones made, 
however (Figure 4.22, overleaf). The terminal D-Ala retained many of the interactions 
that were made by the terminal D-Ala of the tetrapeptide, losing only the hydrogen 
bond to Ala146. The carbonyl oxygen of the penultimate D-Ala completed the 
coordination geometry of the zinc ion in place of the L-Lys, whilst the L-Lys was moved 
upwards one position, with the carbonyl oxygen now placed within hydrogen bonding 
distance of Glu204. Slight rearrangement of the sidechain of Asp136 could place it 
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within hydrogen bonding distance of the Nζ of the lysine sidechain, though this 
interaction could not be made with cross-linked material. Finally, the sidechain of        
D-γ-Gln was able to interact with Glu205, with neither MurNAc nor L-Ala contacting 
the protein. In VanXYc, the O1 of the MurNAc sugar would be positioned to interact 
with Arg119, stabilising the ligand further and possibly explaining the preference of 
this enzyme for pentapeptides; this prediction is based upon the closed conformation 
of the bisubstrate selectivity loop, and thus may not be valid for VanXYc complexed 
with the pentapeptide.  
 
 
Figure 4.22: The predicted interactions of MurNAc-pentapeptide with SpLdcB. The pentapeptide was based on the 
structure of SpLdcB with M-Tri-Lys(D-Asn) bound. The tetrapeptide ligand was moved as a rigid body and two D-Ala 
residues added to the C-terminus. The D-Asn moiety was not present on the pentapeptide hydrolysed by SpLdcB in 
TLC experiments and so was removed from the model. The ligand is shown in ball and stick representation, with 
interacting amino acids shown as stick with white carbons. The overall structure of the protein is shown as a 
surface, whilst the zinc ion is shown as a grey sphere. Potential hydrogen bonds made by the pentapeptide ligand 
with SpLdcB are shown as black dashed lines. 
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In both BsLdcB and BaLdcB, two key interaction predicted by the SpLdcB-pentapeptide 
model were not possible; Glu205 was replaced by proline whilst lysine was present in 
place of Asp136. The inability of these amino acids to stabilise the protein-ligand 
complex likely could result in weaker binding of the pentapeptide to perhaps explain 
the lack of activity of BsLdcB and BaLdcB against the pentapeptide. 
4.3.2 Construction and characterisation of active site mutants  
The crystal structure of SpLdcB with bound ligand allowed for the identification of two 
residues, Arg120 and Glu204, that might participate in substrate recognition and/or 
catalysis. Both Glu204 and Arg120 are strictly conserved in LdcB sequences, in addition 
to VanY, VanXYg and VanXYc. Indeed, both residues are found in the active sites of 
several zinc-carboxypeptidases (Christianson and Lipscomb, 1989; Odintsov et al., 
2004). Glu204 is positioned to activate the zinc-bound water for nucleophilic attack, 
whilst Arg120 is capable of contributing to the polarisation of the carbonyl oxygen of 
the tetrapeptide, preparing it for nucleophilic attack.  
To confirm the importance of these residues in LdcB enzymes, Quikchange site-
directed mutagenesis was used to produce alanine substitutions. Additionally, an 
E204H mutant was constructed in an effort to probe the differences between E-x-x-H 
and H-x-H members of the LAS family of enzymes.  
4.3.2.1 Confirmation of mutant folding 
Prior to embarking on activity assays utilising the mutant forms of SpLdcB, circular 
dichroism (CD) was used to confirm that the mutageneses had no impact on protein 
folding. A CD scan from 250 - 190 nm revealed that all mutant proteins were folded 
similar to wild-type SpLdcB (Figure 4.23), with minor differences below 200 nm likely 
due to an increase in noise in this region (Kelly and Price, 2000). The mutated proteins 
were thus entirely suitable for activity assays. 
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Figure 4.23: Circular dichroism (CD) spectra of SpLdcB and three mutants. The overall shape of each spectrum is 
identical, with mostly equal peak intensities, indicating that the three mutants fold in a similar manner to that of the 
wild-type. 
 
4.3.2.2 Thin-layer chromatography (TLC) of mutant SpLdcB reaction products  
To assess the impact the single mutations had on SpLdcB, the mutants (700 μM) were 
each incubated against the tetra-D substrate (20 mM) for 2 hours in the presence of a 
molar equivalent of zinc. The reactions were spotted onto a silica TLC plate, the 
products resolved and the TLC stained with ninhydrin. Only the SpLdcB variants E204H 
and E204A appeared to have any noticeable effect on catalysis (Figure 4.24). 
 
 
Figure 4.24: Activity of wild-type (WT) SpLdcB compared to three active site mutants. Thin layer chromatography 
(TLC) of WT and mutant SpLdcB incubated with Tetra-D. SpLdcB activity appears unaffected by the R120A mutation, 
while the E204A and E204H mutants experience a severe decrease in activity. 
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To resolve the differences between the E204H and E204A mutants and wild-type 
SpLdcB a time-course was performed using lower concentrations of protein (50 μM), 
from which samples were taken at 15 minute intervals and the reaction stopped by the 
addition of ethanol to a final concentration of 50%. The reaction products were 
resolved by TLC as described above, with both the E204A and E204H showing reduced 
catalytic activity (Figure 4.25, overleaf). The E204A mutant showed slightly lower 
catalytic activity compared to the wild-type protein, producing similar levels of D-Ala 
only after 30 minutes, while the E204H mutant was significantly slower. 
 
 
Figure 4.25: Time-course TLC of WT, E204A and E204H SpLdcB. Thin-layer chromatography (TLC) of WT, E204A and 
E204H SpLdcB incubated with Tetra-D. Samples were taken at 15 minute intervals and the reaction halted with the 
addition of ethanol. SpLdcB activity was most affected by the E204H mutant. 
 
To relate the activity of the active site mutants to the structure of SpLdcB, in silico 
mutagenesis was performed in COOT (Emsley et al., 2010) on both the apo and         
ligand-bound SpLdcB structures (Figure 4.26, overleaf). The mutation of Glu204 to 
alanine resulted in a sidechain that could neither participate in catalysis nor form 
hydrogen bonds with the D-γ-Gln moiety of the substrate. The reduced catalytic rate 
likely results from effects on both Km and Vmax. Like the E204A mutant, the E204H 
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mutant appeared to be unable to participate in catalysis, as all the conformations that 
positioned the histidine near the zinc ion resulted in steric clashes with other active 
site amino acids. Indeed, the only conformation that the histidine could occupy was 
near the path of the incoming ligand (within 1.4 Å of the sidechain), likely causing 
conformational changes in the ligand and/or the protein, reducing the Km.    
 
 
Figure 4.26: In silico mutagenesis of SpLdcB E204A and E204H. Panels A and B show the native enzyme; no clashes 
between E204 and the mainchain of SpLdcB or the M-Tri-Lys(D-Asn) ligand can be seen. Panels C and D show the 
E204A mutant; the alanine does not clash with any other amino acids, mainchain or ligand, but cannot interact with 
the ligand. Panels E and F show the E204H mutant; the histidine clashes with either the main protein chain (E) or 
the ligand (F) in many sidechain orientations. Histidine 102 is not show coordinating the zinc ion in panels A, C & E, 
and only D-γ-Gln of the ligand is show in panels B, D and F for clarity. The ligand is shown in ball and stick 
representation, the zinc ion as a grey sphere and protein amino acids as sticks with white carbons, with the 
exception of E204H in panel E, in which the carbons have been coloured differently to allow the various rotomers to 
be distinguished. 
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4.4 Kinetic characterisation of SpLdcB for Ala-D-γ-Gln-Lys-D-Ala  
Though the TLC experiments confirmed that LdcB enzymes have LD-carboxypeptidase 
activity, a quantitative assay was required for a more detailed analysis. Whilst the 
release of D-alanine is not measurable directly, linked assays have been used 
previously to monitor peptidase reactions (McKevitt et al., 2007).  
SpLdcb, BsLdcB and BaLdcB (overexpression plasmid provided by Dr. Djalal Meziane-
Cherif, Institut Pasteur, France) were purified, the native metal removed by dialysis 
against 50 mM EDTA, and reloaded with zinc at a 1:1 stoichiometry following removal 
of the EDTA. Proteins were flash-frozen in liquid nitrogen and provided to 
collaborators in the Institut Pasteur (Paris, France) for kinetic analysis. All kinetic 
experiments were performed by Dr. Djalal Meziane-Cherif and were based upon the 
amino-acid oxidase-lactate dehydrogenase coupled assay (Araoz et al., 2000). In brief, 
the D-alanine liberated from the tetrapeptide by the action of an LD-carboxypeptidase 
is converted into pyruvate by D-amino acid oxidase, with pyruvate then reduced by 
lactate dehydrogenase (LDH) in a NADH dependent manner. The conversion of NADH 
to NAD+ was followed at 340 nm in an Uvikon UV931 spectrophotometer to monitor 
the velocity of the LD-carboxypeptidase (Figure 4.27, overleaf). Steady-state kinetic 
parameters were obtained by fitting the data to the Michaelis-Menten equation in the 
program Sigmaplot v11.0 (Systat Software Inc. Unfortunately, due to the limited 
availability of the substrate (Ala-D-γ-Gln-Lys-D-Ala), a custom synthesis by Activotec 
(Cambridge, UK), saturation could not be achieved for SpLdcB or BaLdcB, and only one 
data point for BsLdcB at saturation was obtained. Additionally, only two repeats could 
be performed for each enzyme. Thus, the kinetic parameters determined by this assay 
are only estimates and more work is required to establish their values more accurately.   
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Figure 4.27: Michaelis-Menten curves for BsLdcB (A), SpLdcB (B) and BaLdcB (C). All curves were plotted in 
Sigmaplot v11.0 from data provided by Dr. Djalal Meziane-Cherif, Institut Pasteur, France. 
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The large difference in substrate affinity and turnover rates between the three LdcB 
enzymes is unlikely to be explained by their substrate specificities. The tetrapeptide 
used in the assay is identical to that found in the cell wall of S. pneumoniae, whereas 
the cell walls of the Bacilli contain D-γ-Glu in place of D-γ-Gln position 2 and meso-
Diaminopimelic acid (meso-DAP) in place of L-Lys at position 3, therefore, SpLdcB 
would be expected to exhibit the strongest Km. If the differences between the 
enzymes’ Km and kcat values are not related to the experimental constraints, the 
differences might be related to the enzymes’ cellular functions. SpLdcB appears to be 
required for division in S. pneumoniae (Barendt et al., 2011), and an overactive enzyme 
is likely to result in aberrant positioning of division septa. BsLdcB appears to be used 
for D-alanine recycling and growth under D-alanine limited conditions (Hoyland et al., 
2014). Under such conditions, the tight affinity of BsLdcB for the tetrapeptide could 
permit efficient cleavage to result in a large pool of D-alanine liberated for 
peptidoglycan synthesis. 
The Km obtained for all three LdcB enzymes, though only estimates, are comparable to 
other carboxypeptidases, including VanXYc for UDP-MurNAc-pentapeptide (1.39 mM 
+/- 0.12; (Meziane-Cherif et al., 2014)  and carboxypeptidase Y (0.07 – 16.5 mM, 
depending on the substrate and pH; (Hayashi et al., 1975). 
4.5 A Proposed catalytic mechanism 
The catalytic mechanism of zinc metallo-carboxypeptidases has been the subject of 
several decades-worth of mechanistic studies, with work focusing on the archetypical 
enzyme carboxypeptidase A (CPA) (Koshland, 1958; Folk and Gladner, 1960; 
Christianson and Lipscomb, 1989; Wu et al., 2010). The mechanism proposed for the 
hydrolysis of C-terminal peptide bonds by CPA is known as the promoted-water 
pathway (Wu et al., 2010) and involves Glu270 acting first as a general base to activate 
a zinc-bound water. The activated water attacks the scissile carbonyl carbon, which has 
been polarised by the effects of the zinc ion and Arg127, before acting as a general 
acid to transfer a proton to the leaving amino group (Wu et al., 2010). 
Although CPA is structurally distinct from SpLdcB (RMSD of 5.68 Å over 100 aligned 
Cαs), their active sites share remarkable similarity, essentially being mirror images of 
each other (Figure 4.28). Both enzymes contain a zinc ion co-ordinated by two 
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histidines (His69, His196 in CPA; His153, His207 in SpLdcB) and an acidic amino acid 
(Glu72 in CPA; Asp160 in SpLdcB) opposite an arginine (Arg127 in CPA; Arg120 in 
SpLdcB). In both proteins the arginine and glutamate/aspartate straddle a water 
molecule, but their positions relative to their counterparts are reversed (Figure 4.26). 
Consequently, the path of the substrate through the active site is also reversed. Given 
the retention of the metal co-ordination and key adjacent amino acids in LdcB, it is 
entirely plausible that the reaction mechanism of LdcB occurs in a similar fashion to 
that of CPA.   
 
 
Figure 4.28: The active sites of SpLdcB and pancreatic carboxypeptidase A (PDB ID: 1HDU (Cho et al., 2002) are 
compared. In each structure, the Zn2+ ion is co-ordinated by two histidines (His69, His196 in carboxypeptidase A; 
His153, His207 in SpLdcB) and an acidic amino acid (Glu72 in pancreatic carboxypeptidase A; Asp160 in SpLdcB). The 
reversed locations of Arg127 and Glu270 in pancreatic carboxypeptidase A relative to Arg120 and Glu204 in SpLdcB 
is matched by a reversal of the path of the respective substrates through the active sites, and the likely retention of 
a common catalytic mechanism.  
 
The use of the promoted-water pathway by LdcB is supported by the effect the E204A 
mutant has on catalysis; mutating glutamate to alanine results in an amino acid with a 
shorter side-chain that is not ionisable and is non-polar, preventing the amino acid 
acting as a general base to activate the catalytic water (Figures 4.25 & 4.26). The 
lowering of the catalytic rate, rather than abolishment of catalysis, in the E204A 
mutant likely arises from the zinc ion acting as the general base to activate the 
catalytic water, as has been previously postulated for CPA (Christianson and Lipscomb, 
1989; Kilshtain-Vardi et al., 2002). In addition, the E204A mutant is likely to possess a 
different pH profile compared to the wild-type enzyme. As with several other zinc 
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metalloproteins that function via a catalytic glutamate, such as CPA (Mock and Tsay, 
1988) or leucine aminopeptidase (Bzymek and Holz, 2004), LdcB is likely most active in 
a pH range of ~5 to 10, with activity rapidly decreasing as the pH approaches and is 
reduced below 4.07, the pKa of glutamate, due to protonation of the catalytic 
glutamate. It should be noted however, that the presence of the catalytic zinc may play 
a role in altering the local environment of the glutamate and so the enzyme may be 
active over a larger pH range than would be expected from an active site comprised of 
just the glutamate. Studies of enzymes that utilise a zinc ion for catalysis, such as 
carbonic anhydrase (Lindskog and Coleman, 1973), have shown that these enzymes 
have optimal activity around pH 7, with activity reducing at lower pH values. 
Therefore, the E204A mutant, in which the zinc acts as the catalytic component of the 
enzyme, would likely have a much narrower activity range with respect to pH, although 
experimental evidence would be required to confirm this. 
An alternative reaction mechanism for CPA is known as the nucleophilic pathway, first 
proposed by Makinen (Makinen et al., 1979), which requires Glu270 to attack the 
scissile carbonyl of the substrate directly. This nucleophilic attack could not occur in 
the E204A mutant of LdcB, yet some catalytic turnover is observed                              
(Figures 4.22 & 4.23), supporting the idea that LdcB utilises the promoted-water 
hypothesis instead. The negligible effect of the R120A mutation on catalysis indicates 
that the bound metal ion is responsible predominantly, if not exclusively, for polarising 
the carbonyl of the scissile peptide bond. Combining this hypothesis with the structural 
data described in this thesis supports a reaction mechanism for LdcB that is 
summarised in Figure 4.29 (overleaf). 
4.6 Summary  
This chapter concerns the biochemical characterisation of LdcB and the role of active 
site residues in ligand binding and catalysis. The identification of key features allowed 
LdcB to be compared to archetypical carboxypeptidases and a reaction mechanism 
proposed. 
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Figure 4.29: The proposed catalytic mechanism of LdcB. 1) The zinc 
ion at the base of the active site is coordinated tetrahedrally by three 
protein ligands and a water molecule. The water molecule is, in turn, 
hydrogen bonded to Glu204. 2) Upon ligand binding, the zinc becomes 
5-coordinate. The ligand is coordinated by several amino acids in the 
active site. 3) The zinc ion polarises the carbonyl oxygen of the 
tetrapeptide, whilst Glu204 abstracts a proton from the zinc-bound 
water. The activated water is then able to attack the polarised 
carbonyl carbon, resulting in a tetrahedral substrate intermediate. 4) 
The intermediate is destabilised, with Glu204 donating a proton to the 
amino-terminal nitrogen of the leaving D-Alanine. 5) Both the D-
alanine and MurNAc-tripeptide products are released by LdcB.   
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Thin-layer chromatography was used to confirm the designation of both SpLdcB and 
BsLdcB as LD-carboxypeptidases, by showing their activity against a synthetic 
tetrapeptide containing a C-terminal LD amino acid linkage and inactivity against the 
same tetrapeptide containing a C-terminal LL amino acid linkage. The use of a linked 
enzyme assay revealed that LdcB enzymes obey Michaelis-Menten kinetics, though the 
limited availability of the tetrapeptide substrate prevented the determination of 
accurate kinetic values for BaLdcB and SpLdcB, and the values obtained for BsLdcB are 
only estimates and likely represent a lower boundary on substrate affinity.   
In addition to explaining the observed enzyme kinetics, the structure of the       
enzyme-product mimic revealed key residues required for the binding of the sugar 
moiety and first 3 amino acids of the cell wall tetrapeptide, and allowed the prediction 
of the residues that interact with the 4th amino acid. Furthermore, comparing SpLdcB 
with carboxypeptidase A, VanX and other LAS family enzymes, in addition to data 
gathered from alanine-substituted mutants, suggests that LdcB uses the promoted-
water pathway during catalysis.  
Knowledge of the molecular level interactions that govern ligand binding and catalysis 
provided by this study would permit the design of enzyme inhibitors, which, given the 
requirement for LdcB for division in S. pneumoniae (Barendt et al., 2011), may prove 
useful as narrow-spectrum antibiotics. Additionally, SpLdcB has been shown to be 
structurally similar to the vancomycin resistance enzymes VanXYc and VanXYg  
(Section 3.4.5), and so interactions that have been identified in SpLdcB with                  
M-Tri-Lys(D-Asn) bound likely hold true for VanXYc and VanXYg, opening up the 
possibility of designing inhibitors against vancomycin resistance. 
 
 
 
 
 
  
 
 
 
 
 
 
 
Chapter 5: 
Metal binding in LdcB enzymes  
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5.1 Introduction 
Metal ions are utilised as cofactors in a wide range of enzymes (Waldron and 
Robinson, 2009). The metal ion can function directly in catalysis, either by forming 
contacts with the substrate, or by activating a nucleophile for subsequent nucleophilic 
attack (Christianson and Lipscomb, 1989; Karsisiotis et al., 2014). Alternatively, the 
large, localised, positive charge of a metal ion can stabilise transition states (Smith et 
al., 1994; Karsisiotis et al., 2014) or perturb the pKa of nearby residues (Harris and 
Turner, 2002), allowing them to participate in catalysis. The displacement of an 
essential metal ion can therefore reduce or even abolish the activities of 
metalloproteins (Tamas et al., 2014). Indeed, we have shown in Chapter 4 that when 
zinc is removed from SpLdcB by incubation with EDTA, catalytic activity is severely 
abated (Section 4.3.1).  
In addition to the action of chelators such as EDTA, metal ions can be displaced from 
enzyme active sites by other metal ions, with the formation of protein:metal 
complexes with stereo- and/or physico-chemical properties that do not support 
catalysis (Waldron and Robinson, 2009). For instance, copper has been observed to 
displace native iron ions from the iron-sulphur cluster enzyme isopropylmalmate 
dehydratase, inactivating the enzyme and inhibiting the biosynthesis of             
branched-chain amino acids (Macomber and Imlay, 2009). The incorrect metal ion can 
also often cause conformational changes, contributing to denaturation and 
aggregation of the protein of interest (Uversky et al., 2001; Lothian et al., 2013).  
In this chapter, the interaction of LdcB with zinc, cobalt and copper was assessed 
(Sections 5.2 and 5.3) and the effect of aberrant metal loading on protein structure 
(Section 5.4) and catalysis (Section 5.5) was determined.  
5.2 Loading non-native metals 
ICP-MS has been used already to demonstrate that SpLdcB purified with ~50% zinc 
occupancy, with a small amount (~5%) of nickel (Section 3.2.2). In an effort to probe 
the capacity of SpLdcB to bind other d-block metals, SpLdcB was dialysed overnight 
against a buffer comprised of 10 mM HEPES pH 8, 100 mM NaCl, 50 mM EDTA to 
remove all bound metal ions. Following the removal of the EDTA by size exclusion 
chromatography (HiTrap Desalting, 5 ml [GE Healthcare]), each fraction was diluted 
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1:10 in Suprapur HNO3 (Merck) to allow the metal content of the SpLdcB fractions to 
be assessed by ICP-MS (Thermo X-series). The concentrations of metal ions in the 
fractions were compared to the concentration of SpLdcB, as determined by the 
Bradford method, to assess the metal occupancy of SpLdcB. SpLdcB was found to be 
completely free of zinc or nickel (Figure 5.1).  
 
 
Figure 5.1: Representative metal content analysis of EDTA treated SpLdcB. The concentration of zinc and nickel 
associated with SpLdcB after a 16 hour incubation with 50 mM EDTA, as assessed by ICP-MS by measuring [66Zn], 
[67Zn] and [60Ni]. Protein concentration was determined by the Bradford method. All readings were taken in 
triplicate and standard deviation shown as error bars.   
 
The metal-free protein was then incubated with a 2-fold molar excess of cobalt 
chloride or copper chloride to introduce these metals into the active site. Excess metal 
was removed by size exclusion chromatography (Superdex S75 analytical 10/40 [GE 
Healthcare]) and each fraction diluted 1:10 in Suprapur HNO3 (Merck) to allow the 
metal occupancy of SpLdcB to be assessed by ICP-MS (Thermo X-series). Copper was 
found to bind to SpLdcB, though the stoichiometry appears to be greater than 1:1 but 
less than 2:1 (Figure 5.2, overleaf); the peak concentration of copper in the peak 
fraction of protein is almost twice that of SpLdcB, suggesting that a second binding site 
for copper may be present and partially occupied in solution. Cobalt was determined 
to bind to SpLdcB at a 1:1 stoichiometry, with a large excess of cobalt eluting from the 
size exclusion column after SpLdcB indicating full occupancy of all metal sites (Figure 
5.2, overleaf). 
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Figure 5.2: Representative metal content analysis of apo-SpLdcB following incubation with copper (left) or cobalt 
(right). The concentration of cobalt and copper associated with SpLdcB after a 30 minute incubation with a 2:1 
excess of the metal and separation of excess metal by size exclusion chromatography, as assessed by ICP-MS. 
Protein concentration was determined by the Bradford method. All readings were taken in triplicate and standard 
deviation shown as error bars. 
 
5.3 The affinity of LdcB for zinc, cobalt and copper 
Whilst the Irving-Williams series would suggest LdcB enzymes should purify with 
copper bound (Irving and Williams, 1953), this was not observed. To investigate why 
LdcB purified from E. coli half occupied with zinc rather than other metals, the affinity 
of LdcB for zinc, copper and cobalt was assessed. The crystal structure of SpLdcB 
demonstrated that SpLdcB possesses multiple metal-binding sites at high metal 
concentrations, such as those used in crystallisation (Section 3.4.3), making SpLdcB 
unsuitable for use in determining the metal affinity of the catalytic metal binding site 
as any affinity obtained would be an average of all the metal binding sites. Despite the 
presence of a 4:1 molar excess of zinc in the crystallisation conditions, the crystal 
structure of BsLdcB revealed only a single binding site for metal ions, allowing the 
affinity of the active site metal binding site to be determined with high accuracy 
(Section 3.4.3). 
All native bound metals were removed from BsLdcB by dialysis against 10 mM HEPES 
pH 8, 100 mM NaCl, 50 mM EDTA for 16 hours. EDTA was removed by size exclusion 
chromatography (Superdex S75 analytical 10/40 [GE Healthcare]) and fractions 
containing protein were pooled to allow the metal content to be assessed by ICP-MS, 
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as described previously (Section 2.4.1). BsLdcB was found to be free of both zinc and 
nickel. 
Increasing concentrations of BsLdcB (0 – 120 µM) were added to                                       
4-(2- pyridylazo)resorcinol (PAR) (200 µM) in complex with Zn2+ (45 µM), Cu2+ (25 µM) 
or Co2+ (10 µM). Uncomplexed PAR absorbs maximally at 415 nm. When PAR forms a 
complex with a d-block metal, the absorption band at 415 nm decreases, and an 
increase in absorption is seen at higher wavelengths, with the exact wavelength of 
maximal absorption dependent on the d-block metal used (McCall and Fierke, 2000). 
The absorbance change in PAR upon the addition of increasing BsLdcB concentrations 
was monitored at 500 nm for zinc, or 514 nm for copper and cobalt. The absorbance 
readings were converted to μM concentrations using previously established extinction 
coefficients (PAR:Zn2+ = 46000 M-1 cm-1 at 500 nm; PAR:Cu2+ = 32000 M-1 cm-1 at          
514 nm; PAR:Co2+ = 50000 M-1 cm-1 at 513 nm (McCall and Fierke, 2000)) and plotted 
against the concentration of BsLdcB. Data were fitted using the following equation, 
adapted from Badarau and Dennison (2011), using Origin7 (OriginLab): 
 
𝐾𝑑 =
[𝐵𝑠LdcB][PAR2M
2+]
βPAR[𝐵𝑠LdcB ∙ M2+][PAR]2
 
 
in which previously published formation constants (βPAR) of PAR with zinc                  
(1.26 x 1017 M-2 (Zhou et al., 1999)) or copper (3.2 x 1017 M-2 (Turski et al., 2012)) were 
used. M2+ represents the metal ion, either Zn2+, Co2+ or Cu2+. 
The binding affinities (Kd) of BsLdcB for zinc and copper were determined to be               
5.61 x 10-17 M (+/-  4.26 x 10-16 M) and 2.39 x 10-15 M (+/- 3.31 x 10-14 M), respectively 
(Figure 5.3, overleaf), whereas BsLdcB was unable to compete with PAR for cobalt 
(Figure 5.3, overleaf).  
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Figure 5.3: Representative data used to determine BsLdcB affinity for (A) Zn2+, (B) Cu2+ and (C) Co2+. In all instances 
increasing concentrations of BsLdcB was added to PAR (200 μM) in complex with Zn2+ (45 μM), Cu2+ (25 μM) or Co2+ 
(10 μM). Lines show the fit to equation 5.1. Kd values are given in the text.   
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The toxicity of d-block metals, yet their requirement for growth, has resulted in the 
evolution of complex regulatory systems in all organisms. A simple model would be 
that a specific metal sensor is triggered when the concentration of ‘free’ metal ion 
rises above a key threshold, as determined by the sensor’s affinity for that metal 
(Outten et al., 1999; Munson et al., 2000; Gudipaty and McEvoy, 2014). Should a 
protein have an affinity for a metal that is below that of the organism’s metal sensor, 
the protein will never encounter the metal ion in a form that it is able to bind, 
preventing the mis-incorporation of metal ions.  
The Kd of the E. coli zinc sensor, ZntR, for zinc is 10-15 M (Hitomi et al., 2001), 2 orders 
of magnitude weaker than the affinity of BsLdcB for zinc. BsLdcB is therefore likely able 
to acquire zinc from the ‘free zinc’ pool of E. coli. With such a great affinity for zinc, it is 
intriguing that only ~50% of SpLdcB purified with the metal bound (Section 3.2.2), 
possibly suggesting that E. coli cannot maintain zinc import at the levels demanded by 
the overexpression of the heterologous protein. In general, overexpression of any of 
the LdcB proteins resulted in yields of ~25 mg/l, or ~1 x 10-3 mol/l, whilst E. coli grown 
in LB has been shown to have a total zinc content of ~4 x 10-4 mol/l (Outten and 
O'Halloran, 2001). The zinc content of E. coli is thus roughly half of that required by the 
overexpression of LdcB proteins, accounting for only half of purified LdcB containing 
zinc. One way in which this could be tested would be to add additional zinc salts to the 
growth media during overexpression and analysing the zinc content of overexpressed 
LdcB. However, it would be important to limit the amount of zinc added as large 
excesses are likely to have a toxic effect on the E. coli. 
The affinity of BsLdcB for copper, 2.39 x 10-15 M, is 2 orders of magnitude weaker than 
the affinity of BsLdcB for zinc, suggesting that only large excesses of copper would be 
able to displace zinc from the active site. Within the cell, this would not occur as the        
E. coli copper sensor, CueR, has an affinity for Cu+ of 10-21 M (Changela et al., 2003), 
resulting in export of copper once the concentration rises above zeptomolar 
concentrations. It should be noted, however, that the affinity of BsLdcB for copper was 
determined in aerobic conditions and thus likely corresponds to an affinity for Cu(II), 
whilst the form of copper encountered in the cytoplasm, a reducing environment 
(Waldron and Robinson, 2009), would be Cu(I). Nevertheless, unless the affinity of 
BsLdcB for Cu(I) is 7 or more orders of magnitude stronger than it is for Cu(II), BsLdcB 
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would never encounter copper in a form that it is able to bind inside the cell. Once on 
the external leaflet of the cytoplasmic membrane, the physiological location of LdcB 
enzymes, it is unlikely that copper would be present in sufficient concentrations to 
effectively displace zinc.  
Although the cobalt affinity of BsLdcB could not be determined using the competition 
assay, the absence of cobalt in the purified LdcB protein indicates that the affinity of 
LdcB for cobalt is weaker than that of the sensor. In E. coli the sensor, RcnR, binds 
cobalt with a nanomolar (10-9 M) (Iwig et al., 2008) affinity and thus it can be inferred 
that SpLdcB binds cobalt weaker than 10-9 M.  
Whilst purified LdcB has been found to purify with small amounts of nickel bound 
(Section 3.2.2), the affinity of BsLdcB for nickel was not assessed by PAR, as Ni(PAR)2 is 
spectrally silent, making it unsuitable for use in the assay (McCall and Fierke, 2000). It 
can, however, be inferred that the nickel affinity of BsLdcB is less than that of RcnR, 
which binds nickel with a kd of at least 2.5 x 10-9 M (Iwig et al., 2008) and acts as a 
nickel sensor in addition to sensing cobalt, due to nickel only occupying a small fraction 
of purified LdcB despite ~45% of the protein being metal-free. The small (~5%) nickel 
content of purified LdcB most likely arises from Ni+-NTA affinity purification, with LdcB 
scavenging nickel from the NTA matrix. 
Despite the abundance of data on LAS-family metallopeptidases, there has been 
relativity few studies to determine the binding affinities of zinc, or other metals, to 
these proteins. NMB0315, a lysostaphin type peptidase from Neisseria meningitides, is 
the only member of the LAS family to have had its affinity for zinc calculated (Wang et 
al., 2011). Wang et al., (2011) utilised isothermal titration calorimetry to determine the 
affinity of NMB0315 for zinc and obtained a Kd value of 1.85 x 10-8 M, much weaker 
than the femtomolar affinity determined for BsLdcB. Inspection of the binding 
isotherm produced by Wang et al., (2011) provides some explanation for the 
calculated affinity; the isotherm contains only one data point on the sigmoidal portion 
of the curve (Figure 5.4, overleaf), suggesting that the data may have been overfitted. 
The sudden increase from ‘free’ zinc to fully occupied protein observed in the isotherm 
suggests that the ITC is operating at the limits of its capability, with nanomolar 
affinities being the tightest binding events measurable by this method, and indicates 
that the true affinity of NMB0315 for zinc is probably stronger. 
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Figure 5.4: ITC isotherm of NMB0315 for zinc taken from Wang et al. (2011). The rapid increase in KCal/Mole 
suggests that the data have been overfitted.  
 
Expanding the search to include non-LAS family enzymes that utilise a His-Asp-His or 
His-Glu-His motif for zinc binding reveals that the affinities of pancreatic 
carboxypeptidase A (CPA) for both zinc and cobalt have been calculated (Coleman and 
Vallee, 1960). Coleman and Vallee (1960) utilised equilibrium dialysis against 100 μM 
cobalt, with 10 nM radiolabelled cobalt (60Co) added to permit the quantification of 
bound vs. free cobalt, to determine that CPA binds cobalt with an affinity of                
1.5 x 10-6 M. Equilibrium dialysis was then used to determine the affinity of CPA for 
zinc, by competing both zinc and cobalt for metal-free CPA, with a Kd of 4.7 x 10-9 M 
obtained for zinc. However, despite the isotope of 60Co allowing for accurate 
determination of cobalt concentration both within the dialysis buffer and bound to 
CPA, it is likely that equilibrium was disturbed during measurement, as CPA had to be 
separated from the dialysis buffer for 60Co quantification, bringing into question the Kd 
obtained of CPA for cobalt. Indeed, it has been noted that binding affinities of 10-6 M 
are often minimal values for metal binding Kd, rather than true values (Waldron and 
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Robinson, 2009), suggesting CPA may bind cobalt with a much tighter affinity. Not only 
would the zinc Kd calculation suffer from similar limitations, the underestimated           
CPA-cobalt affinity would also affect the calculation, possibly explaining the 6 orders of 
magnitude difference between CPA zinc affinity and BsLdcB zinc affinity, despite both 
enzymes sharing almost identical zinc binding sites. The only difference is the 
substitution of Asp142 in BsLdcB for Glu72 in CPA. 
Searching the literature of all zinc-metalloenzymes reveals a range of binding motifs, 
though only a select few have had their zinc-affinities calculated. Carbonic anhydrase II 
coordinates zinc with three histidines (H94, H96 and H119) and a Kd of 4 x 10-12 M 
(Kiefer et al., 1993). The Kd is increased to 2 x 10-14 M by the addition of an artificial 
fourth ligand (E199) that occupies the position of the substrate (Ippolito et al., 1995) 
and which thus greatly reduces activity. The addition of a fourth amino acid ligand is 
found in nature in the Trx2 subfamily of thioredoxins, in which thioredoxin 2 binds zinc 
with four cysteine residues and an affinity of 4 x 10-18 M, however, whilst the affinity is 
comparable to the zinc Kd of BsLdcB, the binding motif is not at all similar to LdcB 
enzymes, which bind with three residues (His, Asp, His). 
5.4 Crystal structures of the SpLdcB:metal complexes 
5.4.1 Crystallisation and structure solution 
Although BsLdcB proved optimal for determining metal binding affinities, due to its 
sole metal binding site, the length of time required to grow BsLdcB crystals                    
(~6 months, Section 3.3.3) makes it an unsuitable protein for structural studies. SpLdcB 
crystals can be obtained in a much shorter amount of time (~1-14 days) and, crucially, 
the presence of multiple metal binding sites would not adversely affect the 
experiment. 
SpLdcB, in the presence of an excess of cobalt or copper (4:1 molar excess), was 
subjected to crystallisation trials as described previously (Sections 3.2 and 3.3). 
Crystals of the cobalt containing complexes were observed to grow from the 
Morpheus (Gorrec, 2009) A4 (0.06 M divalents (MgCl2 and CaCl2), 0.1 M Buffer system 
1 [imidazole; MES (acid)] pH 6.5, 37.5% MPD_P1K_P3350 [MPD, PEG1000, PEG3350]) 
and D4 conditions (0.12 M Alcohols [1,6-hexanediol; 1-butanol; 1,2-propandiol 
(racemic); 2-propanol; 1,4-butanediol; 1,3-propandiol], Buffer system 1 [imidazole; 
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MES (acid)] pH 6.5, 37.5% MPD_P1K_P3350 [MPD, PEG1000, PEG3350]) over a period 
of 7 days, while crystals of the copper containing complexes grew from PACT (Newman 
et al., 2005) C10 (0.2 M MgCl2, 0.1 M HEPES pH 7.0, 20% w/v PEG 6000). Crystal 
optimisation occurred as previously described (Section 2.6.1) and was performed 
under supervision by Ms. Atikah Mohd Sukor. The optimised crystals can be seen in 
Figure 5.5, with the highest quality crystals growing from 0.06 M divalents (MgCl2 and 
CaCl2), 0.1 M Buffer system 1 [imidazole; MES (acid)] pH 6.5, 37.5% MPD_P1K_P3350 
[MPD, PEG1000, PEG3350] (SpLdcB:cobalt) and from 0.2 M MgCl2, 0.1 M HEPES pH 7.0, 
20% w/v PEG 6000 (SpLdcB:copper). 
 
 
Figure 5.5: Crystal forms of SpLdcB:cobalt (left) and SpLdcB:copper (right).  
 
 
Figure 5.6: An example diffraction pattern of SpLdcB:cobalt (left) and SpLdcB:copper (right). Cobalt crystals 
diffracted to ~2 Å, copper crystals diffracted to ~ 2.8 Å. 
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Crystals were harvested, cryo-protected in paratone-N oil and flash cooled in liquid 
nitrogen. Diffraction was assessed in-house, with two images being taken at relative 
phi angles 90° apart. Crystals were ranked based upon spot sharpness, mosaicity and 
strength of diffraction. Representative diffraction patterns of the best crystals can be 
found in Figure 5.6 (previous page). The best crystals were taken to Diamond Light 
Source for data collection on beamline IO4. Diffraction data sets were collected from 
the same crystal for both SpLdcB:cobalt and SpLdcB:copper above and below the 
theoretical K atomic absorption edge (K-edge) for the respective metal, with 0.1° 
oscillations and 0.1 s exposures per image. The total number of images collected was 
based upon the predicted space group of each crystal to ensure that complete data 
sets were collected. As with a SAD data collection, the use of incident X-rays at, or just 
above, the K-edge of an element causes an electron transition which results in 
anomalous scattering and a breakdown in Friedel’s law, whereby Friedel pairs no 
longer scatter with equal amplitude and opposite phases. The breakdown in Friedel’s 
law can be exploited to obtain the phase information required for structure solution. 
Anomalous difference maps can also be calculated using phases from a solved 
structure that will generate peaks of difference density that correspond only to the 
anomalously scattering metal ion.   
Diffraction data sets were integrated with XDS (Kabsch, 2010) and reduced with SCALA 
(Evans, 2005). The SpLdcB:cobalt crystal was assigned to space group P43 with unit cell 
dimensions of a = b = 53.6 Å, c = 65.0 Å, based upon the systematic absence of 
reflections h+k+l=4n and differentiated from the enantiomorphic space group, P41 
based on statistics obtained following molecular replacement and refinement. The 
SpLdcB:copper crystal belonged to spacegroup P21 with unit cell dimensions of               
a = 72.2 Å, b = 37.6 Å, c = 72.80 Å, with a  angle of 96.2˚. Data collection statistics can 
be found in Tables 5.1 and 5.2.   
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Table 5.1: Summary of X-ray data collection statistics for SpLdcB:cobalt above (High) and below (Low) the K-edge 
of the ion. 
aRmerge = hi|Ii(h) - I(h)/hiIi(h), where Ii(h) and I(h) are the ith and mean measurement of the intensity of 
reflection h. 
 
Table 5.2: Summary of X-ray data collection statistics for SpLdcB:copper above (High) and below (Low) the K-edge 
of the ion. 
aRmerge = hi|Ii(h) - I(h)/hiIi(h), where Ii(h) and I(h) are the ith and mean measurement of the intensity of 
reflection h. 
 
Matthews’ coefficient calculations (Matthews, 1968) of SpLdcB:cobalt predicted that 1 
molecule was present per asymmetric unit, with a solvent content of 44.2%, whilst 2 
molecules of SpLdcB:copper were predicted, with a solvent content of 47.0%. PHASER 
(McCoy et al., 2007) was used to solve both structures, using the “SpLdcB:Cobalt High” 
and “SpLdcB:Copper High” datasets and the co-ordinates of SpLdcB as a molecular 
replacement model. The correctly-positioned protein models were subjected to one 
round of rigid body refinement in Refmac5 (Winn et al., 2011) before cycles of manual 
building in COOT and restrained refinement in PHENIX.REFINE (Afonine et al., 2012). 
Final refinement statistics can be found in Table 5.3. 
Data collection SpLdcB:Cobalt High SpLdcB:Cobalt Low 
Space Group P43 P43 
Unit cell dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
53.6, 53.6, 65.0 
90, 90, 90 
 
53.7, 53.7, 65.1 
90, 90, 90 
Wavelength (Å) 1.605 1.631 
Resolution (Å) 41.38 - 1.80 
(1.84-1.80)* 
41.38 - 1.80 
(1.84-1.80)* 
Multiplicity 
Anomalous Multiplicity 
3.2 (3.2) 
1.5 (1.5) 
3.1 (2.5) 
1.5 (1.5) 
Rmergea 0.089 (0.212) 0.049 (0.191) 
I/σI 15.2 (7.8) 15.9 (5.5) 
Completeness (%) 99.5 (98.9) 98.8 (94.8) 
Anomalous Completeness (%) 86.9 (69.7) 82.0 (21.6) 
Data collection SpLdcB:Copper High SpLdcB:Copper Low 
Space Group P21 P21 
Unit cell dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
72.2, 37.6, 72.8 
  90, 96.2, 90 
 
72.4, 37.6, 72.9 
90, 96.3, 90 
Wavelength (Å) 1.494 1.631 
Resolution (Å) 48.41 -2.80 
(2.95 – 2.8) 
48.45 -2.80 
(2.95 – 2.8) 
Multiplicity 
Anomalous Multiplicity 
3.2 (3.2) 
1.4 (1.8) 
3.1 (3.2) 
1.4 (1.8) 
Rmergea 0.039 (0.115) 0.043 (0.078) 
I/σI 18.3 (8.0) 17.6 (9.9) 
Completeness (%)   
Anomalous Completeness (%) 
99.3 (99.6) 
81.5 (76.3) 
96.3 (99.0) 
73.9 (75.8) 
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Table 5.3: Summary of X-ray data refinement statistics for SpLdcB:cobalt and SpLdcB:copper. 
* Highest resolution shell shown in parentheses. 
aRwork/Rfree = |Fpobs – Fpcalc|/Fpobs, where Fpobs and Fpcalc are the observed and calculated structure factor 
amplitudes, respectively. 
 
Following structure solution, anomalous difference maps were calculated. Anomalous 
difference maps calculated with data collected above the K-edge (“High”) revealed 
difference peaks greater than 10 σ corresponding to the location of the catalytic metal 
ion (Figure 5.7), while difference maps calculated from data collected below the           
K-edge (“Low”) of the respective metal ion were featureless (not shown). 
 
 
Figure 5.7: Anomalous difference maps. The active sites of cobalt (A) or copper (B = chain A, C = chain B) 
substituted SpLdcB showing the coordination of the metal ion (pink or gold sphere) by water (red sphere) and 
protein ligands. Anomalous difference maps (orange net) are contoured at at 10 σ. Protein ligands are shown in the 
stick representation with pink (SpLdcB:cobalt) or blue (SpLdcB:copper) carbons. 
 
 
 SpLdcB:Cobalt SpLdcB:Copper 
Resolution (Å) 53.6 - 1.8 35.8 – 2.8 
No. Reflections 16222 (9700) 14072 (9322) 
Rwork/Rfreea 0.168/0.204 0.252/0.288 
No. atoms 
Protein 
# proteins/AU 
  Ion/Ligand 
Water 
- 
1434 
1 
7/5 
99 
- 
2733 
2 
11/0 
12 
B factors (Å2) 
Protein 
Ion/Ligand 
Water 
- 
18.4 
27.6/15.7 
22.4 
- 
36.9/49.9 
90.3/- 
34.5 
R.m.s deviations 
  Bond lengths (Å) 
Bond angles (°) 
- 
0.022 
2.00 
- 
0.009 
1.24 
Ramachandran  
   favoured (%) 
   allowed   (%) 
- 
98.9 
100 
- 
94.4 
99.1 
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5.4.2 Crystal structures of the SpLdcB:cobalt complex 
Overall, the structure of SpLdcB bound to cobalt is indistinguishable from SpLdcB with 
zinc bound in the closed conformation (core RMSD: 0.57 Å over 181 aligned Cαs) 
(Figure 5.8). Closer inspection of the active sites reveals small differences between the 
structures. As reported previously (Section 3.4.1), SpLdcB binds zinc in a tetrahedral 
coordination sphere; His152, Asp160 and His207 are the liganding amino acids, and an 
unknown molecule acts as the fourth ligand (Section 3.4.2). The SpLdcB:cobalt 
structure reveals that SpLdcB binds cobalt in a trigonal bipyramidal coordination 
sphere, with His152, Asp160, His207 and two water molecules acting as ligands    
(Figure 5.9, overleaf).  
 
 
Figure 5.8: Apo SpLdcB with zinc bound superposed onto SpLdcB:cobalt. SpLdcB:zinc is shown as a white cartoon 
ribbon, SpLdcB:cobalt as a violet cartoon ribbon.  
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Figure 5.9: Metal binding in SpLdcB:cobalt superposed onto the apo structure of SpLdcB with zinc bound. Cobalt 
substituted SpLdcB coordinates cobalt in a trigonal bipyramidal geometry. His153, Asp160 and His207 contribute 
contacts from the protein, with solvent molecules completing the 5-coordinate geometry. SpLdcB:cobalt carbons 
are shown in pink, zinc-bound SpLdcB carbons are shown in white. The cobalt and zinc ions are indicated by the 
label M2+, with the cobalt ion shown as a pink sphere, and the zinc ion shown in grey.   
 
The crystal structure of VanX solved previously with bound zinc showed clear 
tetrahedral coordination of the metal ion (Bussiere et al., 1998). Electronic absorption 
spectroscopy and extended X-ray absorption fine structure (EXAFS) spectroscopy 
studies of VanX with cobalt demonstrated that the metal was 5-coordinate (Breece et 
al., 2005). Breece at al., (2005) argued that cobalt is likely to bind in the same 
coordination geometry as zinc, owing to the smaller ionic radius, and so postulated 
that the crystal structure of VanX with zinc bound fails to represent the coordination 
geometry of VanX:zinc in solution. The ionic radii of d-block metals are dependent 
upon their coordination; whilst cobalt bound in the same geometry as zinc always 
possesses a smaller ionic radius (tetrahedral Co2+ 58 pm vs. Zn2+ of 60 pm, trigonal 
bipyramidal Co2+ 67 pm vs. Zn2+ of 68 pm (Shannon, 1976)), a 5-coordinate cobalt ion 
has a much larger ionic radius than 4-coordinate zinc. The expected coordination 
number can therefore not be determined simply by examining ionic radii as suggested 
by Breece et al., (2005). Both cobalt and zinc have also been shown to transition 
between 4- and 5-coordinate without an appreciable energy barrier (Bertini and 
Claudio, 1994). It is therefore likely that cobalt binds VanX and LdcB in a 5-coordinate 
manner, while zinc binds 4-coordinate, but that the coordination numbers are fluid. 
Indeed, a 5-coordinate metal ion is expected for LdcB:zinc during catalysis                 
(Section 4.5).    
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5.4.3 Crystal structures of the SpLdcB:copper complex 
Two monomers are present in the asymmetric unit of SpLdcB:copper, chains A and B. 
Both chains are observed to be in the open conformation and are very similar to 
SpLdcB with M-Tri-Lys(D-Asn) bound (Figure 5.10) (chain A core RMSD: 1.01 Å over 182 
aligned Cαs; chain B core RMSD: 0.91 Å over 169 aligned Cαs). The open state of the 
enzyme is perhaps stabilised by a hydrogen bond interaction between Asp116, located 
on the mobile loop/at the N-terminus of α-helix 4, and Gly67 of a neighbouring chain, 
with the hydrogen bond only possible in the enzyme’s open conformation. However, 
no other residues could be observed to form crystal contacts, raising the possibility 
that the enzyme simply happened to be in the open conformation during 
incorporation into the crystal lattice.  Inspection of the active sites reveals that the two 
chains bind copper in different coordination spheres; copper is found in a trigonal 
bipyramidal geometry in chain A, whilst it is found tetrahedrally in chain B. The 
catalytic Glu204 is orientated differently in the two chains; in chain A, Glu204 is 
positioned to interact with a copper-bound water, mimicking the orientation found in 
the closed conformation of SpLdcB (Figure 5.11, overleaf). In chain B, Glu204 adopts 
the same orientation as when it is interacting with an incoming substrate (Figure 5.11, 
overleaf) (Section 4.2.3), despite the lack of electron density indicating a bound ligand.  
 
 
 
Figure 5.10: Chain A (left) and chain B (right) of SpLdcB:copper superposed onto the structure of SpLdcB with         
M-Tri-Lys(D-Asn) bound. SpLdcB chain A is shown as light blue cartoon ribbon, chain B is shown as dark blue 
cartoon ribbon and SpLdcB:M-Tri-Lys(D-Asn) is shown as a white cartoon ribbon.  
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Figure 5.11: The metal binding site of SpLdcB:copper, compared to apo and ligand-bound SpLdcB. Chain A of the 
SpLdcB:copper structure coordinates copper in a trigonal bipyramidal geometry whilst chain B coordinates copper 
tetrahedrally. Superposing chain A of SpLdcB:copper onto apo SpLdcB reveals that the catalytic glutamate, E204, is 
positioned to interact with the nucleophilic water and perform catalysis (A).  Superposing chain B of SpLdcB:copper 
onto ligand-bound SpLdcB reveals that E204 adopts an orientation required to coordinate the tetrapeptide ligand 
(B). In both chains A and B, as in apo and ligand-bound SpLdcB, the metal ion is coordinated by His153, Asp160 and 
His207. The coordination geometry is completed by two solvent molecules in chain A of SpLdcB:copper, one solvent 
molecule in chain B of SpLdcB, an unknown ligand in apo SpLdcB (electron density of the unknown ligand not 
shown) and by a carboxylic oxygen in ligand-bound SpLdcB (ligand not shown for clarity). M2+ is used to refer to the 
metal ion, with zinc shown as a grey sphere and copper as a gold sphere. Water molecules are shown as red spheres 
and amino acids are shown in stick representation with white (apo SpLdcB) or blue (SpLdcB:copper) carbons.   
 
5.5 The effects of d-block metals on catalysis 
The substitution of the catalytic ion with other metals has often been used to produce 
inactive enzymes that remain capable of binding substrates but are unable to process 
them, trapping enzyme-substrate complexes. However, cobalt-substituted zinc 
enzymes often retain their catalytic activity and, in some cases, the catalytic rate is 
increased significantly (Folk and Gladner, 1960; Bertini and Claudio, 1994; Kuzuya and 
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Inouye, 2001). By contrast, copper has been shown to abolish catalytic activity in a 
number of zinc enzymes, including thermolysin and β-lactamase II (Hakansson et al., 
1994; Hernandez Valladares et al., 2000), although non-negligible activity has been 
detected in other copper substitutions; Carboxypeptidase A substituted with copper 
demonstrates kcat/Km values up to 24% against esters and up to 2.5% towards peptides, 
compared to the zinc enzyme  (Schaffer and Auld, 1986).  
The activity of SpLdcB substituted with zinc, copper and cobalt was assessed as 
described previously (Section 2.5.1.1), and the reactions were spotted onto a silica TLC 
plate (Sigma) to allow the products to be resolved (Figure 5.12).  
 
 
Figure 5.12: Activity of SpLdcB loaded with zinc, cobalt or copper against peptidoglycan tetrapeptides. Thin layer 
chromatography (TLC) of SpLdcB loaded with various metals incubated with the tetra-D substrate. D-alanine is less 
polar than the tetrapeptide and migrates faster in TLC. SpLdcB loaded with any of the three d-block metals appears 
to hydrolyse the substrate at similar rates. 
 
No discernible difference in activity was observed between zinc, copper or cobalt-
loaded SpLdcB, with each reaction running to completion within 15 minutes. These 
results are compatible with data obtained by Dr. Christine Aldridge, Newcastle 
University, in which various metal-loaded SpLdcB samples were incubated against cell 
wall material isolated from a ΔldcB strain of S. pneumoniae (Figure 5.13, overleaf). In 
these experiments SpLdcB was incubated against the cell wall substrates for 16 hours 
prior to HPLC separation of the products, and so this end-point assay cannot reveal 
differences in rates of activity. 
151 
 
 
Figure 5.13: HPLC chromatograms of muropeptides from S. pneumoniae strains, obtained after incubating PG 
with or without SpLdcB loaded with zinc, cobalt or copper, followed by digestion with cellosyl and reduction with 
sodium borohydride. The muropeptides: Tri, GlcNAc―MurNAc(r)―L-Ala―D--Gln―L-Lys; Tetra, 
GlcNAc―MurNAc(r)―L-Ala―D--Gln―L-Lys ―D-Ala; TetraTri, GlcNAc―MurNAc―L-Ala―D--Gln―L-Lys―D-Ala-L-
Lys―D--Gln―L-Ala―MurNAc(r)―GlcNAc; TetraTetra, GlcNAc―MurNAc―L-Ala―D--Gln―L-Lys―(D-Ala)―D-
Ala―L-Lys―D--Gln―L-Ala―MurNAc(r)―GlcNAc. 
 
Consistent with the release of D-Ala from Tetra-D (Figure 5.12, previous page),              
cobalt-substituted SpLdcB retains full activity against S. pneumonia muropeptides. As 
described above, both cobalt and zinc can switch from 4- to 5-coordinate without 
appreciable energy barriers and their similar ionic radii likely permits their 
interchangeability (Bertini and Claudio, 1994).  
Copper-substituted SpLdcB also appears to retain full activity. Although it is possible 
that the long reaction time in this assay masks differences in activity rates between the 
various metal-loaded enzymes, the same incubation times were used to assess the 
E204A and E204H SpLdcB mutants (Section 4.3.2.2). Clear differences in activity were 
observed between the wild-type and mutated enzymes within 15 minutes. 
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Consequently, it would seem that copper does not significantly affect catalysis in 
comparison to zinc.  
Previous comparisons of the active sites of inactive and active copper substituted 
enzymes have revealed that, in most instances, the copper ion is coordinated in the 
same geometry as the zinc ion, suggesting that an abnormal coordination sphere is not 
the cause of inhibition (Bertini and Claudio, 1994). Indeed, the crystal structure of 
SpLdcB with copper bound reveals two coordination geometries; tetrahedral as seen in 
native SpLdcB with zinc bound, and trigonal bipyrimidal, which the zinc is predicted to 
adopt during catalysis (Section 4.5). Whilst the catalytic glutamate (E204) is deflected 
away from the copper ion in chain B of the SpLdcB:copper crystal structure, this 
conformation is also observed in the ligand-bound SpLdcB structure, suggesting that 
the residue is naturally flexible and the presence of copper has not forced the 
conformational change. Supporting this, chain A of the SpLdcB:copper crystal structure 
reveals that E204 remains located in an ideal position for catalysis, able to interact 
with one of the copper-coordinating water molecules (Figure 5.11).  
It is worth noting that previous studies of VanXYc have shown that the addition of 
either copper or cobalt to purified enzyme causes complete inhibition of dipeptidase 
activity (Podmore and Reynolds, 2002), which was exploited by Meziane-Cherif et al. 
(2014) to obtain the structure of VanXYc in complex with D-Ala-D-Ala (PDBid: 4OAK). 
Interestingly, the addition of zinc was found to also inhibit VanXYc (Podmore and 
Reynolds, 2002), suggesting that excess metal ions may cause adverse conformational 
changes within VanXYc, rather than directly inhibiting catalysis. The crystal structure of 
VanXYc with copper bound shows no evidence of adverse conformational changes, 
however Meziane-Cherif et al., (2014) obtained this structure by soaking a crystal of 
VanXYc with phenanthroline, a metal chelator, to remove the natively bound zinc, 
before washing the crystals and soaking in copper, possibly preventing structural 
changes from occurring. Likewise, Meziane-Cherif et al., (2014) used soaking to 
introduce D-Ala-D-Ala into the active site of the enzyme, and the kinetics of VanXYc 
may be radically different within the crystal structure compared to in solution, 
explaining why the dipeptide was not hydrolysed. 
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5.6 Summary 
This chapter describes metal binding stoichiometries and affinity measurements of 
BsLdcB for zinc, cobalt and copper and presents the crystal structures of SpLdcB with 
copper and cobalt bound, to determine the effect of these metals on protein stability 
and activity. 
Zinc was found to bind to BsLdcB with the greatest affinity (5.62 x 10-17 M), whilst 
copper bound with an affinity 2 orders of magnitude weaker (2.39 x 10-15 M). BsLdcB 
was unable to compete with PAR for cobalt, suggesting a weak affinity but preventing 
accurate determination of a Kd value. The absence of cobalt from SpLdcB and BsLdcB 
purified from E. coli suggests that the affinity of LdcB enzymes for this metal is weaker 
than 10-9 M, the affinity of the cobalt sensor RcnR (Iwig et al., 2008). Metal binding 
affinities of 10-6 M or weaker are likely to be significant underestimates (Waldron and 
Robinson, 2009), suggesting that cobalt may bind to BsLdcB with a Kd between 10-7 and 
10-8 M. The PAR assay therefore appears to be unsuitable in determining affinities that 
are weaker than 10-8 M. The affinity of BsLdcB for zinc was compared to other zinc-
containing proteins and was found to be at the higher-end of zinc affinities, though it 
was not possible to compare BsLdcB with other LAS family enzymes owing to a lack of 
published literature; the only other LAS family enzyme, NMB0315, with a calculated 
affinity for zinc (1.85 x 10-8 M) was determined to suffer from experimental errors 
(Section 5.3). Comparing the zinc affinity of BsLdcB with carboxypeptidase A (CPA), 
which share an almost identical, if inverted, active site, suggest that BsLdcB binds zinc 
with 8 orders of magnitude greater affinity than CPA (10-17 vs. 10-9 M) (Coleman and 
Vallee, 1960). Given the experiments on CPA were conducted >50 years ago, using 
radioactive cobalt to determine the amount bound to CPA at equilibrium following 
dialysis against four different concentrations of cobalt or cobalt-zinc mixtures, it is 
highly likely that the reported CPA zinc affinity is also underestimated by several 
orders of magnitude.  
The crystal structure of SpLdcB with cobalt bound revealed that cobalt binds SpLdcB in 
a manner similar to zinc, although the cobalt ion is coordinated by an extra solvent 
ligand and so has trigonal bipyrimidal geometry. The cobalt structure likely represents 
the transition state of SpLdcB; during catalysis the zinc ion is expected to adopt 
trigonal bipyramidal geometry to coordinate the reaction intermediate (Section 4.5). 
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Similarly, the crystal structure of SpLdcB with copper bound demonstrates that copper 
is able to bind the enzyme in either a 4- or 5- coordinate geometry, mimicking the 
coordination spheres of zinc and cobalt, respectively.  
It has been demonstrated (Section 5.5) that the cobalt and copper substituted forms 
of SpLdcB retain their activity and are not inhibited in any noticeable way. Whilst many 
cobalt substituted enzymes have been shown to retain, or even show enhanced, 
activity, it is rare for copper substituted zinc enzymes to continue functioning as 
efficiently as the enzyme with zinc bound (Folk and Gladner, 1960; Schaffer and Auld, 
1986; Bertini and Claudio, 1994; Hakansson et al., 1994; Hernandez Valladares et al., 
2000; Kuzuya and Inouye, 2001). In dipeptidyl peptidase III, active site flexibility 
appears to be a contributory factor in metal-substitution protein activity (Fukasawa et 
al., 2011); the rigidity of the copper coordination sphere can displace the catalytic 
residue by a small, but thermodynamically significant, distance to prevent the 
acid/base/nucleophile from participating in catalysis (Fukasawa et al., 2011). The 
structure of SpLdcB with copper bound clearly demonstrates that the catalytic residues 
retain similar orientations to those found in the zinc or cobalt bound structures, with 
the catalytic glutamate, E204, able to be positioned to either perform catalysis or to 
stabilise incoming ligands or reaction products.   
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Chapter 6: 
Summary and Discussion 
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6.1 Summary of the major findings of this thesis  
The crystal structures of LdcB from S. pneumoniae (SpLdcB) and B. subtilis (BsLdcB) are 
presented in this thesis. Se-Met substituted SpLdcB was solved at a resolution of 1.8 Å 
(PDBid: 4OX5) and BsLdcB was solved to 2.0 Å (PDBid: 4OX3). Both structures reveal a 
single domain, globular protein composed of two sub-domains around a V-shaped 
active site, at the bottom of which is the catalytic zinc ion (Section 3.4). The structures 
confirmed LdcB as a member of the LAS group of zinc metalloproteases, several 
members of which are active against peptidoglycan, albeit with different substrate 
specificities to LdcB. These include the Gly-Gly endopeptidase lysostaphin (Korndörfer 
et al., 2008) and the DD-/LD- endopeptidase MepA (Marcyjaniak et al., 2004). The 
structure of SpLdcB in complex with a product mimic, M-Tri-Lys(D-Asn), was also 
solved, which elucidated the molecular basis of peptidoglycan recognition of cell wall 
modifying members of the LAS family, including the vancomycin resistance enzymes 
VanY, VanXYg and VanXYc (Section 4.2). 
This thesis also presents biochemical evidence consistent with LdcB acting as an              
LD-carboxypeptidase, with the enzyme showing no activity against stem tetrapeptide 
mimics ending in a canonical LL peptide bond (Ala-D-γ-Gln-Lys-Ala) (Section 4.3). 
Interestingly, LdcB did show minor activity against peptidoglycan pentapeptides ending 
in a DD-peptide bond (Ala-D-γ-Gln-Lys-D-Ala-D-Ala) (Section 4.3), but this activity is 
unlikely to present itself in vivo. 
Finally, the requirement for zinc in the active site of the enzyme was assessed, with 
EDTA-treated LdcB having no activity against substrate (Section 4.3), though 
replacement of the active site zinc with copper or cobalt did not appear to inhibit the 
enzyme (Section 5.5). The affinities of LdcB for zinc, copper and cobalt were 
determined, which demonstrated that LdcB binds zinc with the highest affinity 
(Section 5.3). 
6.2 Other LdcB structures 
During the course of this study, another group solved the structure of SpLdcB, though 
they retained the DacB nomenclature for this enzyme (Abdullah et al., 2014). DacB           
(D-Ala-D-Ala carboxypeptidase B) is the original name designated for E. coli PBP4 
(Kishida et al., 2006), a DD-endo/DD-carboxypeptidase, and to avoid confusion 
157 
 
Hoyland et al., (2014) suggested that the nomenclature LdcB should be adopted 
instead when referring to the LD-carboxypeptidase. For the sole purpose of clarity in 
this section, the structure solved by Abdullah et al., (2014) will be referred to as DacB, 
whereas the structure reported herein will be referred to as SpLdcB. 
Overall, the structure of DacB is almost identical to that of SpLdcB. The two 
conformations of DacB reported by Abdullah et al., (2014) are consistent with the open 
and closed conformations observed for SpLdcB (Section 3.4 and 4.2). The apo form of 
SpLdcB superposes onto the closed conformation of DacB with a core RMSD of         
0.60 Å over 180 aligned Cαs, and onto the open conformation with a core RMSD of 
0.85 Å over 176 aligned Cαs, with the slight increase in RMSD being due to the 
movement of a loop between Asp167 and Glu171. The ligand-bound form of SpLdcB 
superposes onto the closed conformation of DacB with a core RMSD of 1.06 Å over 178 
aligned Cαs, and onto the open conformation with a core RMSD of 1.17 Å over 183 
aligned Cαs. The major differences between the liganded, open conformation of 
SpLdcB and the open conformation reported for DacB appear to occur around α-
helices 2 and 3 (Figure 6.1). These differences are minor – given the small effect on the 
overall RMSD – and likely result from flexibility in this region of the enzyme. Indeed, 
the loop connecting α-helix 2 and 3 could not be built in the apo structure of SpLdcB 
(Section 3.4) suggesting that local disorder does affect this region of LdcB/DacB. 
 
 
Figure 6.1: Ligand-bound SpLdcB compared to the open conformation of DacB (PDBid: 4D0Y). The major 
differences between the two structures can be found in α-helices 2 and 3, likely due to disorder of nearby loops. 
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Neither chain in the DacB structure was found to contain a biologically-relevant ligand, 
although a phosphate molecule, introduced during purification or crystallisation, 
coordinates the zinc ion identically to that found in BsLdcB (Section 3.4.2). Whilst the 
open conformation of DacB is identical to the ligand-bound form of SpLdcB, the 
catalytic Glu204 remains in the position observed for apo SpLdcB. The movement of 
this residue in the ligand-bound form of SpLdcB is therefore not a consequence of the 
opening of the enzyme, but instead of ligand binding and/or catalysis (Figure 6.2).  
 
 
Figure 6.2: The position of Glu204 in the crystal structures of apo SpLdcB (PDBid: 40X5), ligand-bound SpLdcB 
(PDBid: 40XD) and the open form of DacB (4D0Y). The catalytic Glu204 in the open conformation of DacB (light 
blue carbons) is in an identical orientation to Glu204 in the closed form of SpLdcB (white carbons). In the open, 
ligand bound conformation of SpLdcB (green carbons) Glu204 moves to interact with D-γ-Gln. 
 
In an attempt to gain insight into substrate recognition by DacB, the structure of 
VanXYc in complex with D-Ala-D-Ala was superposed onto that of DacB and the             
D-Ala-D-Ala moiety replaced manually with L-Lys-D-Ala (Abdullah et al., 2014). 
Abdullah et al., (2014) used the closed conformation of DacB as the model, due to its 
greater similarity to VanXYc compared to the open conformation. However, the 
orientation of Trp206 obscures the entrance of the active site and would sterically 
occlude the full-length tetrapeptide, making the open conformation a better model for 
this analysis (Figure 6.3).  
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Figure 6.3: The position of Trp206 in open and closed DacB. The closed conformation of Trp206 sterically clashes 
with the D-γ-Gln of the M-Tri-Lys(D-Asn) ligand (superposed from PDBid: 4OXD), whilst Trp206 in the open 
conformation allows the ligands to bind to the active site. The M-Tri-Lys(D-Asn) ligand is shown in ball-and-stick 
representation and the surface of the close conformation of DacB is shown in transparent blue. The two 
conformations of Trp206 are shown as sticks. 
 
Whilst the contacts between DacB and the D-Ala moiety of the modelled substrate are 
similar to  those between SpLdcB and M-Tri-Lys(D-Asn) (Hoyland et al., 2014), the 
position of the L-Lys is incompatible with the catalytic properties of the enzyme; the 
carbonyl oxygen of the L-Lys is not positioned to allow it to complete the tetrahedral 
coordination geometry of the active site zinc, a requirement of the polarisation of  the 
C=O double bond for nucleophilic attack by an activated water (Figure 6.4).  
 
 
Figure 6.4: The position of the carbonyl oxygen of L-Lys in a model of L-Lys-D-Ala bound to DacB, taken from 
Abdullah et al., (2014). The carbonyl oxygen (indicated by a red circle) is not coordinating to the metal ion (red or 
white sphere) when modelled into DacB (gold carbons). The authors superposed DacB onto VanXYg (white carbons) 
to position the ligand model.  
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The sidechain of the L-Lys is orientated to form a hydrogen bond with Ser145 in the 
structure of DacB (Figure 6.4, previous page). Whilst this contact is possible in 
uncrosslinked tetrapeptides, SpLdcB is active against both uncrosslinked and 
crosslinked substrates, suggesting that the sidechain of the L-Lys projects out of the 
enzyme, along the path proposed by Hoyland et al., (2014). Finally, Abdullah et al., 
(2014) comment that Trp206 could stabilise the substrate as seen in the structure of 
VanXYc with D-Ala-D-Ala bound (PDBid: 4MUS) (Figure 6.5), in which Trp155 stabilises 
the amino-terminus of the D-Ala-D-Ala dipeptide. This role is not possible in the 
conformation adopted by Trp206 in the open, ligand-bound conformation of LdcB 
(Section 4.2). 
 
 
Figure 6.5: The hydrogen bond interaction between Trp206 and the tetrapeptide is not possible in the ligand-
bound enzyme conformation. The interactions between Trp206 and the main-chain amino group of the L-Lys in the 
tetrapeptide ligand in the closed enzyme conformation (left) hypothesised by Abdullah et al., (2014), mimicking the 
interaction observed between D-Ala-D-Ala and VanXYc by Meziane-Cherif et al. (2014) (right), is not possible in the 
open, ligand bound conformation of LdcB/DacB. The closed conformation of DacB is shown as a blue surface, with 
the open and closed conformations of Trp206 shown as sticks. The M-Tri-Lys(D-Asn) ligand was obtained by 
superposing the ligand-bound form of SpLdcB (PDBid: 4OXD) onto the closed conformation of DacB, and is shown in 
ball-and-stick representation. The surface of VanXYc is shown as a transparent grey, with Trp155 shown in stick 
representation. The D-Ala-D-Ala ligand is shown in ball-and-stick representation. 
 
6.3 The LdcB represents an ancestral form of the vancomycin resistance enzymes 
Within the LAS family of which LdcB is a member, LdcB shares most structural and 
sequence similarity with the vancomycin resistance enzymes VanY, VanXYg and VanXYc 
(Hoyland et al., 2014; Meziane-Cherif et al., 2014). VanY and VanXYc are active against 
cell wall pentapeptides, and VanXYg and VanXYc are capable of hydrolysing                  
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D-Ala-D-Ala dipeptides (Meziane-Cherif et al., 2014). Meziane-Cherif et al., (2014) have 
suggested that LdcB may represent an ancestral form of the vancomycin resistance 
enzymes, with minor changes to the activity and the specificity of LdcB resulting in the 
repurposing of the LD-tetracarboxypeptidase into a DD-pentacarboxypeptidase/DD-
dipeptidase (Meziane-Cherif et al., 2014). In Figure 6.6, a phylogenetic tree compares 
LdcB to VanY, VanXYg and VanXYc.  
 
 
Figure 6.6: Phylogram comparing LdcB sequences with VanY and VanXYg from Enterococcus faecium, and VanXYc 
from Enterococcus gallinarum. The VanY and VanXY enzymes occupy a branch of the tree with LdcB from L. lactis, 
with the branch splitting from ancestral LdcB enzymes. Sequence alignments were performed by Muscle (Edgar, 
2004), the model was chosen based upon maximum likelihood calculations by the RAxML web-server (Stamatakis, 
2006; Stamatakis et al., 2008) and Figtree (http://tree.bio.ed.ac.uk/software/figtree/) used to generate the 
phylogram. Support values for the branches are shown and branch length is related to the number of changes 
within the protein sequences, weighted by the model chosen by RAxML.    
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The tree reveals that VanY and the VanXY enzymes appear to be most closely related 
to LdcB from Lactococcus lactis and seem to form a small clade with LdcBs from            
B. subtilis, B. anthracis and L. monocytogenes, which split from the tree following the 
divergence of the other LdcB enzymes. It should be noted, however, that the                   
LD-carboxypeptidase activities have only been shown for LdcB from S. pneumoniae 
(Barendt et al., 2011; Abdullah et al., 2014; Hoyland et al., 2014), L. lactis (Courtin et 
al., 2006), B. subtilis (Hoyland et al., 2014) and B. anthracis (Section 4.4), and the other 
LdcB enzymes have been identified only through sequence similarities. It remains to be 
seen from whether the other LdcB enzymes possess LD-carboxypeptidase activity. 
Comparing the structures of BsLdcB, BaLdcB and SpLdcB might permit the 
identification of features that confer LD-carboxypeptidase activity, distinct from either 
DD-carboxypeptidase or D-Ala-D-Ala dipeptidase activity. For example, a loop known 
as the β4-α5/bi-substrate selectivity loop determines the substrate selectivity of the 
VanXY enzymes (Meziane-Cherif et al., 2014). It is believed that in the open 
conformation of VanXYc the active site is enlarged and the enzyme is capable of 
binding and hydrolysing the stem pentapeptide, whilst the closed conformation 
effectively caps the active site and allows for the efficient hydrolysis only of                     
D-Ala-D-Ala dipeptides (Meziane-Cherif et al., 2014). Though LdcB enzymes lack the           
bi-substrate selectivity loop, they do possess a short, flexible loop (β4-α4) in an 
equivalent position, the conformation of which changes on tetrapeptide binding 
(Section 4.2) (Hoyland et al., 2014). It is not unreasonable to suggest that a small 
increase in the length of the β4-α4 loop could result in the formation of the                        
bi-substrate selectivity loop to provide in LdcB enzymes with the ability to hydrolyse    
D-Ala-D-Ala dipeptides efficiently, an activity that SpLdcB possesses only under high 
substrate concentrations and long incubation times (Section 4.3.1). SpLdcB also 
possesses minor activity against pentapeptides (Section 4.3.1). A position that could 
be adopted by the pentapeptide in SpLdcB has been modelled (Section 4.3.1), and the 
pentapeptide substrate could make many of the same contacts to the protein as does 
the tetrapeptide, but with each amino acid of the peptide shifted 1 position upwards. 
In this position, the MurNAc sugar and the L-alanine project out above the surface of 
SpLdcB and do not make contact with the enzyme (Figure 6.7). 
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Figure 6.7: The pentapeptide model projecting above the surface of SpLdcB. The MurNAc and L-Ala moieties of the 
pentapeptide model fail to make contact with SpLdcB 
 
In the VanXY enzymes, the larger bi-substrate selectivity loop allows Arg119 to contact 
the O1 of the MurNAc sugar, stabilising the pentapeptide. However in the crystal 
structures of VanXY published to date, the enzymes are found in their dipeptidase 
conformation (Meziane-Cherif et al., 2014), and thus any contacts made by the                     
bi-substrate selectivity loop may not be maintained in the presence of a pentapeptide 
substrate. 
Comparing the neighbouring genes of the confirmed LdcB enzymes (SpLdcB, BaLdcB 
and BsLdcB), using the genome2d webserver (de Jong et al., 2012) to predict operons, 
suggests that BsLdcB and BaLdcB do not belong to an operon and are distinct from 
known peptidoglycan recycling genes. SpLdcB is predicted to be part of an operon 
(operon 0208 in S. pneumoniae R6) containing the hypothetical genes spr0552 and 
spr0553. spr0552 is predicted to code for a hypothetical zinc peptidase of the M42 or 
M20 family, whilst spr0553 is predicted to code for a hypothetical deaminase enzyme. 
Without experimental evidence confirming the existence and function of these 
predicted proteins, hypothesising a function for the operon is difficult, although the 
presence of the second zinc peptidase may suggest a role in further degrading the 
stem peptide from a tripeptide to a dipeptide.   
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6.4 Convergent evolution between peptidases  
Although evolutionary distinct, LdcB shares a remarkable similarity with pancreatic 
carboxypeptidase A (CPA). Whilst the overall structures of the two enzymes are 
dissimilar, the active sites are essentially mirror-images of one another (Figure 6.8), 
suggesting that similar catalytic mechanisms may be employed. Two catalytic 
mechanisms have been proposed for CPA, the promoted water pathway and the 
nucleophilic attack pathway. In the nucleophilic attack pathway, Glu270 of CPA is 
thought to attack the scissile carbonyl of the substrate to form an acyl-enzyme 
intermediate, and Arg127 aids to position the substrate. This intermediate then 
undergoes nucleophilic attacked by a zinc-bound water, deacylating the intermediate 
to result in product formation (Wu et al., 2010). In the promoted water pathway, 
Glu270 acts as a general base to activate a zinc-bound water for attack on the scissile 
carbonyl carbon; its polarisation is stimulated by the proximity of the zinc ion and 
Arg127. This pathway does not result in an acyl-enzyme intermediate, but the 
substrate forms a tetrahedral intermediate with the catalytic zinc ion instead. Glu270 
cleaves the peptide bond of the leaving group by donating a proton (Wu et al., 2010). 
In SpLdcB, Glu204 and Arg120 are the functional equivalents of CPA Glu270 and 
Arg127.   
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Figure 6.8: The active site of CPA (A) and SpLdcB (B). Despite possessing dissimilar overall structures, the active 
sites of the two zinc metallopeptidases are remarkably similar. Arg127 and Glu270 of CPA are reversed in SpLdcB 
(Arg120 and Glu204). CPA carbons are shown in green whilst SpLdcB carbons are shown in white. Both structures 
are shown in stick representation, with the catalytic zinc ion shown as a grey sphere. 
 
Evidence for the nucleophilic attack mechanism for CPA stems mainly from studying 
the accumulation of acyl-intermediates at low temperature (Makinen et al., 1979). 
Ester-containing substrates rather than peptides were used in these studies, and hence 
the conclusions drawn may not be relevant for proteolysis. However, crystallographic, 
kinetic and oxygen-exchange studies of CPA support the promoted water pathway 
(Breslow and Wernick, 1977; Wu et al., 2010). In particular, the oxygen-exchange 
studies, which monitored the transfer of oxygen-18 from a labelled substrate                 
(i.e. N-benzoylglycine) in the presence of a cocatlayst (i.e. phenylalanine) during the 
synthesis and subsequent hydrolysis of N-benzoylglycylphenylalanine, noted that the 
rates of oxygen transfer agreed closely with the rate expected from a direct hydrolysis 
reaction (e.g. the promoted water pathway), without the formation of any                  
acyl-enzyme intermediates, as would be produced in a nucleophilic attack by a protein 
amino acid (Breslow and Wernick, 1977). More recently, free-energy simulations of the 
hydrolysis of esters and peptides have predicted that a lower energy barrier has to be 
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overcome for the promoted-water pathway than the nucleophilic attack mechanism 
(Xu et al., 2009; Wu et al., 2010). Some turnover of the tetrapeptide substrate occurs 
in the Glu204Ala mutant of SpLdcB (Section 4.3.2.2), which is unlikely to occur should 
the enzyme utilise the nucleophilic pathway; the nucleophilic pathway requires a 
carboxylate side-chain, which alanine does not possess but glutamate does, to attack 
the carbonyl oxygen of the substrate lysine to from an acyl enzyme intermediate. The 
similarities between the actives sites of CPA and LdcB therefore suggest that LdcB is 
also likely to utilise the promoted water pathway. 
In addition to possessing similar active sites, LdcB and CPA are both examples of 
Koshland’s induced fit hypothesis (Koshland, 1958; Christianson and Lipscomb, 1989). 
Upon binding substrate, CPA undergoes a conformational change in which the 
backbone of several residues is displaced, and Tyr248 flips from an ‘up’ position to 
‘down’, allowing it to form hydrogen bonds with the incoming ligand (Steitz et al., 
1967). In SpLdcB, ligand binding causes a loop between Asp167 and Glu171 to fold into 
an additional turn in α-helix 4 and the indole ring of Trp206 to move by ~9 Å, 
increasing the size of the active site (Section 4.2). The sidechain of Glu204 moves to 
interact with the D-γ-Gln moiety, though it is unclear if this movement occurs prior to, 
or post, hydrolysis; the promoted water hypothesis suggests that Glu204 has to              
re-orientate following catalysis to stabilise the leaving tripeptide, as Glu204 would 
otherwise be unable of participating as either a general acid or a base. A similar 
stabilising effect has not been noted for Glu270 of CPA, although the interactions 
between Tyr248 and the incoming ligand (Steitz et al., 1967) likely act to stabilise the 
dipeptide in its place. In summary, LdcB and CPA appear to have evolved similar 
mechanisms for catalysis, despite sharing little sequence identity or overall structural 
homology, and are therefore excellent examples of convergent evolution.  
6.5 The physiological role of LdcB 
The physiological effect of ldcB deletion appears to differ between bacterial species. 
For instance, ΔldcB S. pneumoniae strains develop a compromised cell morphology, 
with division asymmetry and mislocalisation of division septa (Barendt et al., 2011). 
The cytoplasm of these cells are less dense than wild-type, suggesting that premature 
cell lysis occurs (Abdullah et al., 2014). By contrast, deletion of ldcB in B. subtilis does 
not result in the appearance of aberrant morphologies during vegetative growth 
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(Hoyland et al., 2014). LdcB does appear to be necessary for B. subtilis growth under  
D-alanine limiting conditions, however, as ΔldcB mutants of a D-alanine auxotroph 
showed a greater growth-rate dependency on exogenously added D-alanine in 
comparison to the D-alanine auxotrophic parental strain (Hoyland et al., 2014).  
Barendt et al., (2011) have suggested that the compromised cell morphology of ΔldcB 
S. pneumoniae is a consequence of the mislocalisation of the penicillin binding proteins 
(PBPs), the enzymes that facilitate the incorporation of new peptidoglycan into the cell 
wall during cell elongation or division. This hypothesis is supported by the finding that 
PBPs localise to their preferred substrate; treating cells with vancomycin (which binds 
to the terminal D-Ala-D-Ala of the stem pentapeptide to prevent it from participating 
in crosslinking), mutating the pentapeptide binding domains of PBPs, or preventing 
nascent peptidoglycan localisation have all been shown to cause delocalisation of PBPs 
(Morlot et al., 2004; Pinho and Errington, 2005; Potluri et al., 2010; Lages et al., 2013). 
In addition, this theory implies that stem tetrapeptides, the substrates of LdcB, are a 
substrate for PBPs; deletion of ldcB results in stem tetrapeptides being present over 
the entire surface of S. pneumoniae (Barendt et al., 2011) and coincides with the 
appearance of aberrant division septa (Barendt et al., 2011). However, the 
tetrapeptides, which can only function as transpeptidation acceptors, not donors, 
being a substrate for PBPs is not supported by observations that ΔldcB mutants 
contain fewer crosslinks in their cell walls than wild-type cells (Barendt et al., 2011) 
Alternatively, the presence of stem tetrapeptides may localise other cell division 
proteins. For example StkP, a protein that links cell division and elongation in the 
Streptococci, has been shown to contain a PASTA domain that is thought to interact 
with peptidoglycan (Yeats et al., 2002; Beilharz et al., 2012). SktP appears to pause 
septation (Beilharz et al., 2012), to allow for the peripheral cell wall biosynthesis that is 
required for cell enlargement prior to division (Higgins and Shockman, 1970; Beilharz 
et al., 2012). The overexpression of StkP causes the development of small, round cells, 
and ΔstkP mutants over-elongate and exhibit multiple division septa (Beilharz et al., 
2012). Both StkP phenotypes resemble those of ΔldcB S. pneumoniae, suggesting a link 
between StkP and LdcB. By contrast, elongation and division are not explicitly linked in 
B. subtilis; cell elongation occurs prior to and post division rather than during division 
(Jensen et al., 2005; Schirner and Errington, 2009), thus StkP localisation is not 
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required to coordinate the two actions, explaining the absence of a morphological 
phenotype upon ldcB deletion.  
The growth of L. lactis, a close relative of S. pneumoniae, has been reported to be 
unaffected by ldcB deletion (Courtin et al., 2006). It is possible that ldcB deletion 
causes a coccus-to-rod transition in L. lactis, a naturally-occurring non-detrimental 
morphological change in this bacterium (Perez-Nunez et al., 2011). The transition 
occurs when the septation machinery, primarily PBP2X, is halted for a greater amount 
of time than would occur naturally, whilst peripheral growth continues unabated 
(Perez-Nunez et al., 2011). As PBP2X co-localises with stem peptide availability (Yeats 
et al., 2002), it is possible that the ldcB deletion causes PBP2X mislocalisation and 
artificially stalls septation, forcing the cells to become rod-like. Although the 
hypothesis that a coccus-to-rod transition has occurred could be solved relatively 
easily by examining ΔldcB L. lactis under a microscope, linking the transition would 
require the labelling of PBP2X, and other division proteins, to determine if they localise 
correctly. 
6.6 Concluding remarks and future work 
The research undertaken in this thesis has focussed on the LD-carboxypeptidase, LdcB, 
the biochemistry and 3-D structure of which confirm its designation as an                          
LD-carboxypeptidase. Nevertheless, several avenues of research remain open. First 
and foremost, the precise mechanism by which LdcB causes morphological changes in 
S. pneumoniae, but not B. subtilis, needs to be elucidated. It has been suggested by 
Barendt et al., (2011) that ldcB deletion causes the mislocalisation of PBPs, and ΔldcB 
mutants resemble cells in which StkP, a division coordinator, is either overexpressed or 
deleted. Clearly, immunofluorescence and/or other methods of determining the 
localisation patterns cell division proteins (GFP-fusions etc.) need to be employed in 
conjunction with ldcB deletions to help determine the links between LdcB and cell 
division.    
Second, although the liganded SpLdcB structure identified at least some of the amino 
acids required for peptidoglycan recognition, the path of the L-lysine was not 
physiologically relevant, nor was the positioning of the D-Asn residue, which occupied 
the position of the D-Ala leaving group. A path for the lysine to follow when the 
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enzyme acts on cross-linked substrates has been proposed, but the introduction of 
bulkier residues (e.g. arginine or tryptophan) and/or the use of longer crosslinks (e.g. a 
penta-glycine bridge rather than a single D-Asn) is required to validate the path. 
Additionally, the co-crystallisation of LdcB with the true, tetrapeptide substrate would 
validate the proposed location of the scissile D-alanine and the interactions that it 
forms with LdcB. 
Third, LdcB might represent a novel, narrow-spectrum antibiotic target. Barendt et al., 
(2011) demonstrated that LdcB is required for correct septum placement in                   
S. pneumoniae, and ΔldcB S. pneumoniae are much less able than wild-type to colonise 
and spread in acute pneumonia mouse models, suggesting LdcB may be a viable drug 
target (Abdullah et al., 2014). The potential design of new antibiotics that target LdcB 
is aided by the crystal structure of SpLdcB in complex with M-Tri-Lys(D-Asn). In 
addition, the M-Tri-Lys(D-Asn) ligand bound to SpLdcB may help elucidate the 
molecular interactions formed between the closely related vancomycin resistance 
enzymes (VanY, VanXYg and VanXYc) and their stem pentapeptide substrate                
(Section 4.2) and could lead to the development of much needed novel inhibitors to 
combat the continuing and unchecked march of vancomycin resistance.    
Finally, although the work completed herein has been successful in characterising LdcB 
enzymes, detailed kinetic parameters of the enzymes activity were not obtained. The 
unavailability of the natural substrate of these enzymes from commercial suppliers is a 
significant hurdle. The development of an extraction protocol to isolate cell wall 
tetrapeptides from the peptidoglycan of ΔldcB strains would allow the natural 
substrate of LdcB to be acquired in larger quantities than custom synthesis can provide 
and would permit a more detailed analysis of the catalytic mechanisms used by LdcB.  
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Appendix 1: General reagents, buffers and growth media 
Electrophoresis: 
• 1 x TAE: 0.4 M Tris-acetate (pH 8.0), 0.01 M EDTA. 
 
• 6 x DNA loading dye: 0.25 % (w/v) bromophenol blue, 0.25 % w/v) xylene cyanol FF, 
40 % (w/v) sucrose. 
 
• 1 x SDS running buffer: 40 mM Tris-HCl (pH 8.5), 250 mM glycine, 0.5 % (w/v) 
SDS. 
 
• 6 x SDS loading dye: 50 mM Tris-HCl (pH 6.8), 2 % (w/v) SDS, 0.1 % (w/v) 
bromophenol blue, 10 % (v/v) glycerol, 1 mM DTT. 
 
• 1 x native running buffer: 40 mM Tris-HCl (pH 8.5), 250 mM glycine. 
 
• 5 x native loading dye: 40 mM Tris-HCl (pH 6.8), 0.06 % (w/v) bromophenol blue, 
13 % (v/v) glycerol. 
 
• Coomassie blue stain: 2.5 g Coomassie blue R-250 in 1 l of destain. 
 
• Destain: 20 % (v/v) ethanol, 10 % (v/v) glacial acetic acid in 1 l H2O. 
 
Stacking Gel (5 %)  
5 % (v/v) Bis-acrylamide, 0.2 M Tris (pH 6.8), 0.1 % (v/v) sodium dodecyl sulphate (SDS), 0.1 % 
(v/v) ammonium persulphate, 0.1 % (v/v) Tetramethylethylenediamine (TEMED) 
Resolving Gel (15 %) 
15 % (v/v) Bis-acrylamide, 0.35 M Tris (pH 8.8), 0.1 % (v/v) SDS, 0.1 % (v/v) ammonium 
persulphate, 0.1 % (v/v) TEMED 
 
Luria Bertani broth (LB): 1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 0.5 % (w/v) 
NaCl. 
LB Agar plates: As LB broth, but with the addition of 1.5 % (w/v) agar prior to 
autoclaving. 
Selenomethionine growth media: 
 20 x M9 media: 0.4 M NH4Cl, 0.4 M KH2PO4, 0.85 M Na2HPO4. 
 Amino acids mix I: Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Pro,   
            Ser, Thr, Val (all at 0.4 g/ml) 
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Amino acids mix II: Phe, Trp, Tyr, Asp (all at 0.4 g/ml) 
Vitamin solution: niacinamide, pyroxidine monohydrochloride, riboflavin, 
thiamine   
                              (all at 1 mg/ml). 
Se-met media: 2 mM MgSO4, 2 x M9 media, 45 uM FeSO4, 0.4 % (w/v) glucose,       
               0.1 % (v/v) amino acid mix I, 0.1 % (v/v) amino acid mix II, 0.01 %  
                          (v/v) vitamin solution, Se-L-Met (0.4 g/l). 
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Appendix 2: Plasmid map of pET28a 
 
 
 
 
 
 
Appendix Figure 2.1: Plasmid map of pET28a. The coding sequences for the various proteins were inserted into 
the multiple cloning site, shown as a black arrow. Image taken from the Merck Millipore website   
http://www.merckmillipore.de/life-science-research/vector-table-novagen-pet-vector-
table/c_HdSb.s1O77QAAAEhPqsLdcab) 
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Appendix 3: Primers used in this study 
 
Appendix Table 3.1: List of mutagenesis primers used in this study. Mutations are underlined, with specific base 
changes in bold. 
Primer Name Sequence Mutation Introduced 
R120AFw GCGATCATTACAGTGGTTTTGCAAGTTATGAAACTCAGACCAAACTC Arg to Ala substitution 
R120ARv GAGTTTGGTCTGAGTTTCATAACTTGCAAAACCACTGTAATGATCGC Arg to Ala substitution 
E204AFw GAAACAGGCTATATGGCTGCGGAATGGCACCTGCGTTATG Glu to Ala substitution 
E204ARv CATAACGCAGGTGCCATTCCGCAGCCATATAGCCTGTTTC Glu to Ala substitution 
E204HFw GAAACAGGCTATATGGCTCACGAATGGCACCTGCGTTATG Glu to His substitution 
E204HRv CATAACGCAGGTGCCATTCGTGAGCCATATAGCCTGTTTC Glu to His substitution 
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Appendix 4: Co-crystallisation conditions of SpLdcB with a range of ligands 
Appendix table 4.1: Crystallisation conditions for SpLdcB with a range of ligands. 
Ligand Condition Components 
M-Tri-Lys PACT C8 0.2 M ammonium chloride, 0.1 M HEPES pH 7, 20% 
w/v PEG 6000 
 MORPH D8 0.12 M alcohols (1,6-hexanediol; 1-butanol;  
1,2-propanediol (racemic); 2-propanol; 1,4-
butanediol; 1,3-propanediol), 0.1 M buffer system 2 
pH 7.5 (sodium HEPES; MOPS (acid)), 37.50% v/v 
MPD_PEG1000_PEG3350 
 INDEX G9 0.1 M potassium thiocyanate, 30 % w/v PEG 2000 
MME 
 MORPH B8 0.09 M halogens (NaF; NaBr; NaI), 0.1 M buffer system 
2 pH 7.5 (sodium HEPES; MOPS (acid)), 
37.50% v/v MPD_PEG1000_PEG3350 
M-Tri-Lys(D-Asn) MORPH D8 0.12 M alcohols (1,6-hexanediol; 1-butanol;  
1,2-propanediol (racemic); 2-propanol; 1,4-
butanediol; 1,3-propanediol), 0.1 M buffer system 2 
pH 7.5 (sodium HEPES; MOPS (acid)), 37.50% v/v 
MPD_PEG1000_PEG3350 
 PACT C8 0.2 M ammonium chloride, 0.1 M HEPES pH 7, 20% 
w/v PEG 6000 
 PACT D8 0.2 M ammonium chloride, 0.1 M tris pH 8.0, 
20 % w/v PEG 6000 
 MORPH E8 0.12 M ethylene glycols (di-ethyleneglycol; tri-
ethyleneglycol; tetra-ethyleneglycol; penta-
ethyleneglycol), 0.1 M buffer system 2 pH 7.5 (sodium 
HEPES; MOPS (acid)), 37.50% v/v 
MPD_PEG1000_PEG3350 
Tri-DAP PACT C8 0.2 M ammonium chloride, 0.1 M HEPES pH 7, 20% 
PEG 6000 
 STRUCTURE G4 0.1 M Na HEPES pH 7.5, 20 % w/v PEG 10,000 
 MORPH F5 0.12 M monosaccharides (D-glucose; D-mannose; D-
galactose; L-fucose; D-xylose; N-acetyl-D-
glucosamine), 0.1 M buffer system 2 
pH 7.5 (sodium HEPES; MOPS (acid)), 30.00% v/v 
PEG500MME_PEG20,000 
MDP PACT C8 0.2 M ammonium chloride, 0.1 M HEPES pH 7, 20% 
PEG 6000 
 STRUCTURE G8 0.1 M Na citrate pH 5.6, 35 % v/v tert-butanol 
 MORPH E8 0.12 M ethylene glycols (di-ethyleneglycol; tri-
ethyleneglycol; tetra-ethyleneglycol; penta-
ethyleneglycol), 0.1 M buffer system 2 pH 7.5 (sodium 
HEPES; MOPS (acid)), 37.50% v/v 
MPD_PEG1000_PEG3350 
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Peptidoglycan surrounds the bacterial cytoplasmic
membrane to protect the cell against osmolysis.
The biosynthesis of peptidoglycan, made of glycan
strands crosslinked by short peptides, is the target
of antibiotics like b-lactams and glycopeptides.
Nascent peptidoglycan contains pentapeptides that
are trimmed by carboxypeptidases to tetra- and
tripeptides. The well-characterized DD-carboxypep-
tidases hydrolyze the terminal D-alanine from the
stem pentapeptide to produce a tetrapeptide. How-
ever, few LD-carboxypeptidases that produce tri-
peptides have been identified, and nothing is known
about substrate specificity in these enzymes. We
report biochemical properties and crystal structures
of the LD-carboxypeptidases LdcB from Strepto-
coccus pneumoniae, Bacillus anthracis, and Bacillus
subtilis. The enzymes are active against bacterial cell
wall tetrapeptides and adopt a zinc-carboxypepti-
dase fold characteristic of the LAS superfamily. We
have also solved the structure of S. pneumoniae
LdcB with a product mimic, elucidating the residues
essential for peptidoglycan recognition and the
conformational changes that occur on ligandbinding.
INTRODUCTION
Bacteria surround their cytoplasmic membrane with a large,
semipermeable barrier, the peptidoglycan (PG) sacculus, which
not only protects the cell from lysis from turgor but also helps
to maintain cell shape. PG comprises repeating units of the
N-acetylglucosamine-N-acetylmuramicacid (GlcNAc—MurNAc)
disaccharide that polymerizes into longglycanchains.Pentapep-
tides, usually comprising L-Ala—D-g-Glu[Gln]—L-Lys—D-Ala—D-Ala, extend from theMurNAcmoiety. In Gram-negative bacte-
ria and some Gram-positive Firmicutes, the L-Lys at position 3
is replaced by meso-diaminopimelic acid (A2pm), which is
amidated in Bacillus subtilis (Vollmer et al., 2008a). Peptides pro-
truding fromadjacent glycan chains are crosslinked by transpep-
tidases to form the net-like PG sacculus, which the cell has to
enlarge in order to grow and to divide (Sauvage et al., 2008).
Newly inserted PGmatures and is turned over by PG hydrolases,
and the balance between synthesis and degradation of PG is key
to normal cell division (Vollmer et al., 2008b). The importance of
PG to the healthy physiology of a bacterium is highlighted by
the fact that its biosynthesis is the target of someof ourmost suc-
cessful antibiotics, b-lactams such as penicillin and glycopep-
tides such as vancomycin, resistance to which in pathogens is
an urgent and currently unmet human health challenge.
In most species, the terminal D-alanine of the nascent penta-
peptide stem is hydrolysed by DD-carboxypeptidases from the
class C penicillin binding protein (PBP) family (Lovering et al.,
2012). LD-carboxypeptidases subsequently hydrolyze the
L-Lys[A2pm]—D-Ala bond to release the tripeptide. Though tri-
peptides are found inmany bacteria, very few of the correspond-
ing LD-carboxypeptidases have been identified. Membrane
preparations of B. subtilis have shown strong LD-carboxypepti-
dase activity against cell-wall-derived tetrapeptides (Arminjon
et al., 1977), though the specific enzyme involved has not been
isolated. The best characterized LD-carboxypeptidase is LD-
carboxypeptidase A (LdcA), a cytoplasmic, penicillin-insensitive
member of the S66 family of serine peptidases that is involved in
PG recycling and is essential for cells entering the stationary
phase (Metz et al., 1986; Templin et al., 1999). The cytoplasmic
localization of LdcA precludes its involvement in the production
of cell wall tripeptides. Other LD-carboxypeptidases either must
be active within the periplasm of Gram-negative bacteria or are
anchored to the exterior of the cell membrane in Gram-positives.
Several LD-carboxypeptidase genes have been identified
recently, including dacB from Lactococcus lactis and Strepto-
coccus pneumoniae (Barendt et al., 2011; Courtin et al., 2006),
csd6 from Helicobacter pylori (Sycuro et al., 2012) and pgp2Structure 22, 949–960, July 8, 2014 ª2014 The Authors 949
Figure 1. Effect of dacA and ldcB Alleles in a D-alanine Auxotroph
(A–C) The growth of strains (A) RD180 (DalrA), (B) KS02 (DldcBDalrA), and (C)
KS03 (DdacADalrA) incubated at 37C in LB medium supplemented with
different concentrations of D-alanine was determined by monitoring the cul-
ture at OD600 and plotting it against time of incubation.
(D) The calculated growth rate of each strain at three different concentrations
of exogenous D-alanine. The values shown represent the average of three
independent experiments. The dashed line shows the growth rate of wild-type
B. subtilis strain 168CA under the same conditions. The error bars represent
the SD of growth rate means at a confidence level of 95%.
Structure
Structure of the LdcB LD-CarboxypeptidasefromCampylobacter jejuni (Frirdich et al., 2014), though it should
be noted that csd6 and pgp2 share no sequence similarity with
dacB. The corresponding null mutants exhibited increased
amounts of tetrapeptides in the cell wall and a concomitant
decrease in tripeptide content (Sycuro et al., 2012; Frirdich
et al., 2014). The S. pneumoniae dacB mutant also displayed
severe morphological defects, developing into small, spherical
cells or elongating into long, thick cells, as a result of division
asymmetry produced by random septum localization (Barendt
et al., 2011). Both the H. pylori csd6 and the C. jejuni pgp2
mutants have a morphological defect, displaying a straight
shape instead of the normal helical morphology, indicating that
csd6 and pgp2 also contribute to cell shape maintenance (Frir-
dich et al., 2014; Sycuro et al., 2012). In C. jejuni (Frirdich et al.,
2012) and H. pylori (Sycuro et al., 2010), cell shape is also linked
to pathogenicity, and PG fragments released by growing cells
are important signaling molecules for immune recognition and
modulation in animals ranging from insects to man (Royet
et al., 2011). Therefore, the PG plays an important role in bac-
terial shape maintenance, viability, virulence and immune
signaling.
In this study, we have investigated the biochemical activity of
S. pneumoniae and B. subtilis DacB against cell wall sacculi and
synthetic tetrapeptides. Both proteins are shown to be active
against cell-wall-derived tetrapeptides and synthetic tetra-
peptides lacking the sugar moiety but are inactive against tetra-950 Structure 22, 949–960, July 8, 2014 ª2014 The Authorspeptides terminating in L-alanine, confirming their classification
as LD-carboxypeptidases. We therefore propose to rename
these enzymes LD-carboxypeptidase B (LdcB). We present the
crystal structures of both LdcB enzymes and the ortholog from
Bacillus anthracis, all of which belong to the LAS (lysostaphin,
D-Ala-D-Ala metallopeptidases, sonic hedgehog) family of
zinc-dependent peptidases. The structure of S. pneumoniae
LdcB with MurNAc—L-Ala—D-g-Gln—L-Lys—(D-Asn) bound
reveals the molecular basis of PG recognition and the key roles
played in catalysis by active site elements. It is surprising that
the active site is reminiscent, yet reversed, of that found in
pancreatic carboxypeptidase A, suggesting that the enzymes
have converged on a common catalytic mechanism.
RESULTS
Role for LdcB In Vivo
The mature PG of S. pneumoniae and B. subtilis contains mostly
tripeptides, indicating the presence of PG-active peptidases in
these organisms (Atrih et al., 1999; Bui et al., 2012). Both species
contain DacA orthologs, DD-carboxypeptidases that cleave
pentapeptides to tetrapeptides; however, the LD-carboxypepti-
dases that produce tripeptides from the tetrapeptides have
remained elusive until recently. The PG of a S. pneumoniae
dacB mutant contained mainly tetrapeptides, suggesting
strongly that SpDacB is an LD-carboxypeptidase (hereinafter
renamed as SpLdcB) (Barendt et al., 2011). Single mutants of
the dacA and dacB orthologs inB. subtilis, dacA, and yodJ (here-
inafter renamed as ldcB), had no obvious phenotype during
vegetative growth, indicating that the trimming of peptides or
the released D-Ala is not required for growth under laboratory
conditions (Atrih et al., 1999). To test whether the released
D-Ala becomes important under D-Ala limiting conditions, we
constructed dacA and ldcB null mutants in a B. subtilis strain
auxotrophic for D-Ala (an alanine racemase [alrA] null mutant)
and assayed growth in the presence of D-Ala. The D-Ala-depen-
dent strain, RD180, required at least 450 mM D-Ala for normal
growth, and it grew more slowly at lower D-Ala concentrations
(Figure 1). However, strains also bearing either the dacA (KS03)
or the ldcB (KS02) alleles exhibited even more severe growth
rate dependencies on D-Ala, with the dacA mutant the most
severely affected. These data suggest strongly that LdcB is an
LD-carboxypeptidase that releases D-Ala from the cell wall,
which can be used to support growth under D-Ala-limiting
conditions.
To test directly whether LdcB functions as an LD-carboxypep-
tidase, we generatedS. pneumoniae andB. subtilis ldcBmutants
and isolated their cell wall PG. Muropeptides were released with
cellosyl and analyzed by HPLC (Figures 2A and 2B). The ldcB
mutant strains lacked tripeptides and containedmainly tetrapep-
tides in their PGs, consistent with previous work indicating that
LdcB is the main enzyme trimming cell wall tetrapeptides
(Barendt et al., 2011). To obtain more direct evidence for an
enzymatic activity, purified, recombinant LdcB enzymes from
S. pneumoniae and B. subtilis (termed SpLdcB and BsLdcB)
were incubatedwith PG isolated from the respective ldcBmutant
strains before digesting with cellosyl and analyzing the resulting
muropeptides by HPLC (Figures 2A and 2B). Both SpLdcB and
BsLdcB almost quantitatively digested PG tetrapeptides with a
Figure 2. Activity of SpLdcB and BsLdcB
against Peptidoglycan and Peptides
(A) HPLC chromatograms of muropeptides from
S. pneumoniae strains, obtained after incubating
PG with or without SpLdcB or SpLdcB(E204A)
in the presence of Zn2+ or EDTA, followed by
digestion with cellosyl and reduction with
sodium borohydride. The muropeptides are: Tri,
GlcNAc—MurNAc(r)—L-Ala—D-g-Gln—L-Lys;
Tetra, GlcNAc—MurNAc(r)—L-Ala—D-g-Gln—L-
Lys-D-Ala; TetraTri, GlcNAc—MurNAc—L-Ala—
D-g-Gln—L-Lys—D-Ala—L-Lys—D-g-Gln—L-
Ala—MurNAc(r)—GlcNAc; TetraTetra, GlcNAc—
MurNAc—L-Ala—D-g-Gln—L-Lys—(D-Ala)—
D-Ala—L-Lys—D-g-Gln—L-Ala—MurNAc(r)—Glc
NAc; deAc, deacetylation at GlcNAc; SA, L-Ser—
L-Ala branch (at L-Lys). GlcNAc, N-acetylglusos-
amine; MurNAc(r), N-acetylmuramitol.
(B) HPLC chromatograms of muropeptides from
B. subtilis strains, obtained after incubating PG
with or without BsLdcB, followed by digestion
with cellosyl and reduction with sodium borohy-
dride. Muropeptides: Tri, GlcNAc—MurNAc(r)—L-
Ala—D-g-Glu—meso-Dap(NH2); Tetra, GlcNAc—
MurNAc(r)—L-Ala—D-g-Glu—meso-Dap(NH2)—
D-Ala; TetraTri, GlcNAc—MurNAc—L-Ala—D-g-
Glu—meso-Dap(NH2)—D-Ala-meso-Dap(NH2)— D-
g-Glu—L-Ala—MurNAc(r)—GlcNAc; TetraTetra,
GlcNAc—MurNAc—L-Ala—D-g-Glu—meso-Dap
(NH2)—(D-Ala)—D-Ala—meso-Dap(NH2)— D-g-
Glu—L-Ala—MurNAc(r)—GlcNAc;meso-Dap(NH2),
meso-diaminopimelic acid (amidated).
(C) TLC of SpLdcB incubated with various sub-
strates.
Structure
Structure of the LdcB LD-Carboxypeptidasecarboxy-terminal D-Ala producing the tripeptides, proving their
LD-carboxypeptidase activity. SpLdcB was active in the pres-
ence of Zn2+ ions and inactive in the presence of EDTA, suggest-
ing a metal-ion-dependent peptidase mechanism.
SpLdcB and BsLdcB Are Catalytically Active against
Synthetic Cell Wall Tetrapeptides
In addition to removing the terminal D-Ala from S. pneumoniae
cell wall PG tetrapeptides (Figure 2A), SpLdcB was also tested
against synthetic tetrapeptides (L-Ala—D-Gln—L-Lys—D-Ala
[tetra-D]) and its L-isomer, L-Ala—D-Gln—L-Lys—L-Ala [tetra-
L]). Though these substrates lack the glycan component and
differ further from the natural substrate by the replacement of
D-g-glutamine with D-glutamine, they have the potential to
discriminate between LD- and LL-carboxypeptidase activities.
SpLdcB was active solely against the tetra-D ligand (Figure 2C),
an activity that was dependent on the presence of zinc and abro-
gated totally in the presence of EDTA (Figure 2C).
Overall Structure of LdcB
The crystal structures of SpLdcB and Bacillus anthracis LdcB
(BaLdcB) were solved by single wavelength anomalous disper-
sion (SAD); BsLdcB was solved by molecular replacement. The
LdcB enzymes are single domain proteins comprising two sub-
domains separated by a V-shaped cleft (Figures 3A–3C). The first
subdomain comprises a four-stranded, antiparallel b sheet (b4–
b7) that opposes the cleft, and the outside face of the b sheet
is flanked by three a helices (a1, a4, and a6). The second subdo-main comprises an N-terminal, three-stranded, antiparallel b
sheet (b1–b3), somewhat discrete from the four helical bundle
(a2, a3, a5, and a7) that makes up the rest of the subdomain.
Though the BaLdcB structure contains the same subdomain, it
is less well structured in this region than BsLdcB and SpLdcB,
and, as a consequence, the b1–b3 sheet is not formed. Neither
subdomain is formed by a contiguous, linear part of the primary
sequence; six loops (b3–a1, b4–a2, a3–b5, b6–a5, a5–b7, and
a6–a7) connect the two subdomains.
The cleft between subdomains is 15–18 A˚ wide at the top
and 15 A˚ deep and narrows down to the base where a Zn2+
ion, added to the enzyme during purification, is located (Fig-
ures 3A–3C), which is coordinated in a tetrahedral manner
by three amino acids. In SpLdcB, the liganding residues are
His153, Asp160, and His207 (Figure 3D); the equivalents in
BsLdcB/BaLdcB are His185/His160, Asp192/Asp167, and
His244/His219 (Figures 3E and 3F). These zinc ligands are uni-
versally conserved in LdcB sequences, consistent with an
important functional role in these enzymes. The active site of
SpLdcB contains unattributed residual electron density that
occupies the position of the fourth ligand in the tetrahedral
coordination sphere of the zinc (Figure 3D). To use the nomen-
clature common to proteases, the unattributed electron den-
sity extends as far as the S1
0 subsite, the location ordinarily
occupied by the scissile amino acid. The electron density in
the S1
0 subsite is of a size, shape, and location corresponding
to that of alanine. The ligand is stabilized in this position
by van der Waals’ contacts between the alanyl methyl groupStructure 22, 949–960, July 8, 2014 ª2014 The Authors 951
Figure 3. Structure of LdcB
(A–C) Cartoon representations of (A) SpLdcB, (B) BsLdcB, and (C) BaLdcB; a helices (red) and b strands (yellow) are numbered. The loops between secondary
structure elements are colored silver. The bound zinc ion is shown as a gray sphere.
(D–F) The active sites of (D) SpLdcB, (E) BsLdcB, and (F) BaLdcB. A zinc ion is coordinated in a tetrahedral manner in the structures by two invariant histidines
and a well-conserved aspartate. Residual electron density in SpLdcB, shown in (D), corresponds to D-alanine in the S1
0 subsite, and an unknown compound in
S1, adjacent to the zinc ion. Electron density corresponding to a phosphate ion, a component of the crystallization medium, in the S1 subsite of BsLdcB shown
in (E) is a mimic of the tetrahedral transition state. A second feature in the S1
0 subsite is unmodeled. The residual difference density features are shown
contoured at a level of 3s and hydrogen bonds are drawn as dashed black lines.
Structure
Structure of the LdcB LD-Carboxypeptidaseand the phenolic side chains of Tyr191 and Tyr201 and by
hydrogen bonds to the side chains of Glu204 and the main
chain amide nitrogen of Tyr144. Despite the high resolution
of the SpLdcB diffraction data, it was not possible to discrim-
inate between either alanyl stereoisomer, both of which are
present in the crystallization conditions. We have modeled
D-Ala because it is the enzymatic product of these enzymes.
However, residual electron density adjacent to the zinc ion
could not be modeled satisfactorily with any ligand arising
from the enzymatic activity, the crystallization media, or purifi-
cation media; consequently, the remaining electron density
has been left unmodeled. Mass differences between native
and denatured protein samples also failed to identify candi-
date molecules corresponding to the residual electron density.
Residual electron density in the vicinity of the fourth zinc ligand
in BsLdcB was fulfilled by a phosphate anion, a component of
the crystallization conditions (Figure 3E), which refined satis-
factorily. The phosphate is located so as to mimic the tetrahe-
dral transition state of amide bond hydrolysis. There is a
further unmodeled electron density feature (Figure 3E), this
time in the S1
0 subsite, that we have not been able to identify
unambiguously.
Comparison of LdcB Structures
SpLdcB, BaLdcB, and BsLdcB share pairwise sequence identi-
ties of 30%, and they superimpose on 155 common Ca
atoms with a root-mean-square deviation (rmsd) of 1.5 A˚–
1.8 A˚ (Figures 3A–3C). The major differences between the
LdcB structures are limited to the rather flexible and uncon-
strained N- and C-termini and the occasional longer loop in
one structure in comparison to the other, as a direct conse-
quence of sequence insertions. The active sites of SpLdcB,952 Structure 22, 949–960, July 8, 2014 ª2014 The AuthorsBaLdcB, and BsLdcB are, to all extents and purposes, indistin-
guishable (Figures 3D–3F). A further BaLdcB structure has been
solved that contains no bound zinc ion, but there are negligible
differences between it and its counterpart with zinc bound (Fig-
ure S1 available online). The active site of the LdcB enzymes is,
therefore, sculpted in a robust fashion, competent for peptidol-
ysis once the catalytic machinery is completed by the incorpo-
ration of zinc.
Structural Comparison with Other Peptidases
Using SpLdcB as a search model in DALI (Holm and Rose-
nstro¨m, 2010), over 100 significantly similar structures were
identified in the Protein Data Bank (PDB), including the struc-
ture of VanXYG, a dipeptidase/DD-carboxypeptidase (PDB ID
4f78 [Meziane-Cherif et al., 2014]; DALI Z score = 17.0); an
endolysin from the Listeria bacteriophage A500 (PDB ID 2vo9
[Korndo¨rfer et al., 2008]; Z = 9.5); VanX, a DD-dipeptidase
(PDB ID 1r44 [Bussiere et al., 1998]; Z = 6.6); and the N-termi-
nal domain of sonic hedgehog, a protease involved in embryo-
genesis (PDB ID 2wg4 [Bishop et al., 2009]; Z = 5.3). Equivalent
results were obtained using the structures of BaLdcB and
BsLdcB as queries in DALI. The matched structures are all
members of the wider LAS superfamily of proteases (Bochtler
et al., 2004), which, although they share very little sequence
identity, possess markedly similar active sites (Figure 4). By
comparison with the VanXYG structure (Meziane-Cherif et al.,
2014), the active site of the LdcB proteins is open and more
solvent accessible. The open nature of the active site is a direct
consequence of the absence of the b4-a5/bisubstrate selec-
tivity loop in LdcB, which enables the recognition of PG, a
molecule far greater in size than the dipeptides utilized by Van-
XYG (Meziane-Cherif et al., 2014).
Figure 4. A Comparison of the Active Sites of LdcB and Other LAS
Family Members
LdcB shares an active site closely superimposable on those of other LAS
family enzymes. The zinc is coordinated by a H-X(3–6)-D-X(not conserved)-H motif.
A glutamate that plays a key role in catalysis is also shown; note that, in D-Ala-
D-Ala carboxypeptidase from Streptomyces albus, the equivalent amino acid
is histidine, the first amino acid in the H-X-H motif common to most LAS
carboxypeptidases. The structures shown, distinguished by the coloring of
carbon atoms, are SpLdcB (white), BsLdcB (green), BaLdcB (orange),
Enterococcus faecalis D,D-dipeptidase/D,D-carboxypeptidase VanXYG (yel-
low; PDB ID 4f78), Enterococcus faecium aminodipeptidase VanX (blue; PDB
ID 1r44) and S. albus D-Ala-D-Ala carboxypeptidase (pink; PDB ID 1lbu).
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Structure of the LdcB LD-CarboxypeptidaseAs with other LAS superfamily members, LdcB contains the
characteristic zinc binding motif (Figure 4), with a consensus
sequence of H-X(3–6)-D-X(not conserved)-H. The fourth zinc ligand
in the structures of other LAS family members tends to be a
solute from the crystallization milieu or a water that is likely to
act as the nucleophile in the reaction (Bussiere et al., 1998). A
second conserved motif in the LAS superfamily, H-X-H, of which
the first histidine is the catalytic residue (Bochtler et al., 2004), is
missing from LdcB enzymes; the catalytic histidine is replaced
spatially by glutamate (i.e., Glu204 in SpLdcB).
SpLdcB Cocrystallized with a Reaction Product
Despite attempting to crystallise LdcB enzymes with a range of
synthetic ligands, one crystal structure was obtained, that of
SpLdcB in complex with MurNAc—L-Ala—D-g-Gln—L-Lys—
(D-Asn) (Figure 5A). This ligand is a close chemical analog of
the true reaction product, as it contains half of the repeating
unit of the glycan component of PG and comprises a tripeptide
stem peptide that is branched at the L-lysine, the location of
the crosslink position in natural PG (Figures 5F and 5G). There
are two chemical differences between this synthetic mimic and
the true reaction product. First, the ligand lacks GlcNAc, the sec-
ond sugar moiety of the glycan repeating unit in PG. Second, the
terminal D-Asn group is covalently attached by a peptide bond
between the main chain carbonyl of the terminal D-Asn and the
side chain Nz of the penultimate lysine. In crosslinks between
peptide stems, the side chain Nz of the penultimate lysine is
linked by a peptide bond to the main chain carbonyl of aD-Ala. Hence, the L-Lys—(D-Asn) linkage is a faithful mimic of
the natural L-Lys—(D-Ala), albeit the chemistry of the side chains
of the terminal D-amino acids clearly differ.
There are six molecules of SpLdcB in this crystallographic
asymmetric unit, though none of the interfaces represent a stable
multimeric form. Five of six protein chains could be built and
refined satisfactorily; the electron density for the sixth copy could
not be improved by any procedure to permit its reliable
modeling, and its absence from the model contributes directly
to the slightly inflated final Rwork and Rfree values (Table 1). The
five built molecules are highly superimposable, with each other
and with the apo SpLdcB structure (rmsds between 0.5 A˚ and
1.1 A˚; Table 2). In chains B, C, and E, the zinc is coordinated
by a likely nucleophilic water to form tetrahedral coordination
geometry. In chain D, the fourth zinc ligand is not evident,
perhaps due to local disorder. Residual electron density was
retained throughout refinement in only one of the five molecules,
chain A, into which MurNAc—L-Ala—D-g-Gln—L-Lys—(D-Asn)
could be built and refined unambiguously (Figure 5A).
The structure of the ligand-bound form of SpLdcB is entirely
consistent with its LD-carboxypeptidase function. First, the
MurNAc moiety is situated at the very top of the intersubdomain
cavity and makes little contact with the protein. This part of the
ligand has the highest B factors (a mean of 93 A˚3, versus a
mean of 83 A˚3 for the intact ligand and a mean of 45 A˚3 for all
atoms modeled) and, thus, the weakest electron density. The
MurNAcO1 andO4 atoms, which define the location of the flank-
ing b1- to b4-linked GlcNAc sugars in PG, project away from the
protein surface so that the glycan chain would be accommo-
dated by the protein without steric clashes. The N-acetyl group
at C1 is stabilized against the side chain of Met202 by van der
Waals’ forces (Figure 5B).
The Ca and Cb atoms of L-alanine at position 1 of the peptide
pack against the face of Tyr144, a conserved amino acid in many
LdcB sequences, to discriminate against the D-stereoisomer in
this subsite, S3. L-alanine is favored by contacts with Tyr144
andMet202, which discriminate against all L-amino acids bulkier
than alanine (Figure 5B). The NH2 group of the D-g-Gln of
position 2 is located in subsite S2, 2.3 A˚ away from and in
hydrogen bonding distance of Glu204 (Figure 5C), an invariant
amino acid in LdcB sequences. Stereoselectivity at this position
is maintained because L-g-glutamine would clash with Tyr144.
The g-glutamine is selected for by specific interactions with the
main chain carbonyl of Ala203 and the side chain of Glu204 while
ensuring that the scissile peptide bond is in the catalytic position.
These key aspects of molecular recognition could not occur with
commonly occurring amino acids. Canonical glutamine can be
accommodated at this position in the synthetic peptide, tetra-D,
because the absence of contacts with one face of the peptide
provides scope for the conformational changes needed to
accommodate glutamine in the absence of the glycan strands
of the natural substrate.
Position 3 of the peptide is occupied by L-lysine. D-lysine
could not be accommodated at this position because of the
presence nearby of Glu107. As expected of a reaction product
complex, the lysine carboxylate is located adjacent to the active
site zinc in subsite S1 (Figure 5D). One of the carboxylic oxygens
completes the zinc tetrahedral geometry with His153/Asp160/
His207, and the second oxygen forms a salt bridge withStructure 22, 949–960, July 8, 2014 ª2014 The Authors 953
Figure 5. SpLdcB with Bound MurNAc—L-Ala—D-g-Gln—L-Lys—(D-Asn)
(A) Cartoon representation of SpLdcB, drawn using the same color scheme as in Figure 3. The MurNAc—Ala—D-g-Gln—L-Lys—(D-Asn) is drawn as a ball-and-
stick model with Refmac-weighted 2Fobs-Fcalc electron density displayed at a contour level of 1 s.
(B–E) The interactions made between the ligand and the protein at each subsite are shown successive panels: (B) S3; (C) S2; (D) S1, and (E) S1
0. Key van derWaals’
interactions are shown as a transparent silver line.
(F) A schematic of the interactions of SpLdcB with the bound peptidoglycan mimic. Hydrogen-bond interactions are shown with a black dotted line, and van der
Waals’ forces are shown with a green arc.
(G) A schematic of the tetrapeptide substrate of SpLdcB, drawn in the same manner as the peptidoglycan mimic in (F). The scissile bond is highlighted by an
arrow. Crosslinks to other stem peptides would take place via the lysine’s terminal amino group on the left.
Structure
Structure of the LdcB LD-CarboxypeptidaseArg120, which is either arginine or lysine in LdcB orthologs. The
L-lysine carboxylate thus represents a posthydrolysis state,
placed appropriately for the peptide bond of the substrate to
be hydrolyzed by the water molecule that fulfils the fourth zinc
ligand in the absence of substrate.
The side chain of the L-lysine twists back against the rest of
the peptide and projects into the protein core to place the termi-
nal D-Asn branch in subsite S1
0, against the main chain atoms of
Tyr144 and the side chains of Tyr191, Tyr201, and His207 (Fig-
ure 5E). The carbonyl of the L-Lys—(D-Asn) peptide bond is con-
tacted by the side chain of Ser151. However, it should be noted
that subsite S1
0 would be occupied by the scissile D-alanine in
the presence of the reaction substrate, and support for this
hypothesis comes from the structure of VanXYG solved in com-
plex with a phosphinate transition state mimic (Figure 6A) (PDB
ID 4muq) (Meziane-Cherif et al., 2014). The phosphinate moiety
is a transition state mimic of peptide bond hydrolysis because
the reaction proceeds via a tetrahedral intermediate that phos-
phinate mimics. VanXYG superimposes on SpLdcB with an
rmsd of 1.6 A˚ on 144 matched Cas, and the alanyl carboxylate
moiety of the phosphinate is situated in an analogous position954 Structure 22, 949–960, July 8, 2014 ª2014 The Authorsto that of the L-Lys—(D-Asn) peptide linkage observed in
SpLdcB (Figure 6A). The phosphate atoms of the phosphinate
transition state mimic superimpose almost identically with the
phosphate anion modeled adjacent to the zinc ion in the struc-
ture of BsLdcB (Figure 3D). Other than Ser151, a role in deter-
mining specificity for the terminal D-alanine can be invoked
for Gln125, and both these amino acids are strictly conserved.
The amide nitrogen of Ala146 also participates in stereoselec-
tivity, but as this is a main chain atom, it is perhaps no surprise
that sequence conservation is not maintained at this position.
However, crosslinks between peptide stems cannot be
accommodated in the observed conformation because of the
burial of the branched amino acid in subsite S1
0 (Figure 6B).
Mere rotation of the side chain torsion angles of the L-lysine
would result in a more thermodynamically favored extended
conformation for this side chain to result in it passing beyond
Arg120, Leu128, and Tyr132 to project beyond the surface of
the protein (Figure 6B; Figure S2). In this conformation, cross-
linked peptide stems attached to the terminal Nz would not be
sterically occluded by the body of the protein, consistent with
the observed cleavage of crosslinked peptides (Figure 2A). In
Table 1. Summary of X-Ray Data Collection and Refinement Statistics
Parameters SpLdcB BsLdcB SpLdcB with Ligand BaLdcB BaLdcB with Zinc
PDB ID 4OX5 4OX3 4OXD 4JID 4MPH
Data collection
Space group I222 P212121 C2 I222 I222
Unit Cell Dimensions
a, b, c (A˚) 48.8, 60.4, 138.2 42.7, 53.7, 102.4 346.0, 42.5, 79.3 76.6, 113.0, 124.6 76.8, 112.3, 125.7
a, b, g () 90, 90, 90 90, 90, 90 90, 93.1, 90 90, 90, 90 90, 90, 90
Wavelength (A˚) 0.98 0.97 0.92 0.97856 1.27696
Resolution (A˚) 20.0–1.80 (1.84–1.80) 47.6–1.70 (1.73–1.70) 47.8–2.80 (2.95–2.80) 29.7–2.30 (2.36–2.30) 28.3–2.03 (2.06–2.03)
Multiplicity 24.3 (14.2) 3.2 (1.7) 3.4 (3.4) 4.2 (3.6) 11.8 (9.9)
Rmerge
a 0.077 (0.108) 0.072 (0.235) 0.134 (0.635) 0.093 (0.542) 0.101 (0.511)
I/sI 34.4 (2.4) 11.9 (2.4) 7.8 (1.9) 13.5 (2.4) 32.1 (4.2)
Completeness (%) 98.6 (86.9) 95.7 (89.3) 98.3 (98.3) 98.3 (94.3) 99.8 (96.9)
Refinement
Resolution (A˚) 20.0–1.80 47.6–2.0 47.8–2.80 29.7–2.3 28.3–2.03
No. of reflections 25,656 (1,157) 35,526 (1,057) 47,327 (1,979) 22,730 (1,226) 67,494 (3,374)
Rwork/Rfree
b 0.191/0.253 0.176/0.247 0.273/0.335 0.194/0.259 0.151/0.189
No. of Atoms
Protein 1,476 1,753 7,014 3,040 2,970
No. of proteins/AU 1 1 6 2 2
Ion/ligand 3/22 1/5 21/51 -/4 2/12
Water 197 230 111 424 466
B Factors (A˚2)
Protein 41.8 16.0 44.3 45.3 35.8
Ion/ligand 36.9/50.7 10.7/23.8 38.7/69.7 /49.8 17.9/60.0
Water 48.2 31.6 28.7 43.6 46.2
Rmsd
Bond lengths (A˚) 0.018 0.015 0.005 0.013 0.0012
Bond angles () 1.96 1.76 0.84 1.36 0.991
Ramachandran
Favored (%) 96.1 96.7 95.8 97.6 98.0
Allowed (%) 100 100 99.6 99.7 100
Highest resolution shell shown in parentheses. AU, asymmetric units.
aRmerge = ShSijIi(h)  hI(h)i/ShSiIi(h), where Ii(h) and hI(h)i are the ith and mean measurement of the intensity of reflection h.
bRwork/Rfree = SjFpobs  Fpcalcj/SFpobs, where Fpobs and Fpcalc are the observed and calculated structure factor amplitudes, respectively.
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Structure of the LdcB LD-Carboxypeptidasesome bacteria, the lysine is replaced with diaminopimelic acid, a
carboxy derivative of lysine that is amidated in bacilli. While the
amidocarboxy derivative could be stabilized in the observed
conformation by a similar set of specific interactions, it would
also sterically occlude crosslinked peptide stems. Diaminopi-
melic acid is thus likely to follow the same path predicted for
lysine by forming a simple, extended conformation to project
into solvent.
Several key structural changes occur on ligand binding in
SpLdcB (Figure 7; Movie S1). First and foremost, substrates are
occluded in the empty formof the enzyme by a loop between res-
idues Gly163 and Glu171, which blocks access to the active site.
Most of these residues (Asp167 toGlu171)moveby10–15 A˚ in the
presence of ligand to open up the cleft by refolding into an addi-
tional turn at the N terminus of a-helix 4. The rearrangement of
these residues is accompanied by further conformational
changes in Trp206, the indole ring of which moves by up to 9 A˚,which not only aids to open up the active site of the enzyme but
also forces the side chain of Glu204 to rearrange to take up a po-
sition capable of interactingwith the substrate. The importance of
Glu204and the zinc ion for catalysis is highlightedby theobserva-
tion that tetra-D is a much poorer substrate for the E204A variant
of SpLdcB (Figure 2A) and by the absence of activity in the pres-
ence of EDTA (Figures 2A and 2C). The conformational changes
seen on ligand binding to SpLdcB contrasts with the absence
of significant conformational changes described for VanXYG in
complex with phosphinate (PDB ID 4muq) (Meziane-Cherif
et al., 2014). Like LdcB, VanXYG maintains the H-X(3–6)-D-
X(not conserved)-Hmotif, and as also observed in LdcB, the catalytic
H-X-H motif is replaced by a glutamate. The resculpting of the N
terminus ofa-helix 4 inSpLdcB to accommodate the tetrapeptide
is not necessary in VanXYG, because this enzyme hydrolyzes a
much smaller substrate, D-Ala-D-Ala dipeptide, which is accom-
modated by the enzyme without significant rearrangement.Structure 22, 949–960, July 8, 2014 ª2014 The Authors 955
Table 2. Rmsd Values between Ligand-Bound SpLdcB Chains
(4OXD) and apo SpLdcB (4OX5)
4OX5 and
4OXD Chain 4OX5
4OXD
Chain A
4OXD
Chain B
4OXD
Chain C
4OXD
Chain D
4OXD
Chain E
4OX5 – 0.73 0.57 0.66 0.69 0.80
4OXD chain A 0.73 – 0.63 0.64 0.76 1.03
4OXD chain B 0.57 0.63 – 0.56 0.65 0.86
4OXD chain C 0.66 0.64 0.56 – 0.56 0.64
4OXD chain D 0.69 0.76 0.65 0.56 – 0.61
4OXD chain E 0.80 1.03 0.86 0.64 0.61 –
Figure 6. A Comparison of the Ligand-Bound Active Sites Carboxy-
peptidases
(A) The active site of SpLdcB (white) with bound MurNAc—L-Ala-D-g-Gln—L-
Lys—(D-Asn) (turquoise carbons) is compared to that of VanXYg (blue) con-
taining a phosphinate transition state analog (pink carbons) of D-Ala—D-Ala
(PDB ID 4muq). The phosphinate in VanXYg coordinates the active site zinc in a
similar manner to that of the lysyl carboxylate in the MurNAc—L-Ala-D-
g-Gln—L-Lys—(D-Asn) bound to SpLdcB. The D-alanyl moiety of the phos-
phinate ligand in VanXYg, which occupies subsite S1
0, is matched by the
D-alanine (green carbons) in SpLdcB (white) and the D-Asn of the MurNAc—
L-Ala-D-g-Gln—L-Lys—(D-Asn) ligand. The zinc ions are shown as gray
spheres.
(B) The proposed positions of the two posthydrolysis ligands (orange carbons)
in the active site of SpLdcB (white). The D-alanine from the SpLdcB structure
occupies the S1
0 site of the protein, while the lysine side chain has been rotated
and modeled in an extended conformation. The altered conformation of the
lysine presents the Nz to the surface of the protein, in an ideal position to
accommodate peptide crosslinks. The zinc ions are shown as gray spheres.
(C) The active sites of SpLdcB and pancreatic carboxypeptidase A (PDB ID
1hdu [Cho et al., 2002]) are compared. In each structure, the Zn2+ ion is co-
ordinated by two histidines (His69 and His196 in carboxypeptidase A; His153
and His207 in SpLdcB) and an acidic amino acid (Glu72 in carboxypeptidase
A; Asp160 in SpLdcB). The reversed locations of Arg127 and Glu270 in
carboxypeptidase A relative to Arg120 and Glu204 in SpLdcB is matched by a
reversal of the path of the respective substrates through the active sites and
the likely retention of a common catalytic mechanism.
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The presence of tripeptides in the bacterial cell wall implies that
LD-carboxypeptidase activity must be present in the extracel-
lular milieu. In this study, we have shown that LdcB, from both
S. pneumoniae and B subtilis, are active against tetrapeptides
found within the bacterial cell wall and are specific for LD link-
ages, confirming the LD-carboxypeptidase classification with a
role in cell wall maturation. The precise in vivo role for LdcB re-
mains to be determined; one possibility is that the enzyme
allows recycling of D-Ala from the cell wall to support further
cell wall synthesis and, thus, growth. Alternatively, the cleavage
of D-Ala from the cell wall might permit the differentiation
between old and new cell walls, a potentially powerful way to
ensure the correct localization of new cell wall synthesis. The
correct localization of new PG synthesis is likely to be more
important to bacteria that have polarized cell growth, such as
Streptococci, in comparison to those that have dispersed
growth along the length of a cylinder (e.g., Bacilli) or that utilize
a division-only mechanism, such as Staphylococci. The cell
morphological defect observed in the S. pneumoniae ldcB
mutant, and the absence of defect in the B. subtilis ldcBmutant,
could be consistent with this premise. Further studies should
distinguish these possibilities.
We also present crystal structures of BaLdcB, BsLdcB, and
SpLdcB, the latter also in complex with a PG-fragment analog
that has enabled the identification of amino acids key to molec-
ular recognition of the substrate and a potential tunnel through
which crosslinked PG peptides may pass during proteolysis.
LdcB belongs to the LAS group of zincmetalloproteases; several
members of this family are active against PG, albeit with different
substrate specificities to LdcB, including the Gly-Gly endopepti-
dase lysostaphin (Korndo¨rfer et al., 2008) and the DD-/LD-endo-
peptidase MepA (Marcyjaniak et al., 2004). LdcB is dissimilar
to other groups of LD-carboxypeptidases, e.g., Pseudomonas
aeruginosa LD-carboxypeptidase LdcA (PDB ID 1ZRS) (Korza
and Bochtler, 2005) that degrades cell wall tetrapeptides in the
cytoplasm. LdcA utilizes a Ser-His-Glu catalytic triad in catalysis
and belongs to the S66 serine protease family of enzymes, a
group with which LdcB shares no similarity (Korza and Bochtler,
2005). Likewise, LdcB shares no sequence similarity with Csd6
and Pgp2, two recently discovered LD-carboxypeptidases that
aid to maintain the helical shape of H. pylori (Sycuro et al.,
2012) and C. jejuni (Frirdich et al., 2014). Csd6 and Pgp2 belong
to an LD-transpeptidase family that utilizes a conserved Cys/His
motif for catalysis (Biarrotte-Sorin et al., 2006), and are,956 Structure 22, 949–960, July 8, 2014 ª2014 The Authors
Figure 7. Conformational Changes in
SpLdcB on Ligand Binding
(A and B) Cartoon representations of (A) apo
SpLdcB and (B) SpLdcB with bound MurNAc-
Ala-D-g-Gln-Lys-(D-Asn) using the same color
scheme as in Figure 3. Key residues that move on
ligand binding are shown in stick representation.
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Structure of the LdcB LD-Carboxypeptidasetherefore, distinct from the metalloprotease LdcB. It is inter-
esting that Csd6 can only hydrolyze D-Ala from monomeric
stem peptides, whereas LdcB is active against both monomeric
and crosslinked (tetra-tetra) stem peptides (Sycuro et al., 2013),
but the absence of structural similarity between these enzymes
precludes useful comparison.
While LdcB shares no structural homology with previously
studied LD-carboxypeptidases, DALI searches revealed a
strong similarity to members of the LAS superfamily. Of the
two consensus sequences that characterize the LAS family,
LdcB lacks the second His-rich motif, which is replaced spatially
by the invariant Glu204, which is oriented away from the zinc ion.
Given the residual activity of the E204A mutant (Figure 2A),
Glu204 probably plays an indirect role in catalysis. The zinc ion
probably plays a more direct role in catalysis, a hypothesis that
is supported by the absence of enzymatic activity in the pres-
ence of EDTA (Figures 2A and 2C). Further support for the role
of the metal ion, and the indirect role for the glutamate, comes
from studies of other zinc-dependent metalloproteases such
as pancreatic carboxypeptidase A, which is of historical impor-
tance given its role in the demonstration of Koshland’s induced
fit hypothesis (Christianson and Lipscomb, 1989; Koshland,
1958). Given the conformational changes seen on binding ligand
(Figure 7; Movie S1), LdcB appears to be another example of
induced fit. Though the two enzymes are structurally distinct,
the active sites of LdcB and pancreatic carboxypeptidase A
are, in essence, mirror images of one another. Both contain a
zinc ion coordinated by two histidines (His69 and His196 in
carboxypeptidase A; His153 and His207 in SpLdcB) and an
acidic amino acid (Glu72 in carboxypeptidase A; Asp160 in
SpLdcB). SpLdcB Arg120 and Glu204 straddle the nucleophilic
water, but their positions relative to their counterparts in pancre-
atic carboxypeptidase A (Arg127 and Glu270) are reversed (Fig-
ure 6C). Consequently, the path of the substrate through the
active site is also reversed. Given the retention of the metal
coordination and key adjacent amino acids in LdcB, it is entirely
plausible that the reactionmechanism of LdcB occurs in a similar
fashion to that of pancreatic carboxypeptidase A, utilizing the
metal ion to activate the nucleophilic water to attack the scissile
peptide bond. The enzymes would thus appear to have
converged on a common mechanism, despite sharing little
overall sequence and structural homology. Confirmation of the
catalytic mechanism utilized by this enzyme, and its precise
role in vivo, is the focus of current research activities in our
laboratories.Structure 22, 949EXPERIMENTAL PROCEDURES
Cloning
B. subtilis ldcB and S. pneumoniae ldcB were
amplified by PCR from B. subtilis 168 andS. pneumoniae R6 genomic DNA, respectively, to generate fragments with
NdeI and XhoI restriction sites. Both fragments were digested with NdeI and
XhoI and ligated with NdeI/XhoI-digested pET28a. B. anthracis ldcB was
PCR amplified from B. anthracis str. Ames ancestor genomic DNA and cloned
into p15TV-LIC (Eschenfeldt et al., 2009) that codes for a N-terminal His6 tag,
followed by a tobacco etch virus (TEV) protease cleavage site. In all cases, the
recombinant constructs were designed to remove membrane-anchoring
amino acids to result in final clones encoding SpLdcB amino acids 56–238;
BsLdcB, 61–273; and BaLdcB, 55–243.
Strain Construction
S. pneumoniae R6DldcB was constructed by transforming strain R6 with
a PCR product covering the ldcB-deletion region from strain IU3880 (D39
Dcps2A0(cps2BCDETFG)H0DdacB <> Pc-kan-rpsL) amplified with primers
P136 and P137 (Barendt et al., 2011), followed by selection on tryptic soy broth
blood agar plates containing 250 mg/ml kanamycin. All strains were grown in
C + Y medium (Horne and Tomasz, 1993), containing kanamycin if required.
Competent bacteria were obtained as described elsewhere, with the addition
of competence-stimulating peptide (Vollmer and Tomasz, 2001).
B. subtilis strains were constructed by transformation of chromosomal DNA
(Anagnostopoulos and Spizizen, 1961; Young and Spizizen, 1961) from strains
bearing null mutations fordacA (MC01, trpC2DdacA cat) or yodJ (MC05, trpC2
DyodJ neo) into strain RD180 (trpC2 DalrA zeo), selecting for the appropriate
resistance markers (chloramphenicol or kanamycin at 5 mg/ml) in the presence
of 40 mg/ml D-alanine, yielding strains KS03 and KS02, respectively.
Growth Curves
B. subtilis strains RD180, KS02, and KS03 were grown overnight at 30C in
Luria broth (LB) supplemented with 40 mg/ml D-Ala. The overnight cultures
were diluted 1:10 with LB supplemented with 40 mg/ml D-Ala and grown at
37C for 2 hr. The cells were collected by centrifugation and resuspended in
D-Ala-free media at 37C. This suspension was used to inoculate media
with various concentrations of D-Ala to an optical density 600 (OD600) of
0.05, and the subsequent growth of each culture at 37C was monitored by
determining the optical density at 600 nm every 20 min for 3 hr. The growth
rate was determined during the exponential growth phase only.
Mutagenesis
A modified QuikChange protocol, incorporating ‘‘touchdown’’ (Don et al.,
1991), was used for site-directed mutagenesis. The annealing temperature
of the first 10 cycles was reduced by one degree per cycle, from 68C to
58C, before a further ten cycles were performed at a constant annealing
temperature of 58C. The extension temperature was maintained at 72C for
11min per cycle. Mutagenic primers (0.3 ml) were mixed with 50 ng of template
DNA, 0.5 mM dinucleotide triphosphates, and 2.5 U of Pfu DNA polymerase
in a total reaction volume of 20 ml. The template plasmid was digested using
DpnI.
Peptidoglycan Activity Assays
Cell wall and PG from S. pneumoniae and B. subtilis strains were isolated
by published procedures (Bui et al., 2012; Garcia-Bustos et al., 1988).
To test for LD-carboxypeptidase activity, PG from S. pneumoniae R6DldcB–960, July 8, 2014 ª2014 The Authors 957
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Structure of the LdcB LD-Carboxypeptidase(1.6 mg/ml) or B. subtilis 168DldcB (3.1 mg/ml) was incubated in a total volume
of 160 ml of 20 mM sodium phosphate, pH 4.8, with 0.13 mg/ml SpLdcB and
0.31 mg/ml BsLdcB, respectively, for 16 hr at 37C. If required, 0.6 mM Zn2+
or 10mMEDTAwas added, and control samples contained no added enzyme.
The PG was digested with 25 mg/ml of the muramidase cellosyl (a kind gift of
Hoechst AG) for 24 hr at 37C. The samples were boiled for 10 min and centri-
fuged for 10 min at 15,000 3 g. The muropeptides present in the supernatant
were reduced with sodium borohydride and analyzed by high-pressure liquid
chromatography (HPLC) (Bui et al., 2012; Garcia-Bustos et al., 1988).
S. pneumoniae and B. subtilis muropeptide peaks were assigned based
on their published elution profile and retention times (Bui et al., 2012; Atrih
et al., 1999). Fractions containing the reduced muropeptides Tetra and
TetraTetra present in B. subtilis strain 168DldcB were collected and analyzed
by mass spectrometry (Bui et al., 2009). We determined a neutral mass of
940.4353 atomic mass units (amu) for Tetra (theoretical: 940.4237 amu) and
of 1862.8406 amu for TetraTetra (theoretical: 1862.8368 amu).
Thin-Layer Chromatography
Tetrapeptides Ala-D-Gln-L-Lys-D-Ala (Tetra-D; Activotec) or Ala-D-Gln-L-
Lys-L-Ala (Tetra-L; Activotec) at 20 mM were incubated with 700 uM of zinc-
loaded SpLdcB or SpLdcB-E153A for 2 hr at 37C in a buffer of 10 mM
HEPES/NaOH, pH 8.0, 100mMNaCl in a reaction volume of 10 ml. One sample
of SpLdcB contained 50 mM EDTA. Ethanol (5 ml) was added to the reactions
before spotting on to silica gel thin-layer chromatography (TLC) aluminum foils
(Sigma). The TLCs were developed in a running buffer of butan-1-ol, acetic
acid, water in a 3:1:1 ratio for 40 min before staining with 0.1% ninhydrin solu-
tion in ethanol (Sigma). The TLC foils were dried and warmed with a domestic
hairdryer for visualizing the results.
Protein Overexpression and Purification
BsLdcB and SpLdcB were prepared in the same way. The proteins were over-
expressed in the methionine auxotrophic B834(DE3) strain of E. coli by growth
in LB media (or in minimal medium supplemented with selenomethionine for
selenomethionine-labeled protein) at 37C up to an OD600 of 0.4 before induc-
tion with 1mM IPTG for 18 hr at 16C. Cells were harvested by centrifugation at
3000 g for 25 min at 4C and the pellet was resuspended in 40 ml buffer A
(50 mMHEPES.NaOH, pH 8.0, 300mMNaCl, 20mM imidazole) per liter of cul-
ture and lysed on ice for 3 min with a Sonopuls HD2070 (Bandelin) sonicator.
The cell lysate was clarified at 33000 g for 20 min and the supernatant loaded
onto a 5 ml Ni+-NTA column (GE Healthcare) pre-equilibrated with buffer A.
The column was washed with buffer A before elution of bound proteins with
buffer B (50 mM HEPES/NaOH, pH 8.0, 300 mM NaCl, 500 mM imidazole).
The fractions containing LdcB were pooled and the N-terminal hexahistidine
tag was removed by digestion with thrombin (Sigma-Aldrich) at 20C for
16 hr at a ratio of 1 unit of enzyme per mg of LdcB. LdcB was concentrated
to a volume of 1 ml before loading onto a Superdex S75 HiLoad 16/60 (GE
Healthcare) gel filtration column pre-equilibrated in buffer C (10 mM HEPES/
NaOH, pH 8.0, 100 mM NaCl).
For BaLdcB, freshly transformed E. coli BL21-CodonPlus (DE3)-RIPL cells
were grown in 0.5 l of LB medium containing 100 mg/ml ampicillin. Cultures
were grown at 37C to an OD600 of 0.8 and induced for 16 hr at 16C with
1 mM IPTG, and the cells were harvested by centrifugation and resuspended
in 20 ml of buffer A (50 mM HEPES, pH 7.5, 300 mM NaCl, 10% [v/v] glycerol)
supplemented with 10% (v/v) BugBuster 103 Protein Extraction Reagent
(Novagen), 25 U Benzonase (Sigma-Aldrich), and 5mM imidazole. Themixture
was stirred for 10 min at room temperature and centrifuged at 20,000 3 g for
45 min, and the supernatant was applied to a 1 ml HisTrap Fast Flow column
(GE Healthcare) equilibrated with buffer A containing 40 mM imidazole. The
protein was eluted with buffer A with a gradient of 40–500 mM imidazole
over 20 ml. Fractions containing the recombinant His-tagged proteins were
identified by SDS-PAGE; pooled; dialyzed overnight against 3 l of 50 mM
HEPES, pH 7.5, 300 mM NaCl, 5% (v/v) glycerol, 1 mM TCEP; and stored at
80C. The His6-tag was cleaved by TEV protease in 500 mM NaCl, 50 mM
Tris-HCl, pH 7.5, 1 mM TCEP, 1 mM EDTA, 20% glycerol.
Crystallization
BsLdcB and SpLdcB were concentrated to 15 mg/ml, and two molar equiv-
alents of zinc chloride were added. Crystallization conditions for BsLdcB958 Structure 22, 949–960, July 8, 2014 ª2014 The Authorsand SpLdcB were obtained by sitting drop vapor diffusion at 20C. The
best SpLdcB crystals were obtained from a 0.1 M mixture of amino acids
(glycine, L-glutamate, and racemates of alanine, serine, and lysine), 0.1 M
Morpheus buffer system 2, pH 7.5, and 37.5% 2-Methyl-2,4-pentanediol
(MPD)/polyethylene glycol (PEG) 1000/PEG 3350 (Gorrec, 2009). A single
BsLdcB crystal grew from 0.1 M phosphate/citrate buffer, pH 4.2, 40%
PEG 300 over a period of 2 months. Crystals of SpLdcB with bound
MurNAc—L-Ala—D-g-Gln—L-Lys—(D-Asn) (InvivoGen) were obtained by
incubating the protein with the ligand at 2 mM final concentration for
30 min at room temperature prior to crystallization against a mother liquor
of 0.1 M ammonium chloride, 0.1 M HEPES/NaOH, pH 8.0, and 20% PEG
6000. Crystals of BaLdcB (zinc free) were grown at 23C using hanging-
drop vapor diffusion by mixing 20 mg/ml protein with reservoir solution
containing 0.3 M sodium chloride, 0.1 M HEPES, pH 7.5. As soaking of
zinc chloride into BaLdcB apo-protein crystals did not provide sufficient oc-
cupancy of zinc into the active site, crystals of BaLdcB (zinc bound) were
grown at 23C by hanging-drop vapor diffusion by mixing 20 mg/ml protein
and 5 mM zinc chloride prior to crystallization with 0.2 M ammonium acetate,
0.1 M sodium acetate, and 30% PEG 4000.
Data Collection and Processing
All crystals were cryoprotected with paratone-N before flash cooling in liquid
nitrogen prior to data collection at 100 K. Diffraction data for BsLdcB and
SpLdcB were on beamline IO2 of the Diamond Light Source. For selenome-
thionine-labeled SpLdcB, diffraction data were collected at a wavelength of
0.98 A˚ to permit phasing by selenomethionine-SAD (Se-SAD). Diffraction
data were integrated with XDS (Kabsch, 2010) and reduced with SCALA
(Evans, 2006). For BaLdcB, diffraction data were collected at on beamlines
21-ID-G at Life Sciences Collaborative Access Team, Advanced Photon
Source, at 0.97856 A˚ (selenomethionine peak; zinc free) and 1.27696 A˚ (Zn2+
peak; zinc bound). The BaLdcB diffraction data were integrated and reduced
with HKL-3000 (Minor et al., 2006).
Structure Solution
The structure of SpLdcB was solved using SHELX (Sheldrick, 2008) as imple-
mented in the HKL2MAP interface (Pape and Schneider, 2004). An initial model
was built by PHENIX.AUTOSOLVE (Adams et al., 2011). The completed
SpLdcB structure was used as the molecular replacement search model in
PHASER (McCoy et al., 2007) to solve BsLdcB and the SpLdcB-ligand com-
plex. The BaLdcB Zn2+-bound structure was solved by SAD phasing using
PHENIX.solve (Adams et al., 2011), which identified the positions of the two
bound Zn2+ ions. The occupancies of the zinc atoms were refined during
model refinement. The BaLdcB Zn2+-free structure was solved by molecular
replacement using the D,D-peptidase domain of the apo structure of VanXYG
(PDB ID 4f78) (Meziane-Cherif et al., 2014).
For all structures, manual building cycles in COOT (Emsley et al., 2010) were
interspersed with restrained refinement in PHENIX.REFINE (Afonine et al.,
2012). B factors were refined isotropically for all structures apart from BsLdcB,
which was refined anisotropically. Noncrystallographic symmetry refinement
was not used. Average B factor and geometric parameters were calculated
using PHENIX and verified with PHENIX.refine and the Research Collaboratory
for Structural Bioinformatics PDB Validation server. Data collection and final
model refinement statistics for all structures can be found in Table 1. The
graphics programs UCSF Chimera and PyMOL were used to generate all
molecular figures presented.
ACCESSION NUMBERS
The PDB accession numbers for SpLdCB, BsLdcB, SpLdcB with bound
ligand, apo BaLdcB, and BaLdcB with bound zinc reported in this paper are
4OX5, 4OX3, 4OXD, 4JID, and 4MPH, respectively.
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Attachment of Capsular Polysaccharide
to the Cell Wall in Streptococcus pneumoniae
Alice Eberhardt,1,*,{ Christopher N. Hoyland,1,* Daniela Vollmer,1,* Stephanie Bisle,1,{
Robert M. Cleverley,1 Ola Johnsborg,2,x Leiv S. Ha˚varstein,2 Richard J. Lewis,1 and Waldemar Vollmer1
Streptococcus pneumoniae protects itself from components of the human immune defense system by a thick
polysaccharide capsule, which in most serotypes is covalently attached to the cell wall peptidoglycan. Members
of the LytR-Cps2A-Psr (LCP) protein family have recently been implicated in the attachment of anionic polymers
to peptidoglycan in Gram-positive bacteria, based on genetic evidence from Bacillus subtilis mutant strains and
on the crystal structure of S. pneumoniae Cps2A containing a tightly bound polyprenol (pyro)phosphate lipid.
Here, we provide evidence that Cps2A and its two pneumococcal homologs, LytR and Psr, contribute to the
maintenance of normal capsule levels and to the retention of the capsular polysaccharide at the cell wall in the
capsular type 2 S. pneumoniae strain D39. GFP fusions of all three LCP proteins showed enhanced localization at
mid-cell, indicating a role in cell wall growth. Single cps2A or psr mutants produced a reduced amount of
capsule. A cps2A lytR double mutant showed greatly impaired growth and cell morphology and lost approxi-
mately half of the total capsule material into the culture supernatant. We also present the crystal structure of the
B. subtilis LCP protein YwtF and provide crystallographic evidence for the phosphotransferase activity of Cps2A,
supporting an enzymatic function in the attachment of capsular polysaccharides to cell wall peptidoglycan.
Introduction
Streptococcus pneumoniae is a major human patho-gen capable of causing otitis media and acute sinusitis
but also severe invasive diseases, such as pneumoniae,
meningitis, bacteremia, and sepsis. Mainly young children,
the elderly, and immune-compromised patients are at risk,
and each year *1 to 2 million patients die from pneumo-
coccal infections.43 The cell surface of the Gram-positive
bacterium S. pneumoniae is made of a peptidoglycan-teichoic
acid cell wall47,48 covered and shielded by a polysaccharide
capsule, allowing it to evade recognition by the innate im-
mune system of the host.6,35 Cell-wall-anchored proteins16,18
and structural modifications in peptidoglycan, such as
N-deacetylation45,46 and O-acetylation,11,44 contribute to
pneumococcal virulence. The most relevant virulence deter-
minant is the capsule, and nonencapsulated pneumococcal
mutants are avirulent. To date, 93 chemically distinct capsule
types have been described.7,9,20,37 Most capsular types are
tightly associated with the bacterial cell wall. From 12 cap-
sular polysaccharides tested, all but one (serotype 3) were
covalently linked to the cell wall, most likely via phospho-
diester bonds to the N-acetylmuramic acid residues in the
glycan chains of the peptidoglycan.38 The peptidoglycan also
carries a complex wall teichoic acid, an anionic cell wall
polymer that binds cell wall proteins and divalent cat-
ions,18,3,25 the biosynthesis of which is the topic of a com-
panion article.12 Novel methods to fractionate and analyze
the complex structure of pneumococcal cell wall have re-
cently been published.8
In the majority of serotypes, the capsular polysaccharide
genes are located between dexB and aliA.5 Here, we focus on
the serotype 2 strain, D39, the capsular region of which be-
gins with the cps2A–D genes (Fig. 1A). All 17 capsular genes
in this region are under control of the promoter upstream of
cps2A.17 The first gene in the region, cps2A, encodes for a
member of the LCP protein family (LytR, Cps2A, and Psr
homologs), which is widespread in Gram-positive bacteria
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and does not occur in Gram negatives. The pleiotropic phe-
notypes of LCP mutant strains of various species have led to
the suggestion that this protein family is a transcriptional
regulator of cell wall processes.27 Cps2A (also called Wzg),
Cps2B (Wzh), Cps2C (Wcd), and Cps2D (Wze) have all been
implicated in the regulation of capsule synthesis in S. pneu-
moniae. Indeed, Cps2D is an autophosphorylating tyrosine
kinase that appears to be regulated by Cps2C4,30 and both
might be spatial regulators that connect capsule synthesis to
cell division.21 Cps2A is required for the full expression of
capsule; cps2A mutant strains contain significantly less cap-
sule material attached to the cell wall.31 However, like other
LCP family members, Cps2A is an integral membrane protein,
the bulk of which is located on the outside face of the cyto-
plasmic membrane (Fig. 1B)19; it is not immediately apparent
that how to reconcile this observation with any role in DNA
binding. A recent report by Kawai et al. provides strong evi-
dence that LCP proteins are the long searched for enzymes
catalyze the covalent attachment of anionic cell wall polymers,
like teichoic acids and capsular polysaccharides, to peptido-
glycan.24 This publication detailed genetic and biochemical
evidence from the characterization of mutant strains of Ba-
cillus subtilis and the crystal structure of the soluble part of
Cps2A. Interestingly, the conserved, LCP domain of Cps2A
contained a (pyro)phosphorylated polyprenol lipid, the precise
chemical identity of which was dependent upon the Escher-
ichia coli expression strain used for purification of the protein.
Preliminary assays showed that Cps2A had weak, metal-
ion-dependent pyrophosphatase activity, supporting an
enzymatic function. Most likely, Cps2A binds the undecaprenol-
pyrophosphoryl-linked capsule precursor to transfer the
phosphorylated capsule chain to C6-OH of MurNAc resi-
dues in the peptidoglycan precursor or polymer.
In this study we have investigated the role of Cps2A,
LytR, and Psr in the attachment of capsular polysaccharides
to the cell wall of capsule type 2 strain D39. We show that all
LCP proteins localize to the cell membrane and are enriched
at mid-cell. Cps2A and psr mutants have a reduced amount
of capsule. Inactivation of lytR proved difficult in the back-
ground of the encapsulated D39 strain, leading to mutants
that were not viable in liquid culture. A suppressor mutant
of a D39 cps2A-lytR double mutant grew with strongly dis-
torted morphology in liquid culture, where it lost a large
portion of its capsule material into the supernatant. LytR,
together with Cps2A, thus plays a role in retaining the cap-
sule at the cell wall. The crystal structure of the LytR ho-
molog from B. subtilis, YwtF, and the pyrophosphorylysis
observed by Cps2A support an enzymatic function of these
proteins. These data and our previous observations24 are
consistent with a model whereby Cps2A is responsible for
the covalent attachment of capsular polysaccharide to the
pneumococcal cell wall, and that LytR can take over this
function in the absence of Cps2A.
Materials and Methods
Bacterial strains, growth conditions,
and genetic transformation
Table 1 contains the strains used in this study. S. pneu-
moniae R626,36 and D392 were grown at 30C or 37C in C+Y
(pneumococal C medium with yeast extract) medium con-
taining 1mg/ml yeast extract.41 To induce the expression of
gfp+ fusions under PczcD control on plasmid pJWV25 and its
derivatives, 0.15mM ZnCl2 was added to the C+Y medium.
Blood agar plates were made of tryptic soy broth (TSB)
medium containing 1.5% agar and 3% defibrinated sheep
FIG. 1. The LCP genes and proteins in Streptococcus pneumoniae. (A) Gene regions of cps2A, psr, and lytR in strain D39.
Cps2A is the first gene of the capsule region and followed by 16 other genes involved in capsular biosynthesis and assembly.
Psr is the last gene in an operon with aroA, aroK, and spd1203. LytR is the last gene in an operon with two genes of unknown
function located upstream. (B) Organization of domains in Cps2A, Psr, and LytR. Cps2A contains 3 predicted transmem-
brane domains, whereas Psr and LytR possess 1 (indicated in blue). The LCP domains are shown in light red; an additional
domain present in Cps2A and Psr is shown in dark red.
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blood. For growth curves, S. pneumoniae was grown over-
night at 37C on TSB blood agar plates with the appropriate
antibiotics. C+Y medium without antibiotics was inoculated
from colonies grown on plates to an OD620 of 0.05–0.07, in-
cubated in a water bath at 37C, and the OD620 was mea-
sured at the indicated time intervals.
E. coli DH5a (Invitrogen) was grown in lysogeny broth (LB)
medium at 37C with aeration. Where necessary, erythromycin
was added at a concentration of 1mg/ml for E. coli and 1mg/
ml for S. pneumoniae, tetracycline was added at 12.5mg/ml
for E. coli and 2.5mg/ml for S. pneumoniae, and kanamycin was
added at 50mg/ml for E. coli and 400mg/ml for S. pneumoniae.
Transformation of S. pneumoniae
DNA was introduced to the pneumococcal strains by
means of natural transformation using 100 ng/ml of CSP-1 to
induce competence in the recipient strain.32 Cultures of S.
pneumoniae were grown at 37C until they reached an OD620
of 0.15–0.2, at which point CSP-1 and the transforming DNA
were added, and the cultures were further incubated for 90–
120min at 37C before plating on selective medium to
identify transformants. S. pneumoniae transformants were
selected by plating on TSB blood agar plates supplemented
with the appropriate antibiotic.
Polymerase chain reaction amplification,
cloning, and sequencing
Chromosomal DNA from S. pneumoniae was isolated us-
ing the Promega Wizard genomic DNA purification sys-
tem. For this, pneumococcal cells from liquid culture were
harvested by centrifugation and resuspended in lysis buffer
(50mM Tris/HCl [pH 8.5], 5mM MgCl2, 25 mg/ml RNase,
and 0.4% DOC). To obtain chromosomal DNA, single colo-
nies were propagated on TSB blood plates after transfor-
mation and cell material from the plate was resuspended in
lysis buffer, and then incubated at 37C for 10min. Plasmids
were purified with the Qiagen plasmid midi kit. Restriction
enzymes and T4 ligase were purchased from Fermentas.
DNA fragments were purified by using the QIAquick PCR
purification kit. DNA was amplified with Phusion high-
fidelity DNA polymerase from Finnzymes. Oligonucleotides
listed in Table 2 were supplied by Sigma. Sequencing was
performed at GATC, Germany.
Cloning of gfp+ fusions
For production of GFP + -tagged proteins in S. pneumoniae,
the zinc-inducible promoter of plasmid pJWV25 was used.13
To generate gfp+ fusions of cps2A, lytR, and psr in the
background of R6 and D39, cps2A was amplified using the
oligonucleotides cps2A_F and cps2A-R, lytR was amplified
using the oligonucleotides lytR_F and lytR_R, and psr was
amplified using the oligonucleotides psr_F and psr_R. The
polymerase chain reaction (PCR) products were digested
with the appropriate restriction enzyme (Table 2), ligated
with digested pJWV25, and transformed into E. coli DH5a
selecting on tetracycline. Transformants were screened by
colony PCR using oligonucleotides pJWV25_scr_F and
pJWV25_scr_R. The integrity of the insert in pJWV25 was
confirmed by sequencing using oligonucleotides
pJWV25_scr_F and pJWV25_scr_R. Correct plasmids were
transformed into R6 and D39 while selecting for tetracycline
resistance, resulting in strains R6 PczcD-gfp + -cps2A, D39
PczcD-gfp+ -cps2A, R6 PczcD-gfp + -lytR, D39 PczcD-gfp+ -lytR,
R6 PczcD-gfp+ -psr, and D39 PczcD-gfp+ -psr. The correct inte-
gration of the pJWV25 derivatives into the bgaA region was
confirmed by PCR amplification with the oligonucleotides
bgaA_check_F and bgaA_check_R.
Gene deletions
D39 cps2A::ermB was created by replacing the cps2A gene
by ermB followed by the promoter of cps2A to ensure native
transcription levels of the downstream genes. Therefore, a
construct consisting of four PCR fragments was consecu-
tively cloned into pGEM-3Z: the 1 kb upstream flanking re-
gion of cps2A (oligonucleotides cps2A_up_F and cps2A_
up_R), the ermB gene (oligonucleotides ermB_F and ermB_R),
the promoter region of cps2A (oligonucleotides Pcps2A_F
and Pcps2A_R), and the 1 kb downstream flanking region of
cps2A (oligonucleotides cps2A_down_F and cps2A_down_R).
Transformants of DH5a were screened by colony PCR using
the oligonucleotides pGEM3Z_scr_F and pGEM3Z_scr_R.
The final knockout construct was sequence verified and
transformed into D39, selecting for erythromycin resistance. To
confirm correct integration of the construct into the capsular
region, the locus was PCR amplified with the oligonucleo-
tides Dcps2A_seq_F and Dcps2A_seq_R and sequenced. D39
cps2A::ermB was transformed with pJWV25-cps2A, resulting
Table 1. Strains Used in This Study
Strain Properties Reference or source
D39 clinical isolate, serotype 2 2
R6 unencapsulated, nonvirulent descendent of D39 26,36
R6 PczcD-gfp + -cps2A tetM, PczcD-gfp+ -cps2A This study
D39 PczcD-gfp+ -cps2A tetM, PczcD-gfp+ -cps2A This study
R6 PczcD-gfp + -lytR tetM, PczcD-gfp+ -lytR This study
D39 PczcD-gfp+ -lytR tetM, PczcD-gfp + -lytR This study
R6 PczcD-gfp + -psr tetM, PczcD-gfp+ -psr This study
D39 PczcD-gfp+ -psr tetM, PczcD-gfp + -psr This study
D39 cps2A::ermB ermB, cps2A::ermB This study
D39 cps2A::ermB PczcD-gfp+ -cps2A tetM, ermB, cps2A::ermB, PczcD-gfp+ -cps2A This study
D39psr ermB, insertion-inactivation of psr using pJDC9 This study
D39 cps2A::ermB lytR::kan PczcD-lytR cps2A::ermB, lytR::kan, PczcD-lytR This study
D39 cps2A::ermB lytR::kan cps2A::ermB, lytR::kan This study
D39 cps2A::ermB psr::kan cps2A::ermB, psr::kan This study
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in D39 cps2A::ermB PczcD-gfp+ -cps2A, which was complemen-
ted with gfp+ -cps2A upon zinc induction.
D39psr contains an insertion-inactivation of psr. This mutant
was generated using the pJDC9-based insertion-deletion mu-
tagenesis method.10 The first 500 bp of psr (omitting the start
codon ATG) was cloned in pJDC9 using the oligonucleotides
psr_F and psr_R. The insert was verified by sequencing and
the plasmid was transformed into D39. Correct integration of
the plasmid into the psr gene was verified by PCR amplifi-
cation. With oligonucleotides intF_psr located in the chromo-
some and intR_pJDC9 on the plasmid, the upstream region of
psr was amplified. The downstream region was checked by
PCR using oligonucleotides intF_pJDC9 and intR_psr.
Construction of D39 cps2A::ermB lytR::kan
PczcD-lytR and D39 cps2A::ermB psr::kan
To construct the D39 cps2A::ermB lytR::kan mutant, a
kanamycin resistance cassette flanked by DNA correspond-
ing to the upstream and downstream regions of the psr locus
was designed. A DNA fragment corresponding to the up-
stream region of psr was amplified by PCR from strain D39
and subsequently fused to the 5¢-end of the kanamycin cas-
sette in a second PCR. Next, a PCR fragment corresponding
to the downstream region of psr was amplified and fused to
the 3¢-end of the resistance cassette. The final fragment was
integrated into the psr locus of D39 cps2A::ermB by natural
transformation.
To construct the D39 cps2A::ermB lytR::kan Pczcd-lytR strain,
pJVW25 was inserted into the genome of the D39 cps2A::
ermB strain as described previously.13 The resulting strain
was subsequently made streptomycin resistant by transfor-
mation with genomic DNA from strain CP1415.33 Next, a
kan::rpsL Janus cassette39 was integrated downstream of the
zinc-inducible PczcD promoter of the chromosomal pJVW25.
The Janus cassette was subsequently replaced by a PCR
fragment consisting of the coding sequence of D39 lytR. Fi-
nally, the wt + copy of lytR was removed by natural trans-
formation with a PCR cassette as described previously,22 and
colonies were selected on agar containing 0.15mM ZnCl2.
D39 cps2A::ermB lytR::kan was created by transforming
D39 cps2A::ermB with chromosomal DNA isolated from D39
Table 2. Oligonucleotides Used in This Study
Name Sequence Restriction site
cps2A_F CAGCAGGCTAGCAGTAGACGTTTTAAAAAATCACGTTCACAG NheI
cps2A_R CATCATGCGGCCGCTCATCTACCCTCCATCACATCCTGTATAGC NotI
lytR_F CAGCAGACTAGTGTTAAAAAAATTATTGGAATGGTGCTAGC SpeI
lytR_R CATCATGCGGCCGCTTAATTATCTTCATCACCAACAGGTGC NotI
psr_F CAGCAGACTAGTAGTAAAGAAAATCCCTTAAGTC SpeI
psr_R CATCATGCGGCCGCTTATCTCAAGCCCATTTGAGCG NotI
pJWV25_scr_F GACAACCATTACCTGTCGAC None
pJWV25_scr_R TTGGTGCAAGGAAGGTCATC None
bgaA_check_F CCACTCGCAACAATCACTTGG None
bgaA_check_R GGTTGAGAACTATTTTGTTCC None
cps2A_up_F GACGACGAATTCCAAATTCCCACTATTAAGG EcoRI
cps2A_up_R GACGATGGTACCGTTCTCTCTTATTGTGAGCG KpnI
ermB_F GACGACGGTACCACAAGTGATTTGTGATTGTTG KpnI
ermB_R GACGACGGATCCTTATTTCCTCCCGTTAAATAATAG BamHI
Pcps2A_F GACGACGGATCCTGTGTACTATATTATATTGAAAC BamHI
Pcps2A_R GACTAGGTCGACGATTAACACCTATACATTG SalI
cps2A_down_F TATACGTCGACGATGGAGGGTAGATGAAATG SalI
cps2A_down_R TACTACAAGCTTCGAAAGGATAATCTCACGG HindIII
pGEM3Z_scr_F AGTCACGACGTTGTAAAACG None
pGEM3Z_scr_R AGCGCAACGCAATTAAGTTG None
psr_F CATCATGAATTCTCCCTTAAGTCATCATGAG EcoRI
psr_R CATCATCCTGCAGGATTTTCTTATCTGAGCCCCC SbfI
intR_pJDC9 TTGTGTGGAATTGTGAGCGG None
intF_pJDC9 TTCGCTATTACGCCAGCTGG None
intF_psr ACTCAAGACAGCACTGGGTG None
intR_psr TTTCTGCCCCTTTTTGCCCC None
Dcps2A_seq_F GCAAGACTTGACAGTAGAAGG None
Dcps2A_seq_R CGAACATTTGGAGAAGAAGG None
lytR_ext_F AGACTGCTACGTTGACTGGC None
lytR_ext_R TCGTAATCAAGCAGCAGTCC None
lytR_int_F TATAGCCTAGCAAGTTAGGG None
lytR_int_R GAATCAGGGAATGGTCAGGC None
bgaA_int_F CATCCGTACAACCCACAACC None
bgaA_int_R ATTACGCTCAGGTCCATTGC None
seq_psr_middle_F CCAAGATGCTAGCGCAAAGA None
psr_flank_R ATCTCCAGACTACGAGCCTG None
YwtF FW GCTTTTGTAAAGCTGACCATGGCTTCTAAGGAAGC NcoI
YwtF RVII GGCGTAATCGCCATCCCGTCTCTTATACACCTAAATCG None
YwtF RV GGCGTAATCGCCATCCCGTCTCGAGTACACCTAAATCG XhoI
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cps2A::ermB lytR::kan PczcD-lytR and selecting colonies for
kanamycin resistance and, therefore, the replacement of lytR
with the kanamycin resistance cassette. The resultant colo-
nies were screened by PCR for the absence of lytR at its locus
using the oligonucleotides lytR_ext_F and lytR_ext_R. The
general absence of lytR was verified using lytR_int_F and
lytR_int_R and the absence of insertions at bgaA locus was
checked using bgaA_int_F and bgaA_int_R. To exclude the
possibility that any mutation occurred in the psr gene, psr
was amplified and sequenced using intF_psr, seq_psr_mid-
dle_F, and psr_flank_R.
Expression of GFP + fusion proteins
in S. pneumonia and fluorescence microscopy
Strains expressing GFP+ fusion proteins were grown and
samples were prepared as published previously.13 The GFP+
signal was recorded using a DeltaVision experimental setup
and the application of an exposure time of 2 sec using an ex-
citation filter (Chroma) and 100% transmission (excitation at
490nm and emission at 535nm). For phase-contrast micros-
copy, the specimens were exposed for 100ms with 100%
transmission. Images taken were deconvoluted using the Del-
taVision deconvolution software (ratio conservative, number of
cycles 15, wavelength 528nm, medium noise filtering).
Western blot and dot blot analyses
The expression and the correct size of the GFP+ fusion
proteins were verified by western blotting. Whole cell lysates of
the strains expressing GFP+ fusions were run in equal
amounts on sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis (SDS-PAGE). The proteins were blotted onto ni-
trocellulose and the GFP+ fusions were detected with anti-GFP
antibody (rabbit polyclonal; Invitrogen). A secondary horse-
radish peroxidase (HRP)-labeled anti-rabbit antibody (goat
polyclonal; Invitrogen) was used in combination with an ECL
kit (Amersham) for visualization of the antibody complexes.
Quantification of capsule per colony
D39 cps2A::ermB, D39, and R6 were transformed with
genomic DNA from D39 cps2A::ermB lytR::kan PczcD-lytR and
selected on TSB blood plates containing kanamycin. Agar
pieces containing a single colony were excised from the
plates and stored at - 20C. Thawed samples were mixed
with 60ml of lysis buffer and the agar was melted for 10min
at 100C. In total, 7 serial 1:3 dilution steps in H2O were
made and 2ml of each dilution was applied to a nitrocellulose
membrane. The membrane was air-dried for 2 h at room
temperature and 15min at 60C, blocked in TBS + 0.5%
casein for 1 h at room temperature, incubated with anti-
serotype 2 serum in 1:10,000 (from rabbit; Statens Serum
Institute) in TBS + 0.5% casein overnight at 4C, washed 3
times for 5min in TBS + 0.2% Tween20, incubated with a
secondary HRP-labeled anti-rabbit antibody (goat polyclon-
al; Invitrogen), washed 3 times for 5min in TBS + 0.2%
Tween20, and detected using an ECL kit (NBS Biologicals) on
photographic films (GE Healthcare).
Quantification of capsule in culture lysate
and supernatant
D39 cps2A::ermB, D39psr, D39 cps2A::ermB lytR::kan, D39
cps2A::ermB psr::kan, D39, and R6 were grown on plates
containing the appropriate antibiotic. C+Y medium was
inoculated from plates to OD620 of 0.08 and grown at 37C.
To quantify total capsular material, an aliquot of culture was
lysed at OD620 0.2 with 0.4% DOC, DNase, and RNase
(10 mg/ml each) at 37C for 10min and centrifuged at
14,000 rpm for 10min at room temperature. The supernatant
was stored at - 20C. A second aliquot of the culture was
centrifuged at 13,000 rpm for 10min at 4C, and the super-
natant was mixed with 0.4% sodium deoxycholate before
storage at - 20C. Samples were thawed at 50C and diluted
1:1.5 in 12 steps with H2O. About 2ml of each dilution was
applied onto nitrocellulose membrane, air-dried, and pro-
cessed as described for colony blots, but here the samples
were washed with TBS without Tween20. The electro-
chemiluminescence signal was detected using Image Quant
LAS 4,000 mini (GE Healthcare).
Visualization of proteins in culture lysate
and supernatant
Whole culture, or culture supernatant (after centrifuging
at 13,000 rpm for 15min at 4C) collected at an OD620 of 0.2
was mixed with sample buffer, and boiled 4 times for 10min
at 100C and vortexed for 1min. The samples were stored
at - 20C before separation by 12% SDS-PAGE and visuali-
zation by silver staining (Proteo Silver Staining Kit; Sigma).
Capsule negative staining with Congo Red
The capsule was visualized by mixing 1 ml Congo Red
solution (2% Congo Red in H2O) with 1ml of liquid culture
(or a colony picked from plate) on a glass slide. The mixture
was spread on the slide and let to air-dry. Cells were visu-
alized with a Nikon Eclipse Ti microscope with phase con-
trast using a 100· oil-immersion objective. The capsule was
visible as a clear area surrounding darker cell bodies on red
background.
Electron microscopy
Cells were grown in C+Y at 37C. At an OD620 of 0.23
(strain D39 cps2A::ermB lytR::kan) or 0.4 (D39), samples were
fixed in 2% glutaraldehyde in sodium cacodylate buffer (pH
7.4) (TAAB Laboratory Equipment) overnight. Samples were
processed by the Electron Microscopy Research Service of
Newcastle University. Briefly, samples were incubated in 1%
osmium tetroxide (Agar Scientific) for 1 h, and then dehy-
drated in an acetone-graded series before being impregnated
with a graded series of epoxy resin (TAAB Laboratory
Equipment) in acetone and finally embedded in 100% resin
and set at 60C for 24 hr. Cells were sectioned and counter-
stained with 2% uranyl acetate and lead citrate (Leica) be-
fore being imaged on a Philips CM100 Compustage
Transmission Electron Microscope (FEI) with an AMT CCD
camera (Deben).
Cloning of B. subtilis ywtF and purification
and crystallization of YwtF
The genetic region encoding the soluble domain of YwtF
(amino acids 44–322, Dtm-YwtF) was amplified from
B. subtilis 168 genomic DNA by PCR, using the primers YwtF
FW and YwtF RVII for the first reaction and this PCR
product, with the primers YwtF FW and YwtF RV, for the
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second round of PCR. The PCR products were digested with
the appropriate restriction enzymes (Table 2), ligated with
similarly restricted pET28a, and transformed into E. coli XL-1
Blue, selecting for kanamycin resistance. The product of this
reaction, pET28a-Dtm-YwtF, placed the open-reading frame
for Dtm-YwtF under a T7, IPTG-inducible promoter and
added a C-terminal hexahistidine tag to the expressed pro-
tein. Sequencing confirmed the correct DNA sequence of
pET28a-Dtm-YwtF.
Expression and purification of Dtm-YwtF
pET28a-Dtm-YwtF was transformed into E. coli BL21(DE3)
selecting for kanamycin resistance and grown at 37C with
shaking in LB media containing kanamycin to an OD595 of
0.6 before expression of Dtm-YwtF was induced by the ad-
dition of 1mM IPTG. The temperature of the culture was
reduced to 18C and the growth was continued for a further
16 h before the cells were pelleted by centrifugation at 4,000 g
at 4C (Beckman J-26-XP, JLA 8.1000 rotor).
Cell pellets were resuspended in 20ml of Ni-NTA buffer A
(50mM Tris-HCl [pH 8.0], 300mM NaCl, and 10mM imid-
azole) before the addition of 1ml of 25 ·EDTA-free complete
protease inhibitor (Roche Diagnostics) and 20 ml of DNAse
(Sigma; final concentration of 5 mg/ml). The cell suspension
was sonicated (Bandelin sonopuls HD2070) on ice for 3min
at 80% power and 70% cycle before being clarified by cen-
trifugation at 20,000 g, 4C for 25min (Beckman J-26-XP with
JA 25.50 rotor).
Soluble cell lysate was loaded manually using an A¨KTA
prime (GE Healthcare) at 1ml/min onto a 5ml Ni2 + -NTA
(Ni-NTA) cartridge (Qiagen), pre-equilibrated in Ni-NTA
buffer A. The column was washed with 40ml of Ni-NTA
buffer A to remove any nonspecifically bound proteins. The
tightly bound proteins were eluted with Ni-NTA buffer B
(50mM Tris-HCl [pH 8.0], 300mM NaCl, and 250mM im-
idazole). The presence of protein was monitored by absorp-
tion at 280 nm and confirmed by SDS-PAGE of the collected
fractions.
Fractions containing the protein of interest were pooled
and concentrated (Amicon Ultra-15 10K; Millipore) to 1ml
before size-exclusion chromatography on a Superdex S75
HiLoad 16/60 (GE healthcare) column pre-equilibrated in gel
filtration buffer (10mM Tris-HCl [pH 8.0] and 250mM NaCl)
using an A¨KTA purifier (GE Healthcare). Eluted proteins
were fractionated by volume and monitored by absorption at
280 nm. SDS-PAGE confirmed the presence and purity of
Dtm-YwtF.
Crystallization
Crystals of Dtm-YwtF were obtained in hanging drops by
mixing equal volumes of protein at 25mg/ml in 10mM Tris
(pH 7.5), 100mM NaCl with a well solution of 0.1M HEPES
(pH 7.5), 20% PEG-3350, 0.2M MgCl2 at 22C. Crystals were
cryoprotected by first transferring them into a drop of the well
solution, followed by a drop of well solution supplemented
with 10% PEG 400, before flash freezing in liquid nitrogen.
Data collection and processing
Diffraction data were collected at the Diamond Light
Source synchrotron on beamline I02. A total of 500 images of
0.4 oscillations were collected at a wavelength of 0.9795 A˚
for Dtm-YwtF. Diffraction data were integrated using
MOSFLM28 and scaled and reduced with SCALA.15 The
crystal structure was solved by molecular replacement using
MolRep42 from the CCP4 suite (Collaborative Computational
Project, Number 4, 1994) and with the previously solved,
lower-resolution crystal structure of Dtm-YwtF (unpublished;
PDBid 3MEJ) as the search model. The correctly positioned
protein model was subjected to one round of rigid body re-
finement in REFMAC5,34 to optimize its location in the crys-
tallographic asymmetric unit. The resultant protein model
was subjected to numerous cycles of restrained refinement in
PHENIX REFINE1 interspersed with manual model building
in COOT14 until the refinement converged (Table 3).
Mass spectrometry of Dtm-YwtF
The purified protein was dialyzed extensively against
10mM ammonium acetate (pH 8.0) and then concentrated to
1mg/ml. Samples were analyzed at the Mass Spectrometry
facility at the Astbury Centre for Structural Molecular Biol-
ogy at the University of Leeds, United Kingdom.
Purification and crystallization of Cps2A(R267A)
Cps2A(R267A) was purified by Ni-NTA affinity and size-
exclusion chromatography as described previously.24 Crys-
tals were grown in hanging drops with well solutions of
either 0.1M sodium acetate (pH 4.6), 8% PEG-4K or 0.2M di-
ammonium citrate (pH 5.0), 15% PEG-3350. The former
crystals were cryoprotected by direct transfer to 0.1M so-
dium acetate (pH 4.6), 6% PEG-4K, 30% ethylene glycol and
then flash frozen in liquid nitrogen, whereas the latter were
transferred to 0.2M di-ammonium citrate (pH 5.0), 15% PEG-
3350, 20% PEG 300 before flash freezing in liquid nitrogen.
Diffraction data were integrated using MOSFLM28 for the
crystals grown in acetate and with XDS23 for the crystals
grown in citrate; both datasets were scaled with SCALA.15
An initial model was obtained by fitting the structure of the
wild-type protein (PDB entry 2XXP24) into the data by mo-
lecular replacement with PHASER.29 The structures were
subsequently refined by iterative rounds of refinement (with
REFMAC34 for acetate crystals and PHENIX1 for citrate
crystals) and rebuilding in COOT.14
Phosphate release assay
Fifty-microliter samples of Cps2A and Cps2A(R267A)
(8mg/ml) were incubated for 5 days at 22C in 20mM di-
ammonium citrate (pH 5.0). About 6 ml of a stock solution of
1M Tris-HCl (pH 8.0) was added and the release of inorganic
phosphate was measured using the colorimetric PiPer assay
(Invitrogen).
Results
Based on the role of LCP proteins in the cell wall assembly
process of B. subtilis, and the crystal structure of the soluble
part of Cps2A, we inferred that the three homologs in
S. pneumoniae (Cps2A, LytR, and Psr; Fig. 1) might have roles
in the attachment of capsule and teichoic acid to peptido-
glycan, which are the last steps in connecting the different
cell wall polymers to build the final cell wall. To obtain
more insights into their cellular function, we first localized
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fluorescent fusions of the three LCP proteins in S. pneumoniae
using a recently published plasmid tool.13
Cellular localization of GFP-Cps2A,
GFP-LytR, and GFP-Psr
To localize the three members of the LCP family in
S. pneumoniae, the cps2A, lytR, or psr genes were cloned into
pJWV25 in such a way that their 5¢-ends were fused to
gfp+ .13 The resulting plasmids were transformed into the
type 2 capsule strain D39 or the nonencapsulated strain R6.
The expression of GFP + -LCP fusion proteins was induced
by the addition of Zn2 + to the growth medium. SDS-PAGE/
western blot analyses of cell lysates confirmed that GFP+ fu-
sion proteins of Cps2A, LytR, or Psr with the correct size
were present in the lysate of the corresponding expression
strains, detected with an anti-GFP antiserum, whereas no
GFP band was visible in negative control lysates (Fig. 2A).
Importantly, GFP bands with lower molecular weights were
either not detectable, or had a low intensity, indicating that
the expressed GFP-fusion proteins were not significantly
degraded in the cell.
Next, we localized the GFP + fusion proteins in D39 PczcD-
gfp+ -cps2A, D39 PczcD-gfp+ -psr, and D39 PczcD-gfp + -lytR
strains by fluorescence microscopy.13 All three GFP-fusion
proteins localized at the cell membrane (Fig. 2B), consistent
with the predicted membrane anchor present in Cps2A, Psr,
and LytR (Fig. 1B). Interestingly, all three proteins were en-
riched at the septal, mid-cell region of the cells, and this effect
was most apparent for GFP + -Psr (Fig. 2B). A similar local-
ization pattern was observed in the nonencapsulated strain
R6 (data not shown), indicating that the membrane locali-
zation of the three proteins, and their enrichment at the
septum, does not depend on the presence of the capsule.
Capsule attachment in lcp mutant strains
grown in liquid medium
In B. subtilis, the three LCP proteins have recently been
implicated in the attachment of anionic polymers to the cell
wall peptidoglycan. Because the B. subtilis LCP proteins ap-
pear to have redundant roles in vivo, we aimed to test the
contribution of each of the pneumococcal LCP proteins in the
capsule attachment to the cell wall. For this, we have pro-
duced strains D39 cps2A::ermB, in which cps2A is replaced by
an erythromycin cassette allowing the expression of the
downstream capsule genes under their native promoter, and
D39psr, in which the psr gene is interrupted by the integra-
tive plasmid pJDC9. Despite several attempts, we were un-
able to stably grow transformants of D39 lytR::kan in liquid
C +Y growth medium (see next section). When growing in
liquid medium, strain D39 cps2A::ermB contained a reduced
amount (29%) of total capsule material compared with the
parental D39 strain (Fig. 3), confirming previous studies.31
D39psr contained slightly reduced amount of capsule (71%).
Like the parental D39 strain, the cps2A and psrmutant strains
did not release significant amounts of capsule into the su-
pernatant, indicating that the capsule, although present in
reduced amount, remains attached to the cell surface (Fig. 3).
We next aimed to investigate the role of lytR in the attach-
ment of capsule to the cell wall.
Capsule attachment in cps2A lytR cells
Inactivation of lytR in the nonencapsulated strain R6 leads
to a severe phenotype where cells are mis-shapened and
enlarged and often display misplaced septa.22 Transforma-
tion of the encapsulated strain D39 with DNA from R6
lytR::kan yielded small colonies but we were unable to
propagate these cells in liquid culture. Therefore, we first
aimed to use strains with a Zn2 + -controlled lytR gene, al-
lowing its repression in the absence of Zn2 + in the growth
medium.13 We constructed D39 cps2A::ermB lytR::kan PczcD-
lytR, which contains the lytR::kan and cps2A::ermB mutations
and, in addition, an ectopic copy of lytR at the bgaA site
under the control of the Zn2 + -inducible promoter PczcD.
However, this strain readily lost the repression of the ectopic
lytR gene in the absence of Zn2 + , resulting in constitutive
expression of lytR from the bgaA site. Presumably, there is a
Table 3. YwtF and Cps2A Crystal Structure Parameters
Cps2A(R267A)–OprP Cps2A(R267A)–OprPP YwtF
Crystallization conditions
0.2M diammonium citrate pH 5 0.1M sodium acetate pH 4.6 0.1M HEPES pH 7.5
15% PEG-3350 8% PEG-4K 20% PEG-3350 0.2M MgCl2
Space group P43212 P43212 P41212
Unit cell (A˚) a= b = 73.19, c = 163.84 a = b = 73.50, c= 163. 79 a = b = 65.74, c = 137.46
Resolution 19.72–1.95 (2.06–1.95) 40.95–1.77 (1.87–1.77) 47.5–1.79 (1.88–1.79)
Completeness 99.9 (99.9) 100 (100) 99.8 (100)
Multiplicity 15.7 (16.1) 13.8 (14.1) 6.1 (6.8)
Average I/sigmaI 34.9 (8.8) 21.6 (7.0) 14.4 (2.9)
Rsym 0.054 (0.364) 0.08 (0.40) 0.069 (0.58)
Rpim 0.014 (0.092) 0.024 (0.109) 0.029 (0.24)
Rcryst 0.189 0.170 0.193
Rfree 0.233 0.199 0.219
RMSD bond lengths (A˚) 0.006 0.012 0.004
RMSD bond angles () 0.971 1.27 0.87
Average B (A˚2) protein 34.1 28.0 36.7
Average B (A˚2) lipid 41.9 49.4 64.0
Wilson B (A˚2) 27.4 20.5 29.1
Ramachandran plot
Favored/allowed (%)
98.4/1.32 98.9/1.1 99.1/0.9
PDBid 4DE8 2XXQ 4DE9
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strong selective pressure to generate suppressor mutations in
the Zn2 + induction system leading to the expression of lytR
without Zn2 + .
Because none of the encapsulated lytR mutants grew sta-
bly in liquid culture, we next quantified the amount of cap-
sule in whole colonies obtained after transforming strains
D39 or D39 cps2A::ermB with DNA from D39 cps2A::ermB
lytR::kan PczcD-lytR with selection for kanamycin resistance
(Fig. 4). The state of the capsule in these transformants was
also visualized by microscopy after staining with Congo
Red. Interestingly, while the D39 transformants were ho-
mogenous, the kanamycin-resistant D39 cps2A::ermB trans-
formants produced two visibly different types of colonies
that differed in the amount of capsule present (Fig. 4). The
majority of transformants, herein referred to as D39
cps2A::ermB lytR::kan, were small and contained a low
amount of, or perhaps no, capsule, comparable to that of R6
lytR::kan transformants. We were not able to grow cells from
this colony type in liquid medium. At low frequency, we also
obtained larger colonies containing capsule, although at a
FIG. 2. Cellular localization of GFP+ -Cps2A, GFP + -Psr, or Gfp + -LytR. (A) Lysates of D39 or R6 cells expressing GFP +
fusion proteins were analyzed by SDS-PAGE (Coomassie staining, left side) and western blot using anti-GFP for detection of
fusion proteins (right side). The GFP + fusion proteins migrate according to their predicted molecular weight. (B) Fluores-
cence microscopy of D39 cells expressing GFP + -Cps2A, GFP+ -Psr, or GFP+ -LytR. SDS-PAGE, sodium dodecyl sulfate–
polyacrylamide gel electrophoresis.
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reduced level to the D39 transformants. We conclude that
these transformants have acquired a secondary, as yet un-
known, mutation that allows the retention of the capsule in
the cps2A lytR background. These transformants could be
grown in liquid culture (see next section), and we refer to this
suppressor strain as D39 cps2A::ermB lytR::kan (S). DNA from
both types of kanamycin-resistant D39 cps2A::ermB trans-
formants was extracted, and we confirmed by PCR analysis
that the cps2A gene was inactivated by the erythromycin
cassette. We also confirmed that the bgaA region was un-
changed and the lytR gene could not be amplified. In addi-
tion, in both transformants, the psr gene sequence was
identical to that in D39. Hence, both types of transformants
were devoid of cps2A and lytR and had an intact psr gene,
indicating that the differences in the amounts of capsules
were not due to a difference in their LCP genes.
The cps2A lytR (S) suppressor mutant loses capsule
material into the supernatant
The suppressor strain D39 cps2A::ermB lytR::kan (S) was
able to grow in liquid C+Y growth medium, although
growth was strongly impaired as indicated by the slower
generation time compared with single cps2A, lytR, or psr
mutant; the double cps2A psr mutant; and the parental strain
(Fig. 5A). The cps2A lytR (S) suppressor mutant grew only to
an optical density of 0.2–0.3 before lysing when inoculated
from a fresh agar plate, and the strain did not grow at all
when it was inoculated from liquid culture.
We next quantified the capsule material in the supernatant
of these cultures relative to the total capsule present in lysate
(Fig. 5B). Interestingly, the D39 cps2A::ermB lytR::kan (S)
suppressor strain released as much as 47% of its total capsule
material into the supernatant, which was significantly more
than the parental strain, the cps2A and psr single mutants,
and the cps2A psr double mutant. The higher amount of
capsule in the supernatant of D39 cps2A::ermB lytR::kan (S)
was not due to lysis of cells, because the supernatant of this
strain contained similar levels of proteins to those of the
other strains (Fig. 5C).
When grown in liquid medium, D39 cps2A::ermB lytR::kan
(S) produced 31% of the total capsule amount of D39 (data
not shown), which is a similar reduction to that seen when
the strain is grown on agar plates (Fig. 4). Indeed, electron
micrographs of thin sections of cells from liquid culture show
a strong reduction in surface-attached capsule compared
with strain D39 (Fig. 6). Further, cells of D39 cps2A::ermB
lytR::kan (S) were inhomogeneous in size and had misplaced
septa, similar to R6 lytR mutant cells. Taken together, these
FIG. 3. The relative percentages of capsule in total cell ly-
sates and in culture supernatants of various strains. Capsules
were quantified by dot blot analysis using an anti-type 2
capsule antiserum. The values are the mean– SD of three
independent samples.
FIG. 4. Relative capsule amount in whole colonies of
transformants. Strains were transformed to introduce the
lytR::kan mutation. Whole colonies of transformants were
taken and resuspended, and the cells were lysed prior to
quantification of the capsule by dot blot analysis. The values
are the mean– SD of three independent samples. The sup-
pressor mutant D39 cps2A::ermB lytR::kan (S) contained far
less capsule than D39 lytR::kan, whereas D39 cps2A::ermB
lytR::kan and R6 lytR::kan have virtually no capsule. Micro-
graph insets above the histograms show capsule-stained cells
of the strains.
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data show that LytR is required for normal cell morphology
and that it contributes with Cps2A to retaining the capsule at
the cell surface.
Crystallographic evidence for polyprenol
pyrophosphatase activity of Cps2A
In a previous report we showed that Cps2A and the B.
subtilis homolog YwtF have a pyrophosphatase activity to-
ward polyprenoid pyrophosphate lipid substrates, a reaction
resembling the transfer of teichoic acid or capsular polysac-
charides onto peptidoglycan.24
We have now obtained crystallographic evidence that
corroborates the ability of Cps2A to hydrolyze the phos-
phate-phosphate bond in polyprenol pyrophosphate lipids.
When the extracellular domain of Cps2A is overexpressed
in E. coli, it co-purifies with endogenous polyisoprenoid
phosphate lipids. Such Cps2A preparations have been
crystallized as complexes with endogenous octaprenyl-
pyrophosphate and decaprenyl-phosphate lipids.24 We have
subsequently found that the crystallization conditions affect
the nature of the lipid bound to the protein. Identical batches
of the Cps2A(R267A) mutant were crystallized under simi-
lar, but slightly different, conditions (0.1M sodium acetate
[pH 4.6] 8% PEG-4K vs. 0.2M di-ammonium citrate [pH 5]
17% PEG-3350) and both crystal forms had the same space
group with near-identical unit cell dimensions. In the struc-
ture of the wild-type Cps2A, Arg267 interacts with the lipid
b-phosphate. The Cps2A(R267A) mutant protein proved to
be, serendipitously, particularly amenable to crystallogra-
phy. The major lipid in this preparation of Cps2A(R267A)
was shown by mass spectroscopy to be octaprenyl-pyro-
phosphate.24 However, in the refined crystal structures (re-
finement statistics in Table 3), the lipid composition of the
FIG. 5. Characterization of the suppressor mutant D39 cps2A::ermB lytR::kan (S). (A) Growth of strains in C+Y at 37C. D39
cps2A::ermB lytR::kan (S) only reaches an OD620 of 0.25 before autolysis begins. (B) Relative capsule amount in culture lysate
and supernatant detected by dot blot analysis. D39 cps2A::ermB lytR::kan (S) loses *47% of its capsule material into the
culture supernatant. (C) Proteins detected in silver-stained SDS-PAGE of the lysate (L) and supernatant (S) samples analyzed
in (B).
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crystallized protein differed. The crystals grown in acetate
buffer clearly show a pyrophosphate lipid head group, even
in electron density maps with phases calculated from only
the protein atoms (Fig. 7A). In the crystals grown from citrate
buffer, only a monophosphate lipid is visible. Further, an
arginine residue, Arg242, has a significantly different posi-
tion in the two crystal forms, which can be attributed to a
salt-bridging interaction between Arg242 and the lipid b-
phosphate.
As the crystals form over a much longer timescale in cit-
rate buffer, not even appearing under a microscope for a
month, the difference in lipid content is likely to be attrib-
utable to a change in the lipid content of the sample occur-
ring during crystallization, presumably because of the
pyrophosphatase activity described previously for Cps2A.24
The Cps2A(R267A) mutant does indeed have pyropho-
sphatase activity in the di-ammonium citrate buffer used for
crystallization. Using a colorimetric PiPer assay, a sample of
190 mM Cps2A(R267A) released 67 – 1.5 mM of inorganic
phosphate after 5 days of incubation at 22C in 20mM di-
ammonium citrate (pH 5.0). It might be argued that the
Cps2A(R267A) sample contains a pre-existing mixture of
lipids and the change in conditions favors crystallization of a
particular protein-lipid complex from the mixture. However,
it is hard to reconcile such a dramatic change in behavior
with such a slight change in buffer pH and with the identical
crystal packing that exists in the two crystal forms. Further,
there are no obvious interactions of buffer ions with the
lipid-binding site that could explain any buffer-specific sta-
bilization of either protein-lipid complex. A change in lipid
composition over the lengthy timescale of crystallization in
citrate buffer, due to the innate pyrophosphatase activity of
Cps2A, therefore, appears to be the most plausible expla-
nation for this major change in crystallization behavior.
The B. subtilis LCP protein YwtF binds
polyisoprenoid lipids
To simplify analysis of the proposed enzymatic function of
LCP proteins, we sought to identify a homolog that could be
isolated with an empty lipid-binding site. Structures of seven
other LCP family proteins are currently in the PDB, none of
which report a bound lipid molecule, though polyethylene
glycol fragments have been built in the hydrophobic tunnel
in PDB entry 3OWQ. The B. subtilis homolog of Cps2A,
YwtF, was purified using a method similar to that of Cps2A
and subjected to sparse matrix crystallization screening.
Crystals were formed under identical conditions to those
reported in the PDB (entry 3MEJ) and diffracted to a maxi-
mum resolution of 1.79 A˚. 3MEJ was used as a starting
model for refinement and was refined to an Rfree of 0.24. This
structure determination revealed a ribbon of electron density
that corresponds to the bound lipid molecule when the
structure of the Cps2A-lipid complex is superimposed on
YwtF.
Electrospray mass spectrometry was subsequently used to
assess whether the sample contained bound polyisoprenoid
lipids (Fig. 7C). Spectra were recorded under both native and
denaturing conditions and were consistent with the mass of
the intact protein, minus initiating methionine (31,883Da).
Additional peaks at 32,607Da and 32,731Da were uniquely
present in the native spectra. The differences in mass rela-
tive to the peak from the intact protein, 724 and 849Da, are
consistent with octaprenyl-pyrophosphate and undecaprenyl-
phosphate, respectively, lipids which have been identified to
co-purify with Cps2A.24 Octaprenyl-pyrophosphate pro-
vided a better fit to the electron density map in the hydro-
phobic tunnel than the undecaprenyl-phosphate; the crystal
packing also did not allow sufficient space to accommodate
FIG. 6. Visualization of surface-attached capsule in D39 and D39 cps2A::ermB lytR::kan (S). Electron micrographs show
reduced amount of cell-surface-associated capsule and aberrant septum placement and cell size. Bar, 0.5 mm.
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FIG. 7. Crystallographic evidence for pyrophosphatase activity of LCP proteins. (A) Effect of crystallization conditions on
the lipid component of Cps2A(R267A) mutant. A complex with pyrophosphate lipid crystallizes in acetate buffer (i) and a
complex with monophosphate lipid crystallizes in citrate buffer (ii). The position of Arg244 in the superimposed structures is
shown in (i); the red color corresponds to Arg244 in the complex with monophosphate lipid. Both 2Fobs-Fcalc maps are
contoured at 1 s within 1.6 A˚ of the bound lipid molecule; (i) shows an unbiased map calculated at an early stage of
refinement, before the addition of lipid (Rfree = 0.27); (ii) represents a map calculated with phases from a fully refined
structure. (B) Structure of the complex between YwtF and octaprenyl-pyrophosphate. The conserved arginines 118, 217, and
242, which form salt bridges with the pyrophosphate head group, are shown. The 2Fobs-Fcalc map is contoured at 1 s within
1.6 A˚ of the bound lipid molecule. (C) Electrospray mass spectra of YwtF recorded under denaturing (upper) and native
(lower) conditions. The spectra under native and denaturing conditions show a peak consistent with the mass of the
expressed protein, minus the initiating methionine (31,883Da). Additional peaks at 32,607 and 32,731Da are unique to the
spectra under native conditions; the mass differences relative to that of the protein-alone 31,883Da (724 and 848Da) are
consistent with the masses of octaprenyl-pyrophosphate and undecaprenyl-pyrophosphate. (D) Model of undecaprenyl-
pyrophosphate–YwtF complex. With the best fit of the lipid into the electron density and the steric constraints of the
hydrophobic tunnel, the hydrophobic tail protrudes slightly into the solvent. However, the tail appears correctly orientated to
interact with the membrane, given the position of the N-terminus of the protein (magenta), which bears the transmembrane
helix.
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the longer lipid. The lipid most convincingly filled the elec-
tron density in the all-cis configuration, rather than in the all-
trans configuration (Fig. 7D), particularly for the isoprenoid
group adjacent to the pyrophosphate. That the enzyme is
stereospecific selective for lipid binding is underlined by fact
that trans-polyprenoid lipids are more abundant in E. coli
than cis-polyprenoid lipids, because of their roles as inter-
mediates in quinone biosynthesis.40 The electron density can
accommodate di-trans, penta-cis octaprenyl-pyrophosphate,
in which the two chiral double bonds furthest from the head
group have the trans configuration. Di-trans, penta-cis octa-
prenyl-pyrophosphate is an intermediate in the synthesis
of undecaprenyl-pyrophosphate40 and may be sequestered
preferentially by LCP proteins when expressed in the cyto-
plasm. Indeed, the final Rfree in refinement was in actual
fact at its lowest (0.22) when di-trans, penta-cis octaprenyl-
pyrophosphate was modeled into the active site.
Attempts to model the longer lipid undecaprenyl-
phosphate into the electron density resulted in a steric clash
between the hydrophobic tail of the lipid and an adjacent
protein molecule in the crystal lattice. In full-length YwtF the
hydrophobic tail may extend out of the protein tunnel to
interact with the membrane. This potential ‘‘exit’’ path from
the hydrophobic lipid tunnel is reasonably orientated with
respect to the N-terminus of the protein, to which the
transmembrane helix is attached, for this to occur (Fig. 7D).
Overall, these structural results support further an enzy-
matic role of LCP proteins in the transfer of phosphorylated
chains of anionic cell wall polymers from an undecaprenyl-
pyrophosphoryl-linked precursor to peptidoglycan on cleav-
age of the pyrophosphoryl bond.
Discussion
LCP proteins are widespread in Gram-positive bacteria
and are often present in multiple versions in one species. Lcp
mutant strains of various species show pleiotropic pheno-
types and, therefore, LCP proteins have been suggested to be
involved in the regulation of some aspects of cell wall me-
tabolism. However, a recent publication24 provided strong
evidence that LCP proteins are not regulatory factors, but are
in fact phosphotransferase enzymes for one of the last steps
in cell wall assembly, the attachment of anionic cell wall
polymers like capsular polysaccharides and teichoic acids, to
peptidoglycan. This hypothesis is strongly supported by
crystal structures of the extracytoplasmic part of pneumo-
coccal Cps2A, which, depending on the E. coli expression
strain from which it was produced, contained either a
phosphorylated or pyrophosphorylated polyprenol lipid;
these are the substrate and product mimics of the phospho-
transferase reaction. The reaction presumably leads to the
teichoic acid or capsule chains becoming attached to C6-OH
of MurNAc residues in peptidoglycan by the formation of a
phosphodiester bond. It is this last reaction in cell wall
synthesis, connecting the major cell wall polymers with each
other, which produces the final and functional cell wall in
Gram-positive bacteria. Perhaps, it is therefore not surprising
that affecting this reaction often leads to pleiotropic pheno-
types as observed in lcp mutants.
The aim of this work was to investigate the role of the
three pneumococcal LCP proteins in the attachment of the
capsule to the cell wall. One of them, CpsA, is encoded by
the first gene of the large capsular gene cluster present in the
different serotypes. A noticeable exception is serotype 3,
which does not contain an lcp family gene in its capsule
cluster and which does not covalently attach its capsule to
peptidoglycan. Cps2A, the CpsA protein present in serotype
2 strains like D39, has been implicated previously in the at-
tachment of capsule to the cell wall because a cps2A mutant
strain has a reduced quantity (*30%–40%) of cell-wall-at-
tached capsular polysaccharide. Because the residual capsule
material is attached to the cell wall, we hypothesized that
other LCP proteins, LytR and Psr, might contribute to cap-
sule attachment in the absence of Cps2A. We also considered
the possibility that Cps2A, LytR, and Psr attach teichoic acid
chains to peptidoglycan to form wall teichoic acid, or attach
teichoic acid chains to the glycolipid anchor to form lipo-
teichoic acid. Either there is one enzyme for each of these
three attachment reactions, or LCP proteins have (semi)re-
dundant roles in cell wall assembly. The latter possibility is
supported by the available crystal structures of Cps2A and
its B. subtilis homologs, which bind the lipid and pyropho-
sphoryl part of the anionic polymer precursor strongly.
These structures also display a surface groove for binding
peptidoglycan chains, but they do not appear to recognize
much or any of the repeating chain of the anionic polymer.
Hence, it is possible that some of these enzymes are ‘‘non-
specific’’ in that they are able to attach different polyprenol
pyrophosphoryl-linked polymers to peptidoglycan. This
hypothesis is supported by the work presented in this article,
which shows that LytR, at least, and perhaps Psr contribute
to capsule–cell wall attachment in the absence of Cps2A.
A role in cell wall assembly is also supported by the locali-
zation of GFP-fusions of all three LCP proteins at mid-cell
(Fig. 2) where the pneumococcal cell wall grows. The fusion
proteins also localized at mid-cell in the capsule-free strain
R6 (not shown), indicating that capsule precursors are not
required for their localization, supporting the hypothesis that
LytR and Psr are active in cell wall assembly, presumably in
the final assembly of teichoic acids. However, the precise role
of each pneumococcal LCP protein in teichoic acid assembly
remains to be determined.
D39 strains that lacked cps2A but expressed all other
capsule genes had significantly reduced amounts of capsule
material (Fig. 3), in confirmation of a previous report and
indicating that LytR and Psr cannot complement fully the
lack of Cps2A in the retention of the capsule. A psr mutant
had slightly reduced amounts of capsule. Perhaps, Psr con-
tributes to capsular assembly, or in this mutant Cps2A and
LytR take over the Psr function to result indirectly in a re-
duced amount of capsule.
We were also unable to obtain a stable lytR mutant in the
D39 background. LytR can be inactivated in the capsule-free
R6 strain, leading to abnormal cell morphology and reduced
growth. Presumably, the presence of a fully functional cap-
sule assembly pathway adds to the growth problems of lytR
mutants that prevent the isolation of viable mutants. Con-
sistent with this premise, the inactivation of lytR in the D39
cps2A::ermB background, which contained less capsule ma-
terial than D39 (Fig. 3), produced viable transformants. In-
terestingly, we have obtained two types of transformants,
both of which were identical genetically, in that they both
contained the cps2A and lytR deletions and retained an intact
psr. The more abundant transformant type had little, if any,
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capsule and was unable to grow in liquid medium; we infer
that this is the true phenotype of a D39 cps2A lytR double
mutant. The second type of transformant, less abundant and
most likely a D39 cps2A lytR double mutant with one or
more suppressor mutation(s), contained capsule and was
able to grow in liquid medium, although at a slow growth
rate and only for one culture cycle. Interestingly, these cells
lost massive amounts of capsule material into the growth
medium without showing significant lysis, indicating that
the capsule material was secreted into the growth medium.
The most likely explanation for our results is as follows.
All three LCP homologs have semiredundant roles in the
attachment of capsular polysaccharide and teichoic acid
precursor chains to peptidoglycan, and perhaps of teichoic
acid precursor chains to the glycolipid anchor. Deleting one
or two of the corresponding genes results in an imbalance in
the assembly of cell wall polymers causing growth defects, in
particular when lytR is deleted. This indicates that LytR has
specific function(s) that cannot readily be taken over by the
two homologs. It could be expected that lcp mutants accu-
mulate lipid-linked teichoic acid or capsule precursors in
their cell membrane. However, in several lcp mutant strains
investigated, the lipid-linked precursors do not accumulate
but the final cell wall polymer is present at a reduced level.
We hypothesize that the cytoplasmic synthesis and polymer-
ization of teichoic acid and capsular polysaccharide chains,
their transport across the membrane, and their attachment to
the cell wall peptidoglycan are coupled, explaining the re-
duced amount of anionic polymers in lcpmutant strains (Figs.
2, 5, and 6). In the D39 cps2A lytR suppressor strain, this
feedback regulation appears to be lost and thus the strain
produces an excess of capsule material that cannot be retained
in the cell wall and is lost into the culture supernatant. We are
currently investigating how the capsule material is released
from the cell membrane in this strain, and which genes are
mutated to produce this phenotype.
At the molecular level, the new structures reported here
bolster the evidence that LCP proteins are the phospho-
transferases that catalyze the transfer of anionic cell wall
polymers (teichoic acids and capsular polysaccharides) from
lipid-linked intermediates onto peptidoglycan. First, the
head group of the lipid changes when the timescale of
crystallization is extended, consistent with pyropho-
sphorolysis of the lipid occurring within a crystallization
drop. This pyrophosphorolysis is consistent with our previ-
ous observation that inorganic phosphate accumulates in
purified preparations of the Cps2A-octaprenyl-pyrophos-
phate complex.24 The pyrophosphorolysis reaction has
chemistry resembling that of the phosphotransfer of teichoic
acid or capsule onto peptidoglycan.
Second, we have also shown that the B. subtilis LCP pro-
tein YwtF binds lipids that resemble the substrate of the
phosphotransfer reaction. The presence of exogenous E. coli
octaprenyl-pyrophosphate lipid in the crystallized protein, in
addition to undecaprenyl-phosphate, was confirmed by
mass spectroscopy. On examination of the structure of YwtF
bound to octaprenyl-pyrophosphate, many of the interac-
tions between charged residues and the lipid head group
resemble those seen in Cps2A.24 The only exception is Asp82
(equivalent to in Asp234 in Cps2A). In Cps2A, Asp234 co-
ordinates a magnesium ion that interacts with the pyro-
phosphate head group, whereas in YwtF, Asp82 is more
distant from the phosphate and is at the start of a disordered
loop region that could not be modeled. In Cps2A, this loop
region is in close proximity to an additional protein domain
that is unique to Cps2A. The proximity of this domain may
stabilize the loop by restraining its conformational mobility,
which may in turn enable Asp234 to coordinate the magne-
sium ion. The disorder in this loop in YwtF may explain
why there is no magnesium bound to the pyrophosphate
head group in the YwtF structure, despite the presence of 0.2M
MgCl2 in the crystallization conditions. Modulation of the
mobility of this loop due to interactions with other components
of the cell wall synthetic machinery could in fact provide a
mechanism to regulate the activity of the enzyme.
The disorder in this loop may also explain the apparent
weaker binding of the lipid to YwtF. In comparing the
crystallographic B factors of the lipid to those of the sur-
rounding protein, the octaprenyl-pyrophosphate appears to
be more mobile in the YwtF structure (Table 3). Further,
purified preparations of YwtF catalyze the pyropho-
sphorolysis of exogenously added geranyl pyrophosphate
but Cps2A, purified in the same manner, is inactive in the
same assay.24 These observations suggest that the endoge-
nous E. coli lipids are more loosely bound to YwtF than in
Cps2A, and that the active site is, therefore, more accessible
to exogenously added substrates.
In summary, our genetic data have provided insights into
the complex mechanisms of capsule attachment in S. pneu-
moniae, pointing to a semiredundant role of all three LCP
proteins in this process. Our structural data have reinforced
the proposed role of LCP proteins as the enzymes that cat-
alyze the transfer of teichoic acid and/or capsular polysac-
charides onto peptidoglycan. Although the precise role each
of these enzymes plays in cell wall assembly has yet to be
defined, their inactivation would seem likely to impair
pneumococcal growth and/or survival at an infection site.
Therefore, we consider Cps2A and its homologs as valid
targets in the search for antimicrobials that target pneumo-
cocci and, potentially, other Gram-positive pathogens.
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Teichoic acids and acidic capsular polysaccharides are
major anionic cell wall polymers (APs) in many bacteria,
with various critical cell functions, including maintenance
of cell shape and structural integrity, charge and cation
homeostasis, and multiple aspects of pathogenesis. We
have identified the widespread LytR–Cps2A–Psr (LCP)
protein family, of previously unknown function, as novel
enzymes required for AP synthesis. Structural and bio-
chemical analysis of several LCP proteins suggest that they
carry out the final step of transferring APs from their
lipid-linked precursor to cell wall peptidoglycan (PG).
In Bacillus subtilis, LCP proteins are found in associ-
ation with the MreB cytoskeleton, suggesting that MreB
proteins coordinate the insertion of the major polymers,
PG and AP, into the cell wall.
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Introduction
The cell wall is crucial for maintaining the structural integrity
and the characteristic shape of a bacterial cell. In Gram-
positive bacteria, a group that contains many important
pathogens, the cell wall has two major components:
(i) peptidoglycan (PG), whose pathway is the target for
some of our most successful antibacterial compounds
(the b-lactams and glycopeptides) and (ii) the PG-attached
anionic cell wall polymers (APs), including wall teichoic
acids (WTAs) and acidic polysaccharides.
WTAs and their lipid-linked versions (lipoteichoic acids)
have a wide range of important cellular roles including
control of autolytic activity, antigenicity and innate immune
recognition, pathogenicity, biofilm formation, efficient release
of secreted proteins into the culture medium, cation homo-
eostasis, antibiotic resistance, and cell elongation and division
(summarized in Weidenmaier and Peschel, 2008).
In Bacillus subtilis, WTA is present in large quantities, roughly
equal to those of PG (Foster and Popham, 2002). Most steps in
the synthesis of WTA are now known, catalysed by a variety of
gene products with a tag prefix (Neuhaus and Baddiley, 2003;
Brown et al, 2008). The polymer is synthesized in the cyto-
plasm, translocated across the membrane by the ABC trans-
porter TagGH (Schirner et al, 2011), and is covalently attached
to PG outside the cell (Yokoyama et al, 1989). The physical
connection of major APs like WTA or capsular polysacchar-
ides to PG builds the final cell wall architecture and is
essential for proper cell wall functionality, but the enzyme
catalysing this important step remains to be identified.
Disruption of most of the tag genes of B. subtilis is lethal.
This lethality can be suppressed by deleting tagO or tagA
to block the earliest steps in the pathway, which presu-
mably prevents either the build up of a toxic intermediate
or the sequestration of an essential metabolite. Nevertheless,
tagO and tagA mutants are severely compromised in cell
growth and they lose the ability to elongate, becoming
rounded and swollen (D’Elia et al, 2006a, b, 2009). tagO
null mutants of the round Staphyloccocus aureus have no
significant growth defect but they are affected in spatial
control of PG synthesis, are hypersensitive to lysozyme,
and are badly impaired in virulence (Weidenmaier and
Peschel, 2008; Atilano et al, 2010).
In most rod-shaped bacteria, cell elongation is governed
largely by the prokaryotic actin homologue, MreB, which
assembles into patches or filaments at the inner surface
of the membrane (Graumann, 2009). MreB is essential for
viability in many bacteria, and its depletion induces severe
morphological defects (Jones et al, 2001; Figge et al, 2004;
Kruse et al, 2005; Slovak et al, 2005; Hu et al, 2007). Many
Gram-positive bacteria have more than one MreB isoform.
The B. subtilis MreB isoforms, MreB, Mbl, and MreBH
largely colocalize and have partially overlapping functions
(Carballido-Lopez et al, 2006; Kawai et al, 2009a). MreB and
Mbl are essential under normal growth conditions, although
the mutants are viable in high Mg2þ concentrations for
reasons that are not yet clear (Formstone and Errington,
2005; Schirner and Errington, 2009). Evidence from several
laboratories supports the idea that the MreB cytoskeleton
somehow spatially regulates the synthesis of PG and poten-
tially other cell wall components, thereby bringing about
controlled expansion of the wall, while retaining a defined
cell shape (Daniel and Errington, 2003; Vats et al, 2009;
Kawai et al, 2009b).
We have now obtained several lines of evidence supporting
the idea of a direct role for the MreB cytoskeleton in WTA
synthesis and cell wall attachment. By searching for MreB-
interacting proteins, we have identified a widely distri-
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buted family of proteins of previously unknown function, the
LytR–Cps2A–Psr (LCP) family, as having a role in the biogen-
esis of WTA and anionic polysaccharides (Hu¨bscher et al,
2008). LCP proteins are present in virtually all gram-positive
bacteria, which characteristically contain PG-attached WTA
and/or APs. Our structural and biochemical data on several
LCP proteins provide strong evidence that this family of
proteins carry out the key step of attaching APs to the cell
wall PG. The LCP proteins present an important novel anti-
biotic target and may aid our understanding of assembly of
heteropolymeric cell walls in fungi and plants.
Results
A role for MreB proteins in WTA synthesis or assembly
B. subtilis mutants affected in genes for lateral wall PG
synthesis (mreC, mreD, rodA, and a double mutant of
pbpA and pbpH) have a common phenotype in which the
cells become spherical (Henriques et al, 1998; Wei et al,
2003; Leaver and Errington, 2005), and their growth requires
high concentrations of Mg2þ (Supplementary Figure S1A).
Mutants lacking all three mreB genes also adopt a spherical
shape (Schirner and Errington, 2009; Kawai et al, 2009a) but
they are not rescued by Mg2þ (Supplementary Figure S1A).
Mutants affected in WTA synthesis are also spherical
(Lazarevic and Karamata, 1995; Soldo et al, 2002; Bhavsar
et al, 2004). We noticed that tagG and tagH mutants were, like
the mreB triple mutant, unresponsive to Mg2þ (Supple-
mentary Figure S1B). We hypothesized that the mreB triple
mutant might be Mg2þ -unresponsive because the MreB
cytoskeleton does not only control the Mg2þ -responsive
PG synthesis, but additionally the Mg2þ -unresponsive WTA
synthesis. To test this hypothesis, we made use of the unique
feature of mutants affected in the later steps of WTA synthe-
sis, which can be rescued by disruption of the tagO gene
(D’Elia et al, 2006a, b). If this was correct, mutation of tagO
might also suppress the lethality of triple mreB mutation.
Figure 1A shows that disruption of tagO suppresses lethality
in a conditional mutant in which the one remaining mreB
homologue is under IPTG control, supporting the idea that
the MreB proteins are required for one or more late steps in
WTA synthesis.
The MreB cytoskeleton associates with known and
novel components of the WTA biosynthetic machinery
We used in vivo cross-linking, followed by IMAC affinity
copurification of oligohistidine-tagged MreB, Mbl, or
MreBH, and liquid chromatography tandem mass spectro-
metry analysis (LC–MS/MS) to identify proteins associated
with the MreB cytoskeleton. The list of proteins that pulled
down with the cytoskeleton (summarized in Figure 2A, with
full data for each of the isoforms in Supplementary Table SI)
included various proteins already known to associate with
MreB, such as PBP1, PBP2A, PBP4, PBPH, and MreC (Kawai
et al, 2009a, b). Importantly, the list also included several
proteins of the WTA pathway: TagD, TagE, TagF, and TagH,
indicative of a role for the cytoskeleton in the synthesis or the
assembly of WTA.
The WTA synthetic pathway of B. subtilis is the best
characterized of any organism. However, although WTA
polymer is known to be covalently linked to PG (Yokoyama
et al, 1989), the transferase required for this reaction has not
been identified. If the MreB protein was responsible for
spatial organization of WTA, this factor should also be
present in the MreB complexes. We analysed the list of
candidates focusing on three key parameters: transmembrane
(TM) topology, with a major (likely catalytic) domain pre-
dicted to be located outside the cytoplasm; gene location in
proximity to known WTA synthetic loci (because WTA sys-
tems are variable and can be exchanged en bloc by genetic
transformation) (Young et al, 1989); and phylogenetic dis-
tribution largely matching that of WTA. This analysis high-
lighted three members of the poorly characterized LCP family
of genes and proteins (Figure 2). All three B. subtilis members
of this gene family (lytR, ywtF, and yvhJ) are located within a
50-kbp segment of DNA that contains virtually all of the
known WTA genes (Figure 2B). The three genes were re-
named tagT (ywtF), tagU (lytR), and tagV (yvhJ).
Bacterial two-hybrid analysis revealed strong interactions
between MreB and the TagT and TagU proteins (Supple-
mentary Figure S2A). GFP fusions were made to each protein
and expressed from the amyE locus under the control of a
xylose-inducible promoter. GFP-TagU at least was functional
based on a complementation tests (see below). Localization
patterns of GFP-TagT and -TagU were reminiscent of those of
MreB proteins, with patterns of distributed dots and tilted
bands. These patterns were disrupted by double mutation of
mreB and mbl, and by dissolution of the membrane potential,
which Strahl and Hamoen (2010) recently showed was re-
quired for localization of MreB and associated proteins
(Supplementary Figure S2C). GFP-TagV gave a less clear-cut
pattern and the localization was not affected by mreB muta-
tion or treatment with CCCP (Supplementary Figure S2C).
These observations again support the idea that TagT and
TagU, at least, are associated with the MreB cytoskeleton.
Triple disruption of the tagTUV genes causes loss of rod
shape and is lethal under normal growth conditions
Single mutants of tagT, tagU, or tagV had no discernible
effect on cell growth or morphology under normal growth
conditions. To test for possible functional redundancy, all
combinations of double mutants were then generated and
confirmed to be viable. DtagTU and DtagUV mutants did not
differ noticeably from the wild type (Figure 1B–D). However,
the DtagTV mutant grew more slowly than the wild type and
the cells were generally wider and often showed abnormal
bulging (Figure 1E). A triple disruption of the tagTUV genes
was apparently not viable. To investigate the phenotype
of a triple mutant, tagV was placed under the control of the
IPTG-inducible Pspac promoter in a DtagTU double mutant
background. The resultant strain grew as normal rod-shaped
cells in the presence of IPTG (Figure 1I). However, when IPTG
was removed, growth was arrested and the morphology of
the cells changed, becoming shorter and wider with notice-
able abnormal bulging (Figure 1G), eventually becoming
almost round (Figure 1H). Thus, at least one functional
TagT, TagU, or TagV protein is required for viability and
normal cell morphogenesis.
Disruption of the tagTUV genes can be suppressed by
tagO mutation but not Mg2þ
If the tagTUV triple mutant was defective in WTA synthesis or
assembly, it should be rescued by deletion of tagO but not by
high Mg2þ concentration. As anticipated, growth of the triple
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Figure 1 Lethal phenotype of a triple mutant of mreB paralogues and tagTUV, and rescue by disruption of tagO. (A) Growth of strains 168
(wild-type), YK992 (DtagO), YK1190 (amyEHPspacHY-mbl DmreB Dmbl DmreBH DtagO), and YK1119 (amyEHPspacHY-mbl DmreB Dmbl DmreBH)
on NA plates with or without 0.1 mM IPTG. (B–E) Cell morphologies of typical fields of strains 168 (wild-type, B), RE204 (DtagTU, C), YK915
(DtagUV, D), and YK917 (DtagTV, E). The cell membranes were stained with Nile Red. Scale bar represents 5 mm. (F–H) Cell morphologies of
typical fields of strain YK914 (DtagTU Pspac-tagV) cultured in the presence (F) or absence (G, H) of 0.5 mM IPTG. Images were taken at 180 (G)
and 240 (H) min after removal of IPTG. The cell membranes were stained with Nile Red. Scale bar represents 5mm. (I) Growth of strains
YK1031 (DtagTU Pspac-tagV pMAP65), YK1030 (DtagTU Pspac-tagV DtagO), YK1033 (DtagTUV DtagO), and YK1163 (DtagO) on LB plates with or
without 0.5 mM IPTG. (J, K) Cell morphologies of typical fields of strains YK1163 (DtagO, J) and YK1033 (DtagTUV DtagO, K). The cell
membranes were stained with Nile Red (right). Scale bar represents 5mm.
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tagTUV mutant was not rescued by culture in the presence of
various concentrations of Mg2þ up to 25 mM (Supplementary
Figure S1C). We then took a null mutation of tagO and
combined this with disruptions of the tagT U and V genes
and Pspac-tagV. The resulting strain grew even in the absence
of IPTG (Figure 1I), suggesting that disruption of tagO
suppresses the lethality of tagTUV triple disruption. To con-
firm this, we were able to construct the quadruple mutant
directly, taking advantage of the proximity of the tagV and
tagO genes (see Supplementary data). The resulting strain
was viable, and its morphological phenotype was indistin-
guishable from that of a tagO single mutant (Figure 1J and K).
TagTUV proteins are required for WTA synthesis or
assembly
To test directly for a WTA defect, cell wall material (the
insoluble PG–WTA complex) was isolated from various
strains and acid treated to solubilize the WTA polymers,
which were subsequently separated by PAGE and visua-
lized by alcian blue-silver staining (Wolters et al, 1990)
(Figure 3A). Extracts of the wild-type strain revealed the
expected ladder-like pattern, representing partially hydro-
lysed WTA polymers with a range of distinct chain lengths
(lanes 1 and 6). WTA material was completely absent from
cells of the tagO mutant, in which the first step in the
WTA pathway is blocked (lane 5). The staining pattern for
the single tagU mutant was indistinguishable from that of
the wild type (lane 2). When the triple tagTUV mutant
containing the Pspac-tagV construct was grown in the pre-
sence or absence of IPTG, the amount of WTA polymer was
greatly reduced in the absence of IPTG (lane 4) compared
with its presence (lane 3), consistent with tagV being
required for WTA accumulation in the wall. Residual WTA
present in lane 4 is probably due to incomplete repression of
the Pspac promoter in the samples.
Cell wall phosphate, which is present only in WTA and is
not found in PG, was also quantified in the various mutants
(Figure 3B). Consistent with a previous report (Soldo et al,
2002; D’Elia et al, 2009), the wall phosphate content of the
tagO null mutant was greatly reduced compared with wild-
type cells. By contrast, the wall phosphate content of the tagU
single mutant or the tagTUV triple mutant containing the
Figure 2 The WTA biosynthetic machinery and LCP family of proteins associated with the MreB cytoskeleton. (A) Summary of proteins
associated with MreB cytoskeleton (see also full data in Supplementary Table SI). WTA synthetic and LCP proteins are indicated in blue and
red, respectively. (B) Genetic organization of three AP systems in B. subtilis, the WTA biosynthetic genes (blue), the teichuronic acid (TU)
biosynthetic genes (green), and the minor TA biosynthetic genes (yellow). lytR homologues, tagT, U, and V, were indicated in red. Numbers
show the position on the B. subtilis chromosome.
Figure 3 Effects of tagTUV mutants on WTA synthesis or assembly.
(A, B) Cells of 168 (wild-type, lanes 1 and 6), RE201 (DtagU, lane 2),
YK914 (DtagTU Pspac-tagV, lanes 3 and 4), and YK992 (DtagO, lane 5)
were cultured with (lane 3) or without (lanes 1, 2 and 4–6) IPTG.
Purified WTA samples were separated and visualized as described
in the Materials and methods (A). Phosphate content of cell wall
was assayed as described in the Materials and methods (B).
White numbers indicate standard deviation from three independent
experiments.
Bacterial cell wall assembly proteins
Y Kawai et al
The EMBO Journal VOL 30 | NO 24 | 2011 &2011 European Molecular Biology Organization4934
Pspac-tagV construct grown in the presence of IPTG had
almost wild-type cell wall phosphate contents. However, in
the absence of IPTG, wall phosphate was greatly reduced,
almost to the levels found in the tagO mutant. We therefore
concluded that TagTUV proteins have a critical function in
the formation of a WTA-loaded cell wall.
The structure of DTM-Cps2A from Streptococcus
pneumoniae
Attempts to develop direct biochemical assays for TagTUV
activity, using mimics of the complex lipid-linked techoic acid
substrate, were not successful in the first instance. To obtain
molecular insights into the LCP family of proteins, and their
likely enzymatic function, we screened a number of LCP
proteins lacking the N-terminal, TM spanning region (DTM-)
for crystallization. We solved the structure of the DTM
version of the capsule synthesis protein CpsA from serotype 2
S. pneumoniae D39 (named DTM-Cps2A from here on) by
selenomethionine SAD and refined the subsequent atomic
model at 1.69 A˚ resolution (Supplementary Table SII).
DTM-Cps2A comprises two distinct domains: domain 1
(the accessory domain) comprises residues 111–213 and
domain 2 (the LCP domain) spans residues 214–481
(Figure 4). The structure of the accessory domain, the
sequence (and indeed the presence) of which is not con-
served in the wider LCP family of proteins, is depicted in
Figure 4A and B, and described in detail in Supplementary
Figure S3. The LCP domain of DTM-Cps2A, which shares
B30% sequence identities with the equivalent domains from
the three B. subtilis LCP proteins, is described below.
The LCP domain binds phosphorylated polyisoprenoid
lipids
The LCP domain has an a–b–a architecture with a five-
stranded b-sheet forming the core of the protein and a-helices
surrounding the sheet on both faces (Figure 4). Two pairs of
b-strands (b4/b5 and b12/b13) extend away from the protein
core to form the interface between the two domains of DTM-
Cps2A, burying some 570 A˚2 of surface area in the process.
Crucially, a polyisoprenoid phosphate lipid was found in a
hydrophobic pocket between the main b-sheet and a-helices
a3–a7 (Figure 4). Presumably, DTM-Cps2A had bound the
lipid when heterologously expressed in the Escherichia coli
host, consistent with its affinity for a lipid-linked capsule
precursor in S. pneumoniae. The lipid was built as mono-
trans, octa-cis decaprenyl-phosphate (dpr-P).
We were subsequently able to solve the structure of DTM-
Cps2A by molecular replacement in the presence of all cis
octaprenyl-pyrophosphate (opr-PP) bound in the lipid-bind-
ing site. Again, no effort was made to load the protein with
lipid prior to crystallization. The variation in lipid content
between preparations of DTM-Cps2A probably represents a
difference in the lipid composition of the two E. coli strains
used: BL21 (DE3) leads to opr-PP being bound whereas B834
(DE3) results in dpr-P being bound. In both cases, the identity
of the bound lipid was determined by electrospray mass
spectroscopy of protein:lipid complexes. Mass differences
between free proteins and lipid-bound proteins were 774
and 724 Da (Supplementary Figure S4A and B), correspond-
ing to dpr-P and opr-PP (equivalent molecular masses 777
and 723 Da, respectively). The electron density maps prior to
the building of the bound lipids, and during refinement, are
consistent with the presence of dpr-P in one structure and
opr-PP in the other. Both lipids are found naturally in bacteria
(Bouhss et al, 2008).
The polyisoprenoid-binding pocket is lined with hydro-
phobic side chains (Figures 4 and 5A and C) from residues
that, although not strictly identical, are completely conserved
in hydrophobic character across the entire LCP family of
proteins. The cavity for the lipid increases in diameter beyond
the sixth isoprenoid, so much so that the lipid is folded back
upon itself where the cavity for lipid binding is at its widest,
and there are fewer interactions with the protein (Figure 5A
and C). Consequently, the electron density in the region of the
sixth prenoid moiety in both the dpr-P and opr-PP complexes
is relatively poor, as is the electron density for the terminal
prenoid group in the dpr-P structure. The key interactions
between lipid and protein are, however, maintained in both
structures (Figure 5A and C).
The phosphate headgroup of the dpr-P lipid is held in place
by a number of conserved, charged residues. The invariant
R267, R362, and R374 form key interactions with all the
phosphate oxygens to form a positively charged pocket in the
protein surface (Figure 5B). The conserved D371 and Q378
are in contact with these arginine residues to stabilize further
their conformations.
The lipid-proximal phosphate in the opr-PP-bound struc-
ture is shifted slightly and now makes contacts to D234,
Figure 4 The structure of DTM-Cps2A. (A, B) Orthogonal views of
the extracellular portion of Cps2A, shown as a cartoon, with the
accessory domain coloured red and the LCP domain coloured green.
The decaprenyl-phosphate present in the active site is shown as a
stick model, with carbon atoms coloured yellow, phosphorous in
orange, and oxygen in red. Secondary structure elements in both
domains are labelled from N- to C-termini of each domain.
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R244, and R362, whereas the lipid-distal phosphate contacts
the invariant arginines, R244, R267, R364, and R374, fixing
the position and orientation of the pyrophosphate
(Figure 5D). In the dpr-P structure, R267 is built in two
conformations, only one of which interacts with the phos-
phate. Similarly, in the dpr-P structure, R244 and R364 point
into solvent, but, as with R267, readjust their conformations
in the presence of a pyrophosphate lipid headgroup.
Since the structure solution of DTM-Cps2A, seven unpub-
lished outputs from the Northeast Structural Genomics
Consortium have been deposited in the PDB that likely
represent structures of other LCP proteins. None of these
entries have been characterized biochemically or genetically.
These structures (PDBids: 3PE5 (from Clostridium leptum,
UNIPROTcode A7VV38); 3QFI (Enterococcus faecalis, Q838I2);
3OWQ (Listeria innocua, Q92CZ6); 3NXH (B. subtilis,
P96499); 3NRO (Listeria monocytogenes, Q8Y889); 3OKZ
(Streptococcus algalactiae, Q8E703), and 3MEJ (B. subtilis,
Q7WY78)) are the only meaningful homologues to DTM-
Cps2A that can be found in the PDB by either secondary
structure matching or amino-acid sequence searches and they
are mostly, and apparently incorrectly, annotated as tran-
scriptional regulators, whereas there is no significant struc-
tural homology of these structures, or of DTM-Cps2A, to
known transcription factors in the PDB. The range of se-
quence identities of the seven hits, in comparison to the
catalytic domain of Cps2A, is between 29 and 32% with
BLAST E-values between 523 and 8–16. All but one (3PE5)
can be superimposed on DTM-Cps2A with r.m.s.d.s of
1.8–2.2 A˚ on 200–230 matched Ca atoms of the catalytic
domain (for 3PE5, the r.m.s.d. is 2.8 A˚ on 224 matched
Cas). None of these seven PDBs contain bound lipid, despite
the close sequence and structural homology in global terms,
and in the regions of the proteins that bind the lipid. The
hydrophobic residues in DTM-Cps2A that are within van der
Waals’ contact of the bound isoprenoid lipids have hydro-
phobic amino acids in the equivalent positions in the other
available structures. The charged amino acids in DTM-Cps2A
in the vicinity of the pyrophosphate headgroup are almost
completely invariant in the other structures (Supplementary
Figure S5). Consequently, it is not evident why DTM-Cps2A
should purify from E. coli with lipids bound, whereas the
other LCP proteins do not.
The LCP proteins likely catalyse a missing step in cell
wall synthesis
Anionic (or acidic) polymers, for instance teichoic acids or
capsular polysaccharides, are synthesized inside the cell, and
are attached to a carrier lipid, undecaprenyl phosphate for
translocation (‘flipping’) to the outside of the cell. In the final
stage of the biosynthesis of the cell wall of bacteria, teichoic
acids are covalently attached to PG, whereby the structure of
the acceptor (PG precursor, nascent PG chain, or cross-linked
PG) is not known. This phosphotransfer reaction links the
phospho-teichoic acid chain to PG MurNAc residues releasing
undecaprenyl phosphate PG whereby. Our structural and
genetic data suggest that the LCP proteins catalyse this step.
The observation of polyisoprenyl (pyro)phosphate lipids
bound to DTM-Cps2A identified the active site for the entire
LCP family (Supplementary Table SIII). The roles of key,
conserved amino acids in the lipid-binding pocket were
confirmed by mutagenesis of the B. subtilis tagU gene (see
below and Figure 6A).
LCP proteins are magnesium-dependent
phosphotransferases
The importance of the two aspartic acids was clarified by our
discovery that D234 and D246 coordinate a magnesium ion
Figure 5 Lipid binding by the LCP domain of DTM-Cps2A. (A, B) decaprenyl-phosphate binding to DTM-Cps2A and (C, D) octaprenyl-
pyrophosphate bound DTM-Cps2A. Protein residues within 4 A˚ of the lipid are shown as stick models, with final, sA-type 2mFobs–DFcalc
electron density maps shown as blue transparent surfaces and contoured in both cases at 1.0s.
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that is situated between the two phosphate groups of opr-PP
in a further structure of DTM-Cps2A (Figure 6B). The pre-
sence of opr-PP in the sample was confirmed by mass
spectrometry. The assignment of magnesium in the struc-
ture was confirmed by a separate structure determination of
DTM-Cps2A–R267A–opr-PP with manganese bound, where
the position of the bound metal ion was verified in an
anomalous difference Fourier (Figure 6B, and the identity
of the bound lipid by mass spectrometry; Supplementary
Figure S4C). The bound Mg2þ obeys near perfect octa-
hedral geometry, with one ligand each from D234, D246
and oxygens from both phosphates (Figure 6B). The other
two coordination positions are filled by water molecules. The
side chain of R244 is displaced by the binding of divalent
cations, and no longer interacts with the pyrophosphate
headgroup. Otherwise, the interactions with the opr-PP lipid
are the same as in the absence of the metal, including the
abuttal of the distal phosphate by the side chain of R267
(Figure 5D), which presumably aids catalysis by stabilizing
the transition state.
The role of magnesium in catalysis was investigated with a
colourimetric assay to measure the liberation of free phos-
phate from DTM-Cps2A that had been purified with opr-PP
bound, to demonstrate the capacity of DTM-Cps2A to cleave
the phosphoester bond in pyrophosphate-containing lipids.
In this assay, the absence of Mg2þ ions from the reaction, or
the presence of EDTA, produced significantly less Pi in an end
point assay than when Mg2þ ions were present (Figure 6C).
Similarly, removal of one of the key Mg2þ coordination
partners, D234, by its mutation to alanine produced signifi-
cantly less free Pi when incubated in the presence of Mg
2þ
(Figure 6C). The key role for the Mg2þ coordination by D234
is consistent with our observation that a B. subtilis TagU
carrying the equivalent mutation, D75A, is not functional
in vivo (Figure 6A; Supplementary Table SIII).
In contrast to DTM-Cps2A, purified preparations of B. sub-
tilis DTM-TagT were not loaded with an E. coli lipid, as
confirmed by X-ray crystallography, and catalysed the hydro-
lysis of the pyrophosphate phosphoester bond in an exogen-
ously added lipid, geranyl pyrophosphate (ger-PP), in a
magnesium-dependent manner (Figure 6D). The addition of
high molecular weight PG, or of a small PG fragment, N-
acetylmuramyl dipeptide, did not stimulate the transfer of the
terminal phosphoryl group to the possible acceptor. Most
likely, the reaction catalysed by the LCP proteins favours
phosphotransfer from AP-loaded substrates (which are not
commercially available), over that from the unloaded dipho-
sphoryl lipid substrate present in our reaction. Nonetheless,
our in vivo and in vitro data strongly suggest that the LCP
family of proteins is the missing enzyme that catalyse the
linkage of teichoic acids and other acidic/APs to PG.
Discussion
LCP proteins are phosphotransferases
Studying the final step of bacterial cell wall synthesis, the
attachment of TA to PG, has been proven very challenging to
multiple laboratories for several reasons: (i) the substrates
have highly complex, heterogeneous structures that are not
commercially available, (ii) the precise identity of the PG
acceptor (precursor, nascent chain, or cross-linked polymer)
is not known, and (iii) the reaction is catalysed at the
Figure 6 The biochemical properties of LCP proteins. (A) Growth
of strains YK1254 (wild-type GFP-TagU), YK1365 (D75A), YK1366
(R83A), YK1367 (D85A), YK1368 (T86F), and YK1369 (T197F) on
NA plates with 0.5 mM IPTG or 0.5% xylose. Western blot analysis
of GFP-TagU levels in strain expressing wild-type and various mutant
GFP-TagU fusions with or without (No) 0.5% xylose indicate correct
accumulation of the proteins and consequently mutations D75A,
R83A, D85A, T86F, and T197F in TagU are unable to sustain growth
in the absence of wild-type copy of tagT, tagU, and tagV. (B) Metal
binding by DTM-Cps2A. Crystals of Cps2A soaked in manganese
show a clear peak in an anomalous difference map calculated
for data collected at the manganese K-edge (orange mesh). Metal
coordinating residues are shown as ball and stick representations,
with the position of R267A shown with blue carbons. (C) Incubation
of DTM-CPS2A–octaprenyl-pyrophosphate complex with magnesium
releases inorganic phosphate. Addition of EDTA, or mutation to alanine
of aspartate 234, which coordinates the catalytic magnesium ion, both
suppress release of inorganic phosphate. Bar length is proportional to
the wild-type experiment with Mg2þ present (76.31±2.9mM released
with Mg2þ present versus 20.60±1.26mM released with EDTA present;
3.38±0.68 released by D234A). (D) Pyrophosphatase activity of
DTM-TagT. A purified DTM-TagT protein catalyses hydrolysis of the
pyrophosphate bond in exogenously added geranyl pyrophosphate
(ger-PP) to generate geranyl monophosphate (ger-P), monitored by
thin layer chromatography. Parallel incubations with the unrelated
protein, EzrA (purified using the same procedures as the LCP
proteins herein) and DTM-Cps2A reveal no pyrophosphatase activ-
ity towards exogenous ger-PP; in the latter case, this can be
attributed to the blockage of the active site by endogenous opr-PP
lipid. Hydrolysis is magnesium dependent, but is not affected by
the addition of the PG fragment, N-acetylmuramyl dipeptide (MDP).
(E) Electrostatic protein surface of the LCP domain of DTM-Cps2A,
with bound octaprenyl-pyrophosphate ligand. The scissile bond in
the phosphotransferase reaction catalysed by this enzyme class
is shown with an arrow. The potential pathway for AP binding is
highlighted in blue, semi-transparent rod (labelled AP), and the
likely position of PG, to which the phosphorylated AP will be
transferred, is shown with the green rod (labelled PG).
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cytoplasmic membrane by integral membrane proteins and
is likely linked to membrane transport of the precursors.
Although we could not reconstitute this complex system
in vitro, in this paper, we present data that, in combination,
strongly suggest that members of the LCP family of proteins
are the long searched for enzymes that attach APs to cell wall
PG. This conclusion is based on the following observations:
(i) the TagTUV paralogues have a role in a late step WTA
synthesis in B. subtilis as shown by genetics and by measure-
ments of the WTA content of a triple mutant strain; (ii) the
cocrystal structures of S. pneumoniae Cps2A containing
bound substrate and product analogues that are consistent
with the missing enzymatic step; (iii) our demonstration that
TagT and Cps2A can both produce a monophosphorylated
lipid from a diphosphorylated substrate in a Mg2þ -dependent
fashion; (iv) the observation of a Mg2þ ion in a location
indicating a role in phosphorolysis; and (v) mutation of key
amino acids in lipid and Mg2þ binding blocks the in vitro
phosphorolysis and abolishes function in vivo. Consistent
with this conclusion, LCP genes found in AP-containing
Gram-positive bacteria are always located in close proximity,
often in the same operon, to genes required for AP synthesis.
Furthermore, mutants lacking members of the LCP family
have been isolated in a number of different bacteria, and in
many cases, these mutants have altered cell wall structures,
autolysin activities, lower antibiotic resistance levels and/or
reduced virulence (Hu¨bscher et al, 2008, 2009). Because of
these pleiotropic effects, some members of the family were
suggested to have a regulatory role in cell wall growth, and
the situation is complicated further by the presence in
S. aureus of a transcriptional activator named LytR that shows
no sequence similarity to LCP proteins (Brunskill and Bayles,
1996). The short cytoplasmic regions of a Cps2A homologue
from Streptococcus iniae were shown to bind DNA in vitro
(Hanson et al, 2011). In addition, early work on the B. subtilis
lytR gene suggested a role in transcriptional regulation be-
cause disruption of lytR resulted in increased transcription of
both lytR and the adjacent lytABC operon (Lazarevic et al,
1992). However, our work does not support a regulatory role
for the LCP proteins. Presumably, many of the published
phenotypes of LCP mutant strains of the various species
studied are indirect consequences of major cell wall altera-
tions and the resulting stress response due to failure of the
attachment of APs to PG.
We were unable to detect free APs in the supernatant of the
triple tagTUV depletion strain (RAD, unpublished data).
Indeed, several previous reports have documented a reduc-
tion of cell wall-attached APs in LCP mutants of various
bacterial species (Massidda et al, 1996; Cieslewicz et al, 2001;
Morona et al, 2006; Hu¨bscher et al, 2009). It seems possible
that feedback regulation blocks the synthesis and or export of
APs when the attachment to PG is impaired.
Implications for the phosphotransferase mechanism
catalysed by LCP proteins
The LCP proteins presumably attach teichoic acid, teichuro-
nic acid, or acidic capsular polysaccharide to cell wall PG via
phosphodiester linkage to N-acteylmuramic acid. Our data on
the three B. subtilis homologues indicate that the enzymes
are not absolutely specific for the type of AP, teichoic acid, or
teichuronic acid they attach, because a major phenotype does
not emerge until all three genes are inactivated. This is
supported by our crystal structures of Cps2A in complex
with reaction product and substrate mimics, which indicate
that the enzymes interact strongly with the pyrophosphoryl-
lipid component of the AP precursor. There is space in the
crystal structure beyond the terminal phosphate of the bound
opr-PP to accommodate the oligosaccharide moiety that links
the lipid to the acidic/AP component. Important interactions
with the sugar that is linked directly to the pyrophosphate
might occur from the conserved arginine pair, Arg362 and
Arg244 of Cps2A. The first two carbohydrate residues of the
AP, called the linkage unit, would project into a cleft on the
surface of DTM-Cps2A (Figure 6E) and the rest of the poly-
meric, main chain component of the AP precursor is unlikely
to interact with the protein. Thus, teichoic/teichuronic acid-
attaching enzymes would only recognize the linkage unit of
the precursor and not the main chain explaining the lack of
specificity of the Bacillus enzymes. The PG polymer could be
accommodated in the groove above b-strands 18 and 19
(Figure 6E). While we have been able to demonstrate the
phosphorolysis of the scissile bond in a substrate mimic, we
have not been able to detect phosphotransfer to a PG accep-
tor. Perhaps, the carbohydrate linkage unit participates in
catalysis, by interacting with conserved arginines. If interac-
tions between the linkage unit of AP and protein atoms of the
LCP enzyme are crucial to the biochemical reaction, it would
help to explain why phosphotransfer efficiency is poor with
just a phosphate anion as a leaving group; after all, the
reaction trajectories for phosphate monoesters differ funda-
mentally from those of phosphate di- and tri-esters (Cleland
and Hengge, 2006).
The crystal structures provide several clues towards the
likely catalytic mechanism. First, Mg2þ appears to be an
essential catalytic requirement. The divalent cation and the
presence of several conserved arginines (e.g. Arg244, Arg267,
and Arg362; Figure 5) may contribute to catalysis by stabiliz-
ing the transition state by the neutralization of the developing
negative charge. Second, there is no obvious amino acid to
act as a base in the activation of the incoming nucleophile.
There are two acidic groups close to the scissile bond, but
both these, Asp234 and Asp246, coordinate the bound mag-
nesium. The coordination of the cation by these two acidic
amino acids, and the interaction of phosphate groups with
neighbouring positively charged amino acids, is reminiscent
of the reaction scheme catalysed by acyl carrier protein (ACP)
synthase (Bunkoczi et al, 2007). That residues Glu181 and
Lys185 participate in general acid and base catalysis in ACP
synthase were confirmed by mutagenesis. Possible functional
equivalents in Cps2A are Asp234, demonstrated herein to be
a crucial amino acid for LCP function, and Arg362, one of
several conserved positively charged residues coordinating
the pyrophosphate. An alternative candidate to act as the
catalytic base is the conserved Asp268, but this is about 5 A˚
away from the likely position of the incoming nucleophile.
Significant conformational changes would be needed to
locate this amino acid in a position to extract a proton from
phosphotransfer acceptor. Other phosphotransfer reactions
do, however, take place without the need for a classic general
acid/base pair (Cleland and Hengge, 2006). Finally, the metal
ion itself may activate the nucleophilic hydroxyl moiety
(Lassila et al, 2011) as the phosphoacceptor approaches the
active site in order to provide the necessary rate enhancement
expected of an enzyme.
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We have been unable to visualize the interactions of PG
and AP building blocks with the protein, primarily because of
the unavailability of some complex substrate components,
but also because the active site of Cps2A is already blocked
with lipids. It remains to be shown how the lipid is loaded
and released from the protein in vivo. Perhaps, the phospho-
lipids of the cell membrane can passively empty the enzyme
active site without recourse to another protein. Alternatively,
the product of the transfer reaction, a monophosphorylated
polyisoprenoid lipid might be actively removed from the
active site, by an as yet unidentified protein, to be ‘flipped’
back across the membrane to its inner face so that the
phospholipid can be recharged by the cytoplasmic Tag path-
way for the enzyme to perform another round of phospho-
transfer.
Fungi and plants also covalently attach polysaccharides
and other polymers to the primary cell wall but the enzymes
catalysing the attachment are not yet known, nor are the
mechanisms of spatiotemporal regulation of these processes
understood (McNeil et al, 1984; Latge, 2007). Thus, our work
could stimulate further studies of the assembly of complex
cell walls in other organisms.
Global role of the MreB cytoskeleton in coordinating
synthesis and assembly of a range of different cell wall
polymers
Synthesis of both PG and WTA is concentrated at a central
growth zone in S. pnuemoniae (Tomasz et al, 1975), a
bacterium that does not contain an MreB cytoskeleton. The
discovery of the TagTUV proteins, other WTA proteins, and
PG synthetic enzymes in association with the three MreB
proteins reinforces the idea that in rod-shaped bacteria, the
cytoskeleton orchestrates the activity of not just the PG-
synthesizing machinery but also a range of other cell wall
components. In support of this idea, several enzymes of both
the PG and WTA synthetic machineries have a pattern of
localization that appears similar to that of the MreB proteins
(Scheffers et al, 2004; Claessen et al, 2008; Formstone et al,
2008) (Supplementary Figure S2). Close association of the
PG- and WTA-synthesizing machineries with the MreB
proteins could provide a means of coordinating the insertion
of WTA with the deposition of PG. Therefore, these results
lend strong support to the emerging picture that the MreB
cytoskeleton plays a pivotal role in organizing and coordi-
nating the different elements of cell envelope morphogenesis
in bacteria.
A novel antibiotic target
Several authors have speculated about the WTA biosynthetic
pathway as a potential antibiotic target (for a review, see
Swoboda et al, 2010). Indeed, Swoboda et al (2009) have
used a cell-based screen to identify a specific inhibitor of
the WTA pathway in S. aureus, which was shown to work
on the ABC transporter orthologous to TarG in B. subtilis.
Since the active site of the putative transferase lies
outside the cytoplasmic membrane, potential antibiotics
targeted on this enzyme would have the advantage of not
needing to cross the cytoplasmic membrane. This external
location is one of the reasons why b-lactams, targeting
the penicillin-binding proteins, have been so successful.
Our discovery of the transferase responsible for transfer of
nascent WTA to the PG, together with structural information
on the substrate and clues to the likely catalytic mechanism,
provides a highly attractive new target for drug discovery
programmes.
Materials and methods
Complete details of all the materials and methods used are provided
in the Supplementary data.
Bacterial strains, plasmids, and primers
Strains and plasmids used in this study are listed in Supplementary
Table SIV and primers are listed in Supplementary Table SV. The
construction of plasmids is described in the Supplementary data.
Media
Cultures of Bacillus strains were grown in Luria–Bertani (LB) or
Difco antibiotic medium 3 (PAB) liquid at 30 or 37 1C, or on LB or
nutrient agar (Oxoid) plates at 37 1C, with appropriate supplements
when necessary.
Microscopic imaging
For fluorescence microscopy, cells from overnight cultures were
diluted into fresh PAB medium and grown to mid-exponential phase
at 30 1C. For live cell imaging, cells were mounted on microscope
slides covered with a thin film of 1.2% agarose in water, essentially
as described previously (Glaser et al, 1997). Images were acquired
with a Sony Cool-Snap HQ cooled CCD camera attached to a Zeiss
Axiovert 200 M microscope. The images were acquired and
analysed with METAMORPH version 6 (Molecular Devices).
Purification of protein complexes
Proteins that copurified from liquid cultures of B. subtilis expressing
MreB-, Mbl-, or MreBH-His were purified as described previously
(Ishikawa et al, 2006; Kawai et al, 2009b). After separation by
electrophoresis, polyacrylamide gels were divided into slices, and
the presence of proteins confirmed by peptide-mass fingerprinting
as described previously (Kuwana et al, 2002). As a negative control,
cells expressing His-tagged Noc, a chromosome-associated negative
regulator of cell division (Wu et al, 2009), were also analysed.
Several proteins were simultaneously identified in both MreB and
Noc complexes (e.g. TufA and ribosomal proteins), suggesting that
they represent a non-specific background.
Extraction of cell wall material
B. subtilis cell cultures were grown in LB to late exponential
phase (OD600¼ 0.7). The cells were harvested, suspended in
water, and then immediately added to 10 volumes of 4% SDS at
100 1C. After 20 min incubation, the cell wall material was washed
with water 10 times, to remove the SDS. The resultant crude prepa-
ration was then suspended in 0.5% NaCl and broken using a bead
beater (Bio101 unit at max power for 30 s). After removing the
glass beads, the suspension was sedimented by centrifugation,
and then washed with water 10 times. The cell wall material was
freeze dried in preweighed tubes and to each tube an appropriate
amount of water was added to equalize the concentration in each
sample. Organic phosphorous was assayed as described previously
(Harwood et al, 1990).
Electrophoresis of teichoic acids
Purified cell wall samples were treated with 1 M HCl for 20 min at
65 1C and then neutralized with NaOH. Glycerol was added to each
hydrolysed sample to give a final concentration of 5%, along with
bromophenol blue (0.001% final concentration). Samples were
electrophoresed at 10 V/cm on a 12% polyacrylamide gel made in
1.2 TBE buffer. The gel was stained with Alcian Blue, followed by
silver staining, as described previously (Wolters et al, 1990).
Protein expression and purification for crystallization
Recombinant DTM-Cps2A (residues 98–481, with a C-terminal
hexahistidine tag) was produced in the methionine auxotroph B834
(DE3) strain of E. coli. Cells were grown in LB media to an OD600 of
0.4 and induced with 1 mM IPTG for 18 h at 16 1C for native protein,
or in minimal medium supplemented with selenomethionine for the
seleno-labelled protein. Recombinant protein was purified as
described in the Supplementary data.
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Crystallization, structure determination, and refinement of
DTM-Cps2A
Crystals of DTM-Cps2A were obtained by sparse-matrix screening
from purified protein at 28 mg/ml. Diffraction data, collected at the
Diamond Light Source were processed with MOSFLM (Leslie, 2006)
and scaled with SCALA (Evans, 2006). The structure was solved
using SHELX (Sheldrick, 2010) within HKL2MAP (Pape and
Schneider, 2004); initial model building was performed using
ARP/wARP (Langer et al, 2008). Refinement proceeded with cycles
of automated refinement in PHENIX (Adams et al, 2010) and
manual rebuilding in COOT (Emsley et al, 2010). Details of the
diffraction data and refined models are reported in Supplementary
Table SII.
Mass spectroscopy of DTM-Cps2A
Mass spectroscopy of DTM-Cps2A was performed on a Waters LCT
Premier XE, using electrospray ionization in both native and
denatured states.
Accession codes
Atomic co-ordinates and native structure factors have been
deposited at the PDB for the wild type complexes with dpr-P, opr-
PP and opr-PP/magnesium and for the R267A mutant of DTM-
Cps2A in complex with opr-PP and manganese with respective
accession codes 2xxp, 3tfl, 3tep and 3tel.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
Acknowledgements
This work was supported by a grant from the UK Biotechnology
and Biological Sciences Research Council to JE, RAD, WV, and RJL.
We thank the various group members for helpful discussions,
and particularly Leendert Hamoen, Susan Firbank, and Romain
Mercier for critical reading of the manuscript and Alice Eberhardt
for help with cloning of cps2A. We also thank Hiroki Yamamoto,
Junichi Sekiguchi, Mark Leaver, and Takuya Morimoto for the gift
of strains, and Didier Blanot for gift of undecaprenyl phosphate
standard, and Dan Herschlag for communicating a preprint of his
review before publication. We also acknowledge the Diamond Light
Source for access to its beamlines, the beamline staff and Arnaud
Basle´ for support during diffraction data collection. We also thank
Adam Dowle, Andrew Leech, and Berni Strongitharm of the York
University Technology Facility for mass spectroscopic analyses.
The authors extend their condolences to the family of Berni
Strongitharm, who sadly passed away in May 2011.
Author contributions: RE, SI, MK, NH, NKB, and CNH performed
the experiments. YK, JM-W, and RMC designed and performed the
experiments, analysed the data, and contributed to the drafting of
the paper. NO contributed to the design of the experiments. RJL,
WV, RAD, and JE contributed to the planning of the experiments,
interpretation of data, and drafting of the paper.
Conflict of interest
The authors declare that they have no conflict of interest.
References
Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N,
Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ,
Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS,
Terwilliger TC, Zwart PH (2010) PHENIX: a comprehensive
Python-based system for macromolecular structure solution.
Acta Crystallogr D Biol Crystallogr 66: 213–221
Atilano ML, Pereira PM, Yates J, Reed P, Veiga H, Pinho MG, Filipe
SR (2010) Teichoic acids are temporal and spatial regulators of
peptidoglycan cross-linking in Staphylococcus aureus. Proc Natl
Acad Sci USA 107: 18991–18996
Bhavsar AP, Erdman LK, Schertzer JW, Brown ED (2004)
Teichoic acid is an essential polymer in Bacillus subtilis that
is functionally distinct from teichuronic acid. J Bacteriol 186:
7865–7873
Bouhss A, Trunkfield AE, Bugg TD, Mengin-Lecreulx D (2008)
The biosynthesis of peptidoglycan lipid-linked intermediates.
FEMS Microbiol Rev 32: 208–233
Brown S, Zhang YH, Walker S (2008) A revised pathway proposed
for Staphylococcus aureus wall teichoic acid biosynthesis based
on in vitro reconstitution of the intracellular steps. Chem Biol 15:
12–21
Brunskill EW, Bayles KW (1996) Identification and molecular
characterization of a putative regulatory locus that affects auto-
lysis in Staphylococcus aureus. J Bacteriol 178: 611–618
Bunkoczi G, Pasta S, Joshi A, Wu X, Kavanagh KL, Smith S,
Oppermann U (2007) Mechanism and substrate recognition of
human holo ACP synthase. Chem Biol 14: 1243–1253
Carballido-Lopez R, Formstone A, Li Y, Ehrlich SD, Noirot P,
Errington J (2006) Actin homolog MreBH governs cell morpho-
genesis by localization of the cell wall hydrolase LytE. Dev Cell 11:
399–409
Cieslewicz MJ, Kasper DL, Wang Y, Wessels MR (2001) Functional
analysis in type Ia group B Streptococcus of a cluster of genes
involved in extracellular polysaccharide production by diverse
species of streptococci. J Biol Chem 276: 139–146
Claessen D, Emmins R, Hamoen LW, Daniel RA, Errington J,
Edwards DH (2008) Control of the cell elongation-division cycle
by shuttling of PBP1 protein in Bacillus subtilis. Mol Microbiol 68:
1029–1046
Cleland WW, Hengge AC (2006) Enzymatic mechanisms of phos-
phate and sulfate transfer. Chem Rev 106: 3252–3278
D’Elia MA, Henderson JA, Beveridge TJ, Heinrichs DE, Brown ED
(2009) The N-acetylmannosamine transferase catalyzes the first
committed step of teichoic acid assembly in Bacillus subtilis and
Staphylococcus aureus. J Bacteriol 191: 4030–4034
D’Elia MA, Millar KE, Beveridge TJ, Brown ED (2006a) Wall teichoic
acid polymers are dispensable for cell viability in Bacillus subtilis.
J Bacteriol 188: 8313–8316
D’Elia MA, Pereira MP, Chung YS, Zhao W, Chau A, Kenney TJ,
Sulavik MC, Black TA, Brown ED (2006b) Lesions in teichoic acid
biosynthesis in Staphylococcus aureus lead to a lethal gain of
function in the otherwise dispensable pathway. J Bacteriol 188:
4183–4189
Daniel RA, Errington J (2003) Control of cell morphogenesis in
bacteria: two distinct ways to make a rod-shaped cell. Cell 113:
767–776
Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and
development of Coot. Acta Crystallogr D Biol Crystallogr 66:
486–501
Evans P (2006) Scaling and assessment of data quality. Acta
Crystallogr D Biol Crystallogr 62: 72–82
Figge RM, Divakaruni AV, Gober JW (2004) MreB, the cell shape-
determining bacterial actin homologue, co-ordinates cell wall
morphogenesis in Caulobacter crescentus. Mol Microbiol 51:
1321–1332
Formstone A, Carballido-Lopez R, Noirot P, Errington J,
Scheffers DJ (2008) Localization and interactions of teichoic
acid synthetic enzymes in Bacillus subtilis. J Bacteriol 190:
1812–1821
Formstone A, Errington J (2005) A magnesium-dependent mreB
null mutant: implications for the role of mreB in Bacillus subtilis.
Mol Microbiol 55: 1646–1657
Foster SJ, Popham DL (2002) Structure and synthesis of cell wall,
spore cortex, teichoic acids, S-layers, and capsules. In Bacillus
subtilis and Its Closest Relatives: From Genes to Cells, Sonenshein
L, Losick R, Hoch JA (eds) pp 21–41. Washington, DC: American
Society for Microbiology
Glaser P, Sharpe ME, Raether B, Perego M, Ohlsen K, Errington J
(1997) Dynamic, mitotic-like behavior of a bacterial protein
required for accurate chromosome partitioning. Genes Dev 11:
1160–1168
Graumann PL (2009) Dynamics of bacterial cytoskeletal elements.
Cell Motil Cytoskeleton 66: 909–914
Hanson BR, Lowe BA, Neely MN (2011) Membrane topology and
DNA-binding ability of the Streptococcal CpsA protein. J Bacteriol
193: 411–420
Bacterial cell wall assembly proteins
Y Kawai et al
The EMBO Journal VOL 30 | NO 24 | 2011 &2011 European Molecular Biology Organization4940
Harwood CR, Coxon RD, Hancock IC (1990) The Bacillus cell
envelope and secrition. In Molecular Biology Methods for
Bacillus, Harwood CR, Cutting SM (eds) pp 328–369. New York
City: John Wiley & Sons Ltd
Henriques AO, Glaser P, Piggot PJ, Moran Jr CP (1998) Control of
cell shape and elongation by the rodA gene in Bacillus subtilis.
Mol Microbiol 28: 235–247
Hu B, Yang G, Zhao W, Zhang Y, Zhao J (2007) MreB is important
for cell shape but not for chromosome segregation of the fila-
mentous cyanobacterium Anabaena sp. PCC 7120. Mol Microbiol
63: 1640–1652
Hu¨bscher J, Luthy L, Berger-Bachi B, Stutzmann Meier P (2008)
Phylogenetic distribution and membrane topology of the LytR-
CpsA-Psr protein family. BMC Genomics 9: 617
Hu¨bscher J, McCallum N, Sifri CD, Majcherczyk PA, Entenza JM,
Heusser R, Berger-Bachi B, Stutzmann Meier P (2009) MsrR
contributes to cell surface characteristics and virulence in
Staphylococcus aureus. FEMS Microbiol Lett 295: 251–260
Ishikawa S, Kawai Y, Hiramatsu K, Kuwano M, Ogasawara N (2006)
A new FtsZ-interacting protein, YlmF, complements the activity of
FtsA during progression of cell division in Bacillus subtilis. Mol
Microbiol 60: 1364–1380
Jones LJ, Carballido-Lopez R, Errington J (2001) Control of cell
shape in bacteria: helical, actin-like filaments in Bacillus subtilis.
Cell 104: 913–922
Kawai Y, Asai K, Errington J (2009a) Partial functional redundancy
of MreB isoforms, MreB, Mbl and MreBH, in cell morphogenesis
of Bacillus subtilis. Mol Microbiol 73: 719–731
Kawai Y, Daniel RA, Errington J (2009b) Regulation of cell wall
morphogenesis in Bacillus subtilis by recruitment of PBP1 to the
MreB helix. Mol Microbiol 71: 1131–1144
Kruse T, Bork-Jensen J, Gerdes K (2005) The morphogenetic
MreBCD proteins of Escherichia coli form an essential mem-
brane-bound complex. Mol Microbiol 55: 78–89
Kuwana R, Kasahara Y, Fujibayashi M, Takamatsu H, Ogasawara N,
Watabe K (2002) Proteomics characterization of novel spore
proteins of Bacillus subtilis. Microbiology 148: 3971–3982
Langer G, Cohen SX, Lamzin VS, Perrakis A (2008) Automated
macromolecular model building for X-ray crystallography using
ARP/wARP version 7. Nat Protoc 3: 1171–1179
Lassila JK, Zalatan JG, Herschlag DL (2011) Biological phosphoryl-
transfer reactions: understanding mechanism and catalysis. Annu
Rev Biochem 80: 669–702
Latge JP (2007) The cell wall: a carbohydrate armour for the fungal
cell. Mol Microbiol 66: 279–290
Lazarevic V, Karamata D (1995) The tagGH operon of Bacillus
subtilis 168 encodes a two-component ABC transporter involved
in the metabolism of two wall teichoic acids. Mol Microbiol 16:
345–355
Lazarevic V, Margot P, Soldo B, Karamata D (1992) Sequencing and
analysis of the Bacillus subtilis lytRABC divergon: a regulatory
unit encompassing the structural genes of the N-acetylmuramoyl-
L-alanine amidase and its modifier. J Gen Microbiol 138:
1949–1961
Leaver M, Errington J (2005) Roles for MreC and MreD proteins
in helical growth of the cylindrical cell wall in Bacillus subtilis.
Mol Microbiol 57: 1196–1209
Leslie AG (2006) The integration of macromolecular diffraction
data. Acta Crystallogr D Biol Crystallogr 62: 48–57
Massidda O, Kariyama R, Daneo-Moore L, Shockman GD (1996)
Evidence that the PBP 5 synthesis repressor (psr) of Enterococcus
hirae is also involved in the regulation of cell wall composition
and other cell wall-related properties. J Bacteriol 178: 5272–5278
McNeil M, Darvill AG, Fry SC, Albersheim P (1984) Structure and
function of the primary cell walls of plants. Annu Rev Biochem
53: 625–663
Morona JK, Morona R, Paton JC (2006) Attachment of capsular
polysaccharide to the cell wall of Streptococcus pneumoniae type
2 is required for invasive disease. Proc Natl Acad Sci USA 103:
8505–8510
Neuhaus FC, Baddiley J (2003) A continuum of anionic charge:
structures and functions of D-alanyl-teichoic acids in gram-posi-
tive bacteria. Microbiol Mol Biol Rev 67: 686–723
Pape T, Schneider TR (2004) HKL2MAP: a graphical user interface
for phasing with SHELX programs. J Appl Cryst 37: 843–844
Scheffers DJ, Jones LJ, Errington J (2004) Several distinct localiza-
tion patterns for penicillin-binding proteins in Bacillus subtilis.
Mol Microbiol 51: 749–764
Schirner K, Errington J (2009) The cell wall regulator sI specifically
suppresses the lethal phenotype of mbl mutants in Bacillus
subtilis. J Bacteriol 191: 1404–1413
Schirner K, Stone LK, Walker S (2011) ABC transporters required for
export of wall teichoic acids do not discriminate between differ-
ent main chain polymers. ACS Chem Biol 6: 407–412
Sheldrick GM (2010) Experimental phasing with SHELXC/D/E:
combining chain tracing with density modification. Acta
Crystallogr D Biol Crystallogr 66: 479–485
Slovak PM, Wadhams GH, Armitage JP (2005) Localization of MreB
in Rhodobacter sphaeroides under conditions causing changes in
cell shape and membrane structure. J Bacteriol 187: 54–64
Soldo B, Lazarevic V, Karamata D (2002) tagO is involved in the
synthesis of all anionic cell-wall polymers in Bacillus subtilis 168.
Microbiology 148: 2079–2087
Strahl H, Hamoen LW (2010) Membrane potential is important for
bacterial cell division. Proc Natl Acad Sci USA 107: 12281–12286
Swoboda JG, Campbell J, Meredith TC, Walker S (2010) Wall
teichoic acid function, biosynthesis, and inhibition.
Chembiochem 11: 35–45
Swoboda JG, Meredith TC, Campbell J, Brown S, Suzuki T,
Bollenbach T, Malhowski AJ, Kishony R, Gilmore MS, Walker S
(2009) Discovery of a small molecule that blocks wall teichoic
acid biosynthesis in Staphylococcus aureus. ACS Chem Biol 4:
875–883
Tomasz A, McDonnell M, Westphal M, Zanati E (1975) Coordinated
incorporation of nascent peptidoglycan and teichoic acid into
pneumococcal cell walls and conservation of peptidoglycan dur-
ing growth. J Biol Chem 250: 337–341
Vats P, Shih YL, Rothfield L (2009) Assembly of the MreB-associated
cytoskeletal ring of Escherichia coli. Mol Microbiol 72: 170–182
Wei Y, Havasy T, McPherson DC, Popham DL (2003) Rod shape
determination by the Bacillus subtilis class B penicillin-binding
proteins encoded by pbpA and pbpH. J Bacteriol 185: 4717–4726
Weidenmaier C, Peschel A (2008) Teichoic acids and related cell-
wall glycopolymers in Gram-positive physiology and host inter-
actions. Nat Rev Microbiol 6: 276–287
Wolters PJ, Hildebrandt KM, Dickie JP, Anderson JS (1990) Polymer
length of teichuronic acid released from cell walls of Micrococcus
luteus. J Bacteriol 172: 5154–5159
Wu LJ, Ishikawa S, Kawai Y, Oshima T, Ogasawara N, Errington J
(2009) Noc protein binds to specific DNA sequences to coordi-
nate cell division with chromosome segregation. EMBO J 28:
1940–1952
Yokoyama K, Mizuguchi H, Araki Y, Kaya S, Ito E (1989)
Biosynthesis of linkage units for teichoic acids in gram-positive
bacteria: distribution of related enzymes and their specificities
for UDP-sugars and lipid-linked intermediates. J Bacteriol 171:
940–946
Young M, Mauel C, Margot P, Karamata D (1989) Pseudo-allelic
relationship between non-homologous genes concerned with
biosynthesis of polyglycerol phosphate and polyribitol phos-
phate teichoic acids in Bacillus subtilis strains 168 and W23.
Mol Microbiol 3: 1805–1812
Bacterial cell wall assembly proteins
Y Kawai et al
&2011 European Molecular Biology Organization The EMBO Journal VOL 30 | NO 24 | 2011 4941
